id	sid	tid	token	lemma	pos
ajlm-2519	1	1	abstract	abstract	ADJ
ajlm-2519	1	2	introduction	introduction	NOUN
ajlm-2519	1	3	methods	method	NOUN
ajlm-2519	1	4	results	result	VERB
ajlm-2519	1	5	discussion	discussion	NOUN
ajlm-2519	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2519	1	7	references	reference	NOUN
ajlm-2519	1	8	about	about	ADP
ajlm-2519	1	9	the	the	DET
ajlm-2519	1	10	author(s	author(s	NOUN
ajlm-2519	1	11	)	)	PUNCT
ajlm-2519	1	12	tiyani	tiyani	PROPN
ajlm-2519	1	13	c.	c.	PROPN
ajlm-2519	1	14	mthombeni	mthombeni	PROPN
ajlm-2519	1	15	department	department	PROPN
ajlm-2519	1	16	of	of	ADP
ajlm-2519	1	17	medicine	medicine	NOUN
ajlm-2519	1	18	usage	usage	NOUN
ajlm-2519	1	19	in	in	ADP
ajlm-2519	1	20	south	south	PROPN
ajlm-2519	1	21	africa	africa	PROPN
ajlm-2519	1	22	(	(	PUNCT
ajlm-2519	1	23	musa	musa	PROPN
ajlm-2519	1	24	)	)	PUNCT
ajlm-2519	1	25	,	,	PUNCT
ajlm-2519	1	26	faculty	faculty	NOUN
ajlm-2519	1	27	of	of	ADP
ajlm-2519	1	28	health	health	NOUN
ajlm-2519	1	29	sciences	sciences	PROPN
ajlm-2519	1	30	,	,	PUNCT
ajlm-2519	1	31	north	north	NOUN
ajlm-2519	1	32	-	-	PUNCT
ajlm-2519	1	33	west	west	NOUN
ajlm-2519	1	34	university	university	NOUN
ajlm-2519	1	35	,	,	PUNCT
ajlm-2519	1	36	potchefstroom	potchefstroom	NOUN
ajlm-2519	1	37	,	,	PUNCT
ajlm-2519	1	38	south	south	PROPN
ajlm-2519	1	39	africa	africa	PROPN
ajlm-2519	1	40	johanita	johanita	PROPN
ajlm-2519	1	41	r.	r.	PROPN
ajlm-2519	1	42	burger	burger	PROPN
ajlm-2519	1	43	department	department	PROPN
ajlm-2519	1	44	of	of	ADP
ajlm-2519	1	45	medicine	medicine	NOUN
ajlm-2519	1	46	usage	usage	NOUN
ajlm-2519	1	47	in	in	ADP
ajlm-2519	1	48	south	south	PROPN
ajlm-2519	1	49	africa	africa	PROPN
ajlm-2519	1	50	(	(	PUNCT
ajlm-2519	1	51	musa	musa	PROPN
ajlm-2519	1	52	)	)	PUNCT
ajlm-2519	1	53	,	,	PUNCT
ajlm-2519	1	54	faculty	faculty	NOUN
ajlm-2519	1	55	of	of	ADP
ajlm-2519	1	56	health	health	NOUN
ajlm-2519	1	57	sciences	sciences	PROPN
ajlm-2519	1	58	,	,	PUNCT
ajlm-2519	1	59	north	north	NOUN
ajlm-2519	1	60	-	-	PUNCT
ajlm-2519	1	61	west	west	NOUN
ajlm-2519	1	62	university	university	NOUN
ajlm-2519	1	63	,	,	PUNCT
ajlm-2519	1	64	potchefstroom	potchefstroom	NOUN
ajlm-2519	1	65	,	,	PUNCT
ajlm-2519	1	66	south	south	PROPN
ajlm-2519	1	67	africa	africa	PROPN
ajlm-2519	1	68	martha	martha	PROPN
ajlm-2519	1	69	s.	s.	PROPN
ajlm-2519	1	70	lubbe	lubbe	PROPN
ajlm-2519	1	71	department	department	PROPN
ajlm-2519	1	72	of	of	ADP
ajlm-2519	1	73	medicine	medicine	NOUN
ajlm-2519	1	74	usage	usage	NOUN
ajlm-2519	1	75	in	in	ADP
ajlm-2519	1	76	south	south	PROPN
ajlm-2519	1	77	africa	africa	PROPN
ajlm-2519	1	78	(	(	PUNCT
ajlm-2519	1	79	musa	musa	PROPN
ajlm-2519	1	80	)	)	PUNCT
ajlm-2519	1	81	,	,	PUNCT
ajlm-2519	1	82	faculty	faculty	NOUN
ajlm-2519	1	83	of	of	ADP
ajlm-2519	1	84	health	health	NOUN
ajlm-2519	1	85	sciences	sciences	PROPN
ajlm-2519	1	86	,	,	PUNCT
ajlm-2519	1	87	north	north	NOUN
ajlm-2519	1	88	-	-	PUNCT
ajlm-2519	1	89	west	west	NOUN
ajlm-2519	1	90	university	university	NOUN
ajlm-2519	1	91	,	,	PUNCT
ajlm-2519	1	92	potchefstroom	potchefstroom	NOUN
ajlm-2519	1	93	,	,	PUNCT
ajlm-2519	1	94	south	south	PROPN
ajlm-2519	1	95	africa	africa	PROPN
ajlm-2519	1	96	marlene	marlene	PROPN
ajlm-2519	1	97	julyan	julyan	PROPN
ajlm-2519	1	98	department	department	PROPN
ajlm-2519	1	99	of	of	ADP
ajlm-2519	1	100	medicine	medicine	NOUN
ajlm-2519	1	101	usage	usage	NOUN
ajlm-2519	1	102	in	in	ADP
ajlm-2519	1	103	south	south	PROPN
ajlm-2519	1	104	africa	africa	PROPN
ajlm-2519	1	105	(	(	PUNCT
ajlm-2519	1	106	musa	musa	PROPN
ajlm-2519	1	107	)	)	PUNCT
ajlm-2519	1	108	,	,	PUNCT
ajlm-2519	1	109	faculty	faculty	NOUN
ajlm-2519	1	110	of	of	ADP
ajlm-2519	1	111	health	health	NOUN
ajlm-2519	1	112	sciences	sciences	PROPN
ajlm-2519	1	113	,	,	PUNCT
ajlm-2519	1	114	north	north	NOUN
ajlm-2519	1	115	-	-	PUNCT
ajlm-2519	1	116	west	west	NOUN
ajlm-2519	1	117	university	university	NOUN
ajlm-2519	1	118	,	,	PUNCT
ajlm-2519	1	119	potchefstroom	potchefstroom	NOUN
ajlm-2519	1	120	,	,	PUNCT
ajlm-2519	1	121	south	south	PROPN
ajlm-2519	1	122	africa	africa	PROPN
ajlm-2519	1	123	molebogeng	molebogeng	PROPN
ajlm-2519	1	124	r.	r.	PROPN
ajlm-2519	1	125	lekalakala	lekalakala	PROPN
ajlm-2519	1	126	-	-	PUNCT
ajlm-2519	1	127	mokaba	mokaba	PROPN
ajlm-2519	1	128	division	division	NOUN
ajlm-2519	1	129	of	of	ADP
ajlm-2519	1	130	medical	medical	ADJ
ajlm-2519	1	131	microbiology	microbiology	NOUN
ajlm-2519	1	132	,	,	PUNCT
ajlm-2519	1	133	department	department	NOUN
ajlm-2519	1	134	of	of	ADP
ajlm-2519	1	135	pathology	pathology	PROPN
ajlm-2519	1	136	,	,	PUNCT
ajlm-2519	1	137	faculty	faculty	NOUN
ajlm-2519	1	138	of	of	ADP
ajlm-2519	1	139	health	health	NOUN
ajlm-2519	1	140	sciences	sciences	PROPN
ajlm-2519	1	141	,	,	PUNCT
ajlm-2519	1	142	university	university	NOUN
ajlm-2519	1	143	of	of	ADP
ajlm-2519	1	144	limpopo	limpopo	PROPN
ajlm-2519	1	145	,	,	PUNCT
ajlm-2519	1	146	polokwane	polokwane	PROPN
ajlm-2519	1	147	,	,	PUNCT
ajlm-2519	1	148	south	south	PROPN
ajlm-2519	1	149	africa	africa	PROPN
ajlm-2519	1	150	polokwane	polokwane	PROPN
ajlm-2519	1	151	laboratory	laboratory	PROPN
ajlm-2519	1	152	,	,	PUNCT
ajlm-2519	1	153	national	national	PROPN
ajlm-2519	1	154	health	health	PROPN
ajlm-2519	1	155	laboratory	laboratory	PROPN
ajlm-2519	1	156	service	service	PROPN
ajlm-2519	1	157	,	,	PUNCT
ajlm-2519	1	158	polokwane	polokwane	PROPN
ajlm-2519	1	159	,	,	PUNCT
ajlm-2519	1	160	south	south	PROPN
ajlm-2519	1	161	africa	africa	PROPN
ajlm-2519	1	162	citation	citation	PROPN
ajlm-2519	1	163	mthombeni	mthombeni	PROPN
ajlm-2519	1	164	tc	tc	PROPN
ajlm-2519	1	165	,	,	PUNCT
ajlm-2519	1	166	burger	burger	PROPN
ajlm-2519	1	167	jr	jr	PROPN
ajlm-2519	1	168	,	,	PUNCT
ajlm-2519	1	169	lubbe	lubbe	PROPN
ajlm-2519	1	170	ms	ms	PROPN
ajlm-2519	1	171	,	,	PUNCT
ajlm-2519	1	172	julyan	julyan	PROPN
ajlm-2519	1	173	m	m	PROPN
ajlm-2519	1	174	,	,	PUNCT
ajlm-2519	1	175	lekalakala	lekalakala	NOUN
ajlm-2519	1	176	-	-	PUNCT
ajlm-2519	1	177	mokaba	mokaba	NOUN
ajlm-2519	1	178	mr	mr	PROPN
ajlm-2519	1	179	.	.	PROPN
ajlm-2519	1	180	eskape	eskape	NOUN
ajlm-2519	1	181	pathogen	pathogen	NOUN
ajlm-2519	1	182	incidence	incidence	NOUN
ajlm-2519	1	183	and	and	CCONJ
ajlm-2519	1	184	antibiotic	antibiotic	ADJ
ajlm-2519	1	185	resistance	resistance	NOUN
ajlm-2519	1	186	in	in	ADP
ajlm-2519	1	187	patients	patient	NOUN
ajlm-2519	1	188	with	with	ADP
ajlm-2519	1	189	bloodstream	bloodstream	NOUN
ajlm-2519	1	190	infections	infection	NOUN
ajlm-2519	1	191	at	at	ADP
ajlm-2519	1	192	a	a	DET
ajlm-2519	1	193	referral	referral	ADJ
ajlm-2519	1	194	hospital	hospital	NOUN
ajlm-2519	1	195	in	in	ADP
ajlm-2519	1	196	limpopo	limpopo	PROPN
ajlm-2519	1	197	,	,	PUNCT
ajlm-2519	1	198	south	south	PROPN
ajlm-2519	1	199	africa	africa	PROPN
ajlm-2519	1	200	,	,	PUNCT
ajlm-2519	1	201	2014–2019	2014–2019	NUM
ajlm-2519	1	202	:	:	PUNCT
ajlm-2519	1	203	a	a	DET
ajlm-2519	1	204	cross	cross	ADJ
ajlm-2519	1	205	-	-	ADJ
ajlm-2519	1	206	sectional	sectional	ADJ
ajlm-2519	1	207	study	study	NOUN
ajlm-2519	1	208	.	.	PUNCT
ajlm-2519	2	1	afr	afr	PROPN
ajlm-2519	2	2	j	j	PROPN
ajlm-2519	2	3	lab	lab	PROPN
ajlm-2519	2	4	med	me	VERB
ajlm-2519	2	5	.	.	PUNCT
ajlm-2519	3	1	2024;13(1	2024;13(1	NUM
ajlm-2519	3	2	)	)	PUNCT
ajlm-2519	3	3	,	,	PUNCT
ajlm-2519	3	4	a2519	a2519	PROPN
ajlm-2519	3	5	.	.	PUNCT
ajlm-2519	3	6	https://doi.org/10.4102/ajlm.v13i1.2519	https://doi.org/10.4102/ajlm.v13i1.2519	NUM
ajlm-2519	3	7	note	note	NOUN
ajlm-2519	3	8	:	:	PUNCT
ajlm-2519	3	9	additional	additional	ADJ
ajlm-2519	3	10	supporting	support	VERB
ajlm-2519	3	11	information	information	NOUN
ajlm-2519	3	12	is	be	AUX
ajlm-2519	3	13	available	available	ADJ
ajlm-2519	3	14	for	for	ADP
ajlm-2519	3	15	download	download	NOUN
ajlm-2519	3	16	alongside	alongside	ADP
ajlm-2519	3	17	the	the	DET
ajlm-2519	3	18	online	online	ADJ
ajlm-2519	3	19	version	version	NOUN
ajlm-2519	3	20	of	of	ADP
ajlm-2519	3	21	this	this	DET
ajlm-2519	3	22	article	article	NOUN
ajlm-2519	3	23	as	as	ADP
ajlm-2519	3	24	online	online	ADJ
ajlm-2519	3	25	supplementary	supplementary	ADJ
ajlm-2519	3	26	materials	material	NOUN
ajlm-2519	3	27	.	.	PUNCT
ajlm-2519	4	1	original	original	ADJ
ajlm-2519	4	2	research	research	NOUN
ajlm-2519	4	3	eskape	eskape	NOUN
ajlm-2519	4	4	pathogen	pathogen	NOUN
ajlm-2519	4	5	incidence	incidence	NOUN
ajlm-2519	4	6	and	and	CCONJ
ajlm-2519	4	7	antibiotic	antibiotic	ADJ
ajlm-2519	4	8	resistance	resistance	NOUN
ajlm-2519	4	9	in	in	ADP
ajlm-2519	4	10	patients	patient	NOUN
ajlm-2519	4	11	with	with	ADP
ajlm-2519	4	12	bloodstream	bloodstream	NOUN
ajlm-2519	4	13	infections	infection	NOUN
ajlm-2519	4	14	at	at	ADP
ajlm-2519	4	15	a	a	DET
ajlm-2519	4	16	referral	referral	ADJ
ajlm-2519	4	17	hospital	hospital	NOUN
ajlm-2519	4	18	in	in	ADP
ajlm-2519	4	19	limpopo	limpopo	PROPN
ajlm-2519	4	20	,	,	PUNCT
ajlm-2519	4	21	south	south	PROPN
ajlm-2519	4	22	africa	africa	PROPN
ajlm-2519	4	23	,	,	PUNCT
ajlm-2519	4	24	2014–2019	2014–2019	NUM
ajlm-2519	4	25	:	:	PUNCT
ajlm-2519	4	26	a	a	DET
ajlm-2519	4	27	cross	cross	ADJ
ajlm-2519	4	28	-	-	ADJ
ajlm-2519	4	29	sectional	sectional	ADJ
ajlm-2519	4	30	study	study	NOUN
ajlm-2519	4	31	tiyani	tiyani	PROPN
ajlm-2519	4	32	c.	c.	PROPN
ajlm-2519	4	33	mthombeni	mthombeni	PROPN
ajlm-2519	4	34	,	,	PUNCT
ajlm-2519	4	35	johanita	johanita	PROPN
ajlm-2519	4	36	r.	r.	PROPN
ajlm-2519	4	37	burger	burger	PROPN
ajlm-2519	4	38	,	,	PUNCT
ajlm-2519	4	39	martha	martha	PROPN
ajlm-2519	4	40	s.	s.	PROPN
ajlm-2519	4	41	lubbe	lubbe	PROPN
ajlm-2519	4	42	,	,	PUNCT
ajlm-2519	4	43	marlene	marlene	PROPN
ajlm-2519	4	44	julyan	julyan	PROPN
ajlm-2519	4	45	,	,	PUNCT
ajlm-2519	4	46	molebogeng	molebogeng	PROPN
ajlm-2519	4	47	r.	r.	PROPN
ajlm-2519	4	48	lekalakala	lekalakala	PROPN
ajlm-2519	4	49	-	-	PUNCT
ajlm-2519	4	50	mokaba	mokaba	PROPN
ajlm-2519	4	51	received	receive	VERB
ajlm-2519	4	52	:	:	PUNCT
ajlm-2519	4	53	03	03	NUM
ajlm-2519	4	54	june	june	PROPN
ajlm-2519	4	55	2024	2024	NUM
ajlm-2519	4	56	;	;	PUNCT
ajlm-2519	4	57	accepted	accept	VERB
ajlm-2519	4	58	:	:	PUNCT
ajlm-2519	4	59	01	01	NUM
ajlm-2519	4	60	oct	oct	PROPN
ajlm-2519	4	61	.	.	PROPN
ajlm-2519	4	62	2024	2024	NUM
ajlm-2519	4	63	;	;	PUNCT
ajlm-2519	4	64	published	publish	VERB
ajlm-2519	4	65	:	:	PUNCT
ajlm-2519	4	66	29	29	NUM
ajlm-2519	4	67	nov	nov	NOUN
ajlm-2519	4	68	.	.	PROPN
ajlm-2519	4	69	2024	2024	NUM
ajlm-2519	4	70	copyright	copyright	NOUN
ajlm-2519	4	71	:	:	PUNCT
ajlm-2519	4	72	©	©	PROPN
ajlm-2519	4	73	2024	2024	NUM
ajlm-2519	4	74	.	.	PUNCT
ajlm-2519	5	1	the	the	DET
ajlm-2519	5	2	author(s	author(s	PROPN
ajlm-2519	5	3	)	)	PUNCT
ajlm-2519	5	4	.	.	PUNCT
ajlm-2519	6	1	licensee	licensee	NOUN
ajlm-2519	6	2	:	:	PUNCT
ajlm-2519	6	3	aosis	aosis	NOUN
ajlm-2519	6	4	.	.	PUNCT
ajlm-2519	7	1	this	this	PRON
ajlm-2519	7	2	is	be	AUX
ajlm-2519	7	3	an	an	DET
ajlm-2519	7	4	open	open	ADJ
ajlm-2519	7	5	access	access	NOUN
ajlm-2519	7	6	article	article	NOUN
ajlm-2519	7	7	distributed	distribute	VERB
ajlm-2519	7	8	under	under	ADP
ajlm-2519	7	9	the	the	DET
ajlm-2519	7	10	terms	term	NOUN
ajlm-2519	7	11	of	of	ADP
ajlm-2519	7	12	the	the	DET
ajlm-2519	7	13	creative	creative	ADJ
ajlm-2519	7	14	commons	common	NOUN
ajlm-2519	7	15	attribution	attribution	NOUN
ajlm-2519	7	16	license	license	NOUN
ajlm-2519	7	17	,	,	PUNCT
ajlm-2519	7	18	which	which	PRON
ajlm-2519	7	19	permits	permit	VERB
ajlm-2519	7	20	unrestricted	unrestricted	ADJ
ajlm-2519	7	21	use	use	NOUN
ajlm-2519	7	22	,	,	PUNCT
ajlm-2519	7	23	distribution	distribution	NOUN
ajlm-2519	7	24	,	,	PUNCT
ajlm-2519	7	25	and	and	CCONJ
ajlm-2519	7	26	reproduction	reproduction	NOUN
ajlm-2519	7	27	in	in	ADP
ajlm-2519	7	28	any	any	DET
ajlm-2519	7	29	medium	medium	NOUN
ajlm-2519	7	30	,	,	PUNCT
ajlm-2519	7	31	provided	provide	VERB
ajlm-2519	7	32	the	the	DET
ajlm-2519	7	33	original	original	ADJ
ajlm-2519	7	34	work	work	NOUN
ajlm-2519	7	35	is	be	AUX
ajlm-2519	7	36	properly	properly	ADV
ajlm-2519	7	37	cited	cite	VERB
ajlm-2519	7	38	.	.	PUNCT
ajlm-2519	8	1	abstract	abstract	ADJ
ajlm-2519	8	2	background	background	NOUN
ajlm-2519	8	3	:	:	PUNCT
ajlm-2519	8	4	there	there	PRON
ajlm-2519	8	5	is	be	VERB
ajlm-2519	8	6	a	a	DET
ajlm-2519	8	7	paucity	paucity	NOUN
ajlm-2519	8	8	of	of	ADP
ajlm-2519	8	9	research	research	NOUN
ajlm-2519	8	10	on	on	ADP
ajlm-2519	8	11	the	the	DET
ajlm-2519	8	12	incidence	incidence	NOUN
ajlm-2519	8	13	and	and	CCONJ
ajlm-2519	8	14	antimicrobial	antimicrobial	ADJ
ajlm-2519	8	15	resistance	resistance	NOUN
ajlm-2519	8	16	(	(	PUNCT
ajlm-2519	8	17	amr	amr	NOUN
ajlm-2519	8	18	)	)	PUNCT
ajlm-2519	8	19	of	of	ADP
ajlm-2519	8	20	enterococcus	enterococcus	NOUN
ajlm-2519	8	21	faecium	faecium	NOUN
ajlm-2519	8	22	,	,	PUNCT
ajlm-2519	8	23	staphylococcus	staphylococcus	NOUN
ajlm-2519	8	24	aureus	aureus	NOUN
ajlm-2519	8	25	,	,	PUNCT
ajlm-2519	8	26	klebsiella	klebsiella	PROPN
ajlm-2519	8	27	pneumoniae	pneumoniae	NOUN
ajlm-2519	8	28	,	,	PUNCT
ajlm-2519	8	29	acinetobacter	acinetobacter	ADV
ajlm-2519	8	30	baumannii	baumannii	PROPN
ajlm-2519	8	31	,	,	PUNCT
ajlm-2519	8	32	pseudomonas	pseudomona	NOUN
ajlm-2519	8	33	aeruginosa	aeruginosa	NOUN
ajlm-2519	8	34	,	,	PUNCT
ajlm-2519	8	35	and	and	CCONJ
ajlm-2519	8	36	enterobacter	enterobacter	ADJ
ajlm-2519	8	37	spp	spp	NOUN
ajlm-2519	8	38	.	.	PUNCT
ajlm-2519	9	1	(	(	PUNCT
ajlm-2519	9	2	eskape	eskape	NOUN
ajlm-2519	9	3	)	)	PUNCT
ajlm-2519	9	4	pathogens	pathogen	NOUN
ajlm-2519	9	5	in	in	ADP
ajlm-2519	9	6	africa	africa	PROPN
ajlm-2519	9	7	because	because	SCONJ
ajlm-2519	9	8	of	of	ADP
ajlm-2519	9	9	the	the	DET
ajlm-2519	9	10	inadequate	inadequate	ADJ
ajlm-2519	9	11	establishment	establishment	NOUN
ajlm-2519	9	12	of	of	ADP
ajlm-2519	9	13	amr	amr	ADJ
ajlm-2519	9	14	surveillance	surveillance	NOUN
ajlm-2519	9	15	systems	system	NOUN
ajlm-2519	9	16	.	.	PUNCT
ajlm-2519	10	1	objective	objective	NOUN
ajlm-2519	10	2	:	:	PUNCT
ajlm-2519	10	3	this	this	DET
ajlm-2519	10	4	study	study	NOUN
ajlm-2519	10	5	reports	report	VERB
ajlm-2519	10	6	on	on	ADP
ajlm-2519	10	7	the	the	DET
ajlm-2519	10	8	incidence	incidence	NOUN
ajlm-2519	10	9	and	and	CCONJ
ajlm-2519	10	10	amr	amr	NOUN
ajlm-2519	10	11	of	of	ADP
ajlm-2519	10	12	bloodstream	bloodstream	NOUN
ajlm-2519	10	13	eskape	eskape	NOUN
ajlm-2519	10	14	pathogens	pathogen	NOUN
ajlm-2519	10	15	at	at	ADP
ajlm-2519	10	16	a	a	DET
ajlm-2519	10	17	referral	referral	ADJ
ajlm-2519	10	18	hospital	hospital	NOUN
ajlm-2519	10	19	in	in	ADP
ajlm-2519	10	20	northern	northern	PROPN
ajlm-2519	10	21	south	south	PROPN
ajlm-2519	10	22	africa	africa	PROPN
ajlm-2519	10	23	.	.	PUNCT
ajlm-2519	11	1	methods	method	NOUN
ajlm-2519	11	2	:	:	PUNCT
ajlm-2519	11	3	this	this	DET
ajlm-2519	11	4	retrospective	retrospective	ADJ
ajlm-2519	11	5	descriptive	descriptive	ADJ
ajlm-2519	11	6	study	study	NOUN
ajlm-2519	11	7	used	use	VERB
ajlm-2519	11	8	routinely	routinely	ADV
ajlm-2519	11	9	collected	collect	VERB
ajlm-2519	11	10	bloodstream	bloodstream	NOUN
ajlm-2519	11	11	isolates	isolate	NOUN
ajlm-2519	11	12	(	(	PUNCT
ajlm-2519	11	13	pathogen	pathogen	NOUN
ajlm-2519	11	14	identification	identification	NOUN
ajlm-2519	11	15	and	and	CCONJ
ajlm-2519	11	16	antimicrobial	antimicrobial	ADJ
ajlm-2519	11	17	susceptibility	susceptibility	NOUN
ajlm-2519	11	18	testing	testing	NOUN
ajlm-2519	11	19	performed	perform	VERB
ajlm-2519	11	20	using	use	VERB
ajlm-2519	11	21	automated	automate	VERB
ajlm-2519	11	22	systems	system	NOUN
ajlm-2519	11	23	)	)	PUNCT
ajlm-2519	11	24	from	from	ADP
ajlm-2519	11	25	the	the	DET
ajlm-2519	11	26	south	south	ADJ
ajlm-2519	11	27	african	african	ADJ
ajlm-2519	11	28	national	national	PROPN
ajlm-2519	11	29	health	health	PROPN
ajlm-2519	11	30	laboratory	laboratory	PROPN
ajlm-2519	11	31	service	service	NOUN
ajlm-2519	11	32	,	,	PUNCT
ajlm-2519	11	33	from	from	ADP
ajlm-2519	11	34	january	january	PROPN
ajlm-2519	11	35	2014	2014	NUM
ajlm-2519	11	36	to	to	ADP
ajlm-2519	11	37	december	december	PROPN
ajlm-2519	11	38	2019	2019	NUM
ajlm-2519	11	39	.	.	PUNCT
ajlm-2519	12	1	resistant	resistant	ADJ
ajlm-2519	12	2	phenotypes	phenotype	NOUN
ajlm-2519	12	3	analysed	analyse	VERB
ajlm-2519	12	4	included	include	VERB
ajlm-2519	12	5	methicillin	methicillin	NOUN
ajlm-2519	12	6	-	-	PUNCT
ajlm-2519	12	7	resistant	resistant	ADJ
ajlm-2519	12	8	s.	s.	PROPN
ajlm-2519	12	9	aureus	aureus	PROPN
ajlm-2519	12	10	and	and	CCONJ
ajlm-2519	12	11	carbapenem	carbapenem	NOUN
ajlm-2519	12	12	-	-	PUNCT
ajlm-2519	12	13	resistant	resistant	ADJ
ajlm-2519	12	14	a.	a.	NOUN
ajlm-2519	12	15	baumannii	baumannii	PROPN
ajlm-2519	12	16	.	.	PUNCT
ajlm-2519	13	1	results	result	NOUN
ajlm-2519	13	2	:	:	PUNCT
ajlm-2519	13	3	the	the	DET
ajlm-2519	13	4	eskape	eskape	NOUN
ajlm-2519	13	5	pathogen	pathogen	NOUN
ajlm-2519	13	6	incidence	incidence	NOUN
ajlm-2519	13	7	rate	rate	NOUN
ajlm-2519	13	8	was	be	AUX
ajlm-2519	13	9	stable	stable	ADJ
ajlm-2519	13	10	from	from	ADP
ajlm-2519	13	11	2014	2014	NUM
ajlm-2519	13	12	to	to	ADP
ajlm-2519	13	13	2019	2019	NUM
ajlm-2519	13	14	(	(	PUNCT
ajlm-2519	13	15	p	p	X
ajlm-2519	13	16	=	=	NOUN
ajlm-2519	13	17	0.133	0.133	NUM
ajlm-2519	13	18	)	)	PUNCT
ajlm-2519	13	19	.	.	PUNCT
ajlm-2519	14	1	the	the	DET
ajlm-2519	14	2	most	most	ADV
ajlm-2519	14	3	isolated	isolated	ADJ
ajlm-2519	14	4	pathogens	pathogen	NOUN
ajlm-2519	14	5	were	be	AUX
ajlm-2519	14	6	s.	s.	PROPN
ajlm-2519	14	7	aureus	aureus	PROPN
ajlm-2519	14	8	(	(	PUNCT
ajlm-2519	14	9	268/746	268/746	PROPN
ajlm-2519	14	10	;	;	PUNCT
ajlm-2519	14	11	35.9	35.9	NUM
ajlm-2519	14	12	%	%	NOUN
ajlm-2519	14	13	)	)	PUNCT
ajlm-2519	14	14	and	and	CCONJ
ajlm-2519	14	15	a.	a.	NOUN
ajlm-2519	14	16	baumannii	baumannii	PROPN
ajlm-2519	14	17	(	(	PUNCT
ajlm-2519	14	18	200/746	200/746	NUM
ajlm-2519	14	19	;	;	PUNCT
ajlm-2519	14	20	26.8	26.8	NUM
ajlm-2519	14	21	%	%	NOUN
ajlm-2519	14	22	)	)	PUNCT
ajlm-2519	14	23	.	.	PUNCT
ajlm-2519	15	1	staphylococcus	staphylococcus	NOUN
ajlm-2519	15	2	aureus	aureus	PROPN
ajlm-2519	15	3	increased	increase	VERB
ajlm-2519	15	4	from	from	ADP
ajlm-2519	15	5	39	39	NUM
ajlm-2519	15	6	isolates	isolate	NOUN
ajlm-2519	15	7	in	in	ADP
ajlm-2519	15	8	2014	2014	NUM
ajlm-2519	15	9	to	to	ADP
ajlm-2519	15	10	75	75	NUM
ajlm-2519	15	11	in	in	ADP
ajlm-2519	15	12	2019	2019	NUM
ajlm-2519	15	13	(	(	PUNCT
ajlm-2519	15	14	p	p	X
ajlm-2519	15	15	=	=	NOUN
ajlm-2519	15	16	0.132	0.132	NUM
ajlm-2519	15	17	)	)	PUNCT
ajlm-2519	15	18	.	.	PUNCT
ajlm-2519	16	1	the	the	DET
ajlm-2519	16	2	incidence	incidence	NOUN
ajlm-2519	16	3	rate	rate	NOUN
ajlm-2519	16	4	of	of	ADP
ajlm-2519	16	5	a.	a.	NOUN
ajlm-2519	16	6	baumannii	baumannii	PROPN
ajlm-2519	16	7	increased	increase	VERB
ajlm-2519	16	8	from	from	ADP
ajlm-2519	16	9	11.9	11.9	NUM
ajlm-2519	16	10	%	%	NOUN
ajlm-2519	16	11	(	(	PUNCT
ajlm-2519	16	12	16/134	16/134	NUM
ajlm-2519	16	13	)	)	PUNCT
ajlm-2519	16	14	in	in	ADP
ajlm-2519	16	15	2015	2015	NUM
ajlm-2519	16	16	to	to	ADP
ajlm-2519	16	17	37.8	37.8	NUM
ajlm-2519	16	18	%	%	NOUN
ajlm-2519	16	19	(	(	PUNCT
ajlm-2519	16	20	68/180	68/180	NUM
ajlm-2519	16	21	)	)	PUNCT
ajlm-2519	16	22	in	in	ADP
ajlm-2519	16	23	2019	2019	NUM
ajlm-2519	16	24	(	(	PUNCT
ajlm-2519	16	25	p	p	NOUN
ajlm-2519	16	26	=	=	NOUN
ajlm-2519	16	27	0.009	0.009	NUM
ajlm-2519	16	28	)	)	PUNCT
ajlm-2519	16	29	.	.	PUNCT
ajlm-2519	17	1	most	most	ADJ
ajlm-2519	17	2	isolates	isolate	NOUN
ajlm-2519	17	3	(	(	PUNCT
ajlm-2519	17	4	417/746	417/746	NUM
ajlm-2519	17	5	;	;	PUNCT
ajlm-2519	17	6	55.9	55.9	NUM
ajlm-2519	17	7	%	%	NOUN
ajlm-2519	17	8	)	)	PUNCT
ajlm-2519	17	9	were	be	AUX
ajlm-2519	17	10	from	from	ADP
ajlm-2519	17	11	the	the	DET
ajlm-2519	17	12	neonatal	neonatal	ADJ
ajlm-2519	17	13	ward	ward	NOUN
ajlm-2519	17	14	.	.	PUNCT
ajlm-2519	18	1	carbapenem	carbapenem	NOUN
ajlm-2519	18	2	-	-	PUNCT
ajlm-2519	18	3	resistant	resistant	ADJ
ajlm-2519	18	4	a.	a.	NOUN
ajlm-2519	18	5	baumannii	baumannii	NOUN
ajlm-2519	18	6	increased	increase	VERB
ajlm-2519	18	7	from	from	ADP
ajlm-2519	18	8	68.8	68.8	NUM
ajlm-2519	18	9	%	%	NOUN
ajlm-2519	18	10	(	(	PUNCT
ajlm-2519	18	11	11/16	11/16	NUM
ajlm-2519	18	12	)	)	PUNCT
ajlm-2519	18	13	in	in	ADP
ajlm-2519	18	14	2014	2014	NUM
ajlm-2519	18	15	to	to	ADP
ajlm-2519	18	16	75.0	75.0	NUM
ajlm-2519	18	17	%	%	NOUN
ajlm-2519	18	18	(	(	PUNCT
ajlm-2519	18	19	51/68	51/68	NUM
ajlm-2519	18	20	)	)	PUNCT
ajlm-2519	18	21	in	in	ADP
ajlm-2519	18	22	2019	2019	NUM
ajlm-2519	18	23	(	(	PUNCT
ajlm-2519	18	24	p	p	NOUN
ajlm-2519	18	25	=	=	NOUN
ajlm-2519	18	26	0.009	0.009	NUM
ajlm-2519	18	27	)	)	PUNCT
ajlm-2519	18	28	.	.	PUNCT
ajlm-2519	19	1	methicillin	methicillin	NOUN
ajlm-2519	19	2	-	-	PUNCT
ajlm-2519	19	3	resistant	resistant	ADJ
ajlm-2519	19	4	s.	s.	PROPN
ajlm-2519	19	5	aureus	aureus	PROPN
ajlm-2519	19	6	decreased	decrease	VERB
ajlm-2519	19	7	from	from	ADP
ajlm-2519	19	8	56.0	56.0	NUM
ajlm-2519	19	9	%	%	NOUN
ajlm-2519	19	10	(	(	PUNCT
ajlm-2519	19	11	14/25	14/25	NUM
ajlm-2519	19	12	)	)	PUNCT
ajlm-2519	19	13	in	in	ADP
ajlm-2519	19	14	2016	2016	NUM
ajlm-2519	19	15	to	to	PART
ajlm-2519	19	16	17.3	17.3	NUM
ajlm-2519	19	17	%	%	NOUN
ajlm-2519	19	18	(	(	PUNCT
ajlm-2519	19	19	13/75	13/75	NUM
ajlm-2519	19	20	)	)	PUNCT
ajlm-2519	19	21	in	in	ADP
ajlm-2519	19	22	2019	2019	NUM
ajlm-2519	19	23	(	(	PUNCT
ajlm-2519	19	24	p	p	X
ajlm-2519	19	25	=	=	NOUN
ajlm-2519	19	26	0.260	0.260	NUM
ajlm-2519	19	27	)	)	PUNCT
ajlm-2519	19	28	.	.	PUNCT
ajlm-2519	20	1	conclusion	conclusion	NOUN
ajlm-2519	20	2	:	:	PUNCT
ajlm-2519	20	3	routine	routine	ADJ
ajlm-2519	20	4	data	datum	NOUN
ajlm-2519	20	5	provide	provide	VERB
ajlm-2519	20	6	essential	essential	ADJ
ajlm-2519	20	7	information	information	NOUN
ajlm-2519	20	8	on	on	ADP
ajlm-2519	20	9	the	the	DET
ajlm-2519	20	10	incidence	incidence	NOUN
ajlm-2519	20	11	of	of	ADP
ajlm-2519	20	12	eskape	eskape	NOUN
ajlm-2519	20	13	pathogens	pathogen	NOUN
ajlm-2519	20	14	and	and	CCONJ
ajlm-2519	20	15	amr	amr	NOUN
ajlm-2519	20	16	phenotypes	phenotype	NOUN
ajlm-2519	20	17	,	,	PUNCT
ajlm-2519	20	18	serving	serve	VERB
ajlm-2519	20	19	as	as	ADP
ajlm-2519	20	20	a	a	DET
ajlm-2519	20	21	basis	basis	NOUN
ajlm-2519	20	22	for	for	ADP
ajlm-2519	20	23	an	an	DET
ajlm-2519	20	24	antibiogram	antibiogram	PROPN
ajlm-2519	20	25	,	,	PUNCT
ajlm-2519	20	26	a	a	DET
ajlm-2519	20	27	surveillance	surveillance	NOUN
ajlm-2519	20	28	tool	tool	NOUN
ajlm-2519	20	29	in	in	ADP
ajlm-2519	20	30	antibiotic	antibiotic	ADJ
ajlm-2519	20	31	stewardship	stewardship	NOUN
ajlm-2519	20	32	programmes	programme	NOUN
ajlm-2519	20	33	.	.	PUNCT
ajlm-2519	21	1	what	what	PRON
ajlm-2519	21	2	this	this	DET
ajlm-2519	21	3	study	study	NOUN
ajlm-2519	21	4	adds	add	VERB
ajlm-2519	21	5	:	:	PUNCT
ajlm-2519	21	6	the	the	DET
ajlm-2519	21	7	study	study	NOUN
ajlm-2519	21	8	provided	provide	VERB
ajlm-2519	21	9	local	local	ADJ
ajlm-2519	21	10	information	information	NOUN
ajlm-2519	21	11	on	on	ADP
ajlm-2519	21	12	the	the	DET
ajlm-2519	21	13	incidence	incidence	NOUN
ajlm-2519	21	14	and	and	CCONJ
ajlm-2519	21	15	amr	amr	NOUN
ajlm-2519	21	16	pattern	pattern	NOUN
ajlm-2519	21	17	of	of	ADP
ajlm-2519	21	18	eskape	eskape	NOUN
ajlm-2519	21	19	pathogens	pathogen	NOUN
ajlm-2519	21	20	,	,	PUNCT
ajlm-2519	21	21	which	which	PRON
ajlm-2519	21	22	is	be	AUX
ajlm-2519	21	23	essential	essential	ADJ
ajlm-2519	21	24	when	when	SCONJ
ajlm-2519	21	25	developing	develop	VERB
ajlm-2519	21	26	empiric	empiric	ADJ
ajlm-2519	21	27	treatment	treatment	NOUN
ajlm-2519	21	28	protocols	protocol	NOUN
ajlm-2519	21	29	for	for	ADP
ajlm-2519	21	30	appropriate	appropriate	ADJ
ajlm-2519	21	31	antibiotic	antibiotic	ADJ
ajlm-2519	21	32	prescribing	prescribing	NOUN
ajlm-2519	21	33	and	and	CCONJ
ajlm-2519	21	34	infection	infection	NOUN
ajlm-2519	21	35	prevention	prevention	NOUN
ajlm-2519	21	36	and	and	CCONJ
ajlm-2519	21	37	control	control	NOUN
ajlm-2519	21	38	practices	practice	NOUN
ajlm-2519	21	39	.	.	PUNCT
ajlm-2519	22	1	keywords	keyword	NOUN
ajlm-2519	22	2	:	:	PUNCT
ajlm-2519	22	3	acinetobacter	acinetobacter	ADV
ajlm-2519	22	4	baumannii	baumannii	PROPN
ajlm-2519	22	5	;	;	PUNCT
ajlm-2519	22	6	bloodstream	bloodstream	NOUN
ajlm-2519	22	7	infections	infection	NOUN
ajlm-2519	22	8	;	;	PUNCT
ajlm-2519	22	9	antibiotic	antibiotic	ADJ
ajlm-2519	22	10	resistance	resistance	NOUN
ajlm-2519	22	11	;	;	PUNCT
ajlm-2519	22	12	klebsiella	klebsiella	NOUN
ajlm-2519	22	13	pneumoniae	pneumoniae	NOUN
ajlm-2519	22	14	;	;	PUNCT
ajlm-2519	22	15	south	south	PROPN
ajlm-2519	22	16	africa	africa	PROPN
ajlm-2519	22	17	;	;	PUNCT
ajlm-2519	22	18	staphylococcus	staphylococcus	NOUN
ajlm-2519	22	19	aureus	aureus	NOUN
ajlm-2519	22	20	.	.	PUNCT
ajlm-2519	23	1	introduction	introduction	NOUN
ajlm-2519	23	2	based	base	VERB
ajlm-2519	23	3	on	on	ADP
ajlm-2519	23	4	estimates	estimate	NOUN
ajlm-2519	23	5	from	from	ADP
ajlm-2519	23	6	the	the	DET
ajlm-2519	23	7	global	global	ADJ
ajlm-2519	23	8	burden	burden	NOUN
ajlm-2519	23	9	of	of	ADP
ajlm-2519	23	10	disease	disease	NOUN
ajlm-2519	23	11	study	study	NOUN
ajlm-2519	23	12	,	,	PUNCT
ajlm-2519	23	13	bacterial	bacterial	ADJ
ajlm-2519	23	14	infections	infection	NOUN
ajlm-2519	23	15	and	and	CCONJ
ajlm-2519	23	16	antimicrobial	antimicrobial	ADJ
ajlm-2519	23	17	resistance	resistance	NOUN
ajlm-2519	23	18	(	(	PUNCT
ajlm-2519	23	19	amr	amr	NOUN
ajlm-2519	23	20	)	)	PUNCT
ajlm-2519	23	21	were	be	AUX
ajlm-2519	23	22	respectively	respectively	ADV
ajlm-2519	23	23	responsible	responsible	ADJ
ajlm-2519	23	24	for	for	ADP
ajlm-2519	23	25	7.7	7.7	NUM
ajlm-2519	23	26	million	million	NUM
ajlm-2519	23	27	and	and	CCONJ
ajlm-2519	23	28	4.9	4.9	NUM
ajlm-2519	23	29	million	million	NUM
ajlm-2519	23	30	global	global	ADJ
ajlm-2519	23	31	deaths	death	NOUN
ajlm-2519	23	32	in	in	ADP
ajlm-2519	23	33	2019	2019	NUM
ajlm-2519	23	34	,	,	PUNCT
ajlm-2519	23	35	making	make	VERB
ajlm-2519	23	36	them	they	PRON
ajlm-2519	23	37	the	the	DET
ajlm-2519	23	38	second	second	ADJ
ajlm-2519	23	39	leading	leading	ADJ
ajlm-2519	23	40	cause	cause	NOUN
ajlm-2519	23	41	of	of	ADP
ajlm-2519	23	42	death	death	NOUN
ajlm-2519	23	43	after	after	ADP
ajlm-2519	23	44	ischaemic	ischaemic	ADJ
ajlm-2519	23	45	heart	heart	NOUN
ajlm-2519	23	46	disease.1,2	disease.1,2	PROPN
ajlm-2519	23	47	therefore	therefore	ADV
ajlm-2519	23	48	,	,	PUNCT
ajlm-2519	23	49	amr	amr	PROPN
ajlm-2519	23	50	has	have	AUX
ajlm-2519	23	51	become	become	VERB
ajlm-2519	23	52	a	a	DET
ajlm-2519	23	53	global	global	ADJ
ajlm-2519	23	54	public	public	ADJ
ajlm-2519	23	55	health	health	PROPN
ajlm-2519	23	56	concern.2,3	concern.2,3	PROPN
ajlm-2519	23	57	the	the	DET
ajlm-2519	23	58	world	world	PROPN
ajlm-2519	23	59	health	health	PROPN
ajlm-2519	23	60	organization	organization	PROPN
ajlm-2519	23	61	’s	’s	PART
ajlm-2519	23	62	(	(	PUNCT
ajlm-2519	23	63	who	who	PRON
ajlm-2519	23	64	)	)	PUNCT
ajlm-2519	23	65	african	african	ADJ
ajlm-2519	23	66	region	region	NOUN
ajlm-2519	23	67	is	be	AUX
ajlm-2519	23	68	no	no	DET
ajlm-2519	23	69	exception	exception	NOUN
ajlm-2519	23	70	.	.	PUNCT
ajlm-2519	24	1	in	in	ADP
ajlm-2519	24	2	2019	2019	NUM
ajlm-2519	24	3	,	,	PUNCT
ajlm-2519	24	4	this	this	DET
ajlm-2519	24	5	region	region	NOUN
ajlm-2519	24	6	had	have	VERB
ajlm-2519	24	7	an	an	DET
ajlm-2519	24	8	estimated	estimate	VERB
ajlm-2519	24	9	1.05	1.05	NUM
ajlm-2519	24	10	million	million	NUM
ajlm-2519	24	11	deaths	death	NOUN
ajlm-2519	24	12	that	that	PRON
ajlm-2519	24	13	were	be	AUX
ajlm-2519	24	14	associated	associate	VERB
ajlm-2519	24	15	with	with	ADP
ajlm-2519	24	16	amr.4	amr.4	PROPN
ajlm-2519	24	17	however	however	ADV
ajlm-2519	24	18	,	,	PUNCT
ajlm-2519	24	19	amr	amr	PROPN
ajlm-2519	24	20	surveillance	surveillance	NOUN
ajlm-2519	24	21	data	datum	NOUN
ajlm-2519	24	22	in	in	ADP
ajlm-2519	24	23	the	the	DET
ajlm-2519	24	24	region	region	NOUN
ajlm-2519	24	25	are	be	AUX
ajlm-2519	24	26	scarce.2,5	scarce.2,5	ADP
ajlm-2519	24	27	the	the	DET
ajlm-2519	24	28	inappropriate	inappropriate	ADJ
ajlm-2519	24	29	use	use	NOUN
ajlm-2519	24	30	of	of	ADP
ajlm-2519	24	31	antibiotics	antibiotic	NOUN
ajlm-2519	24	32	is	be	AUX
ajlm-2519	24	33	the	the	DET
ajlm-2519	24	34	leading	lead	VERB
ajlm-2519	24	35	cause	cause	NOUN
ajlm-2519	24	36	of	of	ADP
ajlm-2519	24	37	multidrug	multidrug	NOUN
ajlm-2519	24	38	-	-	PUNCT
ajlm-2519	24	39	resistant	resistant	ADJ
ajlm-2519	24	40	pathogens,3	pathogens,3	NOUN
ajlm-2519	24	41	particularly	particularly	ADV
ajlm-2519	24	42	in	in	ADP
ajlm-2519	24	43	lowand	lowand	ADJ
ajlm-2519	24	44	middle	middle	ADJ
ajlm-2519	24	45	-	-	PUNCT
ajlm-2519	24	46	income	income	NOUN
ajlm-2519	24	47	countries	country	NOUN
ajlm-2519	24	48	,	,	PUNCT
ajlm-2519	24	49	where	where	SCONJ
ajlm-2519	24	50	multidrug	multidrug	NOUN
ajlm-2519	24	51	-	-	PUNCT
ajlm-2519	24	52	resistant	resistant	ADJ
ajlm-2519	24	53	bacteria	bacteria	NOUN
ajlm-2519	24	54	accounted	account	VERB
ajlm-2519	24	55	for	for	ADP
ajlm-2519	24	56	15.5	15.5	NUM
ajlm-2519	24	57	%	%	NOUN
ajlm-2519	24	58	of	of	ADP
ajlm-2519	24	59	healthcare	healthcare	NOUN
ajlm-2519	24	60	-	-	PUNCT
ajlm-2519	24	61	acquired	acquire	VERB
ajlm-2519	24	62	infections	infection	NOUN
ajlm-2519	24	63	in	in	ADP
ajlm-2519	24	64	2011.6	2011.6	NUM
ajlm-2519	24	65	most	most	ADV
ajlm-2519	24	66	multidrug	multidrug	NOUN
ajlm-2519	24	67	-	-	PUNCT
ajlm-2519	24	68	resistant	resistant	ADJ
ajlm-2519	24	69	healthcare	healthcare	NOUN
ajlm-2519	24	70	-	-	PUNCT
ajlm-2519	24	71	associated	associate	VERB
ajlm-2519	24	72	infections	infection	NOUN
ajlm-2519	24	73	are	be	AUX
ajlm-2519	24	74	caused	cause	VERB
ajlm-2519	24	75	by	by	ADP
ajlm-2519	24	76	six	six	NUM
ajlm-2519	24	77	pathogens	pathogen	NOUN
ajlm-2519	24	78	,	,	PUNCT
ajlm-2519	24	79	namely	namely	ADV
ajlm-2519	24	80	enterococcus	enterococcus	NOUN
ajlm-2519	24	81	faecium	faecium	NOUN
ajlm-2519	24	82	,	,	PUNCT
ajlm-2519	24	83	staphylococcus	staphylococcus	NOUN
ajlm-2519	24	84	aureus	aureus	NOUN
ajlm-2519	24	85	,	,	PUNCT
ajlm-2519	24	86	klebsiella	klebsiella	PROPN
ajlm-2519	24	87	pneumoniae	pneumoniae	NOUN
ajlm-2519	24	88	,	,	PUNCT
ajlm-2519	24	89	acinetobacter	acinetobacter	ADV
ajlm-2519	24	90	baumannii	baumannii	PROPN
ajlm-2519	24	91	,	,	PUNCT
ajlm-2519	24	92	pseudomonas	pseudomona	NOUN
ajlm-2519	24	93	aeruginosa	aeruginosa	NOUN
ajlm-2519	24	94	,	,	PUNCT
ajlm-2519	24	95	and	and	CCONJ
ajlm-2519	24	96	enterobacter	enterobacter	ADJ
ajlm-2519	24	97	spp	spp	NOUN
ajlm-2519	24	98	.	.	PROPN
ajlm-2519	24	99	,	,	PUNCT
ajlm-2519	24	100	known	know	VERB
ajlm-2519	24	101	as	as	ADP
ajlm-2519	24	102	eskape	eskape	NOUN
ajlm-2519	24	103	,	,	PUNCT
ajlm-2519	24	104	which	which	PRON
ajlm-2519	24	105	are	be	AUX
ajlm-2519	24	106	capable	capable	ADJ
ajlm-2519	24	107	of	of	ADP
ajlm-2519	24	108	‘	'	PUNCT
ajlm-2519	24	109	escaping	escape	VERB
ajlm-2519	24	110	’	'	PUNCT
ajlm-2519	24	111	the	the	DET
ajlm-2519	24	112	biocidal	biocidal	ADJ
ajlm-2519	24	113	properties	property	NOUN
ajlm-2519	24	114	of	of	ADP
ajlm-2519	24	115	antibiotics.6,7	antibiotics.6,7	PROPN
ajlm-2519	24	116	the	the	DET
ajlm-2519	24	117	eskape	eskape	NOUN
ajlm-2519	24	118	pathogens	pathogen	NOUN
ajlm-2519	24	119	are	be	AUX
ajlm-2519	24	120	characterised	characterise	VERB
ajlm-2519	24	121	as	as	ADP
ajlm-2519	24	122	opportunistic	opportunistic	ADJ
ajlm-2519	24	123	infections	infection	NOUN
ajlm-2519	24	124	and	and	CCONJ
ajlm-2519	24	125	are	be	AUX
ajlm-2519	24	126	associated	associate	VERB
ajlm-2519	24	127	with	with	ADP
ajlm-2519	24	128	the	the	DET
ajlm-2519	24	129	highest	high	ADJ
ajlm-2519	24	130	risk	risk	NOUN
ajlm-2519	24	131	of	of	ADP
ajlm-2519	24	132	mortality	mortality	NOUN
ajlm-2519	24	133	and	and	CCONJ
ajlm-2519	24	134	increased	increase	VERB
ajlm-2519	24	135	healthcare	healthcare	NOUN
ajlm-2519	24	136	costs.6,7,8	costs.6,7,8	NOUN
ajlm-2519	24	137	in	in	ADP
ajlm-2519	24	138	2017	2017	NUM
ajlm-2519	24	139	,	,	PUNCT
ajlm-2519	24	140	the	the	DET
ajlm-2519	24	141	who	who	PRON
ajlm-2519	24	142	released	release	VERB
ajlm-2519	24	143	its	its	PRON
ajlm-2519	24	144	first	first	ADJ
ajlm-2519	24	145	edition	edition	NOUN
ajlm-2519	24	146	of	of	ADP
ajlm-2519	24	147	the	the	DET
ajlm-2519	24	148	12	12	NUM
ajlm-2519	24	149	bacterial	bacterial	ADJ
ajlm-2519	24	150	drug	drug	NOUN
ajlm-2519	24	151	-	-	PUNCT
ajlm-2519	24	152	pathogen	pathogen	NOUN
ajlm-2519	24	153	priority	priority	NOUN
ajlm-2519	24	154	list	list	NOUN
ajlm-2519	24	155	–	–	PUNCT
ajlm-2519	24	156	a	a	DET
ajlm-2519	24	157	list	list	NOUN
ajlm-2519	24	158	of	of	ADP
ajlm-2519	24	159	drug	drug	NOUN
ajlm-2519	24	160	-	-	PUNCT
ajlm-2519	24	161	pathogen	pathogen	NOUN
ajlm-2519	24	162	combination	combination	NOUN
ajlm-2519	24	163	bacteria	bacteria	NOUN
ajlm-2519	24	164	that	that	PRON
ajlm-2519	24	165	pose	pose	VERB
ajlm-2519	24	166	the	the	DET
ajlm-2519	24	167	greatest	great	ADJ
ajlm-2519	24	168	threat	threat	NOUN
ajlm-2519	24	169	to	to	ADP
ajlm-2519	24	170	human	human	ADJ
ajlm-2519	24	171	health	health	NOUN
ajlm-2519	24	172	because	because	SCONJ
ajlm-2519	24	173	of	of	ADP
ajlm-2519	24	174	the	the	DET
ajlm-2519	24	175	emergence	emergence	NOUN
ajlm-2519	24	176	of	of	ADP
ajlm-2519	24	177	multidrug	multidrug	NOUN
ajlm-2519	24	178	resistance.9	resistance.9	NOUN
ajlm-2519	24	179	all	all	DET
ajlm-2519	24	180	eskape	eskape	NOUN
ajlm-2519	24	181	drug	drug	NOUN
ajlm-2519	24	182	-	-	PUNCT
ajlm-2519	24	183	pathogen	pathogen	NOUN
ajlm-2519	24	184	resistant	resistant	ADJ
ajlm-2519	24	185	combinations	combination	NOUN
ajlm-2519	24	186	–	–	PUNCT
ajlm-2519	24	187	for	for	ADP
ajlm-2519	24	188	example	example	NOUN
ajlm-2519	24	189	critical	critical	ADJ
ajlm-2519	24	190	priority	priority	NOUN
ajlm-2519	24	191	carbapenem	carbapenem	NOUN
ajlm-2519	24	192	-	-	PUNCT
ajlm-2519	24	193	resistant	resistant	ADJ
ajlm-2519	24	194	a.	a.	NOUN
ajlm-2519	24	195	baumannii	baumannii	NOUN
ajlm-2519	24	196	(	(	PUNCT
ajlm-2519	24	197	crab	crab	NOUN
ajlm-2519	24	198	)	)	PUNCT
ajlm-2519	24	199	,	,	PUNCT
ajlm-2519	24	200	carbapenem	carbapenem	NOUN
ajlm-2519	24	201	-	-	PUNCT
ajlm-2519	24	202	resistant	resistant	ADJ
ajlm-2519	24	203	p.	p.	NOUN
ajlm-2519	24	204	aeruginosa	aeruginosa	PROPN
ajlm-2519	24	205	,	,	PUNCT
ajlm-2519	24	206	carbapenem	carbapenem	NOUN
ajlm-2519	24	207	-	-	PUNCT
ajlm-2519	24	208	resistant	resistant	ADJ
ajlm-2519	24	209	k.	k.	NOUN
ajlm-2519	24	210	pneumoniae	pneumoniae	NOUN
ajlm-2519	24	211	(	(	PUNCT
ajlm-2519	24	212	k.	k.	NOUN
ajlm-2519	24	213	pneumoniae	pneumoniae	PROPN
ajlm-2519	24	214	)	)	PUNCT
ajlm-2519	24	215	,	,	PUNCT
ajlm-2519	24	216	third	third	ADJ
ajlm-2519	24	217	-	-	PUNCT
ajlm-2519	24	218	generation	generation	NOUN
ajlm-2519	24	219	cephalosporin	cephalosporin	NOUN
ajlm-2519	24	220	-	-	PUNCT
ajlm-2519	24	221	resistant	resistant	ADJ
ajlm-2519	24	222	k.	k.	NOUN
ajlm-2519	24	223	pneumoniae	pneumoniae	NOUN
ajlm-2519	24	224	(	(	PUNCT
ajlm-2519	24	225	3gcr	3gcr	PROPN
ajlm-2519	24	226	k.	k.	NOUN
ajlm-2519	24	227	pneumoniae	pneumoniae	PROPN
ajlm-2519	24	228	)	)	PUNCT
ajlm-2519	24	229	,	,	PUNCT
ajlm-2519	24	230	high	high	ADJ
ajlm-2519	24	231	priority	priority	NOUN
ajlm-2519	24	232	vancomycin	vancomycin	NOUN
ajlm-2519	24	233	-	-	PUNCT
ajlm-2519	24	234	resistant	resistant	ADJ
ajlm-2519	24	235	e.	e.	PROPN
ajlm-2519	24	236	faecium	faecium	PROPN
ajlm-2519	24	237	,	,	PUNCT
ajlm-2519	24	238	methicillin	methicillin	NOUN
ajlm-2519	24	239	-	-	PUNCT
ajlm-2519	24	240	resistant	resistant	ADJ
ajlm-2519	24	241	s.	s.	PROPN
ajlm-2519	24	242	aureus	aureus	PROPN
ajlm-2519	24	243	(	(	PUNCT
ajlm-2519	24	244	mrsa	mrsa	NOUN
ajlm-2519	24	245	)	)	PUNCT
ajlm-2519	24	246	,	,	PUNCT
ajlm-2519	24	247	third	third	ADJ
ajlm-2519	24	248	-	-	PUNCT
ajlm-2519	24	249	generation	generation	NOUN
ajlm-2519	24	250	cephalosporinand	cephalosporinand	NOUN
ajlm-2519	24	251	carbapenem	carbapenem	NOUN
ajlm-2519	24	252	-	-	PUNCT
ajlm-2519	24	253	resistant	resistant	ADJ
ajlm-2519	24	254	enterobacter	enterobacter	NOUN
ajlm-2519	24	255	spp	spp	NOUN
ajlm-2519	24	256	.	.	PUNCT
ajlm-2519	24	257	,	,	PUNCT
ajlm-2519	24	258	and	and	CCONJ
ajlm-2519	24	259	vancomycin	vancomycin	NOUN
ajlm-2519	24	260	-	-	PUNCT
ajlm-2519	24	261	resistant	resistant	ADJ
ajlm-2519	24	262	s.	s.	PROPN
ajlm-2519	24	263	aureus	aureus	PROPN
ajlm-2519	24	264	–	–	PUNCT
ajlm-2519	24	265	are	be	AUX
ajlm-2519	24	266	on	on	ADP
ajlm-2519	24	267	the	the	DET
ajlm-2519	24	268	who	who	PRON
ajlm-2519	24	269	’s	’	VERB
ajlm-2519	24	270	priority	priority	NOUN
ajlm-2519	24	271	list	list	NOUN
ajlm-2519	24	272	and	and	CCONJ
ajlm-2519	24	273	serve	serve	VERB
ajlm-2519	24	274	as	as	ADP
ajlm-2519	24	275	important	important	ADJ
ajlm-2519	24	276	indicators	indicator	NOUN
ajlm-2519	24	277	for	for	ADP
ajlm-2519	24	278	amr	amr	NOUN
ajlm-2519	24	279	surveillance	surveillance	NOUN
ajlm-2519	24	280	and	and	CCONJ
ajlm-2519	24	281	research.9	research.9	ADJ
ajlm-2519	24	282	bacterial	bacterial	ADJ
ajlm-2519	24	283	bloodstream	bloodstream	NOUN
ajlm-2519	24	284	,	,	PUNCT
ajlm-2519	24	285	lower	low	ADJ
ajlm-2519	24	286	-	-	PUNCT
ajlm-2519	24	287	respiratory	respiratory	ADJ
ajlm-2519	24	288	tract	tract	NOUN
ajlm-2519	24	289	,	,	PUNCT
ajlm-2519	24	290	and	and	CCONJ
ajlm-2519	24	291	intra	intra	ADJ
ajlm-2519	24	292	-	-	ADJ
ajlm-2519	24	293	abdominal	abdominal	ADJ
ajlm-2519	24	294	infections	infection	NOUN
ajlm-2519	24	295	dominated	dominate	VERB
ajlm-2519	24	296	the	the	DET
ajlm-2519	24	297	global	global	ADJ
ajlm-2519	24	298	and	and	CCONJ
ajlm-2519	24	299	regional	regional	ADJ
ajlm-2519	24	300	burdens	burden	NOUN
ajlm-2519	24	301	of	of	ADP
ajlm-2519	24	302	amr	amr	PROPN
ajlm-2519	24	303	in	in	ADP
ajlm-2519	24	304	2019.1,2,4	2019.1,2,4	NUM
ajlm-2519	24	305	the	the	DET
ajlm-2519	24	306	six	six	NUM
ajlm-2519	24	307	eskape	eskape	NOUN
ajlm-2519	24	308	pathogens	pathogen	NOUN
ajlm-2519	24	309	were	be	AUX
ajlm-2519	24	310	among	among	ADP
ajlm-2519	24	311	the	the	DET
ajlm-2519	24	312	10	10	NUM
ajlm-2519	24	313	commonly	commonly	ADV
ajlm-2519	24	314	isolated	isolate	VERB
ajlm-2519	24	315	bloodstream	bloodstream	NOUN
ajlm-2519	24	316	infections	infection	NOUN
ajlm-2519	24	317	responsible	responsible	ADJ
ajlm-2519	24	318	for	for	ADP
ajlm-2519	24	319	amr	amr	ADJ
ajlm-2519	24	320	-	-	PUNCT
ajlm-2519	24	321	related	relate	VERB
ajlm-2519	24	322	deaths	death	NOUN
ajlm-2519	24	323	worldwide	worldwide	ADV
ajlm-2519	24	324	in	in	ADP
ajlm-2519	24	325	2019.1,2	2019.1,2	NUM
ajlm-2519	24	326	lowand	lowand	ADJ
ajlm-2519	24	327	middle	middle	ADJ
ajlm-2519	24	328	-	-	PUNCT
ajlm-2519	24	329	income	income	NOUN
ajlm-2519	24	330	countries	country	NOUN
ajlm-2519	24	331	,	,	PUNCT
ajlm-2519	24	332	especially	especially	ADV
ajlm-2519	24	333	in	in	ADP
ajlm-2519	24	334	africa	africa	PROPN
ajlm-2519	24	335	,	,	PUNCT
ajlm-2519	24	336	have	have	AUX
ajlm-2519	24	337	a	a	DET
ajlm-2519	24	338	high	high	ADJ
ajlm-2519	24	339	burden	burden	NOUN
ajlm-2519	24	340	of	of	ADP
ajlm-2519	24	341	bloodstream	bloodstream	NOUN
ajlm-2519	24	342	infections	infection	NOUN
ajlm-2519	24	343	by	by	ADP
ajlm-2519	24	344	eskape	eskape	NOUN
ajlm-2519	24	345	pathogens.2,4,8,10	pathogens.2,4,8,10	X
ajlm-2519	24	346	the	the	DET
ajlm-2519	24	347	amr	amr	ADJ
ajlm-2519	24	348	status	status	NOUN
ajlm-2519	24	349	of	of	ADP
ajlm-2519	24	350	specific	specific	ADJ
ajlm-2519	24	351	healthcare	healthcare	NOUN
ajlm-2519	24	352	settings	setting	NOUN
ajlm-2519	24	353	varies	vary	VERB
ajlm-2519	24	354	based	base	VERB
ajlm-2519	24	355	on	on	ADP
ajlm-2519	24	356	the	the	DET
ajlm-2519	24	357	epidemiology	epidemiology	NOUN
ajlm-2519	24	358	of	of	ADP
ajlm-2519	24	359	bacterial	bacterial	ADJ
ajlm-2519	24	360	infections	infection	NOUN
ajlm-2519	24	361	,	,	PUNCT
ajlm-2519	24	362	the	the	DET
ajlm-2519	24	363	antibiotics	antibiotic	NOUN
ajlm-2519	24	364	used	use	VERB
ajlm-2519	24	365	,	,	PUNCT
ajlm-2519	24	366	and	and	CCONJ
ajlm-2519	24	367	the	the	DET
ajlm-2519	24	368	geographic	geographic	ADJ
ajlm-2519	24	369	area.1,2,11	area.1,2,11	NOUN
ajlm-2519	24	370	in	in	ADP
ajlm-2519	24	371	south	south	PROPN
ajlm-2519	24	372	africa	africa	PROPN
ajlm-2519	24	373	,	,	PUNCT
ajlm-2519	24	374	there	there	PRON
ajlm-2519	24	375	were	be	VERB
ajlm-2519	24	376	39	39	NUM
ajlm-2519	24	377	000	000	NUM
ajlm-2519	24	378	amr	amr	ADJ
ajlm-2519	24	379	-	-	PUNCT
ajlm-2519	24	380	related	relate	VERB
ajlm-2519	24	381	deaths	death	NOUN
ajlm-2519	24	382	in	in	ADP
ajlm-2519	24	383	2019.12	2019.12	NUM
ajlm-2519	24	384	according	accord	VERB
ajlm-2519	24	385	to	to	ADP
ajlm-2519	24	386	national	national	ADJ
ajlm-2519	24	387	laboratory	laboratory	NOUN
ajlm-2519	24	388	surveillance	surveillance	NOUN
ajlm-2519	24	389	data	datum	NOUN
ajlm-2519	24	390	,	,	PUNCT
ajlm-2519	24	391	40.0	40.0	NUM
ajlm-2519	24	392	%	%	NOUN
ajlm-2519	24	393	of	of	ADP
ajlm-2519	24	394	positive	positive	ADJ
ajlm-2519	24	395	blood	blood	NOUN
ajlm-2519	24	396	cultures	culture	NOUN
ajlm-2519	24	397	in	in	ADP
ajlm-2519	24	398	south	south	PROPN
ajlm-2519	24	399	africa	africa	PROPN
ajlm-2519	24	400	contain	contain	VERB
ajlm-2519	24	401	one	one	NUM
ajlm-2519	24	402	or	or	CCONJ
ajlm-2519	24	403	more	more	ADJ
ajlm-2519	24	404	eskape	eskape	NOUN
ajlm-2519	24	405	pathogens.11	pathogens.11	NOUN
ajlm-2519	24	406	between	between	ADP
ajlm-2519	24	407	2014	2014	NUM
ajlm-2519	24	408	and	and	CCONJ
ajlm-2519	24	409	2019	2019	NUM
ajlm-2519	24	410	,	,	PUNCT
ajlm-2519	24	411	the	the	DET
ajlm-2519	24	412	bloodstream	bloodstream	NOUN
ajlm-2519	24	413	pathogens	pathogen	NOUN
ajlm-2519	24	414	isolated	isolate	VERB
ajlm-2519	24	415	the	the	DET
ajlm-2519	24	416	most	most	ADJ
ajlm-2519	24	417	in	in	ADP
ajlm-2519	24	418	neonates	neonate	NOUN
ajlm-2519	24	419	in	in	ADP
ajlm-2519	24	420	south	south	PROPN
ajlm-2519	24	421	africa	africa	PROPN
ajlm-2519	24	422	were	be	AUX
ajlm-2519	24	423	k.	k.	PROPN
ajlm-2519	24	424	pneumoniae	pneumoniae	ADJ
ajlm-2519	24	425	(	(	PUNCT
ajlm-2519	24	426	28.0	28.0	NUM
ajlm-2519	24	427	%	%	NOUN
ajlm-2519	24	428	)	)	PUNCT
ajlm-2519	24	429	,	,	PUNCT
ajlm-2519	24	430	a.	a.	NOUN
ajlm-2519	24	431	baumannii	baumannii	PROPN
ajlm-2519	24	432	(	(	PUNCT
ajlm-2519	24	433	14.0	14.0	NUM
ajlm-2519	24	434	%	%	NOUN
ajlm-2519	24	435	)	)	PUNCT
ajlm-2519	24	436	,	,	PUNCT
ajlm-2519	24	437	and	and	CCONJ
ajlm-2519	24	438	s.	s.	PROPN
ajlm-2519	24	439	aureus	aureus	PROPN
ajlm-2519	24	440	(	(	PUNCT
ajlm-2519	24	441	12.0%).13	12.0%).13	PRON
ajlm-2519	24	442	similarly	similarly	ADV
ajlm-2519	24	443	,	,	PUNCT
ajlm-2519	24	444	in	in	ADP
ajlm-2519	24	445	2020	2020	NUM
ajlm-2519	24	446	,	,	PUNCT
ajlm-2519	24	447	from	from	ADP
ajlm-2519	24	448	a	a	DET
ajlm-2519	24	449	mixed	mixed	ADJ
ajlm-2519	24	450	population	population	NOUN
ajlm-2519	24	451	of	of	ADP
ajlm-2519	24	452	patients	patient	NOUN
ajlm-2519	24	453	,	,	PUNCT
ajlm-2519	24	454	k.	k.	PROPN
ajlm-2519	24	455	pneumoniae	pneumoniae	PROPN
ajlm-2519	24	456	was	be	AUX
ajlm-2519	24	457	the	the	DET
ajlm-2519	24	458	eskape	eskape	NOUN
ajlm-2519	24	459	pathogen	pathogen	NOUN
ajlm-2519	24	460	isolated	isolate	VERB
ajlm-2519	24	461	the	the	DET
ajlm-2519	24	462	most	most	ADJ
ajlm-2519	24	463	in	in	ADP
ajlm-2519	24	464	the	the	DET
ajlm-2519	24	465	bloodstream	bloodstream	NOUN
ajlm-2519	24	466	in	in	ADP
ajlm-2519	24	467	south	south	PROPN
ajlm-2519	24	468	africa	africa	PROPN
ajlm-2519	24	469	,	,	PUNCT
ajlm-2519	24	470	followed	follow	VERB
ajlm-2519	24	471	by	by	ADP
ajlm-2519	24	472	s.	s.	PROPN
ajlm-2519	24	473	aureus	aureus	PROPN
ajlm-2519	24	474	,	,	PUNCT
ajlm-2519	24	475	a.	a.	NOUN
ajlm-2519	24	476	baumannii	baumannii	PROPN
ajlm-2519	24	477	,	,	PUNCT
ajlm-2519	24	478	e.	e.	PROPN
ajlm-2519	24	479	faecium	faecium	PROPN
ajlm-2519	24	480	and	and	CCONJ
ajlm-2519	24	481	p.	p.	NOUN
ajlm-2519	24	482	aeruginosa.11	aeruginosa.11	VERB
ajlm-2519	24	483	the	the	DET
ajlm-2519	24	484	susceptibility	susceptibility	NOUN
ajlm-2519	24	485	of	of	ADP
ajlm-2519	24	486	k.	k.	PROPN
ajlm-2519	24	487	pneumoniae	pneumoniae	ADJ
ajlm-2519	24	488	to	to	PART
ajlm-2519	24	489	meropenem	meropenem	PROPN
ajlm-2519	24	490	in	in	ADP
ajlm-2519	24	491	south	south	PROPN
ajlm-2519	24	492	africa	africa	PROPN
ajlm-2519	24	493	decreased	decrease	VERB
ajlm-2519	24	494	significantly	significantly	ADV
ajlm-2519	24	495	from	from	ADP
ajlm-2519	24	496	98.0	98.0	NUM
ajlm-2519	24	497	%	%	NOUN
ajlm-2519	24	498	in	in	ADP
ajlm-2519	24	499	2014	2014	NUM
ajlm-2519	24	500	to	to	ADP
ajlm-2519	24	501	89.0	89.0	NUM
ajlm-2519	24	502	%	%	NOUN
ajlm-2519	24	503	in	in	ADP
ajlm-2519	24	504	2019	2019	NUM
ajlm-2519	24	505	(	(	PUNCT
ajlm-2519	24	506	p	p	X
ajlm-2519	24	507	=	=	NOUN
ajlm-2519	24	508	0.033	0.033	NUM
ajlm-2519	24	509	)	)	PUNCT
ajlm-2519	24	510	.	.	PUNCT
ajlm-2519	25	1	during	during	ADP
ajlm-2519	25	2	the	the	DET
ajlm-2519	25	3	same	same	ADJ
ajlm-2519	25	4	period	period	NOUN
ajlm-2519	25	5	,	,	PUNCT
ajlm-2519	25	6	the	the	DET
ajlm-2519	25	7	a.	a.	NOUN
ajlm-2519	25	8	baumannii	baumannii	PROPN
ajlm-2519	25	9	isolates	isolate	NOUN
ajlm-2519	25	10	decreased	decrease	VERB
ajlm-2519	25	11	susceptibility	susceptibility	NOUN
ajlm-2519	25	12	to	to	PART
ajlm-2519	25	13	meropenem	meropenem	PROPN
ajlm-2519	25	14	(	(	PUNCT
ajlm-2519	25	15	23.0	23.0	NUM
ajlm-2519	25	16	%	%	NOUN
ajlm-2519	25	17	to	to	ADP
ajlm-2519	25	18	12.0	12.0	NUM
ajlm-2519	25	19	%	%	NOUN
ajlm-2519	25	20	;	;	PUNCT
ajlm-2519	26	1	p	p	X
ajlm-2519	26	2	=	=	PUNCT
ajlm-2519	26	3	0.051).13	0.051).13	X
ajlm-2519	27	1	the	the	DET
ajlm-2519	27	2	latest	late	ADJ
ajlm-2519	27	3	(	(	PUNCT
ajlm-2519	27	4	2020	2020	NUM
ajlm-2519	27	5	)	)	PUNCT
ajlm-2519	27	6	amr	amr	NOUN
ajlm-2519	27	7	data	datum	NOUN
ajlm-2519	27	8	for	for	ADP
ajlm-2519	27	9	eskape	eskape	NOUN
ajlm-2519	27	10	pathogens	pathogen	NOUN
ajlm-2519	27	11	in	in	ADP
ajlm-2519	27	12	south	south	PROPN
ajlm-2519	27	13	africa	africa	PROPN
ajlm-2519	27	14	showed	show	VERB
ajlm-2519	27	15	that	that	SCONJ
ajlm-2519	27	16	the	the	DET
ajlm-2519	27	17	incidence	incidence	NOUN
ajlm-2519	27	18	of	of	ADP
ajlm-2519	27	19	extended	extend	VERB
ajlm-2519	27	20	-	-	PUNCT
ajlm-2519	27	21	spectrum	spectrum	NOUN
ajlm-2519	27	22	beta	beta	NOUN
ajlm-2519	27	23	-	-	PUNCT
ajlm-2519	27	24	lactamase	lactamase	NOUN
ajlm-2519	27	25	-	-	PUNCT
ajlm-2519	27	26	producing	produce	VERB
ajlm-2519	27	27	k.	k.	NOUN
ajlm-2519	27	28	pneumoniae	pneumoniae	NOUN
ajlm-2519	27	29	increased	increase	VERB
ajlm-2519	27	30	from	from	ADP
ajlm-2519	27	31	65.0	65.0	NUM
ajlm-2519	27	32	%	%	NOUN
ajlm-2519	27	33	in	in	ADP
ajlm-2519	27	34	2016	2016	NUM
ajlm-2519	27	35	to	to	ADP
ajlm-2519	27	36	70.0	70.0	NUM
ajlm-2519	27	37	%	%	NOUN
ajlm-2519	27	38	in	in	ADP
ajlm-2519	27	39	2020	2020	NUM
ajlm-2519	27	40	,	,	PUNCT
ajlm-2519	27	41	and	and	CCONJ
ajlm-2519	27	42	carbapenem	carbapenem	NOUN
ajlm-2519	27	43	-	-	PUNCT
ajlm-2519	27	44	resistant	resistant	ADJ
ajlm-2519	27	45	k.	k.	NOUN
ajlm-2519	27	46	pneumoniae	pneumoniae	NOUN
ajlm-2519	27	47	was	be	AUX
ajlm-2519	27	48	at	at	ADP
ajlm-2519	27	49	40.0%.11	40.0%.11	VERB
ajlm-2519	27	50	methicillin	methicillin	NOUN
ajlm-2519	27	51	-	-	PUNCT
ajlm-2519	27	52	resistant	resistant	ADJ
ajlm-2519	27	53	s.	s.	PROPN
ajlm-2519	27	54	aureus	aureus	PROPN
ajlm-2519	27	55	decreased	decrease	VERB
ajlm-2519	27	56	from	from	ADP
ajlm-2519	27	57	23.0	23.0	NUM
ajlm-2519	27	58	%	%	NOUN
ajlm-2519	27	59	in	in	ADP
ajlm-2519	27	60	2016	2016	NUM
ajlm-2519	27	61	to	to	ADP
ajlm-2519	27	62	18.0	18.0	NUM
ajlm-2519	27	63	%	%	NOUN
ajlm-2519	27	64	in	in	ADP
ajlm-2519	27	65	2020	2020	NUM
ajlm-2519	27	66	.	.	PUNCT
ajlm-2519	28	1	also	also	ADV
ajlm-2519	28	2	in	in	ADP
ajlm-2519	28	3	2020	2020	NUM
ajlm-2519	28	4	,	,	PUNCT
ajlm-2519	28	5	crab	crab	NOUN
ajlm-2519	28	6	was	be	AUX
ajlm-2519	28	7	80.0	80.0	NUM
ajlm-2519	28	8	%	%	NOUN
ajlm-2519	28	9	,	,	PUNCT
ajlm-2519	28	10	carbapenem	carbapenem	NOUN
ajlm-2519	28	11	-	-	PUNCT
ajlm-2519	28	12	resistant	resistant	ADJ
ajlm-2519	28	13	p.	p.	NOUN
ajlm-2519	28	14	aeruginosa	aeruginosa	NOUN
ajlm-2519	28	15	was	be	AUX
ajlm-2519	28	16	33.0	33.0	NUM
ajlm-2519	28	17	%	%	NOUN
ajlm-2519	28	18	,	,	PUNCT
ajlm-2519	28	19	and	and	CCONJ
ajlm-2519	28	20	vancomycin	vancomycin	ADV
ajlm-2519	28	21	-	-	PUNCT
ajlm-2519	28	22	resistant	resistant	ADJ
ajlm-2519	28	23	e.	e.	PROPN
ajlm-2519	28	24	faecium	faecium	PROPN
ajlm-2519	28	25	was	be	AUX
ajlm-2519	28	26	1.3	1.3	NUM
ajlm-2519	28	27	%	%	NOUN
ajlm-2519	28	28	,	,	PUNCT
ajlm-2519	28	29	with	with	ADP
ajlm-2519	28	30	provincial	provincial	ADJ
ajlm-2519	28	31	variations	variation	NOUN
ajlm-2519	28	32	attributed	attribute	VERB
ajlm-2519	28	33	to	to	ADP
ajlm-2519	28	34	differences	difference	NOUN
ajlm-2519	28	35	in	in	ADP
ajlm-2519	28	36	the	the	DET
ajlm-2519	28	37	empirical	empirical	ADJ
ajlm-2519	28	38	use	use	NOUN
ajlm-2519	28	39	of	of	ADP
ajlm-2519	28	40	different	different	ADJ
ajlm-2519	28	41	antibiotics.11	antibiotics.11	NOUN
ajlm-2519	28	42	previously	previously	ADV
ajlm-2519	28	43	,	,	PUNCT
ajlm-2519	28	44	south	south	PROPN
ajlm-2519	28	45	africa	africa	PROPN
ajlm-2519	28	46	conducted	conduct	VERB
ajlm-2519	28	47	sentinel	sentinel	ADJ
ajlm-2519	28	48	amr	amr	ADJ
ajlm-2519	28	49	surveillance	surveillance	NOUN
ajlm-2519	28	50	mainly	mainly	ADV
ajlm-2519	28	51	in	in	ADP
ajlm-2519	28	52	urban	urban	ADJ
ajlm-2519	28	53	academic	academic	ADJ
ajlm-2519	28	54	hospitals	hospital	NOUN
ajlm-2519	28	55	.	.	PUNCT
ajlm-2519	29	1	therefore	therefore	ADV
ajlm-2519	29	2	,	,	PUNCT
ajlm-2519	29	3	there	there	PRON
ajlm-2519	29	4	was	be	VERB
ajlm-2519	29	5	inadequate	inadequate	ADJ
ajlm-2519	29	6	amr	amr	NOUN
ajlm-2519	29	7	surveillance	surveillance	NOUN
ajlm-2519	29	8	data	datum	NOUN
ajlm-2519	29	9	from	from	ADP
ajlm-2519	29	10	rural	rural	ADJ
ajlm-2519	29	11	hospitals	hospital	NOUN
ajlm-2519	29	12	,	,	PUNCT
ajlm-2519	29	13	particularly	particularly	ADV
ajlm-2519	29	14	those	those	PRON
ajlm-2519	29	15	in	in	ADP
ajlm-2519	29	16	limpopo	limpopo	PROPN
ajlm-2519	29	17	province.14,15,16,17	province.14,15,16,17	PROPN
ajlm-2519	29	18	a	a	DET
ajlm-2519	29	19	nationwide	nationwide	ADJ
ajlm-2519	29	20	public	public	ADJ
ajlm-2519	29	21	sector	sector	NOUN
ajlm-2519	29	22	study13	study13	NOUN
ajlm-2519	29	23	and	and	CCONJ
ajlm-2519	29	24	several	several	ADJ
ajlm-2519	29	25	single	single	ADJ
ajlm-2519	29	26	-	-	PUNCT
ajlm-2519	29	27	centre	centre	NOUN
ajlm-2519	29	28	bloodstream	bloodstream	NOUN
ajlm-2519	29	29	culture	culture	NOUN
ajlm-2519	29	30	studies	study	NOUN
ajlm-2519	29	31	from	from	ADP
ajlm-2519	29	32	gauteng,18	gauteng,18	PROPN
ajlm-2519	29	33	kwazulu	kwazulu	PROPN
ajlm-2519	29	34	-	-	PUNCT
ajlm-2519	29	35	natal19	natal19	NOUN
ajlm-2519	29	36	and	and	CCONJ
ajlm-2519	29	37	the	the	DET
ajlm-2519	29	38	western	western	ADJ
ajlm-2519	29	39	cape20,21	cape20,21	NOUN
ajlm-2519	29	40	show	show	NOUN
ajlm-2519	29	41	incidence	incidence	NOUN
ajlm-2519	29	42	and	and	CCONJ
ajlm-2519	29	43	amr	amr	NOUN
ajlm-2519	29	44	variability	variability	NOUN
ajlm-2519	29	45	of	of	ADP
ajlm-2519	29	46	eskape	eskape	NOUN
ajlm-2519	29	47	pathogens	pathogen	NOUN
ajlm-2519	29	48	according	accord	VERB
ajlm-2519	29	49	to	to	ADP
ajlm-2519	29	50	the	the	DET
ajlm-2519	29	51	health	health	NOUN
ajlm-2519	29	52	sector	sector	NOUN
ajlm-2519	29	53	(	(	PUNCT
ajlm-2519	29	54	public	public	ADJ
ajlm-2519	29	55	versus	versus	ADP
ajlm-2519	29	56	private	private	ADJ
ajlm-2519	29	57	)	)	PUNCT
ajlm-2519	29	58	,	,	PUNCT
ajlm-2519	29	59	location	location	NOUN
ajlm-2519	29	60	,	,	PUNCT
ajlm-2519	29	61	hospital	hospital	NOUN
ajlm-2519	29	62	ward	ward	NOUN
ajlm-2519	29	63	,	,	PUNCT
ajlm-2519	29	64	patient	patient	ADJ
ajlm-2519	29	65	age	age	NOUN
ajlm-2519	29	66	(	(	PUNCT
ajlm-2519	29	67	e.g.	e.g.	ADV
ajlm-2519	29	68	,	,	PUNCT
ajlm-2519	29	69	neonates	neonate	NOUN
ajlm-2519	29	70	versus	versus	ADP
ajlm-2519	29	71	adults	adult	NOUN
ajlm-2519	29	72	)	)	PUNCT
ajlm-2519	29	73	,	,	PUNCT
ajlm-2519	29	74	level	level	NOUN
ajlm-2519	29	75	of	of	ADP
ajlm-2519	29	76	healthcare	healthcare	NOUN
ajlm-2519	29	77	(	(	PUNCT
ajlm-2519	29	78	i.e.	i.e.	X
ajlm-2519	29	79	,	,	PUNCT
ajlm-2519	29	80	district	district	NOUN
ajlm-2519	29	81	,	,	PUNCT
ajlm-2519	29	82	regional	regional	ADJ
ajlm-2519	29	83	,	,	PUNCT
ajlm-2519	29	84	and	and	CCONJ
ajlm-2519	29	85	national	national	ADJ
ajlm-2519	29	86	hospitals	hospital	NOUN
ajlm-2519	29	87	)	)	PUNCT
ajlm-2519	29	88	,	,	PUNCT
ajlm-2519	29	89	the	the	DET
ajlm-2519	29	90	source	source	NOUN
ajlm-2519	29	91	of	of	ADP
ajlm-2519	29	92	infection	infection	NOUN
ajlm-2519	29	93	(	(	PUNCT
ajlm-2519	29	94	e.g.	e.g.	ADV
ajlm-2519	29	95	,	,	PUNCT
ajlm-2519	29	96	community	community	NOUN
ajlm-2519	29	97	-	-	PUNCT
ajlm-2519	29	98	acquired	acquire	VERB
ajlm-2519	29	99	versus	versus	ADP
ajlm-2519	29	100	hospital	hospital	NOUN
ajlm-2519	29	101	-	-	PUNCT
ajlm-2519	29	102	acquired	acquire	VERB
ajlm-2519	29	103	infections	infection	NOUN
ajlm-2519	29	104	)	)	PUNCT
ajlm-2519	29	105	,	,	PUNCT
ajlm-2519	29	106	and	and	CCONJ
ajlm-2519	29	107	increased	increase	VERB
ajlm-2519	29	108	antibiotic	antibiotic	ADJ
ajlm-2519	29	109	resistance	resistance	NOUN
ajlm-2519	29	110	of	of	ADP
ajlm-2519	29	111	gram	gram	NOUN
ajlm-2519	29	112	-	-	PUNCT
ajlm-2519	29	113	negative	negative	ADJ
ajlm-2519	29	114	bacteria	bacteria	NOUN
ajlm-2519	29	115	.	.	PUNCT
ajlm-2519	30	1	these	these	DET
ajlm-2519	30	2	observed	observed	ADJ
ajlm-2519	30	3	variations	variation	NOUN
ajlm-2519	30	4	emphasise	emphasise	VERB
ajlm-2519	30	5	the	the	DET
ajlm-2519	30	6	importance	importance	NOUN
ajlm-2519	30	7	of	of	ADP
ajlm-2519	30	8	local	local	ADJ
ajlm-2519	30	9	data	datum	NOUN
ajlm-2519	30	10	on	on	ADP
ajlm-2519	30	11	the	the	DET
ajlm-2519	30	12	incidence	incidence	NOUN
ajlm-2519	30	13	and	and	CCONJ
ajlm-2519	30	14	antibiotic	antibiotic	ADJ
ajlm-2519	30	15	resistance	resistance	NOUN
ajlm-2519	30	16	,	,	PUNCT
ajlm-2519	30	17	particularly	particularly	ADV
ajlm-2519	30	18	for	for	ADP
ajlm-2519	30	19	local	local	ADJ
ajlm-2519	30	20	policy	policy	NOUN
ajlm-2519	30	21	and	and	CCONJ
ajlm-2519	30	22	practice	practice	NOUN
ajlm-2519	30	23	interventions	intervention	NOUN
ajlm-2519	30	24	such	such	ADJ
ajlm-2519	30	25	as	as	ADP
ajlm-2519	30	26	developing	develop	VERB
ajlm-2519	30	27	empirical	empirical	ADJ
ajlm-2519	30	28	treatment	treatment	NOUN
ajlm-2519	30	29	formularies	formulary	NOUN
ajlm-2519	30	30	by	by	ADP
ajlm-2519	30	31	hospital	hospital	NOUN
ajlm-2519	30	32	infection	infection	NOUN
ajlm-2519	30	33	prevention	prevention	NOUN
ajlm-2519	30	34	and	and	CCONJ
ajlm-2519	30	35	control	control	NOUN
ajlm-2519	30	36	and	and	CCONJ
ajlm-2519	30	37	antibiotic	antibiotic	ADJ
ajlm-2519	30	38	stewardship	stewardship	NOUN
ajlm-2519	30	39	programmes.11,13	programmes.11,13	NOUN
ajlm-2519	30	40	the	the	DET
ajlm-2519	30	41	surveillance	surveillance	NOUN
ajlm-2519	30	42	of	of	ADP
ajlm-2519	30	43	eskape	eskape	NOUN
ajlm-2519	30	44	pathogen	pathogen	NOUN
ajlm-2519	30	45	incidence	incidence	NOUN
ajlm-2519	30	46	and	and	CCONJ
ajlm-2519	30	47	priority	priority	NOUN
ajlm-2519	30	48	drug	drug	NOUN
ajlm-2519	30	49	-	-	PUNCT
ajlm-2519	30	50	pathogen	pathogen	NOUN
ajlm-2519	30	51	-	-	PUNCT
ajlm-2519	30	52	resistant	resistant	ADJ
ajlm-2519	30	53	combinations	combination	NOUN
ajlm-2519	30	54	must	must	AUX
ajlm-2519	30	55	therefore	therefore	ADV
ajlm-2519	30	56	be	be	AUX
ajlm-2519	30	57	prioritised	prioritise	VERB
ajlm-2519	30	58	and	and	CCONJ
ajlm-2519	30	59	strengthened	strengthen	VERB
ajlm-2519	30	60	to	to	PART
ajlm-2519	30	61	understand	understand	VERB
ajlm-2519	30	62	their	their	PRON
ajlm-2519	30	63	magnitude.2,8,10	magnitude.2,8,10	NOUN
ajlm-2519	30	64	against	against	ADP
ajlm-2519	30	65	this	this	DET
ajlm-2519	30	66	background	background	NOUN
ajlm-2519	30	67	,	,	PUNCT
ajlm-2519	30	68	this	this	DET
ajlm-2519	30	69	study	study	NOUN
ajlm-2519	30	70	reports	report	VERB
ajlm-2519	30	71	on	on	ADP
ajlm-2519	30	72	the	the	DET
ajlm-2519	30	73	incidence	incidence	NOUN
ajlm-2519	30	74	of	of	ADP
ajlm-2519	30	75	eskape	eskape	NOUN
ajlm-2519	30	76	pathogens	pathogen	NOUN
ajlm-2519	30	77	,	,	PUNCT
ajlm-2519	30	78	selected	select	VERB
ajlm-2519	30	79	combinations	combination	NOUN
ajlm-2519	30	80	of	of	ADP
ajlm-2519	30	81	who	who	PRON
ajlm-2519	30	82	priority	priority	VERB
ajlm-2519	30	83	drug	drug	NOUN
ajlm-2519	30	84	-	-	PUNCT
ajlm-2519	30	85	pathogen	pathogen	NOUN
ajlm-2519	30	86	resistance	resistance	NOUN
ajlm-2519	30	87	and	and	CCONJ
ajlm-2519	30	88	resistance	resistance	NOUN
ajlm-2519	30	89	to	to	ADP
ajlm-2519	30	90	reserve	reserve	NOUN
ajlm-2519	30	91	(	(	PUNCT
ajlm-2519	30	92	last	last	ADJ
ajlm-2519	30	93	resort	resort	NOUN
ajlm-2519	30	94	)	)	PUNCT
ajlm-2519	30	95	antibiotics	antibiotic	NOUN
ajlm-2519	30	96	using	use	VERB
ajlm-2519	30	97	routinely	routinely	ADV
ajlm-2519	30	98	collected	collect	VERB
ajlm-2519	30	99	data	datum	NOUN
ajlm-2519	30	100	of	of	ADP
ajlm-2519	30	101	patients	patient	NOUN
ajlm-2519	30	102	with	with	ADP
ajlm-2519	30	103	bloodstream	bloodstream	NOUN
ajlm-2519	30	104	infections	infection	NOUN
ajlm-2519	30	105	limpopo	limpopo	PROPN
ajlm-2519	30	106	province	province	PROPN
ajlm-2519	30	107	,	,	PUNCT
ajlm-2519	30	108	south	south	PROPN
ajlm-2519	30	109	africa	africa	PROPN
ajlm-2519	30	110	.	.	PUNCT
ajlm-2519	31	1	methods	method	NOUN
ajlm-2519	31	2	ethical	ethical	ADJ
ajlm-2519	31	3	considerations	consideration	NOUN
ajlm-2519	31	4	the	the	DET
ajlm-2519	31	5	study	study	NOUN
ajlm-2519	31	6	obtained	obtain	VERB
ajlm-2519	31	7	ethical	ethical	ADJ
ajlm-2519	31	8	clearance	clearance	NOUN
ajlm-2519	31	9	from	from	ADP
ajlm-2519	31	10	the	the	DET
ajlm-2519	31	11	north	north	NOUN
ajlm-2519	31	12	-	-	PUNCT
ajlm-2519	31	13	west	west	PROPN
ajlm-2519	31	14	university	university	PROPN
ajlm-2519	31	15	health	health	PROPN
ajlm-2519	31	16	research	research	PROPN
ajlm-2519	31	17	ethics	ethic	NOUN
ajlm-2519	31	18	committee	committee	PROPN
ajlm-2519	31	19	(	(	PUNCT
ajlm-2519	31	20	approval	approval	NOUN
ajlm-2519	31	21	number	number	NOUN
ajlm-2519	31	22	nwu-00312	nwu-00312	NOUN
ajlm-2519	31	23	-	-	PUNCT
ajlm-2519	31	24	20	20	NUM
ajlm-2519	31	25	-	-	PUNCT
ajlm-2519	31	26	a1	a1	NOUN
ajlm-2519	31	27	)	)	PUNCT
ajlm-2519	31	28	.	.	PUNCT
ajlm-2519	32	1	the	the	DET
ajlm-2519	32	2	national	national	PROPN
ajlm-2519	32	3	health	health	PROPN
ajlm-2519	32	4	laboratory	laboratory	PROPN
ajlm-2519	32	5	services	service	NOUN
ajlm-2519	32	6	manager	manager	NOUN
ajlm-2519	32	7	for	for	ADP
ajlm-2519	32	8	academic	academic	ADJ
ajlm-2519	32	9	affairs	affair	NOUN
ajlm-2519	32	10	and	and	CCONJ
ajlm-2519	32	11	research	research	NOUN
ajlm-2519	32	12	granted	grant	VERB
ajlm-2519	32	13	permission	permission	NOUN
ajlm-2519	32	14	to	to	PART
ajlm-2519	32	15	access	access	VERB
ajlm-2519	32	16	the	the	DET
ajlm-2519	32	17	data	datum	NOUN
ajlm-2519	32	18	source	source	NOUN
ajlm-2519	32	19	.	.	PUNCT
ajlm-2519	33	1	the	the	DET
ajlm-2519	33	2	head	head	NOUN
ajlm-2519	33	3	of	of	ADP
ajlm-2519	33	4	the	the	DET
ajlm-2519	33	5	limpopo	limpopo	PROPN
ajlm-2519	33	6	department	department	PROPN
ajlm-2519	33	7	of	of	ADP
ajlm-2519	33	8	health	health	NOUN
ajlm-2519	33	9	granted	grant	VERB
ajlm-2519	33	10	data	datum	NOUN
ajlm-2519	33	11	access	access	NOUN
ajlm-2519	33	12	permission	permission	NOUN
ajlm-2519	33	13	and	and	CCONJ
ajlm-2519	33	14	use	use	NOUN
ajlm-2519	33	15	of	of	ADP
ajlm-2519	33	16	the	the	DET
ajlm-2519	33	17	study	study	NOUN
ajlm-2519	33	18	centre	centre	NOUN
ajlm-2519	33	19	name	name	NOUN
ajlm-2519	33	20	in	in	ADP
ajlm-2519	33	21	publications	publication	NOUN
ajlm-2519	33	22	.	.	PUNCT
ajlm-2519	34	1	the	the	DET
ajlm-2519	34	2	north	north	NOUN
ajlm-2519	34	3	-	-	PUNCT
ajlm-2519	34	4	west	west	PROPN
ajlm-2519	34	5	university	university	PROPN
ajlm-2519	34	6	health	health	PROPN
ajlm-2519	34	7	research	research	PROPN
ajlm-2519	34	8	ethics	ethic	NOUN
ajlm-2519	34	9	committee	committee	PROPN
ajlm-2519	34	10	also	also	ADV
ajlm-2519	34	11	granted	grant	VERB
ajlm-2519	34	12	a	a	DET
ajlm-2519	34	13	patient	patient	NOUN
ajlm-2519	34	14	informed	inform	VERB
ajlm-2519	34	15	consent	consent	NOUN
ajlm-2519	34	16	waiver	waiver	NOUN
ajlm-2519	34	17	since	since	SCONJ
ajlm-2519	34	18	the	the	DET
ajlm-2519	34	19	data	datum	NOUN
ajlm-2519	34	20	set	set	VERB
ajlm-2519	34	21	was	be	AUX
ajlm-2519	34	22	provided	provide	VERB
ajlm-2519	34	23	without	without	ADP
ajlm-2519	34	24	patient	patient	ADJ
ajlm-2519	34	25	names	name	NOUN
ajlm-2519	34	26	and	and	CCONJ
ajlm-2519	34	27	other	other	ADJ
ajlm-2519	34	28	personal	personal	ADJ
ajlm-2519	34	29	details	detail	NOUN
ajlm-2519	34	30	(	(	PUNCT
ajlm-2519	34	31	unique	unique	ADJ
ajlm-2519	34	32	identification	identification	NOUN
ajlm-2519	34	33	codes	code	NOUN
ajlm-2519	34	34	only	only	ADV
ajlm-2519	34	35	)	)	PUNCT
ajlm-2519	34	36	.	.	PUNCT
ajlm-2519	35	1	the	the	DET
ajlm-2519	35	2	data	datum	NOUN
ajlm-2519	35	3	set	set	VERB
ajlm-2519	35	4	was	be	AUX
ajlm-2519	35	5	received	receive	VERB
ajlm-2519	35	6	in	in	ADP
ajlm-2519	35	7	a	a	DET
ajlm-2519	35	8	password	password	NOUN
ajlm-2519	35	9	-	-	PUNCT
ajlm-2519	35	10	protected	protect	VERB
ajlm-2519	35	11	microsoft	microsoft	PROPN
ajlm-2519	35	12	excel	excel	PROPN
ajlm-2519	35	13	®	®	PROPN
ajlm-2519	35	14	(	(	PUNCT
ajlm-2519	35	15	microsoft	microsoft	PROPN
ajlm-2519	35	16	corp	corp	PROPN
ajlm-2519	35	17	.	.	PROPN
ajlm-2519	35	18	,	,	PUNCT
ajlm-2519	35	19	redmond	redmond	PROPN
ajlm-2519	35	20	,	,	PUNCT
ajlm-2519	35	21	washington	washington	PROPN
ajlm-2519	35	22	,	,	PUNCT
ajlm-2519	35	23	united	united	PROPN
ajlm-2519	35	24	states	states	PROPN
ajlm-2519	35	25	)	)	PUNCT
ajlm-2519	35	26	spreadsheet	spreadsheet	NOUN
ajlm-2519	35	27	file	file	NOUN
ajlm-2519	35	28	and	and	CCONJ
ajlm-2519	35	29	was	be	AUX
ajlm-2519	35	30	stored	store	VERB
ajlm-2519	35	31	on	on	ADP
ajlm-2519	35	32	a	a	DET
ajlm-2519	35	33	password	password	NOUN
ajlm-2519	35	34	-	-	PUNCT
ajlm-2519	35	35	protected	protect	VERB
ajlm-2519	35	36	computer	computer	NOUN
ajlm-2519	35	37	.	.	PUNCT
ajlm-2519	36	1	this	this	DET
ajlm-2519	36	2	manuscript	manuscript	NOUN
ajlm-2519	36	3	does	do	AUX
ajlm-2519	36	4	not	not	PART
ajlm-2519	36	5	report	report	VERB
ajlm-2519	36	6	on	on	ADP
ajlm-2519	36	7	the	the	DET
ajlm-2519	36	8	use	use	NOUN
ajlm-2519	36	9	of	of	ADP
ajlm-2519	36	10	any	any	DET
ajlm-2519	36	11	animal	animal	NOUN
ajlm-2519	36	12	or	or	CCONJ
ajlm-2519	36	13	human	human	ADJ
ajlm-2519	36	14	data	datum	NOUN
ajlm-2519	36	15	or	or	CCONJ
ajlm-2519	36	16	tissue	tissue	NOUN
ajlm-2519	36	17	.	.	PUNCT
ajlm-2519	37	1	data	datum	NOUN
ajlm-2519	37	2	collection	collection	NOUN
ajlm-2519	37	3	a	a	DET
ajlm-2519	37	4	retrospective	retrospective	ADJ
ajlm-2519	37	5	,	,	PUNCT
ajlm-2519	37	6	quantitative	quantitative	ADJ
ajlm-2519	37	7	descriptive	descriptive	ADJ
ajlm-2519	37	8	study	study	NOUN
ajlm-2519	37	9	design	design	NOUN
ajlm-2519	37	10	was	be	AUX
ajlm-2519	37	11	adopted	adopt	VERB
ajlm-2519	37	12	.	.	PUNCT
ajlm-2519	38	1	the	the	DET
ajlm-2519	38	2	data	datum	NOUN
ajlm-2519	38	3	were	be	AUX
ajlm-2519	38	4	retrieved	retrieve	VERB
ajlm-2519	38	5	from	from	ADP
ajlm-2519	38	6	the	the	DET
ajlm-2519	38	7	national	national	PROPN
ajlm-2519	38	8	health	health	PROPN
ajlm-2519	38	9	laboratory	laboratory	PROPN
ajlm-2519	38	10	service	service	NOUN
ajlm-2519	38	11	(	(	PUNCT
ajlm-2519	38	12	nhls	nhls	NOUN
ajlm-2519	38	13	)	)	PUNCT
ajlm-2519	38	14	database	database	NOUN
ajlm-2519	38	15	,	,	PUNCT
ajlm-2519	38	16	the	the	DET
ajlm-2519	38	17	national	national	ADJ
ajlm-2519	38	18	repository	repository	NOUN
ajlm-2519	38	19	for	for	ADP
ajlm-2519	38	20	all	all	DET
ajlm-2519	38	21	laboratory	laboratory	NOUN
ajlm-2519	38	22	tests	test	NOUN
ajlm-2519	38	23	performed	perform	VERB
ajlm-2519	38	24	by	by	ADP
ajlm-2519	38	25	south	south	ADJ
ajlm-2519	38	26	african	african	ADJ
ajlm-2519	38	27	public	public	ADJ
ajlm-2519	38	28	hospitals.22	hospitals.22	NOUN
ajlm-2519	38	29	no	no	DET
ajlm-2519	38	30	patient	patient	ADJ
ajlm-2519	38	31	demographic	demographic	ADJ
ajlm-2519	38	32	and	and	CCONJ
ajlm-2519	38	33	clinical	clinical	ADJ
ajlm-2519	38	34	data	datum	NOUN
ajlm-2519	38	35	were	be	AUX
ajlm-2519	38	36	extracted	extract	VERB
ajlm-2519	38	37	for	for	ADP
ajlm-2519	38	38	the	the	DET
ajlm-2519	38	39	study	study	NOUN
ajlm-2519	38	40	.	.	PUNCT
ajlm-2519	39	1	extracted	extract	VERB
ajlm-2519	39	2	study	study	NOUN
ajlm-2519	39	3	variables	variable	NOUN
ajlm-2519	39	4	include	include	VERB
ajlm-2519	39	5	the	the	DET
ajlm-2519	39	6	ward	ward	NOUN
ajlm-2519	39	7	name	name	NOUN
ajlm-2519	39	8	,	,	PUNCT
ajlm-2519	39	9	specimen	speciman	NOUN
ajlm-2519	39	10	type	type	NOUN
ajlm-2519	39	11	(	(	PUNCT
ajlm-2519	39	12	blood	blood	NOUN
ajlm-2519	39	13	)	)	PUNCT
ajlm-2519	39	14	,	,	PUNCT
ajlm-2519	39	15	patient	patient	ADJ
ajlm-2519	39	16	unique	unique	ADJ
ajlm-2519	39	17	identification	identification	NOUN
ajlm-2519	39	18	codes	code	NOUN
ajlm-2519	39	19	,	,	PUNCT
ajlm-2519	39	20	organism	organism	NOUN
ajlm-2519	39	21	name	name	NOUN
ajlm-2519	39	22	,	,	PUNCT
ajlm-2519	39	23	year	year	NOUN
ajlm-2519	39	24	of	of	ADP
ajlm-2519	39	25	isolation	isolation	NOUN
ajlm-2519	39	26	,	,	PUNCT
ajlm-2519	39	27	and	and	CCONJ
ajlm-2519	39	28	antimicrobial	antimicrobial	ADJ
ajlm-2519	39	29	susceptibility	susceptibility	NOUN
ajlm-2519	39	30	test	test	NOUN
ajlm-2519	39	31	outcome	outcome	NOUN
ajlm-2519	39	32	(	(	PUNCT
ajlm-2519	39	33	intermediate	intermediate	ADJ
ajlm-2519	39	34	,	,	PUNCT
ajlm-2519	39	35	resistant	resistant	ADJ
ajlm-2519	39	36	,	,	PUNCT
ajlm-2519	39	37	or	or	CCONJ
ajlm-2519	39	38	sensitive	sensitive	ADJ
ajlm-2519	39	39	)	)	PUNCT
ajlm-2519	39	40	.	.	PUNCT
ajlm-2519	40	1	the	the	DET
ajlm-2519	40	2	data	datum	NOUN
ajlm-2519	40	3	represented	represent	VERB
ajlm-2519	40	4	all	all	DET
ajlm-2519	40	5	blood	blood	NOUN
ajlm-2519	40	6	culture	culture	NOUN
ajlm-2519	40	7	specimens	specimen	NOUN
ajlm-2519	40	8	performed	perform	VERB
ajlm-2519	40	9	at	at	ADP
ajlm-2519	40	10	the	the	DET
ajlm-2519	40	11	509	509	NUM
ajlm-2519	40	12	-	-	PUNCT
ajlm-2519	40	13	bed	bed	NOUN
ajlm-2519	40	14	mankweng	mankweng	ADJ
ajlm-2519	40	15	tertiary	tertiary	ADJ
ajlm-2519	40	16	hospital	hospital	NOUN
ajlm-2519	40	17	.	.	PUNCT
ajlm-2519	41	1	there	there	PRON
ajlm-2519	41	2	were	be	VERB
ajlm-2519	41	3	454	454	NUM
ajlm-2519	41	4	beds	bed	NOUN
ajlm-2519	41	5	designated	designate	VERB
ajlm-2519	41	6	as	as	ADP
ajlm-2519	41	7	either	either	DET
ajlm-2519	41	8	level	level	NOUN
ajlm-2519	41	9	1	1	NUM
ajlm-2519	41	10	(	(	PUNCT
ajlm-2519	41	11	district	district	NOUN
ajlm-2519	41	12	)	)	PUNCT
ajlm-2519	41	13	or	or	CCONJ
ajlm-2519	41	14	level	level	NOUN
ajlm-2519	41	15	2	2	NUM
ajlm-2519	41	16	(	(	PUNCT
ajlm-2519	41	17	regional	regional	ADJ
ajlm-2519	41	18	)	)	PUNCT
ajlm-2519	41	19	,	,	PUNCT
ajlm-2519	41	20	and	and	CCONJ
ajlm-2519	41	21	55	55	NUM
ajlm-2519	41	22	as	as	ADP
ajlm-2519	41	23	level	level	NOUN
ajlm-2519	41	24	3	3	NUM
ajlm-2519	41	25	(	(	PUNCT
ajlm-2519	41	26	tertiary	tertiary	ADJ
ajlm-2519	41	27	services	service	NOUN
ajlm-2519	41	28	beds	bed	NOUN
ajlm-2519	41	29	)	)	PUNCT
ajlm-2519	41	30	.	.	PUNCT
ajlm-2519	42	1	the	the	DET
ajlm-2519	42	2	hospital	hospital	NOUN
ajlm-2519	42	3	is	be	AUX
ajlm-2519	42	4	approximately	approximately	ADV
ajlm-2519	42	5	30	30	NUM
ajlm-2519	42	6	km	km	NOUN
ajlm-2519	42	7	east	east	ADV
ajlm-2519	42	8	of	of	ADP
ajlm-2519	42	9	polokwane	polokwane	PROPN
ajlm-2519	42	10	in	in	ADP
ajlm-2519	42	11	the	the	DET
ajlm-2519	42	12	capricorn	capricorn	PROPN
ajlm-2519	42	13	district	district	PROPN
ajlm-2519	42	14	of	of	ADP
ajlm-2519	42	15	limpopo	limpopo	PROPN
ajlm-2519	42	16	province	province	PROPN
ajlm-2519	42	17	,	,	PUNCT
ajlm-2519	42	18	south	south	PROPN
ajlm-2519	42	19	africa	africa	PROPN
ajlm-2519	42	20	.	.	PUNCT
ajlm-2519	43	1	mankweng	mankweng	PROPN
ajlm-2519	43	2	tertiary	tertiary	ADJ
ajlm-2519	43	3	hospital	hospital	NOUN
ajlm-2519	43	4	is	be	AUX
ajlm-2519	43	5	the	the	DET
ajlm-2519	43	6	primary	primary	ADJ
ajlm-2519	43	7	hospital	hospital	NOUN
ajlm-2519	43	8	for	for	ADP
ajlm-2519	43	9	the	the	DET
ajlm-2519	43	10	surrounding	surround	VERB
ajlm-2519	43	11	community	community	NOUN
ajlm-2519	43	12	(	(	PUNCT
ajlm-2519	43	13	population	population	NOUN
ajlm-2519	43	14	of	of	ADP
ajlm-2519	43	15	~260	~260	NOUN
ajlm-2519	43	16	000	000	NUM
ajlm-2519	43	17	to	to	ADP
ajlm-2519	43	18	280	280	NUM
ajlm-2519	43	19	000	000	NUM
ajlm-2519	43	20	)	)	PUNCT
ajlm-2519	43	21	.	.	PUNCT
ajlm-2519	44	1	in	in	ADP
ajlm-2519	44	2	addition	addition	NOUN
ajlm-2519	44	3	,	,	PUNCT
ajlm-2519	44	4	the	the	DET
ajlm-2519	44	5	hospital	hospital	NOUN
ajlm-2519	44	6	offers	offer	VERB
ajlm-2519	44	7	24	24	NUM
ajlm-2519	44	8	-	-	PUNCT
ajlm-2519	44	9	h	h	NOUN
ajlm-2519	44	10	tertiary	tertiary	ADJ
ajlm-2519	44	11	services	service	NOUN
ajlm-2519	44	12	and	and	CCONJ
ajlm-2519	44	13	receives	receive	VERB
ajlm-2519	44	14	referrals	referral	NOUN
ajlm-2519	44	15	from	from	ADP
ajlm-2519	44	16	district	district	NOUN
ajlm-2519	44	17	and	and	CCONJ
ajlm-2519	44	18	regional	regional	ADJ
ajlm-2519	44	19	hospitals	hospital	NOUN
ajlm-2519	44	20	in	in	ADP
ajlm-2519	44	21	limpopo	limpopo	PROPN
ajlm-2519	44	22	province.23	province.23	PROPN
ajlm-2519	44	23	all	all	DET
ajlm-2519	44	24	eskape	eskape	NOUN
ajlm-2519	44	25	pathogens	pathogen	NOUN
ajlm-2519	44	26	isolated	isolate	VERB
ajlm-2519	44	27	from	from	ADP
ajlm-2519	44	28	bloodstream	bloodstream	NOUN
ajlm-2519	44	29	infection	infection	NOUN
ajlm-2519	44	30	and	and	CCONJ
ajlm-2519	44	31	their	their	PRON
ajlm-2519	44	32	respective	respective	ADJ
ajlm-2519	44	33	antibiotic	antibiotic	ADJ
ajlm-2519	44	34	susceptibility	susceptibility	NOUN
ajlm-2519	44	35	results	result	VERB
ajlm-2519	44	36	from	from	ADP
ajlm-2519	44	37	january	january	PROPN
ajlm-2519	44	38	2014	2014	NUM
ajlm-2519	44	39	to	to	ADP
ajlm-2519	44	40	december	december	PROPN
ajlm-2519	44	41	2019	2019	NUM
ajlm-2519	44	42	were	be	AUX
ajlm-2519	44	43	included	include	VERB
ajlm-2519	44	44	in	in	ADP
ajlm-2519	44	45	the	the	DET
ajlm-2519	44	46	study	study	NOUN
ajlm-2519	44	47	.	.	PUNCT
ajlm-2519	45	1	the	the	DET
ajlm-2519	45	2	study	study	NOUN
ajlm-2519	45	3	period	period	NOUN
ajlm-2519	45	4	was	be	AUX
ajlm-2519	45	5	chosen	choose	VERB
ajlm-2519	45	6	to	to	PART
ajlm-2519	45	7	correspond	correspond	VERB
ajlm-2519	45	8	to	to	PART
ajlm-2519	45	9	available	available	ADJ
ajlm-2519	45	10	antimicrobial	antimicrobial	ADJ
ajlm-2519	45	11	consumption	consumption	NOUN
ajlm-2519	45	12	data	datum	NOUN
ajlm-2519	45	13	extracted	extract	VERB
ajlm-2519	45	14	from	from	ADP
ajlm-2519	45	15	the	the	DET
ajlm-2519	45	16	limpopo	limpopo	PROPN
ajlm-2519	45	17	province	province	PROPN
ajlm-2519	45	18	pharmaceutical	pharmaceutical	NOUN
ajlm-2519	45	19	depot	depot	NOUN
ajlm-2519	45	20	,	,	PUNCT
ajlm-2519	45	21	which	which	PRON
ajlm-2519	45	22	had	have	AUX
ajlm-2519	45	23	previously	previously	ADV
ajlm-2519	45	24	been	be	AUX
ajlm-2519	45	25	analysed	analyse	VERB
ajlm-2519	45	26	and	and	CCONJ
ajlm-2519	45	27	published	publish	VERB
ajlm-2519	45	28	.	.	PUNCT
ajlm-2519	46	1	the	the	DET
ajlm-2519	46	2	data	datum	NOUN
ajlm-2519	46	3	comprised	comprise	VERB
ajlm-2519	46	4	all	all	DET
ajlm-2519	46	5	patients	patient	NOUN
ajlm-2519	46	6	with	with	ADP
ajlm-2519	46	7	positive	positive	ADJ
ajlm-2519	46	8	blood	blood	NOUN
ajlm-2519	46	9	cultures	culture	NOUN
ajlm-2519	46	10	.	.	PUNCT
ajlm-2519	47	1	blood	blood	NOUN
ajlm-2519	47	2	cultures	culture	NOUN
ajlm-2519	47	3	are	be	AUX
ajlm-2519	47	4	considered	consider	VERB
ajlm-2519	47	5	the	the	DET
ajlm-2519	47	6	‘	'	PUNCT
ajlm-2519	47	7	gold	gold	ADJ
ajlm-2519	47	8	standard	standard	NOUN
ajlm-2519	47	9	’	'	PUNCT
ajlm-2519	47	10	investigation	investigation	NOUN
ajlm-2519	47	11	for	for	ADP
ajlm-2519	47	12	detecting	detect	VERB
ajlm-2519	47	13	micro	micro	NOUN
ajlm-2519	47	14	-	-	NOUN
ajlm-2519	47	15	organisms	organism	NOUN
ajlm-2519	47	16	in	in	ADP
ajlm-2519	47	17	blood	blood	NOUN
ajlm-2519	47	18	(	(	PUNCT
ajlm-2519	47	19	bloodstream	bloodstream	NOUN
ajlm-2519	47	20	infections	infection	NOUN
ajlm-2519	47	21	)	)	PUNCT
ajlm-2519	47	22	.	.	PUNCT
ajlm-2519	48	1	the	the	DET
ajlm-2519	48	2	nhls	nhls	PROPN
ajlm-2519	48	3	used	use	VERB
ajlm-2519	48	4	different	different	ADJ
ajlm-2519	48	5	blood	blood	NOUN
ajlm-2519	48	6	culture	culture	NOUN
ajlm-2519	48	7	bottles	bottle	NOUN
ajlm-2519	48	8	to	to	PART
ajlm-2519	48	9	collect	collect	VERB
ajlm-2519	48	10	blood	blood	NOUN
ajlm-2519	48	11	samples	sample	NOUN
ajlm-2519	48	12	.	.	PUNCT
ajlm-2519	49	1	two	two	NUM
ajlm-2519	49	2	blood	blood	NOUN
ajlm-2519	49	3	culture	culture	NOUN
ajlm-2519	49	4	bottles	bottle	NOUN
ajlm-2519	49	5	(	(	PUNCT
ajlm-2519	49	6	aerobic	aerobic	ADJ
ajlm-2519	49	7	and	and	CCONJ
ajlm-2519	49	8	anaerobic	anaerobic	NOUN
ajlm-2519	49	9	)	)	PUNCT
ajlm-2519	49	10	were	be	AUX
ajlm-2519	49	11	used	use	VERB
ajlm-2519	49	12	for	for	ADP
ajlm-2519	49	13	adults	adult	NOUN
ajlm-2519	49	14	,	,	PUNCT
ajlm-2519	49	15	and	and	CCONJ
ajlm-2519	49	16	one	one	NUM
ajlm-2519	49	17	for	for	ADP
ajlm-2519	49	18	paediatric	paediatric	ADJ
ajlm-2519	49	19	patients.24	patients.24	NOUN
ajlm-2519	49	20	the	the	DET
ajlm-2519	49	21	samples	sample	NOUN
ajlm-2519	49	22	are	be	AUX
ajlm-2519	49	23	inverted	invert	VERB
ajlm-2519	49	24	8–10	8–10	NOUN
ajlm-2519	49	25	times.24	times.24	NOUN
ajlm-2519	49	26	blood	blood	NOUN
ajlm-2519	49	27	culture	culture	NOUN
ajlm-2519	49	28	samples	sample	NOUN
ajlm-2519	49	29	were	be	AUX
ajlm-2519	49	30	stored	store	VERB
ajlm-2519	49	31	at	at	ADP
ajlm-2519	49	32	20	20	NUM
ajlm-2519	49	33	°	°	ADP
ajlm-2519	49	34	c	c	NOUN
ajlm-2519	49	35	–	–	PUNCT
ajlm-2519	49	36	25	25	NUM
ajlm-2519	49	37	°	°	NUM
ajlm-2519	49	38	c	c	NOUN
ajlm-2519	49	39	until	until	SCONJ
ajlm-2519	49	40	the	the	DET
ajlm-2519	49	41	nhls	nhls	PROPN
ajlm-2519	49	42	courier	courier	NOUN
ajlm-2519	49	43	collected	collect	VERB
ajlm-2519	49	44	them	they	PRON
ajlm-2519	49	45	from	from	ADP
ajlm-2519	49	46	mankweng	mankweng	ADJ
ajlm-2519	49	47	tertiary	tertiary	ADJ
ajlm-2519	49	48	hospital	hospital	NOUN
ajlm-2519	49	49	and	and	CCONJ
ajlm-2519	49	50	transported	transport	VERB
ajlm-2519	49	51	to	to	ADP
ajlm-2519	49	52	pietersburg	pietersburg	ADJ
ajlm-2519	49	53	tertiary	tertiary	ADJ
ajlm-2519	49	54	hospital	hospital	NOUN
ajlm-2519	49	55	nhls	nhls	PROPN
ajlm-2519	49	56	laboratory	laboratory	PROPN
ajlm-2519	49	57	for	for	ADP
ajlm-2519	49	58	further	further	ADJ
ajlm-2519	49	59	processing	processing	NOUN
ajlm-2519	49	60	(	(	PUNCT
ajlm-2519	49	61	pathogen	pathogen	NOUN
ajlm-2519	49	62	identification	identification	NOUN
ajlm-2519	49	63	and	and	CCONJ
ajlm-2519	49	64	amr	amr	NOUN
ajlm-2519	49	65	testing	testing	NOUN
ajlm-2519	49	66	)	)	PUNCT
ajlm-2519	49	67	.	.	PUNCT
ajlm-2519	50	1	laboratory	laboratory	NOUN
ajlm-2519	50	2	analyses	analysis	NOUN
ajlm-2519	50	3	in	in	ADP
ajlm-2519	50	4	the	the	DET
ajlm-2519	50	5	nhls	nhls	NOUN
ajlm-2519	50	6	,	,	PUNCT
ajlm-2519	50	7	blood	blood	NOUN
ajlm-2519	50	8	culture	culture	NOUN
ajlm-2519	50	9	bottles	bottle	NOUN
ajlm-2519	50	10	were	be	AUX
ajlm-2519	50	11	sent	send	VERB
ajlm-2519	50	12	to	to	ADP
ajlm-2519	50	13	the	the	DET
ajlm-2519	50	14	microbiology	microbiology	NOUN
ajlm-2519	50	15	laboratory	laboratory	NOUN
ajlm-2519	50	16	for	for	ADP
ajlm-2519	50	17	incubation	incubation	NOUN
ajlm-2519	50	18	in	in	ADP
ajlm-2519	50	19	the	the	DET
ajlm-2519	50	20	automated	automate	VERB
ajlm-2519	50	21	blood	blood	NOUN
ajlm-2519	50	22	culture	culture	NOUN
ajlm-2519	50	23	system	system	NOUN
ajlm-2519	50	24	after	after	ADP
ajlm-2519	50	25	inoculation	inoculation	NOUN
ajlm-2519	50	26	with	with	ADP
ajlm-2519	50	27	appropriate	appropriate	ADJ
ajlm-2519	50	28	blood	blood	NOUN
ajlm-2519	50	29	volumes.24	volumes.24	NOUN
ajlm-2519	50	30	once	once	SCONJ
ajlm-2519	50	31	blood	blood	NOUN
ajlm-2519	50	32	cultures	culture	NOUN
ajlm-2519	50	33	became	become	VERB
ajlm-2519	50	34	positive	positive	ADJ
ajlm-2519	50	35	for	for	ADP
ajlm-2519	50	36	growth	growth	NOUN
ajlm-2519	50	37	,	,	PUNCT
ajlm-2519	50	38	they	they	PRON
ajlm-2519	50	39	were	be	AUX
ajlm-2519	50	40	removed	remove	VERB
ajlm-2519	50	41	from	from	ADP
ajlm-2519	50	42	the	the	DET
ajlm-2519	50	43	machine	machine	NOUN
ajlm-2519	50	44	for	for	ADP
ajlm-2519	50	45	manual	manual	ADJ
ajlm-2519	50	46	subculture	subculture	NOUN
ajlm-2519	50	47	techniques	technique	NOUN
ajlm-2519	50	48	and	and	CCONJ
ajlm-2519	50	49	gram	gram	NOUN
ajlm-2519	50	50	staining	stain	VERB
ajlm-2519	50	51	following	follow	VERB
ajlm-2519	50	52	standard	standard	ADJ
ajlm-2519	50	53	operating	operating	NOUN
ajlm-2519	50	54	procedures.24	procedures.24	NOUN
ajlm-2519	50	55	the	the	DET
ajlm-2519	50	56	laboratory	laboratory	NOUN
ajlm-2519	50	57	used	use	VERB
ajlm-2519	50	58	the	the	DET
ajlm-2519	50	59	vitek	vitek	NOUN
ajlm-2519	50	60	®	®	NOUN
ajlm-2519	50	61	2	2	NUM
ajlm-2519	50	62	(	(	PUNCT
ajlm-2519	50	63	biomérieux	biomérieux	PROPN
ajlm-2519	50	64	,	,	PUNCT
ajlm-2519	50	65	marcy	marcy	PROPN
ajlm-2519	50	66	l’étoile	l’étoile	PROPN
ajlm-2519	50	67	,	,	PUNCT
ajlm-2519	50	68	france	france	PROPN
ajlm-2519	50	69	)	)	PUNCT
ajlm-2519	50	70	automated	automate	VERB
ajlm-2519	50	71	systems	system	NOUN
ajlm-2519	50	72	for	for	ADP
ajlm-2519	50	73	bacterial	bacterial	ADJ
ajlm-2519	50	74	identification	identification	NOUN
ajlm-2519	50	75	and	and	CCONJ
ajlm-2519	50	76	antimicrobial	antimicrobial	ADJ
ajlm-2519	50	77	susceptibility	susceptibility	NOUN
ajlm-2519	50	78	testing	testing	NOUN
ajlm-2519	50	79	,	,	PUNCT
ajlm-2519	50	80	except	except	SCONJ
ajlm-2519	50	81	for	for	ADP
ajlm-2519	50	82	colistin	colistin	NOUN
ajlm-2519	50	83	,	,	PUNCT
ajlm-2519	50	84	where	where	SCONJ
ajlm-2519	50	85	broth	broth	ADJ
ajlm-2519	50	86	microdilution	microdilution	NOUN
ajlm-2519	50	87	was	be	AUX
ajlm-2519	50	88	used	use	VERB
ajlm-2519	50	89	where	where	SCONJ
ajlm-2519	50	90	indicated	indicate	VERB
ajlm-2519	50	91	.	.	PUNCT
ajlm-2519	51	1	the	the	DET
ajlm-2519	51	2	definitions	definition	NOUN
ajlm-2519	51	3	of	of	ADP
ajlm-2519	51	4	the	the	DET
ajlm-2519	51	5	who	who	PRON
ajlm-2519	51	6	priority	priority	NOUN
ajlm-2519	51	7	list	list	NOUN
ajlm-2519	51	8	for	for	ADP
ajlm-2519	51	9	drug	drug	NOUN
ajlm-2519	51	10	-	-	PUNCT
ajlm-2519	51	11	pathogen	pathogen	NOUN
ajlm-2519	51	12	combination	combination	NOUN
ajlm-2519	51	13	eskape	eskape	NOUN
ajlm-2519	51	14	bacteria	bacteria	NOUN
ajlm-2519	51	15	were	be	AUX
ajlm-2519	51	16	based	base	VERB
ajlm-2519	51	17	on	on	ADP
ajlm-2519	51	18	the	the	DET
ajlm-2519	51	19	definitions	definition	NOUN
ajlm-2519	51	20	provided	provide	VERB
ajlm-2519	51	21	by	by	ADP
ajlm-2519	51	22	the	the	DET
ajlm-2519	51	23	centers	center	NOUN
ajlm-2519	51	24	for	for	ADP
ajlm-2519	51	25	disease	disease	NOUN
ajlm-2519	51	26	prevention	prevention	NOUN
ajlm-2519	51	27	and	and	CCONJ
ajlm-2519	51	28	control	control	NOUN
ajlm-2519	51	29	(	(	PUNCT
ajlm-2519	51	30	table	table	NOUN
ajlm-2519	51	31	1).25	1).25	NUM
ajlm-2519	51	32	the	the	DET
ajlm-2519	51	33	vitek	vitek	PROPN
ajlm-2519	51	34	®	®	NOUN
ajlm-2519	51	35	2	2	NUM
ajlm-2519	51	36	machine	machine	NOUN
ajlm-2519	51	37	tests	test	NOUN
ajlm-2519	51	38	antimicrobial	antimicrobial	ADJ
ajlm-2519	51	39	susceptibility	susceptibility	NOUN
ajlm-2519	51	40	using	use	VERB
ajlm-2519	51	41	the	the	DET
ajlm-2519	51	42	broth	broth	NOUN
ajlm-2519	51	43	microdilution	microdilution	NOUN
ajlm-2519	51	44	method	method	NOUN
ajlm-2519	51	45	and	and	CCONJ
ajlm-2519	51	46	64	64	NUM
ajlm-2519	51	47	-	-	PUNCT
ajlm-2519	51	48	well	well	NOUN
ajlm-2519	51	49	plastic	plastic	ADJ
ajlm-2519	51	50	cards	card	NOUN
ajlm-2519	51	51	with	with	ADP
ajlm-2519	51	52	17–20	17–20	NUM
ajlm-2519	51	53	antimicrobial	antimicrobial	ADJ
ajlm-2519	51	54	agents	agent	NOUN
ajlm-2519	51	55	.	.	PUNCT
ajlm-2519	52	1	the	the	DET
ajlm-2519	52	2	vitek	vitek	PROPN
ajlm-2519	52	3	®	®	NOUN
ajlm-2519	52	4	2	2	NUM
ajlm-2519	52	5	ast	ast	VERB
ajlm-2519	52	6	-	-	PUNCT
ajlm-2519	52	7	n255	n255	NUM
ajlm-2519	52	8	cards	card	NOUN
ajlm-2519	52	9	were	be	AUX
ajlm-2519	52	10	used	use	VERB
ajlm-2519	52	11	for	for	ADP
ajlm-2519	52	12	gram	gram	NOUN
ajlm-2519	52	13	-	-	PUNCT
ajlm-2519	52	14	negative	negative	ADJ
ajlm-2519	52	15	antimicrobial	antimicrobial	ADJ
ajlm-2519	52	16	susceptibility	susceptibility	NOUN
ajlm-2519	52	17	testing	testing	NOUN
ajlm-2519	52	18	and	and	CCONJ
ajlm-2519	52	19	the	the	DET
ajlm-2519	52	20	ast	ast	PROPN
ajlm-2519	52	21	-	-	PUNCT
ajlm-2519	52	22	p603	p603	PROPN
ajlm-2519	52	23	cards	card	NOUN
ajlm-2519	52	24	for	for	ADP
ajlm-2519	52	25	gram	gram	NOUN
ajlm-2519	52	26	-	-	PUNCT
ajlm-2519	52	27	positive	positive	NOUN
ajlm-2519	52	28	.	.	PUNCT
ajlm-2519	53	1	the	the	DET
ajlm-2519	53	2	vitek	vitek	PROPN
ajlm-2519	53	3	®	®	NOUN
ajlm-2519	53	4	2	2	NUM
ajlm-2519	53	5	antimicrobial	antimicrobial	ADJ
ajlm-2519	53	6	test	test	NOUN
ajlm-2519	53	7	panel	panel	NOUN
ajlm-2519	53	8	comprises	comprise	VERB
ajlm-2519	53	9	amikacin	amikacin	PROPN
ajlm-2519	53	10	,	,	PUNCT
ajlm-2519	53	11	amoxicillin	amoxicillin	PROPN
ajlm-2519	53	12	with	with	ADP
ajlm-2519	53	13	clavulanic	clavulanic	ADJ
ajlm-2519	53	14	acid	acid	NOUN
ajlm-2519	53	15	,	,	PUNCT
ajlm-2519	53	16	ampicillin	ampicillin	NOUN
ajlm-2519	53	17	-	-	PUNCT
ajlm-2519	53	18	amoxicillin	amoxicillin	PROPN
ajlm-2519	53	19	,	,	PUNCT
ajlm-2519	53	20	cefazolin	cefazolin	PROPN
ajlm-2519	53	21	-	-	PUNCT
ajlm-2519	53	22	cephalexin	cephalexin	PROPN
ajlm-2519	53	23	,	,	PUNCT
ajlm-2519	53	24	cefazolin	cefazolin	PROPN
ajlm-2519	53	25	,	,	PUNCT
ajlm-2519	53	26	cefepime	cefepime	NOUN
ajlm-2519	53	27	,	,	PUNCT
ajlm-2519	53	28	cefotaxime	cefotaxime	NOUN
ajlm-2519	53	29	-	-	PUNCT
ajlm-2519	53	30	ceftriaxone	ceftriaxone	NOUN
ajlm-2519	53	31	,	,	PUNCT
ajlm-2519	53	32	cefoxitin	cefoxitin	NOUN
ajlm-2519	53	33	,	,	PUNCT
ajlm-2519	53	34	ceftazidime	ceftazidime	NOUN
ajlm-2519	53	35	,	,	PUNCT
ajlm-2519	53	36	cefuroxime	cefuroxime	ADJ
ajlm-2519	53	37	,	,	PUNCT
ajlm-2519	53	38	cephalexin	cephalexin	PROPN
ajlm-2519	53	39	,	,	PUNCT
ajlm-2519	53	40	chloramphenicol	chloramphenicol	NOUN
ajlm-2519	53	41	,	,	PUNCT
ajlm-2519	53	42	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2519	53	43	,	,	PUNCT
ajlm-2519	53	44	clindamycin	clindamycin	NOUN
ajlm-2519	53	45	,	,	PUNCT
ajlm-2519	53	46	cloxacillin	cloxacillin	NOUN
ajlm-2519	53	47	,	,	PUNCT
ajlm-2519	53	48	ertapenem	ertapenem	PROPN
ajlm-2519	53	49	,	,	PUNCT
ajlm-2519	53	50	erythromycin	erythromycin	NOUN
ajlm-2519	53	51	-	-	PUNCT
ajlm-2519	53	52	azithromycin	azithromycin	NOUN
ajlm-2519	53	53	,	,	PUNCT
ajlm-2519	53	54	fusidic	fusidic	ADJ
ajlm-2519	53	55	acid	acid	NOUN
ajlm-2519	53	56	,	,	PUNCT
ajlm-2519	53	57	gentamicin	gentamicin	NOUN
ajlm-2519	53	58	,	,	PUNCT
ajlm-2519	53	59	imipenem	imipenem	PROPN
ajlm-2519	53	60	,	,	PUNCT
ajlm-2519	53	61	linezolid	linezolid	PROPN
ajlm-2519	53	62	,	,	PUNCT
ajlm-2519	53	63	meropenem	meropenem	ADJ
ajlm-2519	53	64	,	,	PUNCT
ajlm-2519	53	65	moxifloxacin	moxifloxacin	ADJ
ajlm-2519	53	66	,	,	PUNCT
ajlm-2519	53	67	mupirocin	mupirocin	NOUN
ajlm-2519	53	68	,	,	PUNCT
ajlm-2519	53	69	nalidixic	nalidixic	ADJ
ajlm-2519	53	70	acid	acid	NOUN
ajlm-2519	53	71	,	,	PUNCT
ajlm-2519	53	72	nitrofurantoin	nitrofurantoin	NOUN
ajlm-2519	53	73	,	,	PUNCT
ajlm-2519	53	74	ofloxacin	ofloxacin	NOUN
ajlm-2519	53	75	,	,	PUNCT
ajlm-2519	53	76	penicillin	penicillin	NOUN
ajlm-2519	53	77	,	,	PUNCT
ajlm-2519	53	78	penicillin	penicillin	NOUN
ajlm-2519	53	79	-	-	PUNCT
ajlm-2519	53	80	ampicillin	ampicillin	PROPN
ajlm-2519	53	81	,	,	PUNCT
ajlm-2519	53	82	piperacillin	piperacillin	NOUN
ajlm-2519	53	83	with	with	ADP
ajlm-2519	53	84	tazobactam	tazobactam	NOUN
ajlm-2519	53	85	,	,	PUNCT
ajlm-2519	53	86	sulphamethoxazole	sulphamethoxazole	VERB
ajlm-2519	53	87	with	with	ADP
ajlm-2519	53	88	trimethoprim	trimethoprim	PROPN
ajlm-2519	53	89	,	,	PUNCT
ajlm-2519	53	90	teicoplanin	teicoplanin	PROPN
ajlm-2519	53	91	,	,	PUNCT
ajlm-2519	53	92	tetracycline	tetracycline	NOUN
ajlm-2519	53	93	,	,	PUNCT
ajlm-2519	53	94	tigecycline	tigecycline	ADV
ajlm-2519	53	95	,	,	PUNCT
ajlm-2519	53	96	tobramycin	tobramycin	PROPN
ajlm-2519	53	97	,	,	PUNCT
ajlm-2519	53	98	and	and	CCONJ
ajlm-2519	53	99	vancomycin	vancomycin	PROPN
ajlm-2519	53	100	.	.	PUNCT
ajlm-2519	54	1	the	the	DET
ajlm-2519	54	2	nhls	nhls	PROPN
ajlm-2519	54	3	employed	employ	VERB
ajlm-2519	54	4	the	the	DET
ajlm-2519	54	5	clinical	clinical	ADJ
ajlm-2519	54	6	and	and	CCONJ
ajlm-2519	54	7	laboratory	laboratory	NOUN
ajlm-2519	54	8	standards	standard	NOUN
ajlm-2519	54	9	institute	institute	NOUN
ajlm-2519	54	10	guidelines	guideline	VERB
ajlm-2519	54	11	m100	m100	PROPN
ajlm-2519	54	12	for	for	ADP
ajlm-2519	54	13	the	the	DET
ajlm-2519	54	14	corresponding	corresponding	ADJ
ajlm-2519	54	15	year	year	NOUN
ajlm-2519	54	16	to	to	PART
ajlm-2519	54	17	interpret	interpret	VERB
ajlm-2519	54	18	all	all	DET
ajlm-2519	54	19	antibiotic	antibiotic	ADJ
ajlm-2519	54	20	susceptibility	susceptibility	NOUN
ajlm-2519	54	21	results.26	results.26	VERB
ajlm-2519	54	22	the	the	DET
ajlm-2519	54	23	clinical	clinical	ADJ
ajlm-2519	54	24	and	and	CCONJ
ajlm-2519	54	25	laboratory	laboratory	NOUN
ajlm-2519	54	26	standards	standard	NOUN
ajlm-2519	54	27	institute	institute	PROPN
ajlm-2519	54	28	m39	m39	PROPN
ajlm-2519	54	29	guideline	guideline	NOUN
ajlm-2519	54	30	(	(	PUNCT
ajlm-2519	54	31	analysis	analysis	NOUN
ajlm-2519	54	32	and	and	CCONJ
ajlm-2519	54	33	presentation	presentation	NOUN
ajlm-2519	54	34	of	of	ADP
ajlm-2519	54	35	cumulative	cumulative	ADJ
ajlm-2519	54	36	antimicrobial	antimicrobial	ADJ
ajlm-2519	54	37	susceptibility	susceptibility	NOUN
ajlm-2519	54	38	test	test	NOUN
ajlm-2519	54	39	data	datum	NOUN
ajlm-2519	54	40	)	)	PUNCT
ajlm-2519	54	41	recommends	recommend	VERB
ajlm-2519	54	42	empirical	empirical	ADJ
ajlm-2519	54	43	therapy	therapy	NOUN
ajlm-2519	54	44	with	with	ADP
ajlm-2519	54	45	an	an	DET
ajlm-2519	54	46	antibiotic	antibiotic	ADJ
ajlm-2519	54	47	or	or	CCONJ
ajlm-2519	54	48	antibiotics	antibiotic	NOUN
ajlm-2519	54	49	that	that	PRON
ajlm-2519	54	50	demonstrated	demonstrate	VERB
ajlm-2519	54	51	80.0	80.0	NUM
ajlm-2519	54	52	%	%	NOUN
ajlm-2519	54	53	to	to	PART
ajlm-2519	54	54	90.0	90.0	NUM
ajlm-2519	54	55	%	%	NOUN
ajlm-2519	54	56	susceptibility	susceptibility	NOUN
ajlm-2519	54	57	to	to	ADP
ajlm-2519	54	58	the	the	DET
ajlm-2519	54	59	most	most	ADV
ajlm-2519	54	60	relevant	relevant	ADJ
ajlm-2519	54	61	organisms	organism	NOUN
ajlm-2519	54	62	associated	associate	VERB
ajlm-2519	54	63	with	with	ADP
ajlm-2519	54	64	a	a	DET
ajlm-2519	54	65	specific	specific	ADJ
ajlm-2519	54	66	infection.27	infection.27	ADJ
ajlm-2519	54	67	table	table	NOUN
ajlm-2519	54	68	1	1	NUM
ajlm-2519	54	69	:	:	PUNCT
ajlm-2519	54	70	 	 	SPACE
ajlm-2519	54	71	antimicrobial	antimicrobial	ADJ
ajlm-2519	54	72	resistance	resistance	NOUN
ajlm-2519	54	73	phenotypes	phenotype	NOUN
ajlm-2519	54	74	definition	definition	NOUN
ajlm-2519	54	75	provided	provide	VERB
ajlm-2519	54	76	by	by	ADP
ajlm-2519	54	77	the	the	DET
ajlm-2519	54	78	united	united	PROPN
ajlm-2519	54	79	states	states	PROPN
ajlm-2519	54	80	centers	center	NOUN
ajlm-2519	54	81	for	for	ADP
ajlm-2519	54	82	disease	disease	NOUN
ajlm-2519	54	83	prevention	prevention	NOUN
ajlm-2519	54	84	and	and	CCONJ
ajlm-2519	54	85	control	control	NOUN
ajlm-2519	54	86	.	.	PUNCT
ajlm-2519	55	1	data	datum	NOUN
ajlm-2519	55	2	analysis	analysis	NOUN
ajlm-2519	55	3	duplicates	duplicate	NOUN
ajlm-2519	55	4	per	per	ADP
ajlm-2519	55	5	patient	patient	NOUN
ajlm-2519	55	6	were	be	AUX
ajlm-2519	55	7	identified	identify	VERB
ajlm-2519	55	8	using	use	VERB
ajlm-2519	55	9	unique	unique	ADJ
ajlm-2519	55	10	patient	patient	ADJ
ajlm-2519	55	11	identifiers	identifier	NOUN
ajlm-2519	55	12	and	and	CCONJ
ajlm-2519	55	13	specimen	speciman	NOUN
ajlm-2519	55	14	collection	collection	NOUN
ajlm-2519	55	15	dates	date	NOUN
ajlm-2519	55	16	(	(	PUNCT
ajlm-2519	55	17	<	<	X
ajlm-2519	55	18	28	28	NUM
ajlm-2519	55	19	days	day	NOUN
ajlm-2519	55	20	)	)	PUNCT
ajlm-2519	55	21	.	.	PUNCT
ajlm-2519	56	1	the	the	DET
ajlm-2519	56	2	data	datum	NOUN
ajlm-2519	56	3	set	set	VERB
ajlm-2519	56	4	was	be	AUX
ajlm-2519	56	5	categorised	categorise	VERB
ajlm-2519	56	6	into	into	ADP
ajlm-2519	56	7	relevant	relevant	ADJ
ajlm-2519	56	8	variables	variable	NOUN
ajlm-2519	56	9	and	and	CCONJ
ajlm-2519	56	10	descriptive	descriptive	ADJ
ajlm-2519	56	11	analysis	analysis	NOUN
ajlm-2519	56	12	was	be	AUX
ajlm-2519	56	13	performed	perform	VERB
ajlm-2519	56	14	and	and	CCONJ
ajlm-2519	56	15	presented	present	VERB
ajlm-2519	56	16	as	as	ADP
ajlm-2519	56	17	frequencies	frequency	NOUN
ajlm-2519	56	18	and	and	CCONJ
ajlm-2519	56	19	proportions	proportion	NOUN
ajlm-2519	56	20	.	.	PUNCT
ajlm-2519	57	1	because	because	SCONJ
ajlm-2519	57	2	of	of	ADP
ajlm-2519	57	3	varying	vary	VERB
ajlm-2519	57	4	antibiotic	antibiotic	ADJ
ajlm-2519	57	5	susceptibility	susceptibility	NOUN
ajlm-2519	57	6	testing	testing	NOUN
ajlm-2519	57	7	done	do	VERB
ajlm-2519	57	8	by	by	ADP
ajlm-2519	57	9	the	the	DET
ajlm-2519	57	10	nhls	nhls	NOUN
ajlm-2519	57	11	over	over	ADP
ajlm-2519	57	12	the	the	DET
ajlm-2519	57	13	years	year	NOUN
ajlm-2519	57	14	for	for	ADP
ajlm-2519	57	15	some	some	DET
ajlm-2519	57	16	drug	drug	NOUN
ajlm-2519	57	17	-	-	PUNCT
ajlm-2519	57	18	pathogen	pathogen	NOUN
ajlm-2519	57	19	combinations	combination	NOUN
ajlm-2519	57	20	,	,	PUNCT
ajlm-2519	57	21	n	n	CCONJ
ajlm-2519	57	22	-	-	PUNCT
ajlm-2519	57	23	values	value	NOUN
ajlm-2519	57	24	fluctuated	fluctuate	VERB
ajlm-2519	57	25	.	.	PUNCT
ajlm-2519	58	1	during	during	ADP
ajlm-2519	58	2	data	data	NOUN
ajlm-2519	58	3	analysis	analysis	NOUN
ajlm-2519	58	4	,	,	PUNCT
ajlm-2519	58	5	isolates	isolate	NOUN
ajlm-2519	58	6	that	that	PRON
ajlm-2519	58	7	tested	test	VERB
ajlm-2519	58	8	intermediate	intermediate	ADJ
ajlm-2519	58	9	or	or	CCONJ
ajlm-2519	58	10	resistant	resistant	ADJ
ajlm-2519	58	11	to	to	ADP
ajlm-2519	58	12	antibiotics	antibiotic	NOUN
ajlm-2519	58	13	were	be	AUX
ajlm-2519	58	14	classified	classify	VERB
ajlm-2519	58	15	as	as	ADP
ajlm-2519	58	16	resistant	resistant	ADJ
ajlm-2519	58	17	strains	strain	NOUN
ajlm-2519	58	18	according	accord	VERB
ajlm-2519	58	19	to	to	ADP
ajlm-2519	58	20	the	the	DET
ajlm-2519	58	21	phenotypes	phenotype	NOUN
ajlm-2519	58	22	(	(	PUNCT
ajlm-2519	58	23	table	table	NOUN
ajlm-2519	58	24	1	1	NUM
ajlm-2519	58	25	)	)	PUNCT
ajlm-2519	58	26	.	.	PUNCT
ajlm-2519	59	1	the	the	DET
ajlm-2519	59	2	mann	mann	PROPN
ajlm-2519	59	3	-	-	PUNCT
ajlm-2519	59	4	kendall	kendall	PROPN
ajlm-2519	59	5	test	test	NOUN
ajlm-2519	59	6	with	with	ADP
ajlm-2519	59	7	a	a	DET
ajlm-2519	59	8	α	α	NOUN
ajlm-2519	59	9	-	-	PUNCT
ajlm-2519	59	10	value	value	NOUN
ajlm-2519	59	11	of	of	ADP
ajlm-2519	59	12	0.05	0.05	NUM
ajlm-2519	59	13	was	be	AUX
ajlm-2519	59	14	used	use	VERB
ajlm-2519	59	15	to	to	PART
ajlm-2519	59	16	determine	determine	VERB
ajlm-2519	59	17	the	the	DET
ajlm-2519	59	18	statistical	statistical	ADJ
ajlm-2519	59	19	significance	significance	NOUN
ajlm-2519	59	20	of	of	ADP
ajlm-2519	59	21	changes	change	NOUN
ajlm-2519	59	22	in	in	ADP
ajlm-2519	59	23	pathogen	pathogen	NOUN
ajlm-2519	59	24	incidence	incidence	NOUN
ajlm-2519	59	25	and	and	CCONJ
ajlm-2519	59	26	drug	drug	NOUN
ajlm-2519	59	27	-	-	PUNCT
ajlm-2519	59	28	pathogen	pathogen	NOUN
ajlm-2519	59	29	resistance	resistance	NOUN
ajlm-2519	59	30	based	base	VERB
ajlm-2519	59	31	on	on	ADP
ajlm-2519	59	32	frequencies	frequency	NOUN
ajlm-2519	59	33	.	.	PUNCT
ajlm-2519	60	1	the	the	DET
ajlm-2519	60	2	analyses	analysis	NOUN
ajlm-2519	60	3	were	be	AUX
ajlm-2519	60	4	performed	perform	VERB
ajlm-2519	60	5	using	use	VERB
ajlm-2519	60	6	the	the	DET
ajlm-2519	60	7	r	r	NOUN
ajlm-2519	60	8	-	-	PUNCT
ajlm-2519	60	9	statistics	statistic	NOUN
ajlm-2519	60	10	package	package	NOUN
ajlm-2519	60	11	version	version	NOUN
ajlm-2519	60	12	1.1.5	1.1.5	NUM
ajlm-2519	60	13	(	(	PUNCT
ajlm-2519	60	14	r	r	NOUN
ajlm-2519	60	15	foundation	foundation	NOUN
ajlm-2519	60	16	for	for	ADP
ajlm-2519	60	17	statistical	statistical	ADJ
ajlm-2519	60	18	computing	computing	NOUN
ajlm-2519	60	19	,	,	PUNCT
ajlm-2519	60	20	vienna	vienna	PROPN
ajlm-2519	60	21	,	,	PUNCT
ajlm-2519	60	22	austria).28	austria).28	PROPN
ajlm-2519	60	23	results	result	VERB
ajlm-2519	60	24	the	the	DET
ajlm-2519	60	25	study	study	NOUN
ajlm-2519	60	26	extracted	extract	VERB
ajlm-2519	60	27	data	datum	NOUN
ajlm-2519	60	28	on	on	ADP
ajlm-2519	60	29	eskape	eskape	NOUN
ajlm-2519	60	30	organism	organism	NOUN
ajlm-2519	60	31	name	name	NOUN
ajlm-2519	60	32	,	,	PUNCT
ajlm-2519	60	33	isolation	isolation	NOUN
ajlm-2519	60	34	ward	ward	NOUN
ajlm-2519	60	35	and	and	CCONJ
ajlm-2519	60	36	year	year	NOUN
ajlm-2519	60	37	,	,	PUNCT
ajlm-2519	60	38	and	and	CCONJ
ajlm-2519	60	39	amr	amr	ADJ
ajlm-2519	60	40	test	test	NOUN
ajlm-2519	60	41	outcomes	outcome	NOUN
ajlm-2519	60	42	,	,	PUNCT
ajlm-2519	60	43	without	without	ADP
ajlm-2519	60	44	patient	patient	NOUN
ajlm-2519	60	45	sociodemographic	sociodemographic	ADJ
ajlm-2519	60	46	or	or	CCONJ
ajlm-2519	60	47	clinical	clinical	ADJ
ajlm-2519	60	48	data	datum	NOUN
ajlm-2519	60	49	.	.	PUNCT
ajlm-2519	61	1	the	the	DET
ajlm-2519	61	2	incidence	incidence	NOUN
ajlm-2519	61	3	of	of	ADP
ajlm-2519	61	4	eskape	eskape	NOUN
ajlm-2519	61	5	pathogens	pathogen	NOUN
ajlm-2519	61	6	isolated	isolate	VERB
ajlm-2519	61	7	from	from	ADP
ajlm-2519	61	8	all	all	DET
ajlm-2519	61	9	positive	positive	ADJ
ajlm-2519	61	10	blood	blood	NOUN
ajlm-2519	61	11	cultures	culture	NOUN
ajlm-2519	61	12	showed	show	VERB
ajlm-2519	61	13	no	no	DET
ajlm-2519	61	14	significant	significant	ADJ
ajlm-2519	61	15	variation	variation	NOUN
ajlm-2519	61	16	between	between	ADP
ajlm-2519	61	17	2014	2014	NUM
ajlm-2519	61	18	and	and	CCONJ
ajlm-2519	61	19	2019	2019	NUM
ajlm-2519	61	20	(	(	PUNCT
ajlm-2519	61	21	p	p	X
ajlm-2519	61	22	=	=	NOUN
ajlm-2519	61	23	0.133	0.133	NUM
ajlm-2519	61	24	)	)	PUNCT
ajlm-2519	61	25	(	(	PUNCT
ajlm-2519	61	26	table	table	NOUN
ajlm-2519	61	27	2	2	NUM
ajlm-2519	61	28	)	)	PUNCT
ajlm-2519	61	29	.	.	PUNCT
ajlm-2519	62	1	table	table	NOUN
ajlm-2519	62	2	2	2	NUM
ajlm-2519	62	3	:	:	PUNCT
ajlm-2519	62	4	 	 	SPACE
ajlm-2519	62	5	incidence	incidence	NOUN
ajlm-2519	62	6	of	of	ADP
ajlm-2519	62	7	eskape	eskape	NOUN
ajlm-2519	62	8	pathogens	pathogen	NOUN
ajlm-2519	62	9	at	at	ADP
ajlm-2519	62	10	a	a	DET
ajlm-2519	62	11	referral	referral	ADJ
ajlm-2519	62	12	hospital	hospital	NOUN
ajlm-2519	62	13	in	in	ADP
ajlm-2519	62	14	limpopo	limpopo	PROPN
ajlm-2519	62	15	,	,	PUNCT
ajlm-2519	62	16	south	south	PROPN
ajlm-2519	62	17	africa	africa	PROPN
ajlm-2519	62	18	,	,	PUNCT
ajlm-2519	62	19	2014–2019	2014–2019	NUM
ajlm-2519	62	20	.	.	PUNCT
ajlm-2519	63	1	between	between	ADP
ajlm-2519	63	2	2014	2014	NUM
ajlm-2519	63	3	and	and	CCONJ
ajlm-2519	63	4	2019	2019	NUM
ajlm-2519	63	5	,	,	PUNCT
ajlm-2519	63	6	s.	s.	PROPN
ajlm-2519	63	7	aureus	aureus	PROPN
ajlm-2519	63	8	(	(	PUNCT
ajlm-2519	63	9	n	n	NOUN
ajlm-2519	63	10	=	=	SYM
ajlm-2519	63	11	268/746	268/746	PROPN
ajlm-2519	63	12	;	;	PUNCT
ajlm-2519	63	13	35.9	35.9	NUM
ajlm-2519	63	14	%	%	NOUN
ajlm-2519	63	15	)	)	PUNCT
ajlm-2519	63	16	was	be	AUX
ajlm-2519	63	17	isolated	isolate	VERB
ajlm-2519	63	18	most	most	ADV
ajlm-2519	63	19	frequently	frequently	ADV
ajlm-2519	63	20	,	,	PUNCT
ajlm-2519	63	21	followed	follow	VERB
ajlm-2519	63	22	by	by	ADP
ajlm-2519	63	23	a.	a.	NOUN
ajlm-2519	63	24	baumannii	baumannii	PROPN
ajlm-2519	63	25	(	(	PUNCT
ajlm-2519	63	26	n	n	NOUN
ajlm-2519	63	27	=	=	SYM
ajlm-2519	63	28	200/746	200/746	NUM
ajlm-2519	63	29	,	,	PUNCT
ajlm-2519	63	30	26.8	26.8	NUM
ajlm-2519	63	31	%	%	NOUN
ajlm-2519	63	32	)	)	PUNCT
ajlm-2519	63	33	,	,	PUNCT
ajlm-2519	63	34	and	and	CCONJ
ajlm-2519	63	35	k.	k.	PROPN
ajlm-2519	63	36	pneumoniae	pneumoniae	NOUN
ajlm-2519	63	37	(	(	PUNCT
ajlm-2519	63	38	n	n	NOUN
ajlm-2519	63	39	=	=	SYM
ajlm-2519	63	40	118/746	118/746	NUM
ajlm-2519	63	41	;	;	PUNCT
ajlm-2519	63	42	15.8	15.8	NUM
ajlm-2519	63	43	%	%	NOUN
ajlm-2519	63	44	)	)	PUNCT
ajlm-2519	63	45	(	(	PUNCT
ajlm-2519	63	46	table	table	NOUN
ajlm-2519	63	47	2	2	NUM
ajlm-2519	63	48	)	)	PUNCT
ajlm-2519	63	49	.	.	PUNCT
ajlm-2519	64	1	staphylococcus	staphylococcus	NOUN
ajlm-2519	64	2	aureus	aureus	PROPN
ajlm-2519	64	3	increased	increase	VERB
ajlm-2519	64	4	from	from	ADP
ajlm-2519	64	5	39	39	NUM
ajlm-2519	64	6	isolates	isolate	NOUN
ajlm-2519	64	7	in	in	ADP
ajlm-2519	64	8	2014	2014	NUM
ajlm-2519	64	9	to	to	ADP
ajlm-2519	64	10	75	75	NUM
ajlm-2519	64	11	in	in	ADP
ajlm-2519	64	12	2019	2019	NUM
ajlm-2519	64	13	(	(	PUNCT
ajlm-2519	64	14	p	p	X
ajlm-2519	64	15	=	=	NOUN
ajlm-2519	64	16	0.132	0.132	NUM
ajlm-2519	64	17	)	)	PUNCT
ajlm-2519	64	18	.	.	PUNCT
ajlm-2519	65	1	acinetobacter	acinetobacter	PROPN
ajlm-2519	65	2	baumannii	baumannii	PROPN
ajlm-2519	65	3	increased	increase	VERB
ajlm-2519	65	4	significantly	significantly	ADV
ajlm-2519	65	5	from	from	ADP
ajlm-2519	65	6	11.9	11.9	NUM
ajlm-2519	65	7	%	%	NOUN
ajlm-2519	65	8	(	(	PUNCT
ajlm-2519	65	9	n	n	NOUN
ajlm-2519	65	10	=	=	SYM
ajlm-2519	65	11	16/134	16/134	NUM
ajlm-2519	65	12	)	)	PUNCT
ajlm-2519	65	13	in	in	ADP
ajlm-2519	65	14	2015	2015	NUM
ajlm-2519	65	15	to	to	ADP
ajlm-2519	65	16	37.8	37.8	NUM
ajlm-2519	65	17	%	%	NOUN
ajlm-2519	65	18	(	(	PUNCT
ajlm-2519	65	19	n	n	NOUN
ajlm-2519	65	20	=	=	SYM
ajlm-2519	65	21	68/180	68/180	NUM
ajlm-2519	65	22	)	)	PUNCT
ajlm-2519	65	23	in	in	ADP
ajlm-2519	65	24	2019	2019	NUM
ajlm-2519	65	25	(	(	PUNCT
ajlm-2519	65	26	p	p	NOUN
ajlm-2519	65	27	=	=	NOUN
ajlm-2519	65	28	0.009	0.009	NUM
ajlm-2519	65	29	)	)	PUNCT
ajlm-2519	65	30	,	,	PUNCT
ajlm-2519	65	31	while	while	SCONJ
ajlm-2519	65	32	k.	k.	PROPN
ajlm-2519	65	33	pneumoniae	pneumoniae	ADJ
ajlm-2519	65	34	isolation	isolation	NOUN
ajlm-2519	65	35	declined	decline	VERB
ajlm-2519	65	36	from	from	ADP
ajlm-2519	65	37	46	46	NUM
ajlm-2519	65	38	in	in	ADP
ajlm-2519	65	39	2014	2014	NUM
ajlm-2519	65	40	and	and	CCONJ
ajlm-2519	65	41	68	68	NUM
ajlm-2519	65	42	in	in	ADP
ajlm-2519	65	43	2015	2015	NUM
ajlm-2519	65	44	to	to	ADP
ajlm-2519	65	45	four	four	NUM
ajlm-2519	65	46	isolates	isolate	NOUN
ajlm-2519	65	47	in	in	ADP
ajlm-2519	65	48	2016	2016	NUM
ajlm-2519	65	49	(	(	PUNCT
ajlm-2519	65	50	p	p	X
ajlm-2519	65	51	=	=	NOUN
ajlm-2519	65	52	0.007	0.007	NUM
ajlm-2519	65	53	)	)	PUNCT
ajlm-2519	65	54	.	.	PUNCT
ajlm-2519	66	1	no	no	DET
ajlm-2519	66	2	k.	k.	NOUN
ajlm-2519	66	3	pneumoniae	pneumoniae	ADJ
ajlm-2519	66	4	isolates	isolate	NOUN
ajlm-2519	66	5	were	be	AUX
ajlm-2519	66	6	identified	identify	VERB
ajlm-2519	66	7	from	from	ADP
ajlm-2519	66	8	2017	2017	NUM
ajlm-2519	66	9	to	to	ADP
ajlm-2519	66	10	2019	2019	NUM
ajlm-2519	66	11	.	.	PUNCT
ajlm-2519	67	1	most	most	ADJ
ajlm-2519	67	2	isolates	isolate	NOUN
ajlm-2519	67	3	(	(	PUNCT
ajlm-2519	67	4	n	n	NOUN
ajlm-2519	67	5	=	=	SYM
ajlm-2519	67	6	417/746	417/746	NUM
ajlm-2519	67	7	;	;	PUNCT
ajlm-2519	67	8	55.9	55.9	NUM
ajlm-2519	67	9	%	%	NOUN
ajlm-2519	67	10	)	)	PUNCT
ajlm-2519	67	11	were	be	AUX
ajlm-2519	67	12	from	from	ADP
ajlm-2519	67	13	the	the	DET
ajlm-2519	67	14	neonatal	neonatal	ADJ
ajlm-2519	67	15	ward	ward	NOUN
ajlm-2519	67	16	and	and	CCONJ
ajlm-2519	67	17	the	the	DET
ajlm-2519	67	18	intensive	intensive	ADJ
ajlm-2519	67	19	care	care	NOUN
ajlm-2519	67	20	unit	unit	NOUN
ajlm-2519	67	21	(	(	PUNCT
ajlm-2519	67	22	n	n	NOUN
ajlm-2519	67	23	=	=	SYM
ajlm-2519	67	24	60/746	60/746	NUM
ajlm-2519	67	25	;	;	PUNCT
ajlm-2519	67	26	8.0	8.0	NUM
ajlm-2519	67	27	%	%	NOUN
ajlm-2519	67	28	)	)	PUNCT
ajlm-2519	67	29	(	(	PUNCT
ajlm-2519	67	30	table	table	NOUN
ajlm-2519	67	31	3	3	NUM
ajlm-2519	67	32	)	)	PUNCT
ajlm-2519	67	33	.	.	PUNCT
ajlm-2519	68	1	table	table	NOUN
ajlm-2519	68	2	3	3	NUM
ajlm-2519	68	3	:	:	PUNCT
ajlm-2519	68	4	 	 	SPACE
ajlm-2519	68	5	number	number	NOUN
ajlm-2519	68	6	of	of	ADP
ajlm-2519	68	7	eskape	eskape	NOUN
ajlm-2519	68	8	pathogens	pathogen	NOUN
ajlm-2519	68	9	in	in	ADP
ajlm-2519	68	10	the	the	DET
ajlm-2519	68	11	isolation	isolation	NOUN
ajlm-2519	68	12	ward	ward	NOUN
ajlm-2519	68	13	at	at	ADP
ajlm-2519	68	14	a	a	DET
ajlm-2519	68	15	referral	referral	ADJ
ajlm-2519	68	16	hospital	hospital	NOUN
ajlm-2519	68	17	in	in	ADP
ajlm-2519	68	18	limpopo	limpopo	PROPN
ajlm-2519	68	19	,	,	PUNCT
ajlm-2519	68	20	south	south	PROPN
ajlm-2519	68	21	africa	africa	PROPN
ajlm-2519	68	22	:	:	PUNCT
ajlm-2519	68	23	2014–2019	2014–2019	NUM
ajlm-2519	68	24	.	.	X
ajlm-2519	69	1	carbapenem	carbapenem	NOUN
ajlm-2519	69	2	-	-	PUNCT
ajlm-2519	69	3	resistant	resistant	ADJ
ajlm-2519	69	4	a.	a.	NOUN
ajlm-2519	69	5	baumannii	baumannii	PROPN
ajlm-2519	69	6	increased	increase	VERB
ajlm-2519	69	7	significantly	significantly	ADV
ajlm-2519	69	8	from	from	ADP
ajlm-2519	69	9	69.8	69.8	NUM
ajlm-2519	69	10	%	%	NOUN
ajlm-2519	69	11	(	(	PUNCT
ajlm-2519	69	12	n	n	NOUN
ajlm-2519	69	13	=	=	SYM
ajlm-2519	69	14	11/16	11/16	NUM
ajlm-2519	69	15	)	)	PUNCT
ajlm-2519	69	16	in	in	ADP
ajlm-2519	69	17	2015	2015	NUM
ajlm-2519	69	18	to	to	ADP
ajlm-2519	69	19	75.0	75.0	NUM
ajlm-2519	69	20	%	%	NOUN
ajlm-2519	69	21	(	(	PUNCT
ajlm-2519	69	22	n	n	NOUN
ajlm-2519	69	23	=	=	SYM
ajlm-2519	69	24	51/68	51/68	NUM
ajlm-2519	69	25	)	)	PUNCT
ajlm-2519	69	26	in	in	ADP
ajlm-2519	69	27	2019	2019	NUM
ajlm-2519	69	28	(	(	PUNCT
ajlm-2519	69	29	p	p	NOUN
ajlm-2519	69	30	=	=	NOUN
ajlm-2519	69	31	0.009	0.009	NUM
ajlm-2519	69	32	)	)	PUNCT
ajlm-2519	69	33	(	(	PUNCT
ajlm-2519	69	34	figure	figure	NOUN
ajlm-2519	69	35	1	1	NUM
ajlm-2519	69	36	)	)	PUNCT
ajlm-2519	69	37	.	.	PUNCT
ajlm-2519	70	1	the	the	DET
ajlm-2519	70	2	incidence	incidence	NOUN
ajlm-2519	70	3	of	of	ADP
ajlm-2519	70	4	mrsa	mrsa	NOUN
ajlm-2519	70	5	isolates	isolate	NOUN
ajlm-2519	70	6	decreased	decrease	VERB
ajlm-2519	70	7	from	from	ADP
ajlm-2519	70	8	14	14	NUM
ajlm-2519	70	9	(	(	PUNCT
ajlm-2519	70	10	56.0	56.0	NUM
ajlm-2519	70	11	%	%	NOUN
ajlm-2519	70	12	,	,	PUNCT
ajlm-2519	70	13	n	n	NOUN
ajlm-2519	70	14	=	=	SYM
ajlm-2519	70	15	25	25	NUM
ajlm-2519	70	16	)	)	PUNCT
ajlm-2519	70	17	in	in	ADP
ajlm-2519	70	18	2016	2016	NUM
ajlm-2519	70	19	to	to	ADP
ajlm-2519	70	20	13	13	NUM
ajlm-2519	70	21	(	(	PUNCT
ajlm-2519	70	22	17.3	17.3	NUM
ajlm-2519	70	23	%	%	NOUN
ajlm-2519	70	24	,	,	PUNCT
ajlm-2519	70	25	n	n	NOUN
ajlm-2519	70	26	=	=	SYM
ajlm-2519	70	27	75	75	NUM
ajlm-2519	70	28	)	)	PUNCT
ajlm-2519	70	29	in	in	ADP
ajlm-2519	70	30	2019	2019	NUM
ajlm-2519	70	31	(	(	PUNCT
ajlm-2519	70	32	p	p	X
ajlm-2519	70	33	=	=	NOUN
ajlm-2519	70	34	0.260	0.260	NUM
ajlm-2519	70	35	)	)	PUNCT
ajlm-2519	70	36	.	.	PUNCT
ajlm-2519	71	1	vancomycin	vancomycin	PROPN
ajlm-2519	71	2	-	-	PUNCT
ajlm-2519	71	3	resistant	resistant	ADJ
ajlm-2519	71	4	s.	s.	PROPN
ajlm-2519	71	5	aureus	aureus	PROPN
ajlm-2519	71	6	was	be	AUX
ajlm-2519	71	7	4.7	4.7	NUM
ajlm-2519	71	8	%	%	NOUN
ajlm-2519	71	9	(	(	PUNCT
ajlm-2519	71	10	n	n	NOUN
ajlm-2519	71	11	=	=	SYM
ajlm-2519	71	12	12/256	12/256	NUM
ajlm-2519	71	13	)	)	PUNCT
ajlm-2519	71	14	.	.	PUNCT
ajlm-2519	72	1	in	in	ADP
ajlm-2519	72	2	general	general	ADJ
ajlm-2519	72	3	,	,	PUNCT
ajlm-2519	72	4	3gcr	3gcr	PROPN
ajlm-2519	72	5	k.	k.	NOUN
ajlm-2519	72	6	pneumoniae	pneumoniae	ADJ
ajlm-2519	72	7	incidence	incidence	NOUN
ajlm-2519	72	8	was	be	AUX
ajlm-2519	72	9	84.7	84.7	NUM
ajlm-2519	72	10	%	%	NOUN
ajlm-2519	72	11	(	(	PUNCT
ajlm-2519	72	12	n	n	NOUN
ajlm-2519	72	13	=	=	SYM
ajlm-2519	72	14	100/118	100/118	NUM
ajlm-2519	72	15	)	)	PUNCT
ajlm-2519	72	16	,	,	PUNCT
ajlm-2519	72	17	with	with	SCONJ
ajlm-2519	72	18	no	no	DET
ajlm-2519	72	19	change	change	NOUN
ajlm-2519	72	20	in	in	ADP
ajlm-2519	72	21	incidence	incidence	NOUN
ajlm-2519	72	22	rates	rate	NOUN
ajlm-2519	72	23	from	from	ADP
ajlm-2519	72	24	82.6	82.6	NUM
ajlm-2519	72	25	%	%	NOUN
ajlm-2519	72	26	(	(	PUNCT
ajlm-2519	72	27	n	n	NOUN
ajlm-2519	72	28	=	=	SYM
ajlm-2519	72	29	38/46	38/46	NUM
ajlm-2519	72	30	)	)	PUNCT
ajlm-2519	72	31	in	in	ADP
ajlm-2519	72	32	2014	2014	NUM
ajlm-2519	72	33	to	to	ADP
ajlm-2519	72	34	86.8	86.8	NUM
ajlm-2519	72	35	%	%	NOUN
ajlm-2519	72	36	(	(	PUNCT
ajlm-2519	72	37	n	n	NOUN
ajlm-2519	72	38	=	=	SYM
ajlm-2519	72	39	59/68	59/68	NUM
ajlm-2519	72	40	)	)	PUNCT
ajlm-2519	72	41	in	in	ADP
ajlm-2519	72	42	2015	2015	NUM
ajlm-2519	72	43	and	and	CCONJ
ajlm-2519	72	44	75.0	75.0	NUM
ajlm-2519	72	45	%	%	NOUN
ajlm-2519	72	46	(	(	PUNCT
ajlm-2519	72	47	n	n	NOUN
ajlm-2519	72	48	=	=	SYM
ajlm-2519	72	49	3/4	3/4	NUM
ajlm-2519	72	50	)	)	PUNCT
ajlm-2519	72	51	in	in	ADP
ajlm-2519	72	52	2016	2016	NUM
ajlm-2519	72	53	(	(	PUNCT
ajlm-2519	72	54	p	p	X
ajlm-2519	72	55	=	=	NOUN
ajlm-2519	72	56	0.070	0.070	NUM
ajlm-2519	72	57	)	)	PUNCT
ajlm-2519	72	58	,	,	PUNCT
ajlm-2519	72	59	and	and	CCONJ
ajlm-2519	72	60	carbapenem	carbapenem	NOUN
ajlm-2519	72	61	-	-	PUNCT
ajlm-2519	72	62	resistant	resistant	ADJ
ajlm-2519	72	63	k.	k.	NOUN
ajlm-2519	72	64	pneumoniae	pneumoniae	NOUN
ajlm-2519	72	65	was	be	AUX
ajlm-2519	72	66	5.9	5.9	NUM
ajlm-2519	72	67	%	%	NOUN
ajlm-2519	72	68	(	(	PUNCT
ajlm-2519	72	69	n	n	NOUN
ajlm-2519	72	70	=	=	SYM
ajlm-2519	72	71	7/118	7/118	NUM
ajlm-2519	72	72	)	)	PUNCT
ajlm-2519	72	73	(	(	PUNCT
ajlm-2519	72	74	p	p	X
ajlm-2519	72	75	=	=	NOUN
ajlm-2519	72	76	0.176	0.176	NUM
ajlm-2519	72	77	)	)	PUNCT
ajlm-2519	72	78	.	.	PUNCT
ajlm-2519	73	1	carbapenem	carbapenem	NOUN
ajlm-2519	73	2	-	-	PUNCT
ajlm-2519	73	3	resistant	resistant	ADJ
ajlm-2519	73	4	p.	p.	NOUN
ajlm-2519	73	5	aeruginosa	aeruginosa	NOUN
ajlm-2519	73	6	was	be	AUX
ajlm-2519	73	7	8.0	8.0	NUM
ajlm-2519	73	8	%	%	NOUN
ajlm-2519	73	9	(	(	PUNCT
ajlm-2519	73	10	n	n	NOUN
ajlm-2519	73	11	=	=	SYM
ajlm-2519	73	12	4/50	4/50	NUM
ajlm-2519	73	13	)	)	PUNCT
ajlm-2519	73	14	.	.	PUNCT
ajlm-2519	74	1	figure	figure	VERB
ajlm-2519	74	2	1	1	NUM
ajlm-2519	74	3	:	:	PUNCT
ajlm-2519	74	4	drug	drug	NOUN
ajlm-2519	74	5	-	-	PUNCT
ajlm-2519	74	6	pathogen	pathogen	NOUN
ajlm-2519	74	7	resistance	resistance	NOUN
ajlm-2519	74	8	of	of	ADP
ajlm-2519	74	9	global	global	ADJ
ajlm-2519	74	10	priority	priority	NOUN
ajlm-2519	74	11	tracer	tracer	NOUN
ajlm-2519	74	12	phenotypes	phenotype	NOUN
ajlm-2519	74	13	at	at	ADP
ajlm-2519	74	14	a	a	DET
ajlm-2519	74	15	referral	referral	ADJ
ajlm-2519	74	16	hospital	hospital	NOUN
ajlm-2519	74	17	in	in	ADP
ajlm-2519	74	18	limpopo	limpopo	PROPN
ajlm-2519	74	19	province	province	PROPN
ajlm-2519	74	20	,	,	PUNCT
ajlm-2519	74	21	south	south	PROPN
ajlm-2519	74	22	africa	africa	PROPN
ajlm-2519	74	23	:	:	PUNCT
ajlm-2519	74	24	2014–2019	2014–2019	NUM
ajlm-2519	74	25	.	.	PUNCT
ajlm-2519	75	1	klebsiella	klebsiella	NOUN
ajlm-2519	75	2	pneumoniae	pneumoniae	ADJ
ajlm-2519	75	3	(	(	PUNCT
ajlm-2519	75	4	n	n	NOUN
ajlm-2519	75	5	=	=	SYM
ajlm-2519	75	6	0/36	0/36	NUM
ajlm-2519	75	7	)	)	PUNCT
ajlm-2519	75	8	was	be	AUX
ajlm-2519	75	9	not	not	PART
ajlm-2519	75	10	resistant	resistant	ADJ
ajlm-2519	75	11	to	to	PART
ajlm-2519	75	12	colistin	colistin	VERB
ajlm-2519	75	13	(	(	PUNCT
ajlm-2519	75	14	see	see	VERB
ajlm-2519	75	15	online	online	ADJ
ajlm-2519	75	16	supplementary	supplementary	ADJ
ajlm-2519	75	17	table	table	NOUN
ajlm-2519	75	18	1	1	NUM
ajlm-2519	75	19	)	)	PUNCT
ajlm-2519	75	20	.	.	PUNCT
ajlm-2519	76	1	colistin	colistin	PROPN
ajlm-2519	76	2	resistance	resistance	PROPN
ajlm-2519	76	3	was	be	AUX
ajlm-2519	76	4	1.1	1.1	NUM
ajlm-2519	76	5	%	%	NOUN
ajlm-2519	76	6	(	(	PUNCT
ajlm-2519	76	7	n	n	NOUN
ajlm-2519	76	8	=	=	SYM
ajlm-2519	76	9	2/190	2/190	NUM
ajlm-2519	76	10	)	)	PUNCT
ajlm-2519	76	11	in	in	ADP
ajlm-2519	76	12	a.	a.	NOUN
ajlm-2519	76	13	baumannii	baumannii	PROPN
ajlm-2519	76	14	and	and	CCONJ
ajlm-2519	76	15	2.4	2.4	NUM
ajlm-2519	76	16	%	%	NOUN
ajlm-2519	76	17	(	(	PUNCT
ajlm-2519	76	18	n	n	NOUN
ajlm-2519	76	19	=	=	SYM
ajlm-2519	76	20	1/41	1/41	NUM
ajlm-2519	76	21	)	)	PUNCT
ajlm-2519	76	22	in	in	ADP
ajlm-2519	76	23	p.	p.	PROPN
ajlm-2519	76	24	aeruginosa	aeruginosa	PROPN
ajlm-2519	76	25	.	.	PUNCT
ajlm-2519	77	1	all	all	DET
ajlm-2519	77	2	samples	sample	NOUN
ajlm-2519	77	3	for	for	ADP
ajlm-2519	77	4	e.	e.	PROPN
ajlm-2519	77	5	faecium	faecium	PROPN
ajlm-2519	77	6	(	(	PUNCT
ajlm-2519	77	7	n	n	NOUN
ajlm-2519	77	8	=	=	NUM
ajlm-2519	77	9	0/100	0/100	NUM
ajlm-2519	77	10	)	)	PUNCT
ajlm-2519	77	11	and	and	CCONJ
ajlm-2519	77	12	s.	s.	PROPN
ajlm-2519	77	13	aureus	aureus	PROPN
ajlm-2519	77	14	(	(	PUNCT
ajlm-2519	77	15	n	n	NOUN
ajlm-2519	77	16	=	=	PUNCT
ajlm-2519	77	17	0/193	0/193	NOUN
ajlm-2519	77	18	)	)	PUNCT
ajlm-2519	77	19	were	be	AUX
ajlm-2519	77	20	susceptible	susceptible	ADJ
ajlm-2519	77	21	to	to	ADP
ajlm-2519	77	22	tigecycline	tigecycline	VERB
ajlm-2519	77	23	.	.	PUNCT
ajlm-2519	78	1	resistance	resistance	NOUN
ajlm-2519	78	2	to	to	ADP
ajlm-2519	78	3	tigecycline	tigecycline	PROPN
ajlm-2519	78	4	was	be	AUX
ajlm-2519	78	5	10.7	10.7	NUM
ajlm-2519	78	6	%	%	NOUN
ajlm-2519	78	7	(	(	PUNCT
ajlm-2519	78	8	n	n	NOUN
ajlm-2519	78	9	=	=	SYM
ajlm-2519	78	10	20/187	20/187	NUM
ajlm-2519	78	11	)	)	PUNCT
ajlm-2519	78	12	for	for	ADP
ajlm-2519	78	13	a.	a.	NOUN
ajlm-2519	78	14	baumannii	baumannii	NOUN
ajlm-2519	78	15	and	and	CCONJ
ajlm-2519	78	16	3.8	3.8	NUM
ajlm-2519	78	17	%	%	NOUN
ajlm-2519	78	18	(	(	PUNCT
ajlm-2519	78	19	n	n	NOUN
ajlm-2519	78	20	=	=	SYM
ajlm-2519	78	21	4/100	4/100	NUM
ajlm-2519	78	22	)	)	PUNCT
ajlm-2519	78	23	for	for	ADP
ajlm-2519	78	24	k.	k.	PROPN
ajlm-2519	78	25	pneumoniae	pneumoniae	PROPN
ajlm-2519	78	26	.	.	PUNCT
ajlm-2519	79	1	linezolid	linezolid	PROPN
ajlm-2519	79	2	resistance	resistance	NOUN
ajlm-2519	79	3	was	be	AUX
ajlm-2519	79	4	found	find	VERB
ajlm-2519	79	5	in	in	ADP
ajlm-2519	79	6	2.0	2.0	NUM
ajlm-2519	79	7	%	%	NOUN
ajlm-2519	79	8	(	(	PUNCT
ajlm-2519	79	9	n	n	NOUN
ajlm-2519	79	10	=	=	SYM
ajlm-2519	79	11	2/100	2/100	NUM
ajlm-2519	79	12	)	)	PUNCT
ajlm-2519	79	13	of	of	ADP
ajlm-2519	79	14	e.	e.	PROPN
ajlm-2519	79	15	faecium	faecium	PROPN
ajlm-2519	79	16	and	and	CCONJ
ajlm-2519	79	17	0.8	0.8	NUM
ajlm-2519	79	18	%	%	NOUN
ajlm-2519	79	19	(	(	PUNCT
ajlm-2519	79	20	n	n	NOUN
ajlm-2519	79	21	=	=	NOUN
ajlm-2519	79	22	2/251	2/251	NUM
ajlm-2519	79	23	)	)	PUNCT
ajlm-2519	79	24	of	of	ADP
ajlm-2519	79	25	s.	s.	PROPN
ajlm-2519	79	26	aureus	aureus	PROPN
ajlm-2519	79	27	isolates	isolate	NOUN
ajlm-2519	79	28	.	.	PUNCT
ajlm-2519	80	1	incidence	incidence	NOUN
ajlm-2519	80	2	rates	rate	NOUN
ajlm-2519	80	3	for	for	ADP
ajlm-2519	80	4	multidrug	multidrug	NOUN
ajlm-2519	80	5	resistance	resistance	NOUN
ajlm-2519	80	6	between	between	ADP
ajlm-2519	80	7	a.	a.	NOUN
ajlm-2519	80	8	baumannii	baumannii	PROPN
ajlm-2519	80	9	and	and	CCONJ
ajlm-2519	80	10	cefepime	cefepime	ADJ
ajlm-2519	80	11	,	,	PUNCT
ajlm-2519	80	12	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2519	80	13	,	,	PUNCT
ajlm-2519	80	14	gentamycin	gentamycin	PROPN
ajlm-2519	80	15	,	,	PUNCT
ajlm-2519	80	16	meropenem	meropenem	ADJ
ajlm-2519	80	17	,	,	PUNCT
ajlm-2519	80	18	and	and	CCONJ
ajlm-2519	80	19	piperacillin	piperacillin	NOUN
ajlm-2519	80	20	with	with	ADP
ajlm-2519	80	21	tazobactam	tazobactam	NOUN
ajlm-2519	80	22	increased	increase	VERB
ajlm-2519	80	23	significantly	significantly	ADV
ajlm-2519	80	24	from	from	ADP
ajlm-2519	80	25	2015	2015	NUM
ajlm-2519	80	26	to	to	ADP
ajlm-2519	80	27	2019	2019	NUM
ajlm-2519	80	28	(	(	PUNCT
ajlm-2519	80	29	p	p	X
ajlm-2519	80	30	=	=	NOUN
ajlm-2519	80	31	0.008	0.008	NUM
ajlm-2519	80	32	)	)	PUNCT
ajlm-2519	80	33	(	(	PUNCT
ajlm-2519	80	34	online	online	ADJ
ajlm-2519	80	35	supplementary	supplementary	ADJ
ajlm-2519	80	36	table	table	NOUN
ajlm-2519	80	37	2	2	NUM
ajlm-2519	80	38	)	)	PUNCT
ajlm-2519	80	39	.	.	PUNCT
ajlm-2519	81	1	there	there	PRON
ajlm-2519	81	2	was	be	VERB
ajlm-2519	81	3	no	no	DET
ajlm-2519	81	4	change	change	NOUN
ajlm-2519	81	5	in	in	ADP
ajlm-2519	81	6	the	the	DET
ajlm-2519	81	7	resistance	resistance	NOUN
ajlm-2519	81	8	rate	rate	NOUN
ajlm-2519	81	9	for	for	ADP
ajlm-2519	81	10	p.	p.	NOUN
ajlm-2519	81	11	aeruginosa	aeruginosa	PROPN
ajlm-2519	81	12	to	to	ADP
ajlm-2519	81	13	amikacin	amikacin	PROPN
ajlm-2519	81	14	(	(	PUNCT
ajlm-2519	81	15	p	p	X
ajlm-2519	81	16	=	=	NOUN
ajlm-2519	81	17	0.242	0.242	NUM
ajlm-2519	81	18	)	)	PUNCT
ajlm-2519	81	19	,	,	PUNCT
ajlm-2519	81	20	cefepime	cefepime	NOUN
ajlm-2519	81	21	(	(	PUNCT
ajlm-2519	81	22	p	p	X
ajlm-2519	81	23	=	=	NOUN
ajlm-2519	81	24	0.060	0.060	NUM
ajlm-2519	81	25	)	)	PUNCT
ajlm-2519	81	26	,	,	PUNCT
ajlm-2519	81	27	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2519	81	28	(	(	PUNCT
ajlm-2519	81	29	p	p	X
ajlm-2519	81	30	=	=	NOUN
ajlm-2519	81	31	0.176	0.176	NUM
ajlm-2519	81	32	)	)	PUNCT
ajlm-2519	81	33	,	,	PUNCT
ajlm-2519	81	34	meropenem	meropenem	PROPN
ajlm-2519	81	35	(	(	PUNCT
ajlm-2519	81	36	p	p	X
ajlm-2519	81	37	=	=	NOUN
ajlm-2519	81	38	0.817	0.817	NUM
ajlm-2519	81	39	)	)	PUNCT
ajlm-2519	81	40	,	,	PUNCT
ajlm-2519	81	41	and	and	CCONJ
ajlm-2519	81	42	piperacillin	piperacillin	NOUN
ajlm-2519	81	43	with	with	ADP
ajlm-2519	81	44	tazobactam	tazobactam	NOUN
ajlm-2519	81	45	(	(	PUNCT
ajlm-2519	81	46	p	p	NOUN
ajlm-2519	81	47	=	=	NOUN
ajlm-2519	81	48	0.159	0.159	NUM
ajlm-2519	81	49	)	)	PUNCT
ajlm-2519	81	50	.	.	PUNCT
ajlm-2519	82	1	discussion	discussion	NOUN
ajlm-2519	82	2	key	key	ADJ
ajlm-2519	82	3	findings	finding	NOUN
ajlm-2519	82	4	of	of	ADP
ajlm-2519	82	5	our	our	PRON
ajlm-2519	82	6	study	study	NOUN
ajlm-2519	82	7	are	be	AUX
ajlm-2519	82	8	that	that	SCONJ
ajlm-2519	82	9	eskape	eskape	NOUN
ajlm-2519	82	10	pathogens	pathogen	NOUN
ajlm-2519	82	11	blood	blood	NOUN
ajlm-2519	82	12	culture	culture	NOUN
ajlm-2519	82	13	isolates	isolate	NOUN
ajlm-2519	82	14	showed	show	VERB
ajlm-2519	82	15	no	no	DET
ajlm-2519	82	16	significant	significant	ADJ
ajlm-2519	82	17	variation	variation	NOUN
ajlm-2519	82	18	between	between	ADP
ajlm-2519	82	19	2014	2014	NUM
ajlm-2519	82	20	and	and	CCONJ
ajlm-2519	82	21	2019	2019	NUM
ajlm-2519	82	22	,	,	PUNCT
ajlm-2519	82	23	and	and	CCONJ
ajlm-2519	82	24	that	that	SCONJ
ajlm-2519	82	25	s.	s.	PROPN
ajlm-2519	82	26	aureus	aureus	PROPN
ajlm-2519	82	27	,	,	PUNCT
ajlm-2519	82	28	a.	a.	NOUN
ajlm-2519	82	29	baumannii	baumannii	PROPN
ajlm-2519	82	30	,	,	PUNCT
ajlm-2519	82	31	and	and	CCONJ
ajlm-2519	82	32	k.	k.	PROPN
ajlm-2519	82	33	pneumoniae	pneumoniae	NOUN
ajlm-2519	82	34	were	be	AUX
ajlm-2519	82	35	the	the	DET
ajlm-2519	82	36	eskape	eskape	NOUN
ajlm-2519	82	37	pathogens	pathogen	NOUN
ajlm-2519	82	38	commonly	commonly	ADV
ajlm-2519	82	39	isolated	isolate	VERB
ajlm-2519	82	40	in	in	ADP
ajlm-2519	82	41	mankweng	mankweng	ADJ
ajlm-2519	82	42	tertiary	tertiary	ADJ
ajlm-2519	82	43	hospital	hospital	NOUN
ajlm-2519	82	44	.	.	PUNCT
ajlm-2519	83	1	most	most	ADJ
ajlm-2519	83	2	of	of	ADP
ajlm-2519	83	3	the	the	DET
ajlm-2519	83	4	eskape	eskape	NOUN
ajlm-2519	83	5	isolates	isolate	NOUN
ajlm-2519	83	6	were	be	AUX
ajlm-2519	83	7	from	from	ADP
ajlm-2519	83	8	the	the	DET
ajlm-2519	83	9	neonatal	neonatal	ADJ
ajlm-2519	83	10	ward	ward	NOUN
ajlm-2519	83	11	,	,	PUNCT
ajlm-2519	83	12	followed	follow	VERB
ajlm-2519	83	13	by	by	ADP
ajlm-2519	83	14	the	the	DET
ajlm-2519	83	15	paediatric	paediatric	ADJ
ajlm-2519	83	16	ward	ward	NOUN
ajlm-2519	83	17	and	and	CCONJ
ajlm-2519	83	18	the	the	DET
ajlm-2519	83	19	intensive	intensive	ADJ
ajlm-2519	83	20	care	care	NOUN
ajlm-2519	83	21	unit	unit	NOUN
ajlm-2519	83	22	.	.	PUNCT
ajlm-2519	84	1	there	there	PRON
ajlm-2519	84	2	was	be	VERB
ajlm-2519	84	3	an	an	DET
ajlm-2519	84	4	increase	increase	NOUN
ajlm-2519	84	5	in	in	ADP
ajlm-2519	84	6	crab	crab	NOUN
ajlm-2519	84	7	,	,	PUNCT
ajlm-2519	84	8	whereas	whereas	SCONJ
ajlm-2519	84	9	mrsa	mrsa	NOUN
ajlm-2519	84	10	decreased	decrease	VERB
ajlm-2519	84	11	.	.	PUNCT
ajlm-2519	85	1	colistin	colistin	PROPN
ajlm-2519	85	2	resistance	resistance	PROPN
ajlm-2519	85	3	was	be	AUX
ajlm-2519	85	4	less	less	ADJ
ajlm-2519	85	5	than	than	ADP
ajlm-2519	85	6	3.0	3.0	NUM
ajlm-2519	85	7	%	%	NOUN
ajlm-2519	85	8	for	for	ADP
ajlm-2519	85	9	gram	gram	NOUN
ajlm-2519	85	10	-	-	PUNCT
ajlm-2519	85	11	negative	negative	ADJ
ajlm-2519	85	12	pathogens	pathogen	NOUN
ajlm-2519	85	13	a.	a.	NOUN
ajlm-2519	85	14	baumannii	baumannii	PROPN
ajlm-2519	85	15	and	and	CCONJ
ajlm-2519	85	16	p.	p.	PROPN
ajlm-2519	85	17	aeruginosa	aeruginosa	PROPN
ajlm-2519	85	18	.	.	PUNCT
ajlm-2519	86	1	in	in	ADP
ajlm-2519	86	2	our	our	PRON
ajlm-2519	86	3	study	study	NOUN
ajlm-2519	86	4	,	,	PUNCT
ajlm-2519	86	5	the	the	DET
ajlm-2519	86	6	blood	blood	NOUN
ajlm-2519	86	7	culture	culture	NOUN
ajlm-2519	86	8	isolates	isolate	NOUN
ajlm-2519	86	9	of	of	ADP
ajlm-2519	86	10	the	the	DET
ajlm-2519	86	11	eskape	eskape	NOUN
ajlm-2519	86	12	pathogens	pathogen	NOUN
ajlm-2519	86	13	corresponded	correspond	VERB
ajlm-2519	86	14	to	to	ADP
ajlm-2519	86	15	the	the	DET
ajlm-2519	86	16	national	national	ADJ
ajlm-2519	86	17	trend	trend	NOUN
ajlm-2519	86	18	in	in	ADP
ajlm-2519	86	19	south	south	PROPN
ajlm-2519	86	20	africa.11	africa.11	NOUN
ajlm-2519	86	21	between	between	ADP
ajlm-2519	86	22	2018	2018	NUM
ajlm-2519	86	23	and	and	CCONJ
ajlm-2519	86	24	2020	2020	NUM
ajlm-2519	86	25	,	,	PUNCT
ajlm-2519	86	26	there	there	PRON
ajlm-2519	86	27	was	be	VERB
ajlm-2519	86	28	no	no	DET
ajlm-2519	86	29	significant	significant	ADJ
ajlm-2519	86	30	variation	variation	NOUN
ajlm-2519	86	31	in	in	ADP
ajlm-2519	86	32	the	the	DET
ajlm-2519	86	33	proportion	proportion	NOUN
ajlm-2519	86	34	(	(	PUNCT
ajlm-2519	86	35	ranging	range	VERB
ajlm-2519	86	36	from	from	ADP
ajlm-2519	86	37	40	40	NUM
ajlm-2519	86	38	%	%	NOUN
ajlm-2519	86	39	to	to	ADP
ajlm-2519	86	40	41	41	NUM
ajlm-2519	86	41	%	%	NOUN
ajlm-2519	86	42	)	)	PUNCT
ajlm-2519	86	43	of	of	ADP
ajlm-2519	86	44	eskape	eskape	NOUN
ajlm-2519	86	45	pathogens	pathogen	NOUN
ajlm-2519	86	46	isolated	isolate	VERB
ajlm-2519	86	47	from	from	ADP
ajlm-2519	86	48	all	all	DET
ajlm-2519	86	49	public	public	ADJ
ajlm-2519	86	50	sector	sector	NOUN
ajlm-2519	86	51	positive	positive	ADJ
ajlm-2519	86	52	blood	blood	NOUN
ajlm-2519	86	53	cultures	culture	NOUN
ajlm-2519	86	54	in	in	ADP
ajlm-2519	86	55	south	south	PROPN
ajlm-2519	86	56	africa	africa	PROPN
ajlm-2519	86	57	,	,	PUNCT
ajlm-2519	86	58	despite	despite	SCONJ
ajlm-2519	86	59	an	an	DET
ajlm-2519	86	60	increase	increase	NOUN
ajlm-2519	86	61	in	in	ADP
ajlm-2519	86	62	the	the	DET
ajlm-2519	86	63	total	total	ADJ
ajlm-2519	86	64	number	number	NOUN
ajlm-2519	86	65	of	of	ADP
ajlm-2519	86	66	blood	blood	NOUN
ajlm-2519	86	67	cultures	culture	NOUN
ajlm-2519	86	68	tested.11	tested.11	VERB
ajlm-2519	86	69	a	a	DET
ajlm-2519	86	70	national	national	ADJ
ajlm-2519	86	71	neonatal	neonatal	ADJ
ajlm-2519	86	72	public	public	ADJ
ajlm-2519	86	73	sector	sector	NOUN
ajlm-2519	86	74	south	south	ADJ
ajlm-2519	86	75	african	african	ADJ
ajlm-2519	86	76	study	study	NOUN
ajlm-2519	86	77	from	from	ADP
ajlm-2519	86	78	2014	2014	NUM
ajlm-2519	86	79	to	to	ADP
ajlm-2519	86	80	2019	2019	NUM
ajlm-2519	86	81	also	also	ADV
ajlm-2519	86	82	found	find	VERB
ajlm-2519	86	83	that	that	SCONJ
ajlm-2519	86	84	despite	despite	SCONJ
ajlm-2519	86	85	increased	increase	VERB
ajlm-2519	86	86	blood	blood	NOUN
ajlm-2519	86	87	culture	culture	NOUN
ajlm-2519	86	88	collection	collection	NOUN
ajlm-2519	86	89	,	,	PUNCT
ajlm-2519	86	90	the	the	DET
ajlm-2519	86	91	annual	annual	ADJ
ajlm-2519	86	92	proportion	proportion	NOUN
ajlm-2519	86	93	of	of	ADP
ajlm-2519	86	94	positive	positive	ADJ
ajlm-2519	86	95	blood	blood	NOUN
ajlm-2519	86	96	cultures	culture	NOUN
ajlm-2519	86	97	remained	remain	VERB
ajlm-2519	86	98	unchanged	unchanged	ADJ
ajlm-2519	86	99	,	,	PUNCT
ajlm-2519	86	100	with	with	ADP
ajlm-2519	86	101	an	an	DET
ajlm-2519	86	102	incidence	incidence	ADJ
ajlm-2519	86	103	risk	risk	NOUN
ajlm-2519	86	104	of	of	ADP
ajlm-2519	86	105	6.0	6.0	NUM
ajlm-2519	86	106	per	per	ADP
ajlm-2519	86	107	1000	1000	NUM
ajlm-2519	86	108	livebirths	livebirth	NOUN
ajlm-2519	86	109	(	(	PUNCT
ajlm-2519	86	110	95	95	NUM
ajlm-2519	86	111	%	%	NOUN
ajlm-2519	86	112	confidence	confidence	NOUN
ajlm-2519	86	113	interval	interval	NOUN
ajlm-2519	86	114	:	:	PUNCT
ajlm-2519	86	115	6.0–6.1).13	6.0–6.1).13	NUM
ajlm-2519	86	116	antimicrobial	antimicrobial	ADJ
ajlm-2519	86	117	use	use	NOUN
ajlm-2519	86	118	is	be	AUX
ajlm-2519	86	119	a	a	DET
ajlm-2519	86	120	significant	significant	ADJ
ajlm-2519	86	121	promoter	promoter	NOUN
ajlm-2519	86	122	of	of	ADP
ajlm-2519	86	123	resistance	resistance	NOUN
ajlm-2519	86	124	,	,	PUNCT
ajlm-2519	86	125	giving	give	VERB
ajlm-2519	86	126	resistant	resistant	ADJ
ajlm-2519	86	127	bacteria	bacteria	NOUN
ajlm-2519	86	128	a	a	DET
ajlm-2519	86	129	selection	selection	NOUN
ajlm-2519	86	130	advantage	advantage	NOUN
ajlm-2519	86	131	over	over	ADP
ajlm-2519	86	132	sensitive	sensitive	ADJ
ajlm-2519	86	133	ones.9	ones.9	NOUN
ajlm-2519	86	134	the	the	DET
ajlm-2519	86	135	observed	observe	VERB
ajlm-2519	86	136	insignificant	insignificant	ADJ
ajlm-2519	86	137	variation	variation	NOUN
ajlm-2519	86	138	in	in	ADP
ajlm-2519	86	139	the	the	DET
ajlm-2519	86	140	incidence	incidence	NOUN
ajlm-2519	86	141	of	of	ADP
ajlm-2519	86	142	eskape	eskape	NOUN
ajlm-2519	86	143	pathogens	pathogen	NOUN
ajlm-2519	86	144	in	in	ADP
ajlm-2519	86	145	our	our	PRON
ajlm-2519	86	146	study	study	NOUN
ajlm-2519	86	147	and	and	CCONJ
ajlm-2519	86	148	across	across	ADP
ajlm-2519	86	149	the	the	DET
ajlm-2519	86	150	south	south	ADJ
ajlm-2519	86	151	african	african	ADJ
ajlm-2519	86	152	public	public	ADJ
ajlm-2519	86	153	sector11	sector11	NOUN
ajlm-2519	86	154	could	could	AUX
ajlm-2519	86	155	be	be	AUX
ajlm-2519	86	156	attributed	attribute	VERB
ajlm-2519	86	157	to	to	ADP
ajlm-2519	86	158	the	the	DET
ajlm-2519	86	159	centralised	centralised	ADJ
ajlm-2519	86	160	medicines	medicine	NOUN
ajlm-2519	86	161	procurement	procurement	NOUN
ajlm-2519	86	162	contracts	contract	NOUN
ajlm-2519	86	163	based	base	VERB
ajlm-2519	86	164	on	on	ADP
ajlm-2519	86	165	the	the	DET
ajlm-2519	86	166	national	national	ADJ
ajlm-2519	86	167	standard	standard	ADJ
ajlm-2519	86	168	treatment	treatment	NOUN
ajlm-2519	86	169	guidelines	guideline	NOUN
ajlm-2519	86	170	and	and	CCONJ
ajlm-2519	86	171	essential	essential	ADJ
ajlm-2519	86	172	medicines	medicine	NOUN
ajlm-2519	86	173	lists.11	lists.11	ADJ
ajlm-2519	86	174	however	however	ADV
ajlm-2519	86	175	,	,	PUNCT
ajlm-2519	86	176	there	there	PRON
ajlm-2519	86	177	is	be	VERB
ajlm-2519	86	178	no	no	DET
ajlm-2519	86	179	definitive	definitive	ADJ
ajlm-2519	86	180	evidence	evidence	NOUN
ajlm-2519	86	181	to	to	PART
ajlm-2519	86	182	explain	explain	VERB
ajlm-2519	86	183	the	the	DET
ajlm-2519	86	184	stable	stable	ADJ
ajlm-2519	86	185	incidence	incidence	NOUN
ajlm-2519	86	186	of	of	ADP
ajlm-2519	86	187	eskape	eskape	NOUN
ajlm-2519	86	188	pathogens	pathogen	NOUN
ajlm-2519	86	189	in	in	ADP
ajlm-2519	86	190	our	our	PRON
ajlm-2519	86	191	study	study	NOUN
ajlm-2519	86	192	or	or	CCONJ
ajlm-2519	86	193	across	across	ADP
ajlm-2519	86	194	south	south	PROPN
ajlm-2519	86	195	africa	africa	PROPN
ajlm-2519	86	196	,	,	PUNCT
ajlm-2519	86	197	therefore	therefore	ADV
ajlm-2519	86	198	ecological	ecological	ADJ
ajlm-2519	86	199	studies	study	NOUN
ajlm-2519	86	200	are	be	AUX
ajlm-2519	86	201	warranted	warrant	VERB
ajlm-2519	86	202	.	.	PUNCT
ajlm-2519	87	1	despite	despite	SCONJ
ajlm-2519	87	2	the	the	DET
ajlm-2519	87	3	overall	overall	ADJ
ajlm-2519	87	4	consistent	consistent	ADJ
ajlm-2519	87	5	eskape	eskape	NOUN
ajlm-2519	87	6	pathogen	pathogen	NOUN
ajlm-2519	87	7	incidence	incidence	NOUN
ajlm-2519	87	8	,	,	PUNCT
ajlm-2519	87	9	our	our	PRON
ajlm-2519	87	10	study	study	NOUN
ajlm-2519	87	11	showed	show	VERB
ajlm-2519	87	12	variation	variation	NOUN
ajlm-2519	87	13	in	in	ADP
ajlm-2519	87	14	the	the	DET
ajlm-2519	87	15	incidence	incidence	NOUN
ajlm-2519	87	16	among	among	ADP
ajlm-2519	87	17	individual	individual	ADJ
ajlm-2519	87	18	eskape	eskape	NOUN
ajlm-2519	87	19	pathogens	pathogen	NOUN
ajlm-2519	87	20	,	,	PUNCT
ajlm-2519	87	21	which	which	PRON
ajlm-2519	87	22	could	could	AUX
ajlm-2519	87	23	be	be	AUX
ajlm-2519	87	24	attributed	attribute	VERB
ajlm-2519	87	25	to	to	ADP
ajlm-2519	87	26	antimicrobial	antimicrobial	ADJ
ajlm-2519	87	27	selection	selection	NOUN
ajlm-2519	87	28	pressure	pressure	NOUN
ajlm-2519	87	29	.	.	PUNCT
ajlm-2519	88	1	staphylococcus	staphylococcus	NOUN
ajlm-2519	88	2	aureus	aureus	NOUN
ajlm-2519	88	3	,	,	PUNCT
ajlm-2519	88	4	a.	a.	NOUN
ajlm-2519	88	5	baumannii	baumannii	PROPN
ajlm-2519	88	6	and	and	CCONJ
ajlm-2519	88	7	k.	k.	PROPN
ajlm-2519	88	8	pneumoniae	pneumoniae	NOUN
ajlm-2519	88	9	were	be	AUX
ajlm-2519	88	10	the	the	DET
ajlm-2519	88	11	most	most	ADV
ajlm-2519	88	12	frequently	frequently	ADV
ajlm-2519	88	13	isolated	isolate	VERB
ajlm-2519	88	14	eskape	eskape	NOUN
ajlm-2519	88	15	pathogens	pathogen	NOUN
ajlm-2519	88	16	in	in	ADP
ajlm-2519	88	17	our	our	PRON
ajlm-2519	88	18	study	study	NOUN
ajlm-2519	88	19	,	,	PUNCT
ajlm-2519	88	20	similar	similar	ADJ
ajlm-2519	88	21	to	to	ADP
ajlm-2519	88	22	a	a	DET
ajlm-2519	88	23	countrywide	countrywide	NOUN
ajlm-2519	88	24	public	public	ADJ
ajlm-2519	88	25	sector	sector	NOUN
ajlm-2519	88	26	neonatal	neonatal	ADJ
ajlm-2519	88	27	population	population	NOUN
ajlm-2519	88	28	study	study	NOUN
ajlm-2519	88	29	in	in	ADP
ajlm-2519	88	30	south	south	PROPN
ajlm-2519	88	31	africa	africa	PROPN
ajlm-2519	88	32	between	between	ADP
ajlm-2519	88	33	2014	2014	NUM
ajlm-2519	88	34	and	and	CCONJ
ajlm-2519	88	35	2019,13	2019,13	PROPN
ajlm-2519	88	36	as	as	ADV
ajlm-2519	88	37	well	well	ADV
ajlm-2519	88	38	as	as	ADP
ajlm-2519	88	39	a	a	DET
ajlm-2519	88	40	south	south	ADJ
ajlm-2519	88	41	african	african	ADJ
ajlm-2519	88	42	national	national	ADJ
ajlm-2519	88	43	mixed	mix	VERB
ajlm-2519	88	44	-	-	PUNCT
ajlm-2519	88	45	population	population	NOUN
ajlm-2519	88	46	report	report	NOUN
ajlm-2519	88	47	from	from	ADP
ajlm-2519	88	48	2020.11	2020.11	NUM
ajlm-2519	88	49	furthermore	furthermore	ADV
ajlm-2519	88	50	,	,	PUNCT
ajlm-2519	88	51	our	our	PRON
ajlm-2519	88	52	findings	finding	NOUN
ajlm-2519	88	53	corroborate	corroborate	VERB
ajlm-2519	88	54	2019	2019	NUM
ajlm-2519	88	55	global1,2	global1,2	PROPN
ajlm-2519	88	56	and	and	CCONJ
ajlm-2519	88	57	other	other	ADJ
ajlm-2519	88	58	single	single	ADJ
ajlm-2519	88	59	-	-	PUNCT
ajlm-2519	88	60	centre	centre	NOUN
ajlm-2519	88	61	trends	trend	NOUN
ajlm-2519	88	62	from	from	ADP
ajlm-2519	88	63	the	the	DET
ajlm-2519	88	64	limpopo	limpopo	PROPN
ajlm-2519	88	65	(	(	PUNCT
ajlm-2519	88	66	2016	2016	NUM
ajlm-2519	88	67	)	)	PUNCT
ajlm-2519	88	68	and	and	CCONJ
ajlm-2519	88	69	kwazulu	kwazulu	VERB
ajlm-2519	88	70	-	-	PUNCT
ajlm-2519	88	71	natal	natal	ADJ
ajlm-2519	88	72	(	(	PUNCT
ajlm-2519	88	73	2011–2015	2011–2015	NOUN
ajlm-2519	88	74	)	)	PUNCT
ajlm-2519	88	75	provinces	province	NOUN
ajlm-2519	88	76	in	in	ADP
ajlm-2519	88	77	south	south	PROPN
ajlm-2519	88	78	africa.29,30	africa.29,30	ADP
ajlm-2519	88	79	the	the	DET
ajlm-2519	88	80	increased	increase	VERB
ajlm-2519	88	81	number	number	NOUN
ajlm-2519	88	82	of	of	ADP
ajlm-2519	88	83	s.	s.	PROPN
ajlm-2519	88	84	aureus	aureus	PROPN
ajlm-2519	88	85	isolates	isolate	NOUN
ajlm-2519	88	86	observed	observe	VERB
ajlm-2519	88	87	in	in	ADP
ajlm-2519	88	88	our	our	PRON
ajlm-2519	88	89	study	study	NOUN
ajlm-2519	88	90	is	be	AUX
ajlm-2519	88	91	concerning	concern	VERB
ajlm-2519	88	92	,	,	PUNCT
ajlm-2519	88	93	as	as	SCONJ
ajlm-2519	88	94	global	global	ADJ
ajlm-2519	88	95	data	datum	NOUN
ajlm-2519	88	96	show	show	VERB
ajlm-2519	88	97	that	that	SCONJ
ajlm-2519	88	98	s.	s.	PROPN
ajlm-2519	88	99	aureus	aureus	PROPN
ajlm-2519	88	100	was	be	AUX
ajlm-2519	88	101	the	the	DET
ajlm-2519	88	102	leading	lead	VERB
ajlm-2519	88	103	cause	cause	NOUN
ajlm-2519	88	104	of	of	ADP
ajlm-2519	88	105	fatal	fatal	ADJ
ajlm-2519	88	106	bloodstream	bloodstream	NOUN
ajlm-2519	88	107	infections	infection	NOUN
ajlm-2519	88	108	,	,	PUNCT
ajlm-2519	88	109	resulting	result	VERB
ajlm-2519	88	110	in	in	ADP
ajlm-2519	88	111	approximately	approximately	ADV
ajlm-2519	88	112	299	299	NUM
ajlm-2519	88	113	000	000	NUM
ajlm-2519	88	114	deaths	death	NOUN
ajlm-2519	88	115	and	and	CCONJ
ajlm-2519	88	116	30	30	NUM
ajlm-2519	88	117	million	million	NUM
ajlm-2519	88	118	years	year	NOUN
ajlm-2519	88	119	of	of	ADP
ajlm-2519	88	120	life	life	NOUN
ajlm-2519	88	121	lost	lose	VERB
ajlm-2519	88	122	in	in	ADP
ajlm-2519	88	123	2019.1	2019.1	NUM
ajlm-2519	88	124	acinetobacter	acinetobacter	ADV
ajlm-2519	88	125	baumannii	baumannii	ADJ
ajlm-2519	88	126	was	be	AUX
ajlm-2519	88	127	the	the	DET
ajlm-2519	88	128	sixth	sixth	ADJ
ajlm-2519	88	129	most	most	ADV
ajlm-2519	88	130	isolated	isolate	VERB
ajlm-2519	88	131	bloodstream	bloodstream	NOUN
ajlm-2519	88	132	pathogen	pathogen	NOUN
ajlm-2519	88	133	globally	globally	ADV
ajlm-2519	88	134	in	in	ADP
ajlm-2519	88	135	2019.1,2	2019.1,2	NUM
ajlm-2519	88	136	the	the	DET
ajlm-2519	88	137	high	high	ADJ
ajlm-2519	88	138	incidence	incidence	NOUN
ajlm-2519	88	139	of	of	ADP
ajlm-2519	88	140	a.	a.	NOUN
ajlm-2519	88	141	baumannii	baumannii	PROPN
ajlm-2519	88	142	in	in	ADP
ajlm-2519	88	143	this	this	DET
ajlm-2519	88	144	study	study	NOUN
ajlm-2519	88	145	is	be	AUX
ajlm-2519	88	146	furthermore	furthermore	ADV
ajlm-2519	88	147	concerning	concern	VERB
ajlm-2519	88	148	since	since	SCONJ
ajlm-2519	88	149	it	it	PRON
ajlm-2519	88	150	is	be	AUX
ajlm-2519	88	151	the	the	DET
ajlm-2519	88	152	leading	lead	VERB
ajlm-2519	88	153	cause	cause	NOUN
ajlm-2519	88	154	of	of	ADP
ajlm-2519	88	155	prolonged	prolonged	ADJ
ajlm-2519	88	156	hospital	hospital	NOUN
ajlm-2519	88	157	stay,2,10	stay,2,10	NOUN
ajlm-2519	88	158	increasing	increase	VERB
ajlm-2519	88	159	the	the	DET
ajlm-2519	88	160	risk	risk	NOUN
ajlm-2519	88	161	of	of	ADP
ajlm-2519	88	162	hospital	hospital	NOUN
ajlm-2519	88	163	-	-	PUNCT
ajlm-2519	88	164	acquired	acquire	VERB
ajlm-2519	88	165	infections	infection	NOUN
ajlm-2519	88	166	and	and	CCONJ
ajlm-2519	88	167	escalating	escalate	VERB
ajlm-2519	88	168	healthcare	healthcare	NOUN
ajlm-2519	88	169	costs	cost	NOUN
ajlm-2519	88	170	,	,	PUNCT
ajlm-2519	88	171	and	and	CCONJ
ajlm-2519	88	172	delaying	delay	VERB
ajlm-2519	88	173	patient	patient	ADJ
ajlm-2519	88	174	access	access	NOUN
ajlm-2519	88	175	to	to	ADP
ajlm-2519	88	176	care	care	NOUN
ajlm-2519	88	177	owing	owe	VERB
ajlm-2519	88	178	to	to	ADP
ajlm-2519	88	179	bed	bed	NOUN
ajlm-2519	88	180	shortages.7,8,31	shortages.7,8,31	ADJ
ajlm-2519	88	181	despite	despite	SCONJ
ajlm-2519	88	182	being	be	AUX
ajlm-2519	88	183	one	one	NUM
ajlm-2519	88	184	of	of	ADP
ajlm-2519	88	185	the	the	DET
ajlm-2519	88	186	bloodstream	bloodstream	NOUN
ajlm-2519	88	187	infections	infection	NOUN
ajlm-2519	88	188	isolated	isolate	VERB
ajlm-2519	88	189	the	the	DET
ajlm-2519	88	190	most	most	ADJ
ajlm-2519	88	191	in	in	ADP
ajlm-2519	88	192	our	our	PRON
ajlm-2519	88	193	study	study	NOUN
ajlm-2519	88	194	,	,	PUNCT
ajlm-2519	88	195	k.	k.	PROPN
ajlm-2519	89	1	pneumoniae	pneumoniae	ADJ
ajlm-2519	89	2	isolation	isolation	NOUN
ajlm-2519	89	3	decreased	decrease	VERB
ajlm-2519	89	4	significantly	significantly	ADV
ajlm-2519	89	5	during	during	ADP
ajlm-2519	89	6	the	the	DET
ajlm-2519	89	7	study	study	NOUN
ajlm-2519	89	8	.	.	PUNCT
ajlm-2519	90	1	this	this	DET
ajlm-2519	90	2	development	development	NOUN
ajlm-2519	90	3	was	be	AUX
ajlm-2519	90	4	encouraging	encouraging	ADJ
ajlm-2519	90	5	,	,	PUNCT
ajlm-2519	90	6	since	since	SCONJ
ajlm-2519	90	7	k.	k.	PROPN
ajlm-2519	90	8	pneumoniae	pneumoniae	PROPN
ajlm-2519	90	9	was	be	AUX
ajlm-2519	90	10	the	the	DET
ajlm-2519	90	11	bloodstream	bloodstream	NOUN
ajlm-2519	90	12	pathogen	pathogen	NOUN
ajlm-2519	90	13	isolated	isolate	VERB
ajlm-2519	90	14	the	the	DET
ajlm-2519	90	15	most	most	ADJ
ajlm-2519	90	16	in	in	ADP
ajlm-2519	90	17	south	south	PROPN
ajlm-2519	90	18	africa	africa	PROPN
ajlm-2519	90	19	between	between	ADP
ajlm-2519	90	20	2014	2014	NUM
ajlm-2519	90	21	and	and	CCONJ
ajlm-2519	90	22	2019,11,13	2019,11,13	NUM
ajlm-2519	90	23	and	and	CCONJ
ajlm-2519	90	24	was	be	AUX
ajlm-2519	90	25	responsible	responsible	ADJ
ajlm-2519	90	26	for	for	ADP
ajlm-2519	90	27	higher	high	ADJ
ajlm-2519	90	28	mortality	mortality	NOUN
ajlm-2519	90	29	from	from	ADP
ajlm-2519	90	30	bloodstream	bloodstream	NOUN
ajlm-2519	90	31	infections	infection	NOUN
ajlm-2519	90	32	in	in	ADP
ajlm-2519	90	33	sub	sub	ADJ
ajlm-2519	90	34	-	-	ADJ
ajlm-2519	90	35	saharan	saharan	ADJ
ajlm-2519	90	36	africa	africa	PROPN
ajlm-2519	90	37	than	than	ADP
ajlm-2519	90	38	s.	s.	PROPN
ajlm-2519	90	39	aureus.1,4	aureus.1,4	ADV
ajlm-2519	90	40	in	in	ADP
ajlm-2519	90	41	south	south	PROPN
ajlm-2519	90	42	africa	africa	PROPN
ajlm-2519	90	43	in	in	ADP
ajlm-2519	90	44	2019	2019	NUM
ajlm-2519	90	45	,	,	PUNCT
ajlm-2519	90	46	s.	s.	PROPN
ajlm-2519	90	47	aureus	aureus	PROPN
ajlm-2519	90	48	infections	infection	NOUN
ajlm-2519	90	49	were	be	AUX
ajlm-2519	90	50	associated	associate	VERB
ajlm-2519	90	51	with	with	ADP
ajlm-2519	90	52	6000	6000	NUM
ajlm-2519	90	53	deaths	death	NOUN
ajlm-2519	90	54	,	,	PUNCT
ajlm-2519	90	55	a.	a.	NOUN
ajlm-2519	90	56	baumannii	baumannii	PROPN
ajlm-2519	90	57	with	with	ADP
ajlm-2519	90	58	6700	6700	NUM
ajlm-2519	90	59	,	,	PUNCT
ajlm-2519	90	60	and	and	CCONJ
ajlm-2519	90	61	k.	k.	NOUN
ajlm-2519	90	62	pneumoniae	pneumoniae	ADJ
ajlm-2519	90	63	with	with	ADP
ajlm-2519	90	64	3200.12	3200.12	NUM
ajlm-2519	90	65	the	the	DET
ajlm-2519	90	66	increased	increase	VERB
ajlm-2519	90	67	incidence	incidence	NOUN
ajlm-2519	90	68	of	of	ADP
ajlm-2519	90	69	multidrug	multidrug	NOUN
ajlm-2519	90	70	-	-	PUNCT
ajlm-2519	90	71	resistant	resistant	ADJ
ajlm-2519	90	72	gram	gram	NOUN
ajlm-2519	90	73	-	-	PUNCT
ajlm-2519	90	74	negative	negative	ADJ
ajlm-2519	90	75	a.	a.	NOUN
ajlm-2519	90	76	baumannii	baumannii	NOUN
ajlm-2519	90	77	in	in	ADP
ajlm-2519	90	78	our	our	PRON
ajlm-2519	90	79	study	study	NOUN
ajlm-2519	90	80	(	(	PUNCT
ajlm-2519	90	81	hospital	hospital	NOUN
ajlm-2519	90	82	setting	setting	NOUN
ajlm-2519	90	83	)	)	PUNCT
ajlm-2519	90	84	could	could	AUX
ajlm-2519	90	85	be	be	AUX
ajlm-2519	90	86	attributed	attribute	VERB
ajlm-2519	90	87	to	to	ADP
ajlm-2519	90	88	inefficient	inefficient	ADJ
ajlm-2519	90	89	infection	infection	NOUN
ajlm-2519	90	90	prevention	prevention	NOUN
ajlm-2519	90	91	and	and	CCONJ
ajlm-2519	90	92	control	control	NOUN
ajlm-2519	90	93	methods	method	NOUN
ajlm-2519	90	94	and	and	CCONJ
ajlm-2519	90	95	limited	limited	ADJ
ajlm-2519	90	96	antimicrobial	antimicrobial	ADJ
ajlm-2519	90	97	stewardship.13	stewardship.13	NOUN
ajlm-2519	90	98	the	the	DET
ajlm-2519	90	99	higher	high	ADJ
ajlm-2519	90	100	eskape	eskape	NOUN
ajlm-2519	90	101	pathogen	pathogen	NOUN
ajlm-2519	90	102	incidence	incidence	NOUN
ajlm-2519	90	103	in	in	ADP
ajlm-2519	90	104	the	the	DET
ajlm-2519	90	105	neonatal	neonatal	ADJ
ajlm-2519	90	106	ward	ward	NOUN
ajlm-2519	90	107	versus	versus	ADP
ajlm-2519	90	108	other	other	ADJ
ajlm-2519	90	109	wards	ward	NOUN
ajlm-2519	90	110	could	could	AUX
ajlm-2519	90	111	be	be	AUX
ajlm-2519	90	112	attributed	attribute	VERB
ajlm-2519	90	113	to	to	ADP
ajlm-2519	90	114	the	the	DET
ajlm-2519	90	115	increased	increase	VERB
ajlm-2519	90	116	risk	risk	NOUN
ajlm-2519	90	117	of	of	ADP
ajlm-2519	90	118	neonatal	neonatal	ADJ
ajlm-2519	90	119	sepsis	sepsis	NOUN
ajlm-2519	90	120	resulting	result	VERB
ajlm-2519	90	121	from	from	ADP
ajlm-2519	90	122	risk	risk	NOUN
ajlm-2519	90	123	factors	factor	NOUN
ajlm-2519	90	124	such	such	ADJ
ajlm-2519	90	125	as	as	ADP
ajlm-2519	90	126	prematurity	prematurity	NOUN
ajlm-2519	90	127	,	,	PUNCT
ajlm-2519	90	128	low	low	ADJ
ajlm-2519	90	129	birth	birth	NOUN
ajlm-2519	90	130	weight	weight	NOUN
ajlm-2519	90	131	,	,	PUNCT
ajlm-2519	90	132	ruptured	ruptured	ADJ
ajlm-2519	90	133	membranes	membrane	NOUN
ajlm-2519	90	134	,	,	PUNCT
ajlm-2519	90	135	previous	previous	ADJ
ajlm-2519	90	136	surgery	surgery	NOUN
ajlm-2519	90	137	,	,	PUNCT
ajlm-2519	90	138	and	and	CCONJ
ajlm-2519	90	139	intrapartum	intrapartum	NOUN
ajlm-2519	90	140	fever.32	fever.32	VERB
ajlm-2519	90	141	these	these	DET
ajlm-2519	90	142	neonatal	neonatal	ADJ
ajlm-2519	90	143	sepsis	sepsis	NOUN
ajlm-2519	90	144	risk	risk	NOUN
ajlm-2519	90	145	factors	factor	NOUN
ajlm-2519	90	146	could	could	AUX
ajlm-2519	90	147	lead	lead	VERB
ajlm-2519	90	148	to	to	ADP
ajlm-2519	90	149	longer	long	ADJ
ajlm-2519	90	150	hospital	hospital	NOUN
ajlm-2519	90	151	stays	stay	NOUN
ajlm-2519	90	152	,	,	PUNCT
ajlm-2519	90	153	during	during	ADP
ajlm-2519	90	154	which	which	PRON
ajlm-2519	90	155	horizontal	horizontal	ADJ
ajlm-2519	90	156	pathogen	pathogen	NOUN
ajlm-2519	90	157	transmission	transmission	NOUN
ajlm-2519	90	158	could	could	AUX
ajlm-2519	90	159	occur	occur	VERB
ajlm-2519	90	160	,	,	PUNCT
ajlm-2519	90	161	particularly	particularly	ADV
ajlm-2519	90	162	in	in	ADP
ajlm-2519	90	163	overcrowded	overcrowded	ADJ
ajlm-2519	90	164	neonatal	neonatal	ADJ
ajlm-2519	90	165	units	unit	NOUN
ajlm-2519	90	166	with	with	ADP
ajlm-2519	90	167	inadequate	inadequate	ADJ
ajlm-2519	90	168	adherence	adherence	NOUN
ajlm-2519	90	169	to	to	ADP
ajlm-2519	90	170	infection	infection	NOUN
ajlm-2519	90	171	prevention	prevention	NOUN
ajlm-2519	90	172	and	and	CCONJ
ajlm-2519	90	173	control	control	NOUN
ajlm-2519	90	174	measures.13	measures.13	PROPN
ajlm-2519	90	175	in	in	ADP
ajlm-2519	90	176	addition	addition	NOUN
ajlm-2519	90	177	,	,	PUNCT
ajlm-2519	90	178	the	the	DET
ajlm-2519	90	179	variation	variation	NOUN
ajlm-2519	90	180	in	in	ADP
ajlm-2519	90	181	ward	ward	NOUN
ajlm-2519	90	182	incidence	incidence	NOUN
ajlm-2519	90	183	could	could	AUX
ajlm-2519	90	184	be	be	AUX
ajlm-2519	90	185	attributed	attribute	VERB
ajlm-2519	90	186	to	to	ADP
ajlm-2519	90	187	differences	difference	NOUN
ajlm-2519	90	188	in	in	ADP
ajlm-2519	90	189	the	the	DET
ajlm-2519	90	190	type	type	NOUN
ajlm-2519	90	191	of	of	ADP
ajlm-2519	90	192	healthcare	healthcare	NOUN
ajlm-2519	90	193	services	service	NOUN
ajlm-2519	90	194	offered	offer	VERB
ajlm-2519	90	195	in	in	ADP
ajlm-2519	90	196	neonatal	neonatal	ADJ
ajlm-2519	90	197	,	,	PUNCT
ajlm-2519	90	198	paediatric	paediatric	ADJ
ajlm-2519	90	199	,	,	PUNCT
ajlm-2519	90	200	and	and	CCONJ
ajlm-2519	90	201	intensive	intensive	ADJ
ajlm-2519	90	202	care	care	NOUN
ajlm-2519	90	203	units	unit	NOUN
ajlm-2519	90	204	,	,	PUNCT
ajlm-2519	90	205	such	such	ADJ
ajlm-2519	90	206	as	as	ADP
ajlm-2519	90	207	premature	premature	ADJ
ajlm-2519	90	208	and	and	CCONJ
ajlm-2519	90	209	low	low	ADJ
ajlm-2519	90	210	-	-	PUNCT
ajlm-2519	90	211	weight	weight	NOUN
ajlm-2519	90	212	neonates	neonate	NOUN
ajlm-2519	90	213	vulnerable	vulnerable	ADJ
ajlm-2519	90	214	to	to	ADP
ajlm-2519	90	215	sepsis	sepsis	NOUN
ajlm-2519	90	216	,	,	PUNCT
ajlm-2519	90	217	vulnerable	vulnerable	ADJ
ajlm-2519	90	218	paediatric	paediatric	ADJ
ajlm-2519	90	219	populations	population	NOUN
ajlm-2519	90	220	,	,	PUNCT
ajlm-2519	90	221	and	and	CCONJ
ajlm-2519	90	222	severely	severely	ADV
ajlm-2519	90	223	ill	ill	ADJ
ajlm-2519	90	224	patients.13,32	patients.13,32	VERB
ajlm-2519	90	225	the	the	DET
ajlm-2519	90	226	ward	ward	NOUN
ajlm-2519	90	227	variation	variation	NOUN
ajlm-2519	90	228	could	could	AUX
ajlm-2519	90	229	also	also	ADV
ajlm-2519	90	230	be	be	AUX
ajlm-2519	90	231	attributed	attribute	VERB
ajlm-2519	90	232	to	to	ADP
ajlm-2519	90	233	differences	difference	NOUN
ajlm-2519	90	234	in	in	ADP
ajlm-2519	90	235	sampling	sample	VERB
ajlm-2519	90	236	practices	practice	NOUN
ajlm-2519	90	237	across	across	ADP
ajlm-2519	90	238	various	various	ADJ
ajlm-2519	90	239	hospital	hospital	NOUN
ajlm-2519	90	240	wards	ward	NOUN
ajlm-2519	90	241	,	,	PUNCT
ajlm-2519	90	242	where	where	SCONJ
ajlm-2519	90	243	the	the	DET
ajlm-2519	90	244	causative	causative	ADJ
ajlm-2519	90	245	pathogen(s	pathogen(s	NOUN
ajlm-2519	90	246	)	)	PUNCT
ajlm-2519	90	247	in	in	ADP
ajlm-2519	90	248	bloodstream	bloodstream	NOUN
ajlm-2519	90	249	infections	infection	NOUN
ajlm-2519	90	250	may	may	AUX
ajlm-2519	90	251	go	go	VERB
ajlm-2519	90	252	undiagnosed	undiagnosed	ADJ
ajlm-2519	90	253	because	because	SCONJ
ajlm-2519	90	254	minimal	minimal	ADJ
ajlm-2519	90	255	blood	blood	NOUN
ajlm-2519	90	256	samples	sample	NOUN
ajlm-2519	90	257	are	be	AUX
ajlm-2519	90	258	collected.13	collected.13	NOUN
ajlm-2519	90	259	this	this	DET
ajlm-2519	90	260	assertion	assertion	NOUN
ajlm-2519	90	261	is	be	AUX
ajlm-2519	90	262	substantiated	substantiate	VERB
ajlm-2519	90	263	by	by	ADP
ajlm-2519	90	264	the	the	DET
ajlm-2519	90	265	findings	finding	NOUN
ajlm-2519	90	266	of	of	ADP
ajlm-2519	90	267	a	a	DET
ajlm-2519	90	268	2018	2018	NUM
ajlm-2519	90	269	study	study	NOUN
ajlm-2519	90	270	conducted	conduct	VERB
ajlm-2519	90	271	at	at	ADP
ajlm-2519	90	272	a	a	DET
ajlm-2519	90	273	tertiary	tertiary	ADJ
ajlm-2519	90	274	hospital	hospital	NOUN
ajlm-2519	90	275	in	in	ADP
ajlm-2519	90	276	gauteng	gauteng	PROPN
ajlm-2519	90	277	,	,	PUNCT
ajlm-2519	90	278	south	south	PROPN
ajlm-2519	90	279	africa	africa	PROPN
ajlm-2519	90	280	,	,	PUNCT
ajlm-2519	90	281	which	which	PRON
ajlm-2519	90	282	showed	show	VERB
ajlm-2519	90	283	that	that	SCONJ
ajlm-2519	90	284	there	there	PRON
ajlm-2519	90	285	was	be	VERB
ajlm-2519	90	286	inconsistent	inconsistent	ADJ
ajlm-2519	90	287	adherence	adherence	NOUN
ajlm-2519	90	288	to	to	ADP
ajlm-2519	90	289	blood	blood	NOUN
ajlm-2519	90	290	culture	culture	NOUN
ajlm-2519	90	291	collection	collection	NOUN
ajlm-2519	90	292	guidelines	guideline	NOUN
ajlm-2519	90	293	,	,	PUNCT
ajlm-2519	90	294	with	with	SCONJ
ajlm-2519	90	295	over	over	ADP
ajlm-2519	90	296	two	two	NUM
ajlm-2519	90	297	-	-	PUNCT
ajlm-2519	90	298	thirds	third	NOUN
ajlm-2519	90	299	(	(	PUNCT
ajlm-2519	90	300	67.0	67.0	NUM
ajlm-2519	90	301	%	%	NOUN
ajlm-2519	90	302	)	)	PUNCT
ajlm-2519	90	303	of	of	ADP
ajlm-2519	90	304	patients	patient	NOUN
ajlm-2519	90	305	who	who	PRON
ajlm-2519	90	306	were	be	AUX
ajlm-2519	90	307	eligible	eligible	ADJ
ajlm-2519	90	308	for	for	ADP
ajlm-2519	90	309	a	a	DET
ajlm-2519	90	310	blood	blood	NOUN
ajlm-2519	90	311	culture	culture	NOUN
ajlm-2519	90	312	not	not	PART
ajlm-2519	90	313	receiving	receive	VERB
ajlm-2519	90	314	one.33	one.33	ADJ
ajlm-2519	90	315	other	other	ADJ
ajlm-2519	90	316	single	single	ADJ
ajlm-2519	90	317	-	-	PUNCT
ajlm-2519	90	318	centre	centre	NOUN
ajlm-2519	90	319	neonatal	neonatal	NOUN
ajlm-2519	90	320	and	and	CCONJ
ajlm-2519	90	321	children	child	NOUN
ajlm-2519	90	322	’s	’s	PART
ajlm-2519	90	323	studies	study	NOUN
ajlm-2519	90	324	from	from	ADP
ajlm-2519	90	325	gauteng	gauteng	PROPN
ajlm-2519	90	326	,	,	PUNCT
ajlm-2519	90	327	kwazulu	kwazulu	PROPN
ajlm-2519	90	328	-	-	PUNCT
ajlm-2519	90	329	natal	natal	NOUN
ajlm-2519	90	330	and	and	CCONJ
ajlm-2519	90	331	the	the	DET
ajlm-2519	90	332	western	western	ADJ
ajlm-2519	90	333	cape	cape	NOUN
ajlm-2519	90	334	in	in	ADP
ajlm-2519	90	335	south	south	PROPN
ajlm-2519	90	336	africa	africa	PROPN
ajlm-2519	90	337	have	have	AUX
ajlm-2519	90	338	previously	previously	ADV
ajlm-2519	90	339	identified	identify	VERB
ajlm-2519	90	340	eskape	eskape	NOUN
ajlm-2519	90	341	pathogens	pathogen	NOUN
ajlm-2519	90	342	as	as	SCONJ
ajlm-2519	90	343	the	the	DET
ajlm-2519	90	344	dominant	dominant	ADJ
ajlm-2519	90	345	isolates	isolate	NOUN
ajlm-2519	90	346	of	of	ADP
ajlm-2519	90	347	bloodstream	bloodstream	NOUN
ajlm-2519	90	348	infections	infection	NOUN
ajlm-2519	90	349	between	between	ADP
ajlm-2519	90	350	2008	2008	NUM
ajlm-2519	90	351	and	and	CCONJ
ajlm-2519	90	352	2018.15,16,17,18,19	2018.15,16,17,18,19	NUM
ajlm-2519	90	353	the	the	DET
ajlm-2519	90	354	overall	overall	ADJ
ajlm-2519	90	355	high	high	ADJ
ajlm-2519	90	356	and	and	CCONJ
ajlm-2519	90	357	increasing	increase	VERB
ajlm-2519	90	358	incidence	incidence	NOUN
ajlm-2519	90	359	of	of	ADP
ajlm-2519	90	360	crab	crab	NOUN
ajlm-2519	90	361	in	in	ADP
ajlm-2519	90	362	this	this	DET
ajlm-2519	90	363	study	study	NOUN
ajlm-2519	90	364	resembles	resemble	VERB
ajlm-2519	90	365	the	the	DET
ajlm-2519	90	366	80.0	80.0	NUM
ajlm-2519	90	367	%	%	NOUN
ajlm-2519	90	368	for	for	ADP
ajlm-2519	90	369	south	south	PROPN
ajlm-2519	90	370	africa	africa	PROPN
ajlm-2519	90	371	observed	observe	VERB
ajlm-2519	90	372	in	in	ADP
ajlm-2519	90	373	2020,11	2020,11	NUM
ajlm-2519	90	374	and	and	CCONJ
ajlm-2519	90	375	the	the	DET
ajlm-2519	90	376	neonatal	neonatal	ADJ
ajlm-2519	90	377	population	population	NOUN
ajlm-2519	90	378	between	between	ADP
ajlm-2519	90	379	2014	2014	NUM
ajlm-2519	90	380	and	and	CCONJ
ajlm-2519	90	381	2019	2019	NUM
ajlm-2519	90	382	(	(	PUNCT
ajlm-2519	90	383	a.	a.	NOUN
ajlm-2519	90	384	baumannii	baumannii	PROPN
ajlm-2519	90	385	isolates	isolate	NOUN
ajlm-2519	90	386	declined	decline	VERB
ajlm-2519	90	387	in	in	ADP
ajlm-2519	90	388	susceptibility	susceptibility	NOUN
ajlm-2519	90	389	to	to	PART
ajlm-2519	90	390	meropenem	meropenem	VERB
ajlm-2519	91	1	[	[	X
ajlm-2519	91	2	23.0	23.0	NUM
ajlm-2519	91	3	%	%	NOUN
ajlm-2519	91	4	to	to	ADP
ajlm-2519	91	5	12.0	12.0	NUM
ajlm-2519	91	6	%	%	NOUN
ajlm-2519	91	7	;	;	PUNCT
ajlm-2519	91	8	p	p	NOUN
ajlm-2519	91	9	=	=	SYM
ajlm-2519	91	10	0.051]),13	0.051]),13	NUM
ajlm-2519	91	11	which	which	PRON
ajlm-2519	91	12	could	could	AUX
ajlm-2519	91	13	drive	drive	VERB
ajlm-2519	91	14	the	the	DET
ajlm-2519	91	15	use	use	NOUN
ajlm-2519	91	16	of	of	ADP
ajlm-2519	91	17	colistin	colistin	NOUN
ajlm-2519	91	18	since	since	SCONJ
ajlm-2519	91	19	a.	a.	PROPN
ajlm-2519	91	20	baumannii	baumannii	PROPN
ajlm-2519	91	21	exhibited	exhibit	VERB
ajlm-2519	91	22	multidrug	multidrug	NOUN
ajlm-2519	91	23	resistance	resistance	NOUN
ajlm-2519	91	24	in	in	ADP
ajlm-2519	91	25	our	our	PRON
ajlm-2519	91	26	study.11,15	study.11,15	NOUN
ajlm-2519	91	27	in	in	ADP
ajlm-2519	91	28	2019	2019	NUM
ajlm-2519	91	29	,	,	PUNCT
ajlm-2519	91	30	crab	crab	NOUN
ajlm-2519	91	31	caused	cause	VERB
ajlm-2519	91	32	50	50	NUM
ajlm-2519	91	33	000	000	NUM
ajlm-2519	91	34	to	to	PART
ajlm-2519	91	35	100	100	NUM
ajlm-2519	91	36	000	000	NUM
ajlm-2519	91	37	amr	amr	ADJ
ajlm-2519	91	38	-	-	PUNCT
ajlm-2519	91	39	related	relate	VERB
ajlm-2519	91	40	deaths	death	NOUN
ajlm-2519	91	41	globally,1	globally,1	VERB
ajlm-2519	91	42	and	and	CCONJ
ajlm-2519	91	43	was	be	AUX
ajlm-2519	91	44	associated	associate	VERB
ajlm-2519	91	45	with	with	ADP
ajlm-2519	91	46	the	the	DET
ajlm-2519	91	47	largest	large	ADJ
ajlm-2519	91	48	mortality	mortality	NOUN
ajlm-2519	91	49	impact	impact	NOUN
ajlm-2519	91	50	of	of	ADP
ajlm-2519	91	51	healthcare	healthcare	NOUN
ajlm-2519	91	52	-	-	PUNCT
ajlm-2519	91	53	acquired	acquire	VERB
ajlm-2519	91	54	infections	infection	NOUN
ajlm-2519	91	55	in	in	ADP
ajlm-2519	91	56	lowand	lowand	ADJ
ajlm-2519	91	57	middle	middle	ADJ
ajlm-2519	91	58	-	-	PUNCT
ajlm-2519	91	59	income	income	NOUN
ajlm-2519	91	60	countries.8	countries.8	PROPN
ajlm-2519	91	61	there	there	PRON
ajlm-2519	91	62	is	be	VERB
ajlm-2519	91	63	a	a	DET
ajlm-2519	91	64	scarcity	scarcity	NOUN
ajlm-2519	91	65	of	of	ADP
ajlm-2519	91	66	data	datum	NOUN
ajlm-2519	91	67	for	for	ADP
ajlm-2519	91	68	a.	a.	NOUN
ajlm-2519	91	69	baumannii	baumannii	PROPN
ajlm-2519	91	70	-	-	PUNCT
ajlm-2519	91	71	colistin	colistin	NOUN
ajlm-2519	91	72	susceptibility	susceptibility	NOUN
ajlm-2519	91	73	and/or	and/or	CCONJ
ajlm-2519	91	74	resistance	resistance	NOUN
ajlm-2519	91	75	in	in	ADP
ajlm-2519	91	76	lowand	lowand	ADJ
ajlm-2519	91	77	middle	middle	ADJ
ajlm-2519	91	78	-	-	PUNCT
ajlm-2519	91	79	income	income	NOUN
ajlm-2519	91	80	countries.2	countries.2	NOUN
ajlm-2519	91	81	acinetobacter	acinetobacter	ADV
ajlm-2519	91	82	baumannii	baumannii	NOUN
ajlm-2519	91	83	was	be	AUX
ajlm-2519	91	84	susceptible	susceptible	ADJ
ajlm-2519	91	85	to	to	PART
ajlm-2519	91	86	colistin	colistin	VERB
ajlm-2519	91	87	in	in	ADP
ajlm-2519	91	88	our	our	PRON
ajlm-2519	91	89	study	study	NOUN
ajlm-2519	91	90	.	.	PUNCT
ajlm-2519	92	1	in	in	ADP
ajlm-2519	92	2	addition	addition	NOUN
ajlm-2519	92	3	,	,	PUNCT
ajlm-2519	92	4	this	this	DET
ajlm-2519	92	5	study	study	NOUN
ajlm-2519	92	6	demonstrated	demonstrate	VERB
ajlm-2519	92	7	that	that	SCONJ
ajlm-2519	92	8	gram	gram	NOUN
ajlm-2519	92	9	-	-	PUNCT
ajlm-2519	92	10	negative	negative	ADJ
ajlm-2519	92	11	a.	a.	NOUN
ajlm-2519	92	12	baumannii	baumannii	PROPN
ajlm-2519	92	13	and	and	CCONJ
ajlm-2519	92	14	p.	p.	PROPN
ajlm-2519	92	15	aeruginosa	aeruginosa	PROPN
ajlm-2519	92	16	colistin	colistin	PROPN
ajlm-2519	92	17	resistance	resistance	NOUN
ajlm-2519	92	18	was	be	AUX
ajlm-2519	92	19	below	below	ADP
ajlm-2519	92	20	3.0	3.0	NUM
ajlm-2519	92	21	%	%	NOUN
ajlm-2519	92	22	,	,	PUNCT
ajlm-2519	92	23	consistent	consistent	ADJ
ajlm-2519	92	24	with	with	ADP
ajlm-2519	92	25	south	south	ADJ
ajlm-2519	92	26	african	african	ADJ
ajlm-2519	92	27	laboratory	laboratory	NOUN
ajlm-2519	92	28	-	-	PUNCT
ajlm-2519	92	29	based	base	VERB
ajlm-2519	92	30	sentinel	sentinel	NOUN
ajlm-2519	92	31	surveillance	surveillance	NOUN
ajlm-2519	92	32	and	and	CCONJ
ajlm-2519	92	33	routine	routine	ADJ
ajlm-2519	92	34	data	datum	NOUN
ajlm-2519	92	35	in	in	ADP
ajlm-2519	92	36	2016	2016	NUM
ajlm-2519	92	37	to	to	ADP
ajlm-2519	92	38	2017.11,15	2017.11,15	NOUN
ajlm-2519	92	39	this	this	PRON
ajlm-2519	92	40	could	could	AUX
ajlm-2519	92	41	be	be	AUX
ajlm-2519	92	42	attributed	attribute	VERB
ajlm-2519	92	43	to	to	ADP
ajlm-2519	92	44	the	the	DET
ajlm-2519	92	45	restricted	restricted	ADJ
ajlm-2519	92	46	use	use	NOUN
ajlm-2519	92	47	of	of	ADP
ajlm-2519	92	48	colistin	colistin	NOUN
ajlm-2519	92	49	in	in	ADP
ajlm-2519	92	50	the	the	DET
ajlm-2519	92	51	south	south	ADJ
ajlm-2519	92	52	african	african	ADJ
ajlm-2519	92	53	public	public	ADJ
ajlm-2519	92	54	sector.11,34,35	sector.11,34,35	NOUN
ajlm-2519	92	55	a	a	DET
ajlm-2519	92	56	2020	2020	NUM
ajlm-2519	92	57	south	south	ADJ
ajlm-2519	92	58	african	african	ADJ
ajlm-2519	92	59	national	national	ADJ
ajlm-2519	92	60	report	report	NOUN
ajlm-2519	92	61	showed	show	VERB
ajlm-2519	92	62	a.	a.	NOUN
ajlm-2519	92	63	baumannii	baumannii	PROPN
ajlm-2519	92	64	tigecycline	tigecycline	PROPN
ajlm-2519	92	65	resistance	resistance	NOUN
ajlm-2519	92	66	at	at	ADP
ajlm-2519	92	67	15.0%,11	15.0%,11	NUM
ajlm-2519	92	68	compared	compare	VERB
ajlm-2519	92	69	to	to	ADP
ajlm-2519	92	70	10.7	10.7	NUM
ajlm-2519	92	71	%	%	NOUN
ajlm-2519	92	72	(	(	PUNCT
ajlm-2519	92	73	n	n	NOUN
ajlm-2519	92	74	=	=	SYM
ajlm-2519	92	75	20/187	20/187	NUM
ajlm-2519	92	76	)	)	PUNCT
ajlm-2519	92	77	in	in	ADP
ajlm-2519	92	78	our	our	PRON
ajlm-2519	92	79	study	study	NOUN
ajlm-2519	92	80	.	.	PUNCT
ajlm-2519	93	1	in	in	ADP
ajlm-2519	93	2	south	south	PROPN
ajlm-2519	93	3	africa	africa	PROPN
ajlm-2519	93	4	,	,	PUNCT
ajlm-2519	93	5	tigecycline	tigecycline	PROPN
ajlm-2519	93	6	is	be	AUX
ajlm-2519	93	7	registered	register	VERB
ajlm-2519	93	8	to	to	PART
ajlm-2519	93	9	treat	treat	VERB
ajlm-2519	93	10	complicated	complicated	ADJ
ajlm-2519	93	11	skinand	skinand	NOUN
ajlm-2519	93	12	soft	soft	ADJ
ajlm-2519	93	13	-	-	PUNCT
ajlm-2519	93	14	tissue	tissue	NOUN
ajlm-2519	93	15	infections	infection	NOUN
ajlm-2519	93	16	,	,	PUNCT
ajlm-2519	93	17	intra	intra	ADJ
ajlm-2519	93	18	-	-	ADJ
ajlm-2519	93	19	abdominal	abdominal	ADJ
ajlm-2519	93	20	infections	infection	NOUN
ajlm-2519	93	21	,	,	PUNCT
ajlm-2519	93	22	and	and	CCONJ
ajlm-2519	93	23	community	community	NOUN
ajlm-2519	93	24	-	-	PUNCT
ajlm-2519	93	25	acquired	acquire	VERB
ajlm-2519	93	26	bacterial	bacterial	ADJ
ajlm-2519	93	27	pneumonia.36	pneumonia.36	NOUN
ajlm-2519	93	28	as	as	ADP
ajlm-2519	93	29	multidrug	multidrug	NOUN
ajlm-2519	93	30	-	-	PUNCT
ajlm-2519	93	31	resistant	resistant	ADJ
ajlm-2519	93	32	infections	infection	NOUN
ajlm-2519	93	33	such	such	ADJ
ajlm-2519	93	34	as	as	ADP
ajlm-2519	93	35	crab	crab	NOUN
ajlm-2519	93	36	increase,37	increase,37	NOUN
ajlm-2519	93	37	clinicians	clinician	NOUN
ajlm-2519	93	38	may	may	AUX
ajlm-2519	93	39	use	use	VERB
ajlm-2519	93	40	high	high	ADJ
ajlm-2519	93	41	doses	dose	NOUN
ajlm-2519	93	42	of	of	ADP
ajlm-2519	93	43	tigecycline	tigecycline	NOUN
ajlm-2519	93	44	for	for	ADP
ajlm-2519	93	45	unregistered	unregistered	ADJ
ajlm-2519	93	46	indications	indication	NOUN
ajlm-2519	93	47	such	such	ADJ
ajlm-2519	93	48	as	as	ADP
ajlm-2519	93	49	sepsis,37,38	sepsis,37,38	PROPN
ajlm-2519	93	50	which	which	PRON
ajlm-2519	93	51	can	can	AUX
ajlm-2519	93	52	lead	lead	VERB
ajlm-2519	93	53	to	to	ADP
ajlm-2519	93	54	secondary	secondary	ADJ
ajlm-2519	93	55	bacteraemia	bacteraemia	NOUN
ajlm-2519	93	56	because	because	SCONJ
ajlm-2519	93	57	of	of	ADP
ajlm-2519	93	58	its	its	PRON
ajlm-2519	93	59	bacteriostatic	bacteriostatic	ADJ
ajlm-2519	93	60	properties.38	properties.38	NOUN
ajlm-2519	93	61	according	accord	VERB
ajlm-2519	93	62	to	to	ADP
ajlm-2519	93	63	a	a	DET
ajlm-2519	93	64	south	south	ADJ
ajlm-2519	93	65	african	african	ADJ
ajlm-2519	93	66	administrative	administrative	ADJ
ajlm-2519	93	67	report	report	NOUN
ajlm-2519	93	68	,	,	PUNCT
ajlm-2519	93	69	clinicians	clinician	NOUN
ajlm-2519	93	70	were	be	AUX
ajlm-2519	93	71	concerned	concern	VERB
ajlm-2519	93	72	with	with	ADP
ajlm-2519	93	73	poor	poor	ADJ
ajlm-2519	93	74	clinical	clinical	ADJ
ajlm-2519	93	75	outcomes	outcome	NOUN
ajlm-2519	93	76	when	when	SCONJ
ajlm-2519	93	77	tigecycline	tigecycline	PROPN
ajlm-2519	93	78	was	be	AUX
ajlm-2519	93	79	used	use	VERB
ajlm-2519	93	80	alone.11	alone.11	VERB
ajlm-2519	93	81	the	the	DET
ajlm-2519	93	82	emergence	emergence	NOUN
ajlm-2519	93	83	of	of	ADP
ajlm-2519	93	84	tigecycline	tigecycline	ADV
ajlm-2519	93	85	-	-	PUNCT
ajlm-2519	93	86	resistant	resistant	ADJ
ajlm-2519	93	87	a.	a.	NOUN
ajlm-2519	93	88	baumannii	baumannii	PROPN
ajlm-2519	93	89	is	be	AUX
ajlm-2519	93	90	complex	complex	ADJ
ajlm-2519	93	91	as	as	ADP
ajlm-2519	93	92	a	a	DET
ajlm-2519	93	93	result	result	NOUN
ajlm-2519	93	94	of	of	ADP
ajlm-2519	93	95	multiple	multiple	ADJ
ajlm-2519	93	96	and	and	CCONJ
ajlm-2519	93	97	multifaceted	multifaceted	ADJ
ajlm-2519	93	98	resistance	resistance	NOUN
ajlm-2519	93	99	mechanisms,38	mechanisms,38	NOUN
ajlm-2519	93	100	necessitating	necessitate	VERB
ajlm-2519	93	101	comprehensive	comprehensive	ADJ
ajlm-2519	93	102	clinical	clinical	ADJ
ajlm-2519	93	103	evidence	evidence	NOUN
ajlm-2519	93	104	and	and	CCONJ
ajlm-2519	93	105	research	research	NOUN
ajlm-2519	93	106	literature	literature	PROPN
ajlm-2519	93	107	review	review	NOUN
ajlm-2519	93	108	before	before	ADP
ajlm-2519	93	109	recommending	recommend	VERB
ajlm-2519	93	110	alternate	alternate	ADJ
ajlm-2519	93	111	therapeutic	therapeutic	ADJ
ajlm-2519	93	112	choices	choice	NOUN
ajlm-2519	93	113	.	.	PUNCT
ajlm-2519	94	1	a	a	DET
ajlm-2519	94	2	medicine	medicine	NOUN
ajlm-2519	94	3	use	use	VERB
ajlm-2519	94	4	evaluation	evaluation	NOUN
ajlm-2519	94	5	study	study	NOUN
ajlm-2519	94	6	for	for	ADP
ajlm-2519	94	7	tigecycline	tigecycline	NOUN
ajlm-2519	94	8	in	in	ADP
ajlm-2519	94	9	our	our	PRON
ajlm-2519	94	10	study	study	NOUN
ajlm-2519	94	11	setting	set	VERB
ajlm-2519	94	12	is	be	AUX
ajlm-2519	94	13	,	,	PUNCT
ajlm-2519	94	14	therefore	therefore	ADV
ajlm-2519	94	15	,	,	PUNCT
ajlm-2519	94	16	recommended	recommend	VERB
ajlm-2519	94	17	.	.	PUNCT
ajlm-2519	95	1	methicillin	methicillin	NOUN
ajlm-2519	95	2	-	-	PUNCT
ajlm-2519	95	3	resistant	resistant	ADJ
ajlm-2519	95	4	s.	s.	PROPN
ajlm-2519	95	5	aureus	aureus	PROPN
ajlm-2519	95	6	decreased	decrease	VERB
ajlm-2519	95	7	in	in	ADP
ajlm-2519	95	8	this	this	DET
ajlm-2519	95	9	study	study	NOUN
ajlm-2519	95	10	,	,	PUNCT
ajlm-2519	95	11	similar	similar	ADJ
ajlm-2519	95	12	to	to	ADP
ajlm-2519	95	13	south	south	ADJ
ajlm-2519	95	14	african	african	ADJ
ajlm-2519	95	15	national	national	PROPN
ajlm-2519	95	16	surveillance	surveillance	NOUN
ajlm-2519	95	17	data	datum	NOUN
ajlm-2519	95	18	for	for	ADP
ajlm-2519	95	19	2016	2016	NUM
ajlm-2519	95	20	,	,	PUNCT
ajlm-2519	95	21	2017	2017	NUM
ajlm-2519	95	22	and	and	CCONJ
ajlm-2519	95	23	2020,11,14	2020,11,14	NUM
ajlm-2519	95	24	and	and	CCONJ
ajlm-2519	95	25	previous	previous	ADJ
ajlm-2519	95	26	single	single	ADJ
ajlm-2519	95	27	-	-	PUNCT
ajlm-2519	95	28	centre	centre	NOUN
ajlm-2519	95	29	studies	study	NOUN
ajlm-2519	95	30	conducted	conduct	VERB
ajlm-2519	95	31	between	between	ADP
ajlm-2519	95	32	2011	2011	NUM
ajlm-2519	95	33	and	and	CCONJ
ajlm-2519	95	34	2012	2012	NUM
ajlm-2519	95	35	in	in	ADP
ajlm-2519	95	36	the	the	DET
ajlm-2519	95	37	gauteng	gauteng	PROPN
ajlm-2519	95	38	and	and	CCONJ
ajlm-2519	95	39	kwazulu	kwazulu	PROPN
ajlm-2519	95	40	-	-	PUNCT
ajlm-2519	95	41	natal	natal	ADJ
ajlm-2519	95	42	provinces	province	NOUN
ajlm-2519	95	43	of	of	ADP
ajlm-2519	95	44	south	south	ADJ
ajlm-2519	95	45	africa.18,19	africa.18,19	NOUN
ajlm-2519	95	46	this	this	DET
ajlm-2519	95	47	observation	observation	NOUN
ajlm-2519	95	48	contradicts	contradict	VERB
ajlm-2519	95	49	global	global	ADJ
ajlm-2519	95	50	mrsa	mrsa	NOUN
ajlm-2519	95	51	data	datum	NOUN
ajlm-2519	95	52	,	,	PUNCT
ajlm-2519	95	53	which	which	PRON
ajlm-2519	95	54	showed	show	VERB
ajlm-2519	95	55	that	that	SCONJ
ajlm-2519	95	56	mrsa	mrsa	NOUN
ajlm-2519	95	57	increased	increase	VERB
ajlm-2519	95	58	by	by	ADP
ajlm-2519	95	59	14.0	14.0	NUM
ajlm-2519	95	60	%	%	NOUN
ajlm-2519	95	61	from	from	ADP
ajlm-2519	95	62	21.0	21.0	NUM
ajlm-2519	95	63	%	%	NOUN
ajlm-2519	95	64	in	in	ADP
ajlm-2519	95	65	2016	2016	NUM
ajlm-2519	95	66	to	to	ADP
ajlm-2519	95	67	35.0	35.0	NUM
ajlm-2519	95	68	%	%	NOUN
ajlm-2519	95	69	in	in	ADP
ajlm-2519	95	70	2020.39	2020.39	NUM
ajlm-2519	95	71	the	the	DET
ajlm-2519	95	72	publication	publication	NOUN
ajlm-2519	95	73	of	of	ADP
ajlm-2519	95	74	the	the	DET
ajlm-2519	95	75	national	national	ADJ
ajlm-2519	95	76	guidelines	guideline	NOUN
ajlm-2519	95	77	for	for	ADP
ajlm-2519	95	78	the	the	DET
ajlm-2519	95	79	prevention	prevention	NOUN
ajlm-2519	95	80	and	and	CCONJ
ajlm-2519	95	81	containment	containment	NOUN
ajlm-2519	95	82	of	of	ADP
ajlm-2519	95	83	antimicrobial	antimicrobial	ADJ
ajlm-2519	95	84	resistance	resistance	NOUN
ajlm-2519	95	85	in	in	ADP
ajlm-2519	95	86	south	south	ADJ
ajlm-2519	95	87	african	african	ADJ
ajlm-2519	95	88	hospitals	hospital	NOUN
ajlm-2519	95	89	in	in	ADP
ajlm-2519	95	90	2017	2017	NUM
ajlm-2519	95	91	may	may	AUX
ajlm-2519	95	92	have	have	AUX
ajlm-2519	95	93	contributed	contribute	VERB
ajlm-2519	95	94	to	to	ADP
ajlm-2519	95	95	the	the	DET
ajlm-2519	95	96	decrease	decrease	NOUN
ajlm-2519	95	97	in	in	ADP
ajlm-2519	95	98	mrsa	mrsa	NOUN
ajlm-2519	95	99	in	in	ADP
ajlm-2519	95	100	our	our	PRON
ajlm-2519	95	101	study	study	NOUN
ajlm-2519	95	102	,	,	PUNCT
ajlm-2519	95	103	and	and	CCONJ
ajlm-2519	95	104	in	in	ADP
ajlm-2519	95	105	south	south	PROPN
ajlm-2519	95	106	africa.37	africa.37	PROPN
ajlm-2519	95	107	however	however	ADV
ajlm-2519	95	108	,	,	PUNCT
ajlm-2519	95	109	more	more	ADJ
ajlm-2519	95	110	research	research	NOUN
ajlm-2519	95	111	on	on	ADP
ajlm-2519	95	112	the	the	DET
ajlm-2519	95	113	progression	progression	NOUN
ajlm-2519	95	114	of	of	ADP
ajlm-2519	95	115	infections	infection	NOUN
ajlm-2519	95	116	is	be	AUX
ajlm-2519	95	117	needed	need	VERB
ajlm-2519	95	118	to	to	PART
ajlm-2519	95	119	support	support	VERB
ajlm-2519	95	120	this	this	DET
ajlm-2519	95	121	assertion.40	assertion.40	PROPN
ajlm-2519	95	122	the	the	DET
ajlm-2519	95	123	incidence	incidence	NOUN
ajlm-2519	95	124	of	of	ADP
ajlm-2519	95	125	mrsa	mrsa	NOUN
ajlm-2519	95	126	remains	remain	VERB
ajlm-2519	95	127	a	a	DET
ajlm-2519	95	128	concern	concern	NOUN
ajlm-2519	95	129	given	give	VERB
ajlm-2519	95	130	the	the	DET
ajlm-2519	95	131	increased	increase	VERB
ajlm-2519	95	132	incidence	incidence	NOUN
ajlm-2519	95	133	of	of	ADP
ajlm-2519	95	134	s.	s.	PROPN
ajlm-2519	95	135	aureus	aureus	PROPN
ajlm-2519	95	136	in	in	ADP
ajlm-2519	95	137	this	this	DET
ajlm-2519	95	138	study	study	NOUN
ajlm-2519	95	139	,	,	PUNCT
ajlm-2519	95	140	as	as	SCONJ
ajlm-2519	95	141	mrsa	mrsa	NOUN
ajlm-2519	95	142	has	have	VERB
ajlm-2519	95	143	the	the	DET
ajlm-2519	95	144	most	most	ADV
ajlm-2519	95	145	significant	significant	ADJ
ajlm-2519	95	146	effect	effect	NOUN
ajlm-2519	95	147	on	on	ADP
ajlm-2519	95	148	hospital	hospital	NOUN
ajlm-2519	95	149	stay	stay	NOUN
ajlm-2519	95	150	(	(	PUNCT
ajlm-2519	95	151	increasing	increase	VERB
ajlm-2519	95	152	the	the	DET
ajlm-2519	95	153	stay	stay	NOUN
ajlm-2519	95	154	by	by	ADP
ajlm-2519	95	155	14	14	NUM
ajlm-2519	95	156	days	day	NOUN
ajlm-2519	95	157	compared	compare	VERB
ajlm-2519	95	158	to	to	ADP
ajlm-2519	95	159	sensitive	sensitive	ADJ
ajlm-2519	95	160	s.	s.	PROPN
ajlm-2519	95	161	aureus	aureus	PROPN
ajlm-2519	95	162	)	)	PUNCT
ajlm-2519	95	163	in	in	ADP
ajlm-2519	95	164	lowand	lowand	ADJ
ajlm-2519	95	165	middle	middle	ADJ
ajlm-2519	95	166	-	-	PUNCT
ajlm-2519	95	167	income	income	NOUN
ajlm-2519	95	168	countries.8	countries.8	PROPN
ajlm-2519	95	169	in	in	ADP
ajlm-2519	95	170	addition	addition	NOUN
ajlm-2519	95	171	,	,	PUNCT
ajlm-2519	95	172	the	the	DET
ajlm-2519	95	173	proportions	proportion	NOUN
ajlm-2519	95	174	of	of	ADP
ajlm-2519	95	175	mrsa	mrsa	NOUN
ajlm-2519	95	176	,	,	PUNCT
ajlm-2519	95	177	together	together	ADV
ajlm-2519	95	178	with	with	ADP
ajlm-2519	95	179	3gcr	3gcr	NUM
ajlm-2519	95	180	escherichia	escherichia	NOUN
ajlm-2519	95	181	coli	coli	NOUN
ajlm-2519	95	182	,	,	PUNCT
ajlm-2519	95	183	serve	serve	VERB
ajlm-2519	95	184	as	as	ADP
ajlm-2519	95	185	global	global	ADJ
ajlm-2519	95	186	indicators	indicator	NOUN
ajlm-2519	95	187	for	for	ADP
ajlm-2519	95	188	the	the	DET
ajlm-2519	95	189	2030	2030	NUM
ajlm-2519	95	190	sustainable	sustainable	ADJ
ajlm-2519	95	191	development	development	NOUN
ajlm-2519	95	192	goals	goal	NOUN
ajlm-2519	95	193	to	to	PART
ajlm-2519	95	194	reduce	reduce	VERB
ajlm-2519	95	195	amr	amr	NOUN
ajlm-2519	95	196	and	and	CCONJ
ajlm-2519	95	197	require	require	VERB
ajlm-2519	95	198	constant	constant	ADJ
ajlm-2519	95	199	monitoring.41	monitoring.41	ADJ
ajlm-2519	95	200	staphylococcus	staphylococcus	NOUN
ajlm-2519	95	201	aureus	aureus	NOUN
ajlm-2519	95	202	was	be	AUX
ajlm-2519	95	203	susceptible	susceptible	ADJ
ajlm-2519	95	204	to	to	ADP
ajlm-2519	95	205	vancomycin	vancomycin	PROPN
ajlm-2519	95	206	(	(	PUNCT
ajlm-2519	95	207	susceptibility	susceptibility	NOUN
ajlm-2519	95	208	above	above	ADP
ajlm-2519	95	209	90.0	90.0	NUM
ajlm-2519	95	210	%	%	NOUN
ajlm-2519	95	211	)	)	PUNCT
ajlm-2519	95	212	,	,	PUNCT
ajlm-2519	95	213	making	make	VERB
ajlm-2519	95	214	it	it	PRON
ajlm-2519	95	215	an	an	DET
ajlm-2519	95	216	empirical	empirical	ADJ
ajlm-2519	95	217	choice	choice	NOUN
ajlm-2519	95	218	,	,	PUNCT
ajlm-2519	95	219	with	with	ADP
ajlm-2519	95	220	tigecycline	tigecycline	NOUN
ajlm-2519	95	221	as	as	ADP
ajlm-2519	95	222	a	a	DET
ajlm-2519	95	223	last	last	ADJ
ajlm-2519	95	224	resort.42	resort.42	NOUN
ajlm-2519	95	225	klebsiella	klebsiella	NOUN
ajlm-2519	95	226	pneumoniae	pneumoniae	ADJ
ajlm-2519	95	227	was	be	AUX
ajlm-2519	95	228	the	the	DET
ajlm-2519	95	229	most	most	ADV
ajlm-2519	95	230	isolated	isolated	ADJ
ajlm-2519	95	231	eskape	eskape	NOUN
ajlm-2519	95	232	pathogen	pathogen	NOUN
ajlm-2519	95	233	in	in	ADP
ajlm-2519	95	234	south	south	PROPN
ajlm-2519	95	235	africa	africa	PROPN
ajlm-2519	95	236	in	in	ADP
ajlm-2519	95	237	2015	2015	NUM
ajlm-2519	95	238	to	to	ADP
ajlm-2519	95	239	2017.11	2017.11	NUM
ajlm-2519	95	240	consequently	consequently	ADV
ajlm-2519	95	241	,	,	PUNCT
ajlm-2519	95	242	the	the	DET
ajlm-2519	95	243	absence	absence	NOUN
ajlm-2519	95	244	of	of	ADP
ajlm-2519	95	245	k.	k.	PROPN
ajlm-2519	95	246	pneumoniae	pneumoniae	ADJ
ajlm-2519	95	247	isolates	isolate	NOUN
ajlm-2519	95	248	during	during	ADP
ajlm-2519	95	249	the	the	DET
ajlm-2519	95	250	last	last	ADJ
ajlm-2519	95	251	3	3	NUM
ajlm-2519	95	252	years	year	NOUN
ajlm-2519	95	253	(	(	PUNCT
ajlm-2519	95	254	2017	2017	NUM
ajlm-2519	95	255	to	to	ADP
ajlm-2519	95	256	2019	2019	NUM
ajlm-2519	95	257	)	)	PUNCT
ajlm-2519	95	258	of	of	ADP
ajlm-2519	95	259	our	our	PRON
ajlm-2519	95	260	study	study	NOUN
ajlm-2519	95	261	was	be	AUX
ajlm-2519	95	262	important	important	ADJ
ajlm-2519	95	263	.	.	PUNCT
ajlm-2519	96	1	the	the	DET
ajlm-2519	96	2	potential	potential	ADJ
ajlm-2519	96	3	contributing	contribute	VERB
ajlm-2519	96	4	factors	factor	NOUN
ajlm-2519	96	5	were	be	AUX
ajlm-2519	96	6	beyond	beyond	ADP
ajlm-2519	96	7	the	the	DET
ajlm-2519	96	8	scope	scope	NOUN
ajlm-2519	96	9	of	of	ADP
ajlm-2519	96	10	our	our	PRON
ajlm-2519	96	11	study	study	NOUN
ajlm-2519	96	12	and	and	CCONJ
ajlm-2519	96	13	will	will	AUX
ajlm-2519	96	14	require	require	VERB
ajlm-2519	96	15	future	future	ADJ
ajlm-2519	96	16	research	research	NOUN
ajlm-2519	96	17	to	to	PART
ajlm-2519	96	18	provide	provide	VERB
ajlm-2519	96	19	practical	practical	ADJ
ajlm-2519	96	20	implications	implication	NOUN
ajlm-2519	96	21	.	.	PUNCT
ajlm-2519	97	1	the	the	DET
ajlm-2519	97	2	resistance	resistance	NOUN
ajlm-2519	97	3	of	of	ADP
ajlm-2519	97	4	3gcr	3gcr	PROPN
ajlm-2519	97	5	k.	k.	NOUN
ajlm-2519	97	6	pneumoniae	pneumoniae	NOUN
ajlm-2519	97	7	in	in	ADP
ajlm-2519	97	8	this	this	DET
ajlm-2519	97	9	study	study	NOUN
ajlm-2519	97	10	is	be	AUX
ajlm-2519	97	11	comparable	comparable	ADJ
ajlm-2519	97	12	to	to	ADP
ajlm-2519	97	13	the	the	DET
ajlm-2519	97	14	south	south	ADJ
ajlm-2519	97	15	african	african	ADJ
ajlm-2519	97	16	report	report	NOUN
ajlm-2519	97	17	between	between	ADP
ajlm-2519	97	18	2015	2015	NUM
ajlm-2519	97	19	and	and	CCONJ
ajlm-2519	97	20	2017,11	2017,11	NOUN
ajlm-2519	97	21	and	and	CCONJ
ajlm-2519	97	22	other	other	ADJ
ajlm-2519	97	23	single	single	ADJ
ajlm-2519	97	24	-	-	PUNCT
ajlm-2519	97	25	centre	centre	NOUN
ajlm-2519	97	26	studies	study	NOUN
ajlm-2519	97	27	in	in	ADP
ajlm-2519	97	28	south	south	PROPN
ajlm-2519	97	29	africa	africa	PROPN
ajlm-2519	97	30	from	from	ADP
ajlm-2519	97	31	the	the	DET
ajlm-2519	97	32	gauteng	gauteng	PROPN
ajlm-2519	97	33	and	and	CCONJ
ajlm-2519	97	34	western	western	ADJ
ajlm-2519	97	35	cape	cape	NOUN
ajlm-2519	97	36	provinces	province	NOUN
ajlm-2519	97	37	of	of	ADP
ajlm-2519	97	38	south	south	PROPN
ajlm-2519	97	39	africa	africa	PROPN
ajlm-2519	97	40	between	between	ADP
ajlm-2519	97	41	2008	2008	NUM
ajlm-2519	97	42	and	and	CCONJ
ajlm-2519	97	43	2013.18,43	2013.18,43	ADJ
ajlm-2519	97	44	however	however	ADV
ajlm-2519	97	45	,	,	PUNCT
ajlm-2519	97	46	carbapenem	carbapenem	NOUN
ajlm-2519	97	47	-	-	PUNCT
ajlm-2519	97	48	resistant	resistant	ADJ
ajlm-2519	97	49	k.	k.	NOUN
ajlm-2519	97	50	pneumoniae	pneumoniae	NOUN
ajlm-2519	97	51	in	in	ADP
ajlm-2519	97	52	our	our	PRON
ajlm-2519	97	53	study	study	NOUN
ajlm-2519	97	54	was	be	AUX
ajlm-2519	97	55	low	low	ADJ
ajlm-2519	97	56	(	(	PUNCT
ajlm-2519	97	57	<	<	X
ajlm-2519	97	58	10.0	10.0	NUM
ajlm-2519	97	59	%	%	NOUN
ajlm-2519	97	60	)	)	PUNCT
ajlm-2519	97	61	,	,	PUNCT
ajlm-2519	97	62	rendering	render	VERB
ajlm-2519	97	63	carbapenems	carbapenem	NOUN
ajlm-2519	97	64	an	an	DET
ajlm-2519	97	65	effective	effective	ADJ
ajlm-2519	97	66	alternative	alternative	ADJ
ajlm-2519	97	67	watch	watch	NOUN
ajlm-2519	97	68	antibiotic	antibiotic	ADJ
ajlm-2519	97	69	for	for	ADP
ajlm-2519	97	70	the	the	DET
ajlm-2519	97	71	management	management	NOUN
ajlm-2519	97	72	of	of	ADP
ajlm-2519	97	73	3gcr	3gcr	PROPN
ajlm-2519	97	74	k.	k.	NOUN
ajlm-2519	97	75	pneumoniae	pneumoniae	NOUN
ajlm-2519	97	76	,	,	PUNCT
ajlm-2519	97	77	and	and	CCONJ
ajlm-2519	97	78	reserve	reserve	NOUN
ajlm-2519	97	79	antibiotics	antibiotic	NOUN
ajlm-2519	97	80	(	(	PUNCT
ajlm-2519	97	81	colistin	colistin	NOUN
ajlm-2519	97	82	and	and	CCONJ
ajlm-2519	97	83	tigecycline	tigecycline	ADJ
ajlm-2519	97	84	)	)	PUNCT
ajlm-2519	97	85	as	as	ADP
ajlm-2519	97	86	a	a	DET
ajlm-2519	97	87	last	last	ADJ
ajlm-2519	97	88	resort.42	resort.42	NOUN
ajlm-2519	97	89	the	the	DET
ajlm-2519	97	90	low	low	ADJ
ajlm-2519	97	91	carbapenem	carbapenem	NOUN
ajlm-2519	97	92	-	-	PUNCT
ajlm-2519	97	93	resistant	resistant	ADJ
ajlm-2519	97	94	k.	k.	NOUN
ajlm-2519	97	95	pneumoniae	pneumoniae	NOUN
ajlm-2519	97	96	in	in	ADP
ajlm-2519	97	97	our	our	PRON
ajlm-2519	97	98	study	study	NOUN
ajlm-2519	97	99	could	could	AUX
ajlm-2519	97	100	have	have	AUX
ajlm-2519	97	101	accelerated	accelerate	VERB
ajlm-2519	97	102	the	the	DET
ajlm-2519	97	103	selection	selection	NOUN
ajlm-2519	97	104	process	process	NOUN
ajlm-2519	97	105	,	,	PUNCT
ajlm-2519	97	106	leading	lead	VERB
ajlm-2519	97	107	to	to	ADP
ajlm-2519	97	108	extensive	extensive	ADJ
ajlm-2519	97	109	carbapenem	carbapenem	PROPN
ajlm-2519	97	110	use	use	NOUN
ajlm-2519	97	111	in	in	ADP
ajlm-2519	97	112	3gcr	3gcr	PROPN
ajlm-2519	97	113	k.	k.	NOUN
ajlm-2519	97	114	pneumoniae	pneumoniae	PROPN
ajlm-2519	97	115	management	management	NOUN
ajlm-2519	97	116	,	,	PUNCT
ajlm-2519	97	117	which	which	PRON
ajlm-2519	97	118	could	could	AUX
ajlm-2519	97	119	have	have	AUX
ajlm-2519	97	120	increased	increase	VERB
ajlm-2519	97	121	crab	crab	NOUN
ajlm-2519	97	122	growth	growth	NOUN
ajlm-2519	97	123	.	.	PUNCT
ajlm-2519	98	1	our	our	PRON
ajlm-2519	98	2	study	study	NOUN
ajlm-2519	98	3	and	and	CCONJ
ajlm-2519	98	4	single	single	ADJ
ajlm-2519	98	5	-	-	PUNCT
ajlm-2519	98	6	centre	centre	NOUN
ajlm-2519	98	7	studies	study	NOUN
ajlm-2519	98	8	conducted	conduct	VERB
ajlm-2519	98	9	in	in	ADP
ajlm-2519	98	10	the	the	DET
ajlm-2519	98	11	western	western	ADJ
ajlm-2519	98	12	cape	cape	NOUN
ajlm-2519	98	13	province	province	NOUN
ajlm-2519	98	14	of	of	ADP
ajlm-2519	98	15	south	south	PROPN
ajlm-2519	98	16	africa	africa	PROPN
ajlm-2519	98	17	between	between	ADP
ajlm-2519	98	18	2008	2008	NUM
ajlm-2519	98	19	and	and	CCONJ
ajlm-2519	98	20	201821,43	201821,43	PROPN
ajlm-2519	98	21	have	have	AUX
ajlm-2519	98	22	yielded	yield	VERB
ajlm-2519	98	23	similar	similar	ADJ
ajlm-2519	98	24	findings	finding	NOUN
ajlm-2519	98	25	,	,	PUNCT
ajlm-2519	98	26	not	not	PART
ajlm-2519	98	27	detecting	detect	VERB
ajlm-2519	98	28	vancomycin	vancomycin	NOUN
ajlm-2519	98	29	-	-	PUNCT
ajlm-2519	98	30	resistant	resistant	ADJ
ajlm-2519	98	31	e.	e.	PROPN
ajlm-2519	98	32	faecium	faecium	PROPN
ajlm-2519	98	33	.	.	PUNCT
ajlm-2519	99	1	nevertheless	nevertheless	ADV
ajlm-2519	99	2	,	,	PUNCT
ajlm-2519	99	3	the	the	DET
ajlm-2519	99	4	latest	late	ADJ
ajlm-2519	99	5	2020	2020	NUM
ajlm-2519	99	6	south	south	ADJ
ajlm-2519	99	7	african	african	ADJ
ajlm-2519	99	8	data	datum	NOUN
ajlm-2519	99	9	indicated	indicate	VERB
ajlm-2519	99	10	a	a	DET
ajlm-2519	99	11	vancomycin	vancomycin	NOUN
ajlm-2519	99	12	-	-	PUNCT
ajlm-2519	99	13	resistant	resistant	ADJ
ajlm-2519	99	14	e.	e.	PROPN
ajlm-2519	99	15	faecium	faecium	PROPN
ajlm-2519	99	16	incidence	incidence	NOUN
ajlm-2519	99	17	rate	rate	NOUN
ajlm-2519	99	18	of	of	ADP
ajlm-2519	99	19	1.3	1.3	NUM
ajlm-2519	99	20	%	%	NOUN
ajlm-2519	99	21	,	,	PUNCT
ajlm-2519	99	22	which	which	PRON
ajlm-2519	99	23	remains	remain	VERB
ajlm-2519	99	24	low.11	low.11	NOUN
ajlm-2519	99	25	based	base	VERB
ajlm-2519	99	26	on	on	ADP
ajlm-2519	99	27	this	this	DET
ajlm-2519	99	28	finding	finding	NOUN
ajlm-2519	99	29	,	,	PUNCT
ajlm-2519	99	30	vancomycin	vancomycin	PROPN
ajlm-2519	99	31	is	be	AUX
ajlm-2519	99	32	considered	consider	VERB
ajlm-2519	99	33	an	an	DET
ajlm-2519	99	34	empirical	empirical	ADJ
ajlm-2519	99	35	choice	choice	NOUN
ajlm-2519	99	36	for	for	ADP
ajlm-2519	99	37	the	the	DET
ajlm-2519	99	38	treatment	treatment	NOUN
ajlm-2519	99	39	of	of	ADP
ajlm-2519	99	40	bloodstream	bloodstream	NOUN
ajlm-2519	99	41	e.	e.	PROPN
ajlm-2519	99	42	faecium	faecium	PROPN
ajlm-2519	99	43	infections	infection	NOUN
ajlm-2519	99	44	.	.	PUNCT
ajlm-2519	100	1	at	at	ADP
ajlm-2519	100	2	the	the	DET
ajlm-2519	100	3	same	same	ADJ
ajlm-2519	100	4	time	time	NOUN
ajlm-2519	100	5	,	,	PUNCT
ajlm-2519	100	6	reserve	reserve	NOUN
ajlm-2519	100	7	antibiotics	antibiotic	NOUN
ajlm-2519	100	8	(	(	PUNCT
ajlm-2519	100	9	linezolid	linezolid	NOUN
ajlm-2519	100	10	and	and	CCONJ
ajlm-2519	100	11	tigecycline	tigecycline	ADJ
ajlm-2519	100	12	)	)	PUNCT
ajlm-2519	100	13	should	should	AUX
ajlm-2519	100	14	only	only	ADV
ajlm-2519	100	15	be	be	AUX
ajlm-2519	100	16	used	use	VERB
ajlm-2519	100	17	as	as	ADP
ajlm-2519	100	18	a	a	DET
ajlm-2519	100	19	last	last	ADJ
ajlm-2519	100	20	resort.44	resort.44	NOUN
ajlm-2519	100	21	compared	compare	VERB
ajlm-2519	100	22	to	to	ADP
ajlm-2519	100	23	previous	previous	ADJ
ajlm-2519	100	24	south	south	ADJ
ajlm-2519	100	25	african	african	ADJ
ajlm-2519	100	26	data	datum	NOUN
ajlm-2519	100	27	from	from	ADP
ajlm-2519	100	28	2020	2020	NUM
ajlm-2519	100	29	,	,	PUNCT
ajlm-2519	100	30	the	the	DET
ajlm-2519	100	31	incidence	incidence	NOUN
ajlm-2519	100	32	rate	rate	NOUN
ajlm-2519	100	33	of	of	ADP
ajlm-2519	100	34	carbapenem	carbapenem	NOUN
ajlm-2519	100	35	-	-	PUNCT
ajlm-2519	100	36	resistant	resistant	ADJ
ajlm-2519	100	37	p.	p.	NOUN
ajlm-2519	100	38	aeruginosa	aeruginosa	NOUN
ajlm-2519	100	39	was	be	AUX
ajlm-2519	100	40	low	low	ADJ
ajlm-2519	100	41	,	,	PUNCT
ajlm-2519	100	42	at	at	ADP
ajlm-2519	100	43	33.0%.11	33.0%.11	NOUN
ajlm-2519	100	44	furthermore	furthermore	ADV
ajlm-2519	100	45	,	,	PUNCT
ajlm-2519	100	46	p.	p.	NOUN
ajlm-2519	100	47	aeruginosa	aeruginosa	PROPN
ajlm-2519	100	48	had	have	VERB
ajlm-2519	100	49	low	low	ADJ
ajlm-2519	100	50	resistance	resistance	NOUN
ajlm-2519	100	51	to	to	ADP
ajlm-2519	100	52	aminoglycosides	aminoglycoside	NOUN
ajlm-2519	100	53	and	and	CCONJ
ajlm-2519	100	54	fluoroquinolones	fluoroquinolone	NOUN
ajlm-2519	100	55	,	,	PUNCT
ajlm-2519	100	56	making	make	VERB
ajlm-2519	100	57	access	access	NOUN
ajlm-2519	100	58	antibiotics	antibiotic	NOUN
ajlm-2519	100	59	(	(	PUNCT
ajlm-2519	100	60	amikacin	amikacin	PROPN
ajlm-2519	100	61	and	and	CCONJ
ajlm-2519	100	62	gentamycin	gentamycin	PROPN
ajlm-2519	100	63	)	)	PUNCT
ajlm-2519	100	64	and	and	CCONJ
ajlm-2519	100	65	watch	watch	VERB
ajlm-2519	100	66	antibiotics	antibiotic	NOUN
ajlm-2519	100	67	(	(	PUNCT
ajlm-2519	100	68	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2519	100	69	and	and	CCONJ
ajlm-2519	100	70	meropenem	meropenem	ADJ
ajlm-2519	100	71	)	)	PUNCT
ajlm-2519	100	72	empirical	empirical	ADJ
ajlm-2519	100	73	choices	choice	NOUN
ajlm-2519	100	74	for	for	ADP
ajlm-2519	100	75	bloodstream	bloodstream	NOUN
ajlm-2519	100	76	infections	infection	NOUN
ajlm-2519	100	77	,	,	PUNCT
ajlm-2519	100	78	with	with	ADP
ajlm-2519	100	79	colistin	colistin	NOUN
ajlm-2519	100	80	as	as	ADP
ajlm-2519	100	81	a	a	DET
ajlm-2519	100	82	last	last	ADJ
ajlm-2519	100	83	resort.42	resort.42	NOUN
ajlm-2519	100	84	limitations	limitation	NOUN
ajlm-2519	100	85	our	our	PRON
ajlm-2519	100	86	study	study	NOUN
ajlm-2519	100	87	had	have	VERB
ajlm-2519	100	88	the	the	DET
ajlm-2519	100	89	following	following	ADJ
ajlm-2519	100	90	limitations	limitation	NOUN
ajlm-2519	100	91	.	.	PUNCT
ajlm-2519	101	1	firstly	firstly	ADV
ajlm-2519	101	2	,	,	PUNCT
ajlm-2519	101	3	the	the	DET
ajlm-2519	101	4	study	study	NOUN
ajlm-2519	101	5	relied	rely	VERB
ajlm-2519	101	6	on	on	ADP
ajlm-2519	101	7	a	a	DET
ajlm-2519	101	8	laboratory	laboratory	NOUN
ajlm-2519	101	9	-	-	PUNCT
ajlm-2519	101	10	based	base	VERB
ajlm-2519	101	11	data	datum	NOUN
ajlm-2519	101	12	set	set	AUX
ajlm-2519	101	13	not	not	PART
ajlm-2519	101	14	linked	link	VERB
ajlm-2519	101	15	to	to	ADP
ajlm-2519	101	16	patient	patient	ADJ
ajlm-2519	101	17	diagnoses	diagnosis	NOUN
ajlm-2519	101	18	and	and	CCONJ
ajlm-2519	101	19	outcomes	outcome	NOUN
ajlm-2519	101	20	,	,	PUNCT
ajlm-2519	101	21	limiting	limit	VERB
ajlm-2519	101	22	inferential	inferential	ADJ
ajlm-2519	101	23	analysis	analysis	NOUN
ajlm-2519	101	24	.	.	PUNCT
ajlm-2519	102	1	consequently	consequently	ADV
ajlm-2519	102	2	,	,	PUNCT
ajlm-2519	102	3	future	future	ADJ
ajlm-2519	102	4	patient	patient	NOUN
ajlm-2519	102	5	-	-	PUNCT
ajlm-2519	102	6	level	level	NOUN
ajlm-2519	102	7	pathogen	pathogen	NOUN
ajlm-2519	102	8	-	-	PUNCT
ajlm-2519	102	9	specific	specific	ADJ
ajlm-2519	102	10	clinical	clinical	ADJ
ajlm-2519	102	11	studies	study	NOUN
ajlm-2519	102	12	are	be	AUX
ajlm-2519	102	13	encouraged	encourage	VERB
ajlm-2519	102	14	to	to	PART
ajlm-2519	102	15	describe	describe	VERB
ajlm-2519	102	16	morbidity	morbidity	NOUN
ajlm-2519	102	17	and	and	CCONJ
ajlm-2519	102	18	mortality	mortality	NOUN
ajlm-2519	102	19	risk	risk	NOUN
ajlm-2519	102	20	factors	factor	NOUN
ajlm-2519	102	21	associated	associate	VERB
ajlm-2519	102	22	with	with	ADP
ajlm-2519	102	23	these	these	DET
ajlm-2519	102	24	infections	infection	NOUN
ajlm-2519	102	25	,	,	PUNCT
ajlm-2519	102	26	particularly	particularly	ADV
ajlm-2519	102	27	in	in	ADP
ajlm-2519	102	28	neonatal	neonatal	ADJ
ajlm-2519	102	29	,	,	PUNCT
ajlm-2519	102	30	paediatric	paediatric	ADJ
ajlm-2519	102	31	,	,	PUNCT
ajlm-2519	102	32	and	and	CCONJ
ajlm-2519	102	33	intensive	intensive	ADJ
ajlm-2519	102	34	care	care	NOUN
ajlm-2519	102	35	units	unit	NOUN
ajlm-2519	102	36	.	.	PUNCT
ajlm-2519	103	1	secondly	secondly	ADV
ajlm-2519	103	2	,	,	PUNCT
ajlm-2519	103	3	our	our	PRON
ajlm-2519	103	4	study	study	NOUN
ajlm-2519	103	5	used	use	VERB
ajlm-2519	103	6	routine	routine	ADJ
ajlm-2519	103	7	laboratory	laboratory	NOUN
ajlm-2519	103	8	data	datum	NOUN
ajlm-2519	103	9	to	to	PART
ajlm-2519	103	10	report	report	VERB
ajlm-2519	103	11	on	on	ADP
ajlm-2519	103	12	phenotypic	phenotypic	ADJ
ajlm-2519	103	13	amr	amr	NOUN
ajlm-2519	103	14	of	of	ADP
ajlm-2519	103	15	eskape	eskape	NOUN
ajlm-2519	103	16	pathogens	pathogen	NOUN
ajlm-2519	103	17	.	.	PUNCT
ajlm-2519	104	1	we	we	PRON
ajlm-2519	104	2	acknowledge	acknowledge	VERB
ajlm-2519	104	3	that	that	SCONJ
ajlm-2519	104	4	in	in	ADP
ajlm-2519	104	5	an	an	DET
ajlm-2519	104	6	ideal	ideal	ADJ
ajlm-2519	104	7	setting	setting	NOUN
ajlm-2519	104	8	,	,	PUNCT
ajlm-2519	104	9	phenotypic	phenotypic	ADJ
ajlm-2519	104	10	and	and	CCONJ
ajlm-2519	104	11	molecular	molecular	ADJ
ajlm-2519	104	12	surveillance	surveillance	NOUN
ajlm-2519	104	13	amr	amr	NOUN
ajlm-2519	104	14	data	datum	NOUN
ajlm-2519	104	15	are	be	AUX
ajlm-2519	104	16	used	use	VERB
ajlm-2519	104	17	together	together	ADV
ajlm-2519	104	18	to	to	PART
ajlm-2519	104	19	classify	classify	VERB
ajlm-2519	104	20	bacterial	bacterial	ADJ
ajlm-2519	104	21	isolates	isolate	NOUN
ajlm-2519	104	22	and	and	CCONJ
ajlm-2519	104	23	describe	describe	VERB
ajlm-2519	104	24	the	the	DET
ajlm-2519	104	25	magnitude	magnitude	NOUN
ajlm-2519	104	26	and	and	CCONJ
ajlm-2519	104	27	mechanism	mechanism	NOUN
ajlm-2519	104	28	of	of	ADP
ajlm-2519	104	29	amr	amr	NOUN
ajlm-2519	104	30	.	.	PROPN
ajlm-2519	105	1	however	however	ADV
ajlm-2519	105	2	,	,	PUNCT
ajlm-2519	105	3	molecular	molecular	ADJ
ajlm-2519	105	4	amr	amr	NOUN
ajlm-2519	105	5	surveillance	surveillance	NOUN
ajlm-2519	105	6	in	in	ADP
ajlm-2519	105	7	south	south	PROPN
ajlm-2519	105	8	africa	africa	PROPN
ajlm-2519	105	9	is	be	AUX
ajlm-2519	105	10	limited	limit	VERB
ajlm-2519	105	11	to	to	ADP
ajlm-2519	105	12	the	the	DET
ajlm-2519	105	13	national	national	ADJ
ajlm-2519	105	14	referral	referral	PROPN
ajlm-2519	105	15	laboratory	laboratory	NOUN
ajlm-2519	105	16	;	;	PUNCT
ajlm-2519	105	17	decentralisation	decentralisation	NOUN
ajlm-2519	105	18	to	to	ADP
ajlm-2519	105	19	rural	rural	ADJ
ajlm-2519	105	20	healthcare	healthcare	NOUN
ajlm-2519	105	21	facilities	facility	NOUN
ajlm-2519	105	22	is	be	AUX
ajlm-2519	105	23	limited	limit	VERB
ajlm-2519	105	24	by	by	ADP
ajlm-2519	105	25	lack	lack	NOUN
ajlm-2519	105	26	of	of	ADP
ajlm-2519	105	27	funding	funding	NOUN
ajlm-2519	105	28	.	.	PUNCT
ajlm-2519	106	1	thirdly	thirdly	ADV
ajlm-2519	106	2	,	,	PUNCT
ajlm-2519	106	3	the	the	DET
ajlm-2519	106	4	use	use	NOUN
ajlm-2519	106	5	of	of	ADP
ajlm-2519	106	6	retrospective	retrospective	ADJ
ajlm-2519	106	7	routine	routine	ADJ
ajlm-2519	106	8	data	datum	NOUN
ajlm-2519	106	9	does	do	AUX
ajlm-2519	106	10	not	not	PART
ajlm-2519	106	11	allow	allow	VERB
ajlm-2519	106	12	for	for	ADP
ajlm-2519	106	13	the	the	DET
ajlm-2519	106	14	determination	determination	NOUN
ajlm-2519	106	15	of	of	ADP
ajlm-2519	106	16	reliability	reliability	NOUN
ajlm-2519	106	17	and	and	CCONJ
ajlm-2519	106	18	validity	validity	NOUN
ajlm-2519	106	19	for	for	ADP
ajlm-2519	106	20	certain	certain	ADJ
ajlm-2519	106	21	observations	observation	NOUN
ajlm-2519	106	22	.	.	PUNCT
ajlm-2519	107	1	fourthly	fourthly	ADV
ajlm-2519	107	2	,	,	PUNCT
ajlm-2519	107	3	the	the	DET
ajlm-2519	107	4	requested	request	VERB
ajlm-2519	107	5	annual	annual	ADJ
ajlm-2519	107	6	blood	blood	NOUN
ajlm-2519	107	7	sample	sample	NOUN
ajlm-2519	107	8	data	datum	NOUN
ajlm-2519	107	9	from	from	ADP
ajlm-2519	107	10	the	the	DET
ajlm-2519	107	11	study	study	NOUN
ajlm-2519	107	12	data	datum	NOUN
ajlm-2519	107	13	source	source	NOUN
ajlm-2519	107	14	were	be	AUX
ajlm-2519	107	15	not	not	PART
ajlm-2519	107	16	provided	provide	VERB
ajlm-2519	107	17	.	.	PUNCT
ajlm-2519	108	1	consequently	consequently	ADV
ajlm-2519	108	2	,	,	PUNCT
ajlm-2519	108	3	due	due	ADP
ajlm-2519	108	4	to	to	ADP
ajlm-2519	108	5	data	datum	NOUN
ajlm-2519	108	6	limitations	limitation	NOUN
ajlm-2519	108	7	,	,	PUNCT
ajlm-2519	108	8	we	we	PRON
ajlm-2519	108	9	could	could	AUX
ajlm-2519	108	10	not	not	PART
ajlm-2519	108	11	determine	determine	VERB
ajlm-2519	108	12	the	the	DET
ajlm-2519	108	13	overall	overall	ADJ
ajlm-2519	108	14	or	or	CCONJ
ajlm-2519	108	15	individual	individual	ADJ
ajlm-2519	108	16	incidence	incidence	NOUN
ajlm-2519	108	17	rate	rate	NOUN
ajlm-2519	108	18	of	of	ADP
ajlm-2519	108	19	bloodstream	bloodstream	NOUN
ajlm-2519	108	20	eskape	eskape	NOUN
ajlm-2519	108	21	pathogens	pathogen	NOUN
ajlm-2519	108	22	.	.	PUNCT
ajlm-2519	109	1	even	even	ADV
ajlm-2519	109	2	though	though	SCONJ
ajlm-2519	109	3	routine	routine	ADJ
ajlm-2519	109	4	surveillance	surveillance	NOUN
ajlm-2519	109	5	data	datum	NOUN
ajlm-2519	109	6	are	be	AUX
ajlm-2519	109	7	available	available	ADJ
ajlm-2519	109	8	in	in	ADP
ajlm-2519	109	9	some	some	DET
ajlm-2519	109	10	low	low	ADJ
ajlm-2519	109	11	-	-	PUNCT
ajlm-2519	109	12	resource	resource	NOUN
ajlm-2519	109	13	settings	setting	NOUN
ajlm-2519	109	14	,	,	PUNCT
ajlm-2519	109	15	limited	limited	ADJ
ajlm-2519	109	16	access	access	NOUN
ajlm-2519	109	17	to	to	ADP
ajlm-2519	109	18	essential	essential	ADJ
ajlm-2519	109	19	variables	variable	NOUN
ajlm-2519	109	20	such	such	ADJ
ajlm-2519	109	21	as	as	ADP
ajlm-2519	109	22	total	total	ADJ
ajlm-2519	109	23	blood	blood	NOUN
ajlm-2519	109	24	cultures	culture	NOUN
ajlm-2519	109	25	could	could	AUX
ajlm-2519	109	26	present	present	VERB
ajlm-2519	109	27	a	a	DET
ajlm-2519	109	28	challenge	challenge	NOUN
ajlm-2519	109	29	to	to	ADP
ajlm-2519	109	30	the	the	DET
ajlm-2519	109	31	estimation	estimation	NOUN
ajlm-2519	109	32	of	of	ADP
ajlm-2519	109	33	prevalence	prevalence	NOUN
ajlm-2519	109	34	and	and	CCONJ
ajlm-2519	109	35	surveillance	surveillance	NOUN
ajlm-2519	109	36	of	of	ADP
ajlm-2519	109	37	infectious	infectious	ADJ
ajlm-2519	109	38	diseases	disease	NOUN
ajlm-2519	109	39	,	,	PUNCT
ajlm-2519	109	40	as	as	SCONJ
ajlm-2519	109	41	was	be	AUX
ajlm-2519	109	42	the	the	DET
ajlm-2519	109	43	case	case	NOUN
ajlm-2519	109	44	in	in	ADP
ajlm-2519	109	45	our	our	PRON
ajlm-2519	109	46	study	study	NOUN
ajlm-2519	109	47	.	.	PUNCT
ajlm-2519	110	1	fifthly	fifthly	ADV
ajlm-2519	110	2	,	,	PUNCT
ajlm-2519	110	3	our	our	PRON
ajlm-2519	110	4	retrospective	retrospective	ADJ
ajlm-2519	110	5	study	study	NOUN
ajlm-2519	110	6	design	design	NOUN
ajlm-2519	110	7	has	have	VERB
ajlm-2519	110	8	the	the	DET
ajlm-2519	110	9	inherent	inherent	ADJ
ajlm-2519	110	10	limitation	limitation	NOUN
ajlm-2519	110	11	of	of	ADP
ajlm-2519	110	12	low	low	ADJ
ajlm-2519	110	13	external	external	ADJ
ajlm-2519	110	14	study	study	NOUN
ajlm-2519	110	15	validity	validity	NOUN
ajlm-2519	110	16	,	,	PUNCT
ajlm-2519	110	17	and	and	CCONJ
ajlm-2519	110	18	our	our	PRON
ajlm-2519	110	19	findings	finding	NOUN
ajlm-2519	110	20	could	could	AUX
ajlm-2519	110	21	not	not	PART
ajlm-2519	110	22	be	be	AUX
ajlm-2519	110	23	generalised	generalise	VERB
ajlm-2519	110	24	to	to	ADP
ajlm-2519	110	25	other	other	ADJ
ajlm-2519	110	26	settings	setting	NOUN
ajlm-2519	110	27	.	.	PUNCT
ajlm-2519	111	1	lastly	lastly	ADV
ajlm-2519	111	2	,	,	PUNCT
ajlm-2519	111	3	other	other	ADJ
ajlm-2519	111	4	limitations	limitation	NOUN
ajlm-2519	111	5	included	include	VERB
ajlm-2519	111	6	missing	miss	VERB
ajlm-2519	111	7	variables	variable	NOUN
ajlm-2519	111	8	and	and	CCONJ
ajlm-2519	111	9	selection	selection	NOUN
ajlm-2519	111	10	bias	bias	NOUN
ajlm-2519	111	11	as	as	SCONJ
ajlm-2519	111	12	not	not	PART
ajlm-2519	111	13	all	all	DET
ajlm-2519	111	14	isolates	isolate	NOUN
ajlm-2519	111	15	were	be	AUX
ajlm-2519	111	16	subjected	subject	VERB
ajlm-2519	111	17	to	to	ADP
ajlm-2519	111	18	antibiotic	antibiotic	ADJ
ajlm-2519	111	19	susceptibility	susceptibility	NOUN
ajlm-2519	111	20	testing	testing	NOUN
ajlm-2519	111	21	,	,	PUNCT
ajlm-2519	111	22	limiting	limit	VERB
ajlm-2519	111	23	essential	essential	ADJ
ajlm-2519	111	24	data	datum	NOUN
ajlm-2519	111	25	analysis	analysis	NOUN
ajlm-2519	111	26	.	.	PUNCT
ajlm-2519	112	1	future	future	ADJ
ajlm-2519	112	2	studies	study	NOUN
ajlm-2519	112	3	should	should	AUX
ajlm-2519	112	4	consider	consider	VERB
ajlm-2519	112	5	confounding	confound	VERB
ajlm-2519	112	6	variables	variable	NOUN
ajlm-2519	112	7	such	such	ADJ
ajlm-2519	112	8	as	as	ADP
ajlm-2519	112	9	infectious	infectious	ADJ
ajlm-2519	112	10	disease	disease	NOUN
ajlm-2519	112	11	diagnostic	diagnostic	ADJ
ajlm-2519	112	12	protocols	protocol	NOUN
ajlm-2519	112	13	,	,	PUNCT
ajlm-2519	112	14	antibiotic	antibiotic	ADJ
ajlm-2519	112	15	stewardship	stewardship	NOUN
ajlm-2519	112	16	programmes	programme	NOUN
ajlm-2519	112	17	,	,	PUNCT
ajlm-2519	112	18	and	and	CCONJ
ajlm-2519	112	19	infection	infection	NOUN
ajlm-2519	112	20	prevention	prevention	NOUN
ajlm-2519	112	21	and	and	CCONJ
ajlm-2519	112	22	control	control	NOUN
ajlm-2519	112	23	measures	measure	NOUN
ajlm-2519	112	24	to	to	PART
ajlm-2519	112	25	improve	improve	VERB
ajlm-2519	112	26	their	their	PRON
ajlm-2519	112	27	contextualisation	contextualisation	NOUN
ajlm-2519	112	28	and	and	CCONJ
ajlm-2519	112	29	interpretation.41	interpretation.41	NOUN
ajlm-2519	112	30	conclusion	conclusion	NOUN
ajlm-2519	112	31	this	this	DET
ajlm-2519	112	32	study	study	NOUN
ajlm-2519	112	33	has	have	AUX
ajlm-2519	112	34	presented	present	VERB
ajlm-2519	112	35	essential	essential	ADJ
ajlm-2519	112	36	information	information	NOUN
ajlm-2519	112	37	on	on	ADP
ajlm-2519	112	38	the	the	DET
ajlm-2519	112	39	incidence	incidence	NOUN
ajlm-2519	112	40	of	of	ADP
ajlm-2519	112	41	eskape	eskape	NOUN
ajlm-2519	112	42	pathogens	pathogen	NOUN
ajlm-2519	112	43	and	and	CCONJ
ajlm-2519	112	44	antibiotic	antibiotic	ADJ
ajlm-2519	112	45	resistance	resistance	NOUN
ajlm-2519	112	46	phenotypes	phenotype	NOUN
ajlm-2519	112	47	included	include	VERB
ajlm-2519	112	48	in	in	ADP
ajlm-2519	112	49	the	the	DET
ajlm-2519	112	50	list	list	NOUN
ajlm-2519	112	51	of	of	ADP
ajlm-2519	112	52	global	global	ADJ
ajlm-2519	112	53	priority	priority	NOUN
ajlm-2519	112	54	drug	drug	NOUN
ajlm-2519	112	55	-	-	PUNCT
ajlm-2519	112	56	pathogen	pathogen	NOUN
ajlm-2519	112	57	combinations	combination	NOUN
ajlm-2519	112	58	in	in	ADP
ajlm-2519	112	59	patients	patient	NOUN
ajlm-2519	112	60	with	with	ADP
ajlm-2519	112	61	bloodstream	bloodstream	NOUN
ajlm-2519	112	62	infections	infection	NOUN
ajlm-2519	112	63	in	in	ADP
ajlm-2519	112	64	mankweng	mankweng	ADJ
ajlm-2519	112	65	tertiary	tertiary	ADJ
ajlm-2519	112	66	hospital	hospital	NOUN
ajlm-2519	112	67	in	in	ADP
ajlm-2519	112	68	limpopo	limpopo	PROPN
ajlm-2519	112	69	province	province	PROPN
ajlm-2519	112	70	,	,	PUNCT
ajlm-2519	112	71	south	south	PROPN
ajlm-2519	112	72	africa	africa	PROPN
ajlm-2519	112	73	.	.	PUNCT
ajlm-2519	113	1	therefore	therefore	ADV
ajlm-2519	113	2	,	,	PUNCT
ajlm-2519	113	3	it	it	PRON
ajlm-2519	113	4	is	be	AUX
ajlm-2519	113	5	essential	essential	ADJ
ajlm-2519	113	6	to	to	PART
ajlm-2519	113	7	establish	establish	VERB
ajlm-2519	113	8	a	a	DET
ajlm-2519	113	9	reliable	reliable	ADJ
ajlm-2519	113	10	and	and	CCONJ
ajlm-2519	113	11	timely	timely	ADJ
ajlm-2519	113	12	surveillance	surveillance	NOUN
ajlm-2519	113	13	system	system	NOUN
ajlm-2519	113	14	,	,	PUNCT
ajlm-2519	113	15	implement	implement	VERB
ajlm-2519	113	16	and	and	CCONJ
ajlm-2519	113	17	maintain	maintain	VERB
ajlm-2519	113	18	infection	infection	NOUN
ajlm-2519	113	19	prevention	prevention	NOUN
ajlm-2519	113	20	and	and	CCONJ
ajlm-2519	113	21	control	control	NOUN
ajlm-2519	113	22	measures	measure	NOUN
ajlm-2519	113	23	,	,	PUNCT
ajlm-2519	113	24	and	and	CCONJ
ajlm-2519	113	25	empirical	empirical	ADJ
ajlm-2519	113	26	alternative	alternative	ADJ
ajlm-2519	113	27	antibiotic	antibiotic	ADJ
ajlm-2519	113	28	treatment	treatment	NOUN
ajlm-2519	113	29	regimens	regimen	NOUN
ajlm-2519	113	30	.	.	PUNCT
ajlm-2519	114	1	the	the	DET
ajlm-2519	114	2	present	present	ADJ
ajlm-2519	114	3	information	information	NOUN
ajlm-2519	114	4	could	could	AUX
ajlm-2519	114	5	serve	serve	VERB
ajlm-2519	114	6	as	as	ADP
ajlm-2519	114	7	a	a	DET
ajlm-2519	114	8	basis	basis	NOUN
ajlm-2519	114	9	for	for	ADP
ajlm-2519	114	10	the	the	DET
ajlm-2519	114	11	development	development	NOUN
ajlm-2519	114	12	of	of	ADP
ajlm-2519	114	13	an	an	DET
ajlm-2519	114	14	institutional	institutional	ADJ
ajlm-2519	114	15	antibiogram	antibiogram	NOUN
ajlm-2519	114	16	that	that	PRON
ajlm-2519	114	17	could	could	AUX
ajlm-2519	114	18	be	be	AUX
ajlm-2519	114	19	used	use	VERB
ajlm-2519	114	20	together	together	ADV
ajlm-2519	114	21	with	with	ADP
ajlm-2519	114	22	institutional	institutional	ADJ
ajlm-2519	114	23	formulary	formulary	NOUN
ajlm-2519	114	24	and	and	CCONJ
ajlm-2519	114	25	prescribing	prescribing	NOUN
ajlm-2519	114	26	guidelines	guideline	NOUN
ajlm-2519	114	27	for	for	ADP
ajlm-2519	114	28	optimal	optimal	ADJ
ajlm-2519	114	29	antibiotic	antibiotic	ADJ
ajlm-2519	114	30	use	use	NOUN
ajlm-2519	114	31	.	.	PUNCT
ajlm-2519	115	1	the	the	DET
ajlm-2519	115	2	surveillance	surveillance	NOUN
ajlm-2519	115	3	data	datum	NOUN
ajlm-2519	115	4	could	could	AUX
ajlm-2519	115	5	provide	provide	VERB
ajlm-2519	115	6	valuable	valuable	ADJ
ajlm-2519	115	7	drug	drug	NOUN
ajlm-2519	115	8	selection	selection	NOUN
ajlm-2519	115	9	information	information	NOUN
ajlm-2519	115	10	on	on	ADP
ajlm-2519	115	11	appropriate	appropriate	ADJ
ajlm-2519	115	12	empirical	empirical	ADJ
ajlm-2519	115	13	therapy	therapy	NOUN
ajlm-2519	115	14	before	before	ADP
ajlm-2519	115	15	the	the	DET
ajlm-2519	115	16	availability	availability	NOUN
ajlm-2519	115	17	of	of	ADP
ajlm-2519	115	18	antibiotic	antibiotic	ADJ
ajlm-2519	115	19	sensitivity	sensitivity	NOUN
ajlm-2519	115	20	testing	testing	NOUN
ajlm-2519	115	21	results	result	NOUN
ajlm-2519	115	22	for	for	ADP
ajlm-2519	115	23	a	a	DET
ajlm-2519	115	24	specific	specific	ADJ
ajlm-2519	115	25	patient	patient	NOUN
ajlm-2519	115	26	.	.	PUNCT
ajlm-2519	116	1	acknowledgements	acknowledgement	NOUN
ajlm-2519	116	2	the	the	DET
ajlm-2519	116	3	authors	author	NOUN
ajlm-2519	116	4	acknowledge	acknowledge	VERB
ajlm-2519	116	5	the	the	DET
ajlm-2519	116	6	national	national	PROPN
ajlm-2519	116	7	health	health	PROPN
ajlm-2519	116	8	laboratory	laboratory	PROPN
ajlm-2519	116	9	services	service	NOUN
ajlm-2519	116	10	staff	staff	NOUN
ajlm-2519	116	11	(	(	PUNCT
ajlm-2519	116	12	thembekile	thembekile	ADJ
ajlm-2519	116	13	shelembe	shelembe	NOUN
ajlm-2519	116	14	)	)	PUNCT
ajlm-2519	116	15	,	,	PUNCT
ajlm-2519	116	16	who	who	PRON
ajlm-2519	116	17	assisted	assist	VERB
ajlm-2519	116	18	with	with	ADP
ajlm-2519	116	19	data	datum	NOUN
ajlm-2519	116	20	extraction	extraction	NOUN
ajlm-2519	116	21	and	and	CCONJ
ajlm-2519	116	22	preparation	preparation	NOUN
ajlm-2519	116	23	.	.	PUNCT
ajlm-2519	117	1	this	this	DET
ajlm-2519	117	2	article	article	NOUN
ajlm-2519	117	3	is	be	AUX
ajlm-2519	117	4	partially	partially	ADV
ajlm-2519	117	5	based	base	VERB
ajlm-2519	117	6	on	on	ADP
ajlm-2519	117	7	the	the	DET
ajlm-2519	117	8	author	author	NOUN
ajlm-2519	117	9	’s	’s	PART
ajlm-2519	117	10	thesis	thesis	NOUN
ajlm-2519	117	11	entitled	entitle	VERB
ajlm-2519	117	12	‘	'	PUNCT
ajlm-2519	117	13	antibiotic	antibiotic	ADJ
ajlm-2519	117	14	utilisation	utilisation	NOUN
ajlm-2519	117	15	in	in	ADP
ajlm-2519	117	16	public	public	ADJ
ajlm-2519	117	17	sector	sector	NOUN
ajlm-2519	117	18	healthcare	healthcare	NOUN
ajlm-2519	117	19	systems	system	NOUN
ajlm-2519	117	20	of	of	ADP
ajlm-2519	117	21	limpopo	limpopo	PROPN
ajlm-2519	117	22	province	province	PROPN
ajlm-2519	117	23	,	,	PUNCT
ajlm-2519	117	24	south	south	PROPN
ajlm-2519	117	25	africa	africa	PROPN
ajlm-2519	117	26	’	'	PUNCT
ajlm-2519	117	27	towards	towards	ADP
ajlm-2519	117	28	the	the	DET
ajlm-2519	117	29	degree	degree	NOUN
ajlm-2519	117	30	of	of	ADP
ajlm-2519	117	31	doctor	doctor	NOUN
ajlm-2519	117	32	of	of	ADP
ajlm-2519	117	33	philosophy	philosophy	NOUN
ajlm-2519	117	34	in	in	ADP
ajlm-2519	117	35	pharmacy	pharmacy	NOUN
ajlm-2519	117	36	in	in	ADP
ajlm-2519	117	37	the	the	DET
ajlm-2519	117	38	department	department	NOUN
ajlm-2519	117	39	of	of	ADP
ajlm-2519	117	40	medicine	medicine	NOUN
ajlm-2519	117	41	usage	usage	NOUN
ajlm-2519	117	42	in	in	ADP
ajlm-2519	117	43	south	south	PROPN
ajlm-2519	117	44	africa	africa	PROPN
ajlm-2519	117	45	,	,	PUNCT
ajlm-2519	117	46	north	north	NOUN
ajlm-2519	117	47	-	-	PUNCT
ajlm-2519	117	48	west	west	PROPN
ajlm-2519	117	49	university	university	PROPN
ajlm-2519	117	50	,	,	PUNCT
ajlm-2519	117	51	south	south	PROPN
ajlm-2519	117	52	africa	africa	PROPN
ajlm-2519	117	53	on	on	ADP
ajlm-2519	117	54	2	2	NUM
ajlm-2519	117	55	august	august	PROPN
ajlm-2519	117	56	2024	2024	NUM
ajlm-2519	117	57	,	,	PUNCT
ajlm-2519	117	58	with	with	ADP
ajlm-2519	117	59	supervisors	supervisor	NOUN
ajlm-2519	117	60	,	,	PUNCT
ajlm-2519	117	61	johanita	johanita	PROPN
ajlm-2519	117	62	r.	r.	PROPN
ajlm-2519	117	63	burger	burger	PROPN
ajlm-2519	117	64	,	,	PUNCT
ajlm-2519	117	65	martha	martha	PROPN
ajlm-2519	117	66	s.	s.	PROPN
ajlm-2519	117	67	lubbe	lubbe	PROPN
ajlm-2519	117	68	and	and	CCONJ
ajlm-2519	117	69	marlene	marlene	PROPN
ajlm-2519	117	70	julyan	julyan	PROPN
ajlm-2519	117	71	.	.	PUNCT
ajlm-2519	118	1	competing	compete	VERB
ajlm-2519	118	2	interests	interest	NOUN
ajlm-2519	118	3	t.c.m	t.c.m	VERB
ajlm-2519	118	4	.	.	PUNCT
ajlm-2519	118	5	works	work	VERB
ajlm-2519	118	6	at	at	ADP
ajlm-2519	118	7	the	the	DET
ajlm-2519	118	8	central	central	ADJ
ajlm-2519	118	9	provincial	provincial	ADJ
ajlm-2519	118	10	office	office	NOUN
ajlm-2519	118	11	of	of	ADP
ajlm-2519	118	12	the	the	DET
ajlm-2519	118	13	limpopo	limpopo	PROPN
ajlm-2519	118	14	department	department	PROPN
ajlm-2519	118	15	of	of	ADP
ajlm-2519	118	16	health	health	PROPN
ajlm-2519	118	17	but	but	CCONJ
ajlm-2519	118	18	is	be	AUX
ajlm-2519	118	19	not	not	PART
ajlm-2519	118	20	involved	involve	VERB
ajlm-2519	118	21	in	in	ADP
ajlm-2519	118	22	the	the	DET
ajlm-2519	118	23	daily	daily	ADJ
ajlm-2519	118	24	operations	operation	NOUN
ajlm-2519	118	25	of	of	ADP
ajlm-2519	118	26	the	the	DET
ajlm-2519	118	27	mankweng	mankweng	ADJ
ajlm-2519	118	28	tertiary	tertiary	ADJ
ajlm-2519	118	29	hospital	hospital	NOUN
ajlm-2519	118	30	.	.	PUNCT
ajlm-2519	119	1	the	the	DET
ajlm-2519	119	2	other	other	ADJ
ajlm-2519	119	3	authors	author	NOUN
ajlm-2519	119	4	declare	declare	VERB
ajlm-2519	119	5	that	that	SCONJ
ajlm-2519	119	6	they	they	PRON
ajlm-2519	119	7	have	have	VERB
ajlm-2519	119	8	no	no	DET
ajlm-2519	119	9	financial	financial	ADJ
ajlm-2519	119	10	or	or	CCONJ
ajlm-2519	119	11	personal	personal	ADJ
ajlm-2519	119	12	relationships	relationship	NOUN
ajlm-2519	119	13	that	that	PRON
ajlm-2519	119	14	may	may	AUX
ajlm-2519	119	15	have	have	AUX
ajlm-2519	119	16	inappropriately	inappropriately	ADV
ajlm-2519	119	17	influenced	influence	VERB
ajlm-2519	119	18	them	they	PRON
ajlm-2519	119	19	in	in	ADP
ajlm-2519	119	20	writing	write	VERB
ajlm-2519	119	21	this	this	DET
ajlm-2519	119	22	article	article	NOUN
ajlm-2519	119	23	.	.	PUNCT
ajlm-2519	120	1	authors	author	NOUN
ajlm-2519	120	2	’	’	PART
ajlm-2519	120	3	contributions	contribution	NOUN
ajlm-2519	120	4	t.c.m	t.c.m	ADV
ajlm-2519	120	5	.	.	PUNCT
ajlm-2519	120	6	designed	design	VERB
ajlm-2519	120	7	the	the	DET
ajlm-2519	120	8	study	study	NOUN
ajlm-2519	120	9	.	.	PUNCT
ajlm-2519	121	1	j.r.b	j.r.b	NOUN
ajlm-2519	121	2	.	.	PROPN
ajlm-2519	121	3	,	,	PUNCT
ajlm-2519	121	4	m.s.l	m.s.l	PROPN
ajlm-2519	121	5	.	.	PUNCT
ajlm-2519	121	6	and	and	CCONJ
ajlm-2519	121	7	m.j	m.j	PROPN
ajlm-2519	121	8	.	.	PROPN
ajlm-2519	121	9	were	be	AUX
ajlm-2519	121	10	involved	involve	VERB
ajlm-2519	121	11	in	in	ADP
ajlm-2519	121	12	conceptualising	conceptualise	VERB
ajlm-2519	121	13	and	and	CCONJ
ajlm-2519	121	14	supervising	supervise	VERB
ajlm-2519	121	15	the	the	DET
ajlm-2519	121	16	work	work	NOUN
ajlm-2519	121	17	.	.	PUNCT
ajlm-2519	122	1	t.c.m	t.c.m	INTJ
ajlm-2519	122	2	.	.	PUNCT
ajlm-2519	122	3	processed	process	VERB
ajlm-2519	122	4	the	the	DET
ajlm-2519	122	5	data	datum	NOUN
ajlm-2519	122	6	,	,	PUNCT
ajlm-2519	122	7	performed	perform	VERB
ajlm-2519	122	8	the	the	DET
ajlm-2519	122	9	analysis	analysis	NOUN
ajlm-2519	122	10	,	,	PUNCT
ajlm-2519	122	11	and	and	CCONJ
ajlm-2519	122	12	designed	design	VERB
ajlm-2519	122	13	tables	table	NOUN
ajlm-2519	122	14	and	and	CCONJ
ajlm-2519	122	15	graphs	graph	NOUN
ajlm-2519	122	16	.	.	PUNCT
ajlm-2519	123	1	j.r.b	j.r.b	NOUN
ajlm-2519	123	2	.	.	PROPN
ajlm-2519	123	3	,	,	PUNCT
ajlm-2519	123	4	m.s.l	m.s.l	PROPN
ajlm-2519	123	5	.	.	PROPN
ajlm-2519	123	6	,	,	PUNCT
ajlm-2519	123	7	m.j	m.j	PROPN
ajlm-2519	123	8	.	.	PROPN
ajlm-2519	123	9	,	,	PUNCT
ajlm-2519	123	10	and	and	CCONJ
ajlm-2519	123	11	m.r.l.-m	m.r.l.-m	PROPN
ajlm-2519	123	12	.	.	PROPN
ajlm-2519	123	13	assisted	assist	VERB
ajlm-2519	123	14	in	in	ADP
ajlm-2519	123	15	interpreting	interpret	VERB
ajlm-2519	123	16	the	the	DET
ajlm-2519	123	17	results	result	NOUN
ajlm-2519	123	18	.	.	PUNCT
ajlm-2519	124	1	t.c.m	t.c.m	INTJ
ajlm-2519	124	2	.	.	PUNCT
ajlm-2519	125	1	took	take	VERB
ajlm-2519	125	2	the	the	DET
ajlm-2519	125	3	lead	lead	NOUN
ajlm-2519	125	4	in	in	ADP
ajlm-2519	125	5	drafting	draft	VERB
ajlm-2519	125	6	the	the	DET
ajlm-2519	125	7	article	article	NOUN
ajlm-2519	125	8	.	.	PUNCT
ajlm-2519	126	1	t.c.m	t.c.m	INTJ
ajlm-2519	126	2	.	.	PROPN
ajlm-2519	126	3	,	,	PUNCT
ajlm-2519	126	4	j.r.b	j.r.b	NOUN
ajlm-2519	126	5	.	.	PROPN
ajlm-2519	126	6	,	,	PUNCT
ajlm-2519	126	7	m.s.l	m.s.l	PROPN
ajlm-2519	126	8	.	.	PROPN
ajlm-2519	126	9	,	,	PUNCT
ajlm-2519	126	10	m.j	m.j	PROPN
ajlm-2519	126	11	.	.	PROPN
ajlm-2519	126	12	and	and	CCONJ
ajlm-2519	126	13	m.r.l.-m	m.r.l.-m	PROPN
ajlm-2519	126	14	.	.	PUNCT
ajlm-2519	126	15	provided	provide	VERB
ajlm-2519	126	16	critical	critical	ADJ
ajlm-2519	126	17	feedback	feedback	NOUN
ajlm-2519	126	18	and	and	CCONJ
ajlm-2519	126	19	helped	help	VERB
ajlm-2519	126	20	shape	shape	VERB
ajlm-2519	126	21	the	the	DET
ajlm-2519	126	22	research	research	NOUN
ajlm-2519	126	23	,	,	PUNCT
ajlm-2519	126	24	data	datum	NOUN
ajlm-2519	126	25	analysis	analysis	NOUN
ajlm-2519	126	26	,	,	PUNCT
ajlm-2519	126	27	and	and	CCONJ
ajlm-2519	126	28	article	article	NOUN
ajlm-2519	126	29	.	.	PUNCT
ajlm-2519	127	1	sources	source	NOUN
ajlm-2519	127	2	of	of	ADP
ajlm-2519	127	3	support	support	NOUN
ajlm-2519	127	4	this	this	DET
ajlm-2519	127	5	research	research	NOUN
ajlm-2519	127	6	received	receive	VERB
ajlm-2519	127	7	no	no	DET
ajlm-2519	127	8	specific	specific	ADJ
ajlm-2519	127	9	grant	grant	NOUN
ajlm-2519	127	10	from	from	ADP
ajlm-2519	127	11	any	any	DET
ajlm-2519	127	12	funding	funding	NOUN
ajlm-2519	127	13	agency	agency	NOUN
ajlm-2519	127	14	in	in	ADP
ajlm-2519	127	15	the	the	DET
ajlm-2519	127	16	public	public	ADJ
ajlm-2519	127	17	,	,	PUNCT
ajlm-2519	127	18	commercial	commercial	ADJ
ajlm-2519	127	19	,	,	PUNCT
ajlm-2519	127	20	or	or	CCONJ
ajlm-2519	127	21	not	not	PART
ajlm-2519	127	22	-	-	PUNCT
ajlm-2519	127	23	for	for	ADP
ajlm-2519	127	24	-	-	PUNCT
ajlm-2519	127	25	profit	profit	NOUN
ajlm-2519	127	26	sectors	sector	NOUN
ajlm-2519	127	27	.	.	PUNCT
ajlm-2519	128	1	data	datum	NOUN
ajlm-2519	128	2	availability	availability	NOUN
ajlm-2519	128	3	the	the	DET
ajlm-2519	128	4	data	datum	NOUN
ajlm-2519	128	5	that	that	PRON
ajlm-2519	128	6	support	support	VERB
ajlm-2519	128	7	the	the	DET
ajlm-2519	128	8	findings	finding	NOUN
ajlm-2519	128	9	of	of	ADP
ajlm-2519	128	10	this	this	DET
ajlm-2519	128	11	study	study	NOUN
ajlm-2519	128	12	are	be	AUX
ajlm-2519	128	13	available	available	ADJ
ajlm-2519	128	14	from	from	ADP
ajlm-2519	128	15	the	the	DET
ajlm-2519	128	16	national	national	PROPN
ajlm-2519	128	17	health	health	PROPN
ajlm-2519	128	18	laboratory	laboratory	PROPN
ajlm-2519	128	19	service	service	NOUN
ajlm-2519	128	20	.	.	PUNCT
ajlm-2519	129	1	the	the	DET
ajlm-2519	129	2	data	datum	NOUN
ajlm-2519	129	3	were	be	AUX
ajlm-2519	129	4	used	use	VERB
ajlm-2519	129	5	under	under	ADP
ajlm-2519	129	6	license	license	NOUN
ajlm-2519	129	7	for	for	ADP
ajlm-2519	129	8	the	the	DET
ajlm-2519	129	9	current	current	ADJ
ajlm-2519	129	10	study	study	NOUN
ajlm-2519	129	11	and	and	CCONJ
ajlm-2519	129	12	are	be	AUX
ajlm-2519	129	13	therefore	therefore	ADV
ajlm-2519	129	14	not	not	PART
ajlm-2519	129	15	publicly	publicly	ADV
ajlm-2519	129	16	available	available	ADJ
ajlm-2519	129	17	.	.	PUNCT
ajlm-2519	130	1	data	datum	NOUN
ajlm-2519	130	2	are	be	AUX
ajlm-2519	130	3	,	,	PUNCT
ajlm-2519	130	4	however	however	ADV
ajlm-2519	130	5	,	,	PUNCT
ajlm-2519	130	6	available	available	ADJ
ajlm-2519	130	7	from	from	ADP
ajlm-2519	130	8	the	the	DET
ajlm-2519	130	9	corresponding	corresponding	ADJ
ajlm-2519	130	10	author	author	NOUN
ajlm-2519	130	11	,	,	PUNCT
ajlm-2519	130	12	t.c.m	t.c.m	INTJ
ajlm-2519	130	13	.	.	PUNCT
ajlm-2519	130	14	,	,	PUNCT
ajlm-2519	130	15	upon	upon	SCONJ
ajlm-2519	130	16	reasonable	reasonable	ADJ
ajlm-2519	130	17	request	request	NOUN
ajlm-2519	130	18	and	and	CCONJ
ajlm-2519	130	19	with	with	ADP
ajlm-2519	130	20	permission	permission	NOUN
ajlm-2519	130	21	of	of	ADP
ajlm-2519	130	22	the	the	DET
ajlm-2519	130	23	national	national	PROPN
ajlm-2519	130	24	health	health	PROPN
ajlm-2519	130	25	laboratory	laboratory	PROPN
ajlm-2519	130	26	service	service	PROPN
ajlm-2519	130	27	.	.	PUNCT
ajlm-2519	131	1	disclaimer	disclaimer	VERB
ajlm-2519	131	2	the	the	DET
ajlm-2519	131	3	views	view	NOUN
ajlm-2519	131	4	and	and	CCONJ
ajlm-2519	131	5	opinions	opinion	NOUN
ajlm-2519	131	6	expressed	express	VERB
ajlm-2519	131	7	in	in	ADP
ajlm-2519	131	8	this	this	DET
ajlm-2519	131	9	article	article	NOUN
ajlm-2519	131	10	are	be	AUX
ajlm-2519	131	11	those	those	PRON
ajlm-2519	131	12	of	of	ADP
ajlm-2519	131	13	the	the	DET
ajlm-2519	131	14	authors	author	NOUN
ajlm-2519	131	15	and	and	CCONJ
ajlm-2519	131	16	are	be	AUX
ajlm-2519	131	17	the	the	DET
ajlm-2519	131	18	product	product	NOUN
ajlm-2519	131	19	of	of	ADP
ajlm-2519	131	20	professional	professional	ADJ
ajlm-2519	131	21	research	research	NOUN
ajlm-2519	131	22	.	.	PUNCT
ajlm-2519	132	1	the	the	DET
ajlm-2519	132	2	article	article	NOUN
ajlm-2519	132	3	does	do	AUX
ajlm-2519	132	4	not	not	PART
ajlm-2519	132	5	necessarily	necessarily	ADV
ajlm-2519	132	6	reflect	reflect	VERB
ajlm-2519	132	7	the	the	DET
ajlm-2519	132	8	official	official	ADJ
ajlm-2519	132	9	policy	policy	NOUN
ajlm-2519	132	10	or	or	CCONJ
ajlm-2519	132	11	position	position	NOUN
ajlm-2519	132	12	of	of	ADP
ajlm-2519	132	13	any	any	DET
ajlm-2519	132	14	affiliated	affiliated	ADJ
ajlm-2519	132	15	institution	institution	NOUN
ajlm-2519	132	16	,	,	PUNCT
ajlm-2519	132	17	funder	funder	NOUN
ajlm-2519	132	18	,	,	PUNCT
ajlm-2519	132	19	agency	agency	NOUN
ajlm-2519	132	20	,	,	PUNCT
ajlm-2519	132	21	or	or	CCONJ
ajlm-2519	132	22	that	that	PRON
ajlm-2519	132	23	of	of	ADP
ajlm-2519	132	24	the	the	DET
ajlm-2519	132	25	publisher	publisher	NOUN
ajlm-2519	132	26	.	.	PUNCT
ajlm-2519	133	1	the	the	DET
ajlm-2519	133	2	authors	author	NOUN
ajlm-2519	133	3	are	be	AUX
ajlm-2519	133	4	responsible	responsible	ADJ
ajlm-2519	133	5	for	for	ADP
ajlm-2519	133	6	this	this	DET
ajlm-2519	133	7	article	article	NOUN
ajlm-2519	133	8	’s	’s	PART
ajlm-2519	133	9	results	result	NOUN
ajlm-2519	133	10	,	,	PUNCT
ajlm-2519	133	11	findings	finding	NOUN
ajlm-2519	133	12	,	,	PUNCT
ajlm-2519	133	13	and	and	CCONJ
ajlm-2519	133	14	content	content	NOUN
ajlm-2519	133	15	.	.	PUNCT
ajlm-2519	134	1	references	reference	NOUN
ajlm-2519	134	2	ikuta	ikuta	PROPN
ajlm-2519	134	3	ks	ks	PROPN
ajlm-2519	134	4	,	,	PUNCT
ajlm-2519	134	5	swetschinski	swetschinski	PROPN
ajlm-2519	134	6	lr	lr	PROPN
ajlm-2519	134	7	,	,	PUNCT
ajlm-2519	134	8	robles	robles	PROPN
ajlm-2519	134	9	aguilar	aguilar	PROPN
ajlm-2519	134	10	g	g	PROPN
ajlm-2519	134	11	,	,	PUNCT
ajlm-2519	134	12	et	et	PROPN
ajlm-2519	134	13	al	al	PROPN
ajlm-2519	134	14	.	.	PUNCT
ajlm-2519	135	1	global	global	ADJ
ajlm-2519	135	2	mortality	mortality	NOUN
ajlm-2519	135	3	associated	associate	VERB
ajlm-2519	135	4	with	with	ADP
ajlm-2519	135	5	33	33	NUM
ajlm-2519	135	6	bacterial	bacterial	ADJ
ajlm-2519	135	7	pathogens	pathogen	NOUN
ajlm-2519	135	8	in	in	ADP
ajlm-2519	135	9	2019	2019	NUM
ajlm-2519	135	10	:	:	PUNCT
ajlm-2519	135	11	a	a	DET
ajlm-2519	135	12	systematic	systematic	ADJ
ajlm-2519	135	13	analysis	analysis	NOUN
ajlm-2519	135	14	for	for	ADP
ajlm-2519	135	15	the	the	DET
ajlm-2519	135	16	global	global	ADJ
ajlm-2519	135	17	burden	burden	NOUN
ajlm-2519	135	18	of	of	ADP
ajlm-2519	135	19	disease	disease	NOUN
ajlm-2519	135	20	study	study	NOUN
ajlm-2519	135	21	2019	2019	NUM
ajlm-2519	135	22	.	.	PUNCT
ajlm-2519	136	1	lancet	lancet	PROPN
ajlm-2519	136	2	.	.	PUNCT
ajlm-2519	137	1	2022;400(10369):2221–2248	2022;400(10369):2221–2248	PROPN
ajlm-2519	137	2	.	.	PUNCT
ajlm-2519	138	1	https://doi.org/10.1016/s0140-6736(22)02185-7	https://doi.org/10.1016/s0140-6736(22)02185-7	PROPN
ajlm-2519	138	2	murray	murray	PROPN
ajlm-2519	138	3	cjl	cjl	PROPN
ajlm-2519	138	4	,	,	PUNCT
ajlm-2519	138	5	ikuta	ikuta	PROPN
ajlm-2519	138	6	ks	ks	PROPN
ajlm-2519	138	7	,	,	PUNCT
ajlm-2519	138	8	sharara	sharara	NOUN
ajlm-2519	138	9	f	f	X
ajlm-2519	138	10	,	,	PUNCT
ajlm-2519	138	11	et	et	PROPN
ajlm-2519	138	12	al	al	PROPN
ajlm-2519	138	13	.	.	PUNCT
ajlm-2519	138	14	global	global	ADJ
ajlm-2519	138	15	burden	burden	NOUN
ajlm-2519	138	16	of	of	ADP
ajlm-2519	138	17	bacterial	bacterial	ADJ
ajlm-2519	138	18	antimicrobial	antimicrobial	ADJ
ajlm-2519	138	19	resistance	resistance	NOUN
ajlm-2519	138	20	in	in	ADP
ajlm-2519	138	21	2019	2019	NUM
ajlm-2519	138	22	:	:	PUNCT
ajlm-2519	138	23	a	a	DET
ajlm-2519	138	24	systematic	systematic	ADJ
ajlm-2519	138	25	analysis	analysis	NOUN
ajlm-2519	138	26	.	.	PUNCT
ajlm-2519	139	1	lancet	lancet	NOUN
ajlm-2519	139	2	.	.	PUNCT
ajlm-2519	140	1	2022;399(10325):629–655	2022;399(10325):629–655	X
ajlm-2519	140	2	.	.	PUNCT
ajlm-2519	141	1	https://doi.org/10.1016/s0140-6736(21)02724-0	https://doi.org/10.1016/s0140-6736(21)02724-0	PROPN
ajlm-2519	141	2	world	world	PROPN
ajlm-2519	141	3	health	health	PROPN
ajlm-2519	141	4	organization	organization	NOUN
ajlm-2519	141	5	.	.	PUNCT
ajlm-2519	142	1	antimicrobial	antimicrobial	ADJ
ajlm-2519	142	2	resistance	resistance	NOUN
ajlm-2519	143	1	[	[	X
ajlm-2519	143	2	homepage	homepage	NOUN
ajlm-2519	143	3	on	on	ADP
ajlm-2519	143	4	the	the	DET
ajlm-2519	143	5	internet	internet	NOUN
ajlm-2519	143	6	]	]	PUNCT
ajlm-2519	143	7	.	.	PUNCT
ajlm-2519	144	1	2023	2023	NUM
ajlm-2519	145	1	[	[	X
ajlm-2519	145	2	cited	cite	VERB
ajlm-2519	145	3	2023	2023	NUM
ajlm-2519	145	4	may	may	AUX
ajlm-2519	145	5	15	15	NUM
ajlm-2519	145	6	]	]	PUNCT
ajlm-2519	145	7	.	.	PUNCT
ajlm-2519	146	1	available	available	ADJ
ajlm-2519	146	2	from	from	ADP
ajlm-2519	146	3	:	:	PUNCT
ajlm-2519	146	4	https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance	https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance	NOUN
ajlm-2519	146	5	sartorius	sartorius	PROPN
ajlm-2519	146	6	b	b	PROPN
ajlm-2519	146	7	,	,	PUNCT
ajlm-2519	146	8	gray	gray	ADJ
ajlm-2519	146	9	ap	ap	PROPN
ajlm-2519	146	10	,	,	PUNCT
ajlm-2519	146	11	weaver	weaver	PROPN
ajlm-2519	146	12	nd	nd	NUM
ajlm-2519	146	13	,	,	PUNCT
ajlm-2519	146	14	et	et	PROPN
ajlm-2519	146	15	al	al	PROPN
ajlm-2519	146	16	.	.	PUNCT
ajlm-2519	147	1	the	the	DET
ajlm-2519	147	2	burden	burden	NOUN
ajlm-2519	147	3	of	of	ADP
ajlm-2519	147	4	bacterial	bacterial	ADJ
ajlm-2519	147	5	antimicrobial	antimicrobial	ADJ
ajlm-2519	147	6	resistance	resistance	NOUN
ajlm-2519	147	7	in	in	ADP
ajlm-2519	147	8	the	the	DET
ajlm-2519	147	9	who	who	PRON
ajlm-2519	147	10	african	african	ADJ
ajlm-2519	147	11	region	region	NOUN
ajlm-2519	147	12	in	in	ADP
ajlm-2519	147	13	2019	2019	NUM
ajlm-2519	147	14	:	:	PUNCT
ajlm-2519	147	15	a	a	DET
ajlm-2519	147	16	cross	cross	ADJ
ajlm-2519	147	17	-	-	ADJ
ajlm-2519	147	18	country	country	ADJ
ajlm-2519	147	19	systematic	systematic	ADJ
ajlm-2519	147	20	analysis	analysis	NOUN
ajlm-2519	147	21	.	.	PUNCT
ajlm-2519	148	1	lancet	lancet	NOUN
ajlm-2519	148	2	glob	glob	PROPN
ajlm-2519	148	3	health	health	NOUN
ajlm-2519	148	4	.	.	PUNCT
ajlm-2519	149	1	2023;12(2):e201	2023;12(2):e201	NUM
ajlm-2519	149	2	–	–	PUNCT
ajlm-2519	149	3	e216	e216	PROPN
ajlm-2519	149	4	.	.	PUNCT
ajlm-2519	150	1	https://doi.org/10.1016/s2214-109x(23)00539-9	https://doi.org/10.1016/s2214-109x(23)00539-9	PROPN
ajlm-2519	150	2	kariuki	kariuki	PROPN
ajlm-2519	150	3	s	s	PROPN
ajlm-2519	150	4	,	,	PUNCT
ajlm-2519	150	5	kering	kere	VERB
ajlm-2519	150	6	k	k	PROPN
ajlm-2519	150	7	,	,	PUNCT
ajlm-2519	150	8	wairimu	wairimu	NOUN
ajlm-2519	150	9	c	c	NOUN
ajlm-2519	150	10	,	,	PUNCT
ajlm-2519	150	11	onsare	onsare	NOUN
ajlm-2519	150	12	r	r	NOUN
ajlm-2519	150	13	,	,	PUNCT
ajlm-2519	150	14	mbae	mbae	NOUN
ajlm-2519	150	15	c.	c.	PROPN
ajlm-2519	150	16	antimicrobial	antimicrobial	ADJ
ajlm-2519	150	17	resistance	resistance	NOUN
ajlm-2519	150	18	rates	rate	NOUN
ajlm-2519	150	19	and	and	CCONJ
ajlm-2519	150	20	surveillance	surveillance	NOUN
ajlm-2519	150	21	in	in	ADP
ajlm-2519	150	22	sub	sub	ADJ
ajlm-2519	150	23	-	-	ADJ
ajlm-2519	150	24	saharan	saharan	ADJ
ajlm-2519	150	25	africa	africa	PROPN
ajlm-2519	150	26	:	:	PUNCT
ajlm-2519	150	27	where	where	SCONJ
ajlm-2519	150	28	are	be	AUX
ajlm-2519	150	29	we	we	PRON
ajlm-2519	150	30	now	now	ADV
ajlm-2519	150	31	?	?	PUNCT
ajlm-2519	151	1	infect	infect	VERB
ajlm-2519	151	2	drug	drug	NOUN
ajlm-2519	151	3	resist	resist	NOUN
ajlm-2519	151	4	.	.	PUNCT
ajlm-2519	152	1	2022;15:3589–3609	2022;15:3589–3609	NOUN
ajlm-2519	152	2	.	.	PUNCT
ajlm-2519	153	1	https://doi.org/10.2147/idr.s342753	https://doi.org/10.2147/idr.s342753	PROPN
ajlm-2519	153	2	allegranzi	allegranzi	PROPN
ajlm-2519	153	3	b	b	PROPN
ajlm-2519	153	4	,	,	PUNCT
ajlm-2519	153	5	bagheri	bagheri	PROPN
ajlm-2519	153	6	nejad	nejad	PROPN
ajlm-2519	153	7	s	s	PROPN
ajlm-2519	153	8	,	,	PUNCT
ajlm-2519	153	9	combescure	combescure	NOUN
ajlm-2519	153	10	c	c	NOUN
ajlm-2519	153	11	,	,	PUNCT
ajlm-2519	153	12	et	et	PROPN
ajlm-2519	153	13	al	al	PROPN
ajlm-2519	153	14	.	.	PUNCT
ajlm-2519	153	15	burden	burden	NOUN
ajlm-2519	153	16	of	of	ADP
ajlm-2519	153	17	endemic	endemic	ADJ
ajlm-2519	153	18	health	health	NOUN
ajlm-2519	153	19	-	-	PUNCT
ajlm-2519	153	20	care	care	NOUN
ajlm-2519	153	21	-	-	PUNCT
ajlm-2519	153	22	associated	associate	VERB
ajlm-2519	153	23	infection	infection	NOUN
ajlm-2519	153	24	in	in	ADP
ajlm-2519	153	25	developing	develop	VERB
ajlm-2519	153	26	countries	country	NOUN
ajlm-2519	153	27	:	:	PUNCT
ajlm-2519	153	28	systematic	systematic	ADJ
ajlm-2519	153	29	review	review	NOUN
ajlm-2519	153	30	and	and	CCONJ
ajlm-2519	153	31	meta	meta	ADJ
ajlm-2519	153	32	-	-	PUNCT
ajlm-2519	153	33	analysis	analysis	NOUN
ajlm-2519	153	34	.	.	PUNCT
ajlm-2519	154	1	lancet	lancet	NOUN
ajlm-2519	154	2	.	.	PUNCT
ajlm-2519	155	1	2011;377(9761):228–241	2011;377(9761):228–241	X
ajlm-2519	155	2	.	.	PUNCT
ajlm-2519	155	3	https://doi.org/10.1016/s0140-6736(10)61458-4	https://doi.org/10.1016/s0140-6736(10)61458-4	PROPN
ajlm-2519	155	4	rice	rice	PROPN
ajlm-2519	155	5	lb	lb	PROPN
ajlm-2519	155	6	.	.	PUNCT
ajlm-2519	155	7	progress	progress	NOUN
ajlm-2519	155	8	and	and	CCONJ
ajlm-2519	155	9	challenges	challenge	NOUN
ajlm-2519	155	10	in	in	ADP
ajlm-2519	155	11	implementing	implement	VERB
ajlm-2519	155	12	the	the	DET
ajlm-2519	155	13	research	research	NOUN
ajlm-2519	155	14	on	on	ADP
ajlm-2519	155	15	eskape	eskape	NOUN
ajlm-2519	155	16	pathogens	pathogen	NOUN
ajlm-2519	155	17	.	.	PUNCT
ajlm-2519	156	1	infect	infect	VERB
ajlm-2519	156	2	control	control	PROPN
ajlm-2519	156	3	hosp	hosp	PROPN
ajlm-2519	156	4	epidemiol	epidemiol	PROPN
ajlm-2519	156	5	.	.	PUNCT
ajlm-2519	157	1	2010;31(s1):s7	2010;31(s1):s7	X
ajlm-2519	157	2	–	–	PUNCT
ajlm-2519	157	3	s10	s10	NOUN
ajlm-2519	157	4	.	.	PUNCT
ajlm-2519	158	1	https://doi.org/10.1086/655995	https://doi.org/10.1086/655995	PROPN
ajlm-2519	158	2	ayobami	ayobami	VERB
ajlm-2519	158	3	o	o	NOUN
ajlm-2519	158	4	,	,	PUNCT
ajlm-2519	158	5	brinkwirth	brinkwirth	NOUN
ajlm-2519	158	6	s	s	PROPN
ajlm-2519	158	7	,	,	PUNCT
ajlm-2519	158	8	eckmanns	eckmanns	PROPN
ajlm-2519	158	9	t	t	PROPN
ajlm-2519	158	10	,	,	PUNCT
ajlm-2519	158	11	markwart	markwart	PROPN
ajlm-2519	158	12	r.	r.	PROPN
ajlm-2519	158	13	antibiotic	antibiotic	PROPN
ajlm-2519	158	14	resistance	resistance	NOUN
ajlm-2519	158	15	in	in	ADP
ajlm-2519	158	16	hospital	hospital	NOUN
ajlm-2519	158	17	-	-	PUNCT
ajlm-2519	158	18	acquired	acquire	VERB
ajlm-2519	158	19	eskape	eskape	NOUN
ajlm-2519	158	20	-	-	PUNCT
ajlm-2519	158	21	e	e	NOUN
ajlm-2519	158	22	infections	infection	NOUN
ajlm-2519	158	23	in	in	ADP
ajlm-2519	158	24	lowand	lowand	ADJ
ajlm-2519	158	25	lower	lower	ADV
ajlm-2519	158	26	-	-	PUNCT
ajlm-2519	158	27	middle	middle	ADJ
ajlm-2519	158	28	-	-	PUNCT
ajlm-2519	158	29	income	income	NOUN
ajlm-2519	158	30	countries	country	NOUN
ajlm-2519	158	31	:	:	PUNCT
ajlm-2519	158	32	a	a	DET
ajlm-2519	158	33	systematic	systematic	ADJ
ajlm-2519	158	34	review	review	NOUN
ajlm-2519	158	35	and	and	CCONJ
ajlm-2519	158	36	meta	meta	ADJ
ajlm-2519	158	37	-	-	PUNCT
ajlm-2519	158	38	analysis	analysis	NOUN
ajlm-2519	158	39	.	.	PUNCT
ajlm-2519	159	1	emerg	emerg	PROPN
ajlm-2519	159	2	microbes	microbe	NOUN
ajlm-2519	159	3	infect	infect	VERB
ajlm-2519	159	4	.	.	PUNCT
ajlm-2519	160	1	2022;11(1):443–451	2022;11(1):443–451	X
ajlm-2519	160	2	.	.	PUNCT
ajlm-2519	161	1	https://doi.org/10.1080/22221751.2022.2030196	https://doi.org/10.1080/22221751.2022.2030196	PROPN
ajlm-2519	161	2	world	world	PROPN
ajlm-2519	161	3	health	health	NOUN
ajlm-2519	161	4	organization	organization	PROPN
ajlm-2519	161	5	.	.	PUNCT
ajlm-2519	162	1	who	who	PRON
ajlm-2519	162	2	publishes	publish	VERB
ajlm-2519	162	3	list	list	NOUN
ajlm-2519	162	4	of	of	ADP
ajlm-2519	162	5	bacteria	bacteria	NOUN
ajlm-2519	162	6	for	for	ADP
ajlm-2519	162	7	which	which	PRON
ajlm-2519	162	8	new	new	ADJ
ajlm-2519	162	9	antibiotics	antibiotic	NOUN
ajlm-2519	162	10	are	be	AUX
ajlm-2519	162	11	urgently	urgently	ADV
ajlm-2519	162	12	needed	need	VERB
ajlm-2519	163	1	[	[	PUNCT
ajlm-2519	163	2	homepage	homepage	NOUN
ajlm-2519	163	3	on	on	ADP
ajlm-2519	163	4	the	the	DET
ajlm-2519	163	5	internet	internet	NOUN
ajlm-2519	163	6	]	]	PUNCT
ajlm-2519	163	7	.	.	PUNCT
ajlm-2519	164	1	2027	2027	NUM
ajlm-2519	165	1	[	[	X
ajlm-2519	165	2	cited	cite	VERB
ajlm-2519	165	3	2023	2023	NUM
ajlm-2519	165	4	may	may	AUX
ajlm-2519	165	5	10	10	NUM
ajlm-2519	165	6	]	]	PUNCT
ajlm-2519	165	7	.	.	PUNCT
ajlm-2519	166	1	available	available	ADJ
ajlm-2519	166	2	from	from	ADP
ajlm-2519	166	3	:	:	PUNCT
ajlm-2519	166	4	https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed	https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed	ADJ
ajlm-2519	166	5	(	(	PUNCT
ajlm-2519	166	6	2017	2017	NUM
ajlm-2519	166	7	)	)	PUNCT
ajlm-2519	166	8	allel	allel	NOUN
ajlm-2519	166	9	k	k	PROPN
ajlm-2519	166	10	,	,	PUNCT
ajlm-2519	166	11	stone	stone	PROPN
ajlm-2519	166	12	j	j	PROPN
ajlm-2519	166	13	,	,	PUNCT
ajlm-2519	166	14	undurraga	undurraga	NOUN
ajlm-2519	166	15	ea	ea	PROPN
ajlm-2519	166	16	,	,	PUNCT
ajlm-2519	166	17	et	et	PROPN
ajlm-2519	166	18	al	al	PROPN
ajlm-2519	166	19	.	.	PUNCT
ajlm-2519	167	1	the	the	DET
ajlm-2519	167	2	impact	impact	NOUN
ajlm-2519	167	3	of	of	ADP
ajlm-2519	167	4	inpatient	inpatient	NOUN
ajlm-2519	167	5	bsis	bsis	NOUN
ajlm-2519	167	6	caused	cause	VERB
ajlm-2519	167	7	by	by	ADP
ajlm-2519	167	8	antibiotic	antibiotic	ADJ
ajlm-2519	167	9	-	-	PUNCT
ajlm-2519	167	10	resistant	resistant	ADJ
ajlm-2519	167	11	bacteria	bacteria	NOUN
ajlm-2519	167	12	in	in	ADP
ajlm-2519	167	13	lowand	lowand	ADJ
ajlm-2519	167	14	middle	middle	ADJ
ajlm-2519	167	15	-	-	PUNCT
ajlm-2519	167	16	income	income	NOUN
ajlm-2519	167	17	countries	country	NOUN
ajlm-2519	167	18	:	:	PUNCT
ajlm-2519	167	19	a	a	DET
ajlm-2519	167	20	systematic	systematic	ADJ
ajlm-2519	167	21	review	review	NOUN
ajlm-2519	167	22	and	and	CCONJ
ajlm-2519	167	23	meta	meta	ADJ
ajlm-2519	167	24	-	-	PUNCT
ajlm-2519	167	25	analysis	analysis	NOUN
ajlm-2519	167	26	.	.	PUNCT
ajlm-2519	168	1	plos	plos	PROPN
ajlm-2519	168	2	med	med	PROPN
ajlm-2519	168	3	.	.	PUNCT
ajlm-2519	169	1	2023;20(6):e1004199	2023;20(6):e1004199	X
ajlm-2519	169	2	.	.	PUNCT
ajlm-2519	169	3	https://doi.org/10.1371/journal.pmed.1004199	https://doi.org/10.1371/journal.pmed.1004199	PROPN
ajlm-2519	169	4	national	national	PROPN
ajlm-2519	169	5	department	department	PROPN
ajlm-2519	169	6	of	of	ADP
ajlm-2519	169	7	health	health	PROPN
ajlm-2519	169	8	(	(	PUNCT
ajlm-2519	169	9	republic	republic	NOUN
ajlm-2519	169	10	of	of	ADP
ajlm-2519	169	11	south	south	PROPN
ajlm-2519	169	12	africa	africa	PROPN
ajlm-2519	169	13	)	)	PUNCT
ajlm-2519	169	14	.	.	PUNCT
ajlm-2519	170	1	surveillance	surveillance	NOUN
ajlm-2519	170	2	for	for	ADP
ajlm-2519	170	3	antimicrobial	antimicrobial	ADJ
ajlm-2519	170	4	resistance	resistance	NOUN
ajlm-2519	170	5	and	and	CCONJ
ajlm-2519	170	6	consumption	consumption	NOUN
ajlm-2519	170	7	of	of	ADP
ajlm-2519	170	8	antimicrobials	antimicrobial	NOUN
ajlm-2519	170	9	in	in	ADP
ajlm-2519	170	10	south	south	PROPN
ajlm-2519	170	11	africa	africa	PROPN
ajlm-2519	171	1	[	[	X
ajlm-2519	171	2	homepage	homepage	NOUN
ajlm-2519	171	3	on	on	ADP
ajlm-2519	171	4	the	the	DET
ajlm-2519	171	5	internet	internet	NOUN
ajlm-2519	171	6	]	]	PUNCT
ajlm-2519	171	7	.	.	PUNCT
ajlm-2519	172	1	2022	2022	NUM
ajlm-2519	173	1	[	[	X
ajlm-2519	173	2	cited	cite	VERB
ajlm-2519	173	3	2023	2023	NUM
ajlm-2519	173	4	jun	jun	PROPN
ajlm-2519	173	5	21	21	NUM
ajlm-2519	173	6	]	]	PUNCT
ajlm-2519	173	7	.	.	PUNCT
ajlm-2519	174	1	available	available	ADJ
ajlm-2519	174	2	from	from	ADP
ajlm-2519	174	3	:	:	PUNCT
ajlm-2519	174	4	https://knowledgehub.health.gov.za/system/files/elibdownloads/2023-04/amr%2520and%2520amc%2520report%2520for%25202021%2520in%2520south%2520african_june2022.pdf	https://knowledgehub.health.gov.za/system/files/elibdownloads/2023-04/amr%2520and%2520amc%2520report%2520for%25202021%2520in%2520south%2520african_june2022.pdf	PROPN
ajlm-2519	174	5	institute	institute	PROPN
ajlm-2519	174	6	for	for	ADP
ajlm-2519	174	7	health	health	NOUN
ajlm-2519	174	8	metrics	metric	NOUN
ajlm-2519	174	9	and	and	CCONJ
ajlm-2519	174	10	evaluation	evaluation	NOUN
ajlm-2519	174	11	.	.	PUNCT
ajlm-2519	175	1	the	the	DET
ajlm-2519	175	2	burden	burden	NOUN
ajlm-2519	175	3	of	of	ADP
ajlm-2519	175	4	antimicrobial	antimicrobial	ADJ
ajlm-2519	175	5	resistance	resistance	NOUN
ajlm-2519	175	6	(	(	PUNCT
ajlm-2519	175	7	amr	amr	NOUN
ajlm-2519	175	8	)	)	PUNCT
ajlm-2519	175	9	in	in	ADP
ajlm-2519	175	10	south	south	PROPN
ajlm-2519	175	11	africa	africa	PROPN
ajlm-2519	176	1	[	[	X
ajlm-2519	176	2	homepage	homepage	NOUN
ajlm-2519	176	3	on	on	ADP
ajlm-2519	176	4	the	the	DET
ajlm-2519	176	5	internet	internet	NOUN
ajlm-2519	176	6	]	]	PUNCT
ajlm-2519	176	7	.	.	PUNCT
ajlm-2519	177	1	2023	2023	NUM
ajlm-2519	178	1	[	[	X
ajlm-2519	178	2	cited	cite	VERB
ajlm-2519	178	3	2023	2023	NUM
ajlm-2519	178	4	dec	dec	PROPN
ajlm-2519	178	5	27	27	NUM
ajlm-2519	178	6	]	]	PUNCT
ajlm-2519	178	7	.	.	PUNCT
ajlm-2519	179	1	available	available	ADJ
ajlm-2519	179	2	from	from	ADP
ajlm-2519	179	3	:	:	PUNCT
ajlm-2519	179	4	https://www.healthdata.org/sites/default/files/files/projects/gram/s__africa_0.pdf	https://www.healthdata.org/sites/default/files/files/projects/gram/s__africa_0.pdf	PROPN
ajlm-2519	179	5	mashau	mashau	PROPN
ajlm-2519	179	6	rc	rc	PROPN
ajlm-2519	179	7	,	,	PUNCT
ajlm-2519	179	8	meiring	meire	VERB
ajlm-2519	179	9	st	st	PROPN
ajlm-2519	179	10	,	,	PUNCT
ajlm-2519	179	11	dramowski	dramowski	VERB
ajlm-2519	179	12	a	a	X
ajlm-2519	179	13	,	,	PUNCT
ajlm-2519	179	14	et	et	PROPN
ajlm-2519	179	15	al	al	PROPN
ajlm-2519	179	16	.	.	PUNCT
ajlm-2519	180	1	culture	culture	NOUN
ajlm-2519	180	2	-	-	PUNCT
ajlm-2519	180	3	confirmed	confirm	VERB
ajlm-2519	180	4	neonatal	neonatal	ADJ
ajlm-2519	180	5	bloodstream	bloodstream	NOUN
ajlm-2519	180	6	infections	infection	NOUN
ajlm-2519	180	7	and	and	CCONJ
ajlm-2519	180	8	meningitis	meningitis	NOUN
ajlm-2519	180	9	in	in	ADP
ajlm-2519	180	10	south	south	PROPN
ajlm-2519	180	11	africa	africa	PROPN
ajlm-2519	180	12	,	,	PUNCT
ajlm-2519	180	13	2014–19	2014–19	PROPN
ajlm-2519	180	14	:	:	PUNCT
ajlm-2519	180	15	a	a	DET
ajlm-2519	180	16	cross	cross	ADJ
ajlm-2519	180	17	-	-	ADJ
ajlm-2519	180	18	sectional	sectional	ADJ
ajlm-2519	180	19	study	study	NOUN
ajlm-2519	180	20	.	.	PUNCT
ajlm-2519	181	1	lancet	lancet	NOUN
ajlm-2519	181	2	glob	glob	PROPN
ajlm-2519	181	3	health	health	NOUN
ajlm-2519	181	4	.	.	PUNCT
ajlm-2519	182	1	2022;10(8):e1170	2022;10(8):e1170	NUM
ajlm-2519	182	2	–	–	PUNCT
ajlm-2519	182	3	e1178	e1178	NOUN
ajlm-2519	182	4	.	.	PUNCT
ajlm-2519	183	1	https://doi.org/10.1016/s2214-109x(22)00246-7	https://doi.org/10.1016/s2214-109x(22)00246-7	PROPN
ajlm-2519	183	2	perovic	perovic	ADJ
ajlm-2519	183	3	o	o	NOUN
ajlm-2519	183	4	,	,	PUNCT
ajlm-2519	183	5	ismail	ismail	PROPN
ajlm-2519	183	6	h	h	PROPN
ajlm-2519	183	7	,	,	PUNCT
ajlm-2519	183	8	van	van	PROPN
ajlm-2519	183	9	schalkwyk	schalkwyk	PROPN
ajlm-2519	183	10	e.	e.	PROPN
ajlm-2519	183	11	antimicrobial	antimicrobial	PROPN
ajlm-2519	183	12	resistance	resistance	NOUN
ajlm-2519	183	13	surveillance	surveillance	NOUN
ajlm-2519	183	14	in	in	ADP
ajlm-2519	183	15	the	the	DET
ajlm-2519	183	16	south	south	ADJ
ajlm-2519	183	17	african	african	ADJ
ajlm-2519	183	18	public	public	ADJ
ajlm-2519	183	19	sector	sector	NOUN
ajlm-2519	183	20	.	.	PUNCT
ajlm-2519	184	1	s	s	PROPN
ajlm-2519	184	2	afr	afr	PROPN
ajlm-2519	184	3	j	j	PROPN
ajlm-2519	184	4	inf	inf	PROPN
ajlm-2519	184	5	dis	dis	PROPN
ajlm-2519	184	6	.	.	PUNCT
ajlm-2519	185	1	2018;33(4):118–129	2018;33(4):118–129	NUM
ajlm-2519	185	2	.	.	PUNCT
ajlm-2519	186	1	https://doi.org/10.1080/23120053.2018.1469851	https://doi.org/10.1080/23120053.2018.1469851	PROPN
ajlm-2519	186	2	ismail	ismail	PROPN
ajlm-2519	186	3	h	h	PROPN
ajlm-2519	186	4	,	,	PUNCT
ajlm-2519	186	5	lowman	lowman	PROPN
ajlm-2519	186	6	w	w	PROPN
ajlm-2519	186	7	,	,	PUNCT
ajlm-2519	186	8	govind	govind	PROPN
ajlm-2519	186	9	cn	cn	PROPN
ajlm-2519	186	10	,	,	PUNCT
ajlm-2519	186	11	et	et	PROPN
ajlm-2519	186	12	al	al	PROPN
ajlm-2519	186	13	.	.	PROPN
ajlm-2519	186	14	surveillance	surveillance	NOUN
ajlm-2519	186	15	and	and	CCONJ
ajlm-2519	186	16	comparison	comparison	NOUN
ajlm-2519	186	17	of	of	ADP
ajlm-2519	186	18	antimicrobial	antimicrobial	ADJ
ajlm-2519	186	19	susceptibility	susceptibility	NOUN
ajlm-2519	186	20	patterns	pattern	NOUN
ajlm-2519	186	21	of	of	ADP
ajlm-2519	186	22	eskape	eskape	NOUN
ajlm-2519	186	23	organisms	organism	NOUN
ajlm-2519	186	24	isolated	isolate	VERB
ajlm-2519	186	25	from	from	ADP
ajlm-2519	186	26	patients	patient	NOUN
ajlm-2519	186	27	with	with	ADP
ajlm-2519	186	28	bacteraemia	bacteraemia	NOUN
ajlm-2519	186	29	in	in	ADP
ajlm-2519	186	30	south	south	PROPN
ajlm-2519	186	31	africa	africa	PROPN
ajlm-2519	186	32	,	,	PUNCT
ajlm-2519	186	33	2016–2017	2016–2017	NUM
ajlm-2519	186	34	.	.	PUNCT
ajlm-2519	187	1	s	s	PROPN
ajlm-2519	187	2	afr	afr	PROPN
ajlm-2519	187	3	med	med	PROPN
ajlm-2519	187	4	j.	j.	PROPN
ajlm-2519	187	5	2019;109(12):934	2019;109(12):934	PROPN
ajlm-2519	187	6	.	.	PUNCT
ajlm-2519	188	1	https://doi.org/10.7196/samj.2019.v109i12.14079	https://doi.org/10.7196/samj.2019.v109i12.14079	PROPN
ajlm-2519	188	2	perovic	perovic	ADJ
ajlm-2519	188	3	o	o	PROPN
ajlm-2519	188	4	,	,	PUNCT
ajlm-2519	188	5	duse	duse	PROPN
ajlm-2519	188	6	a	a	PRON
ajlm-2519	188	7	,	,	PUNCT
ajlm-2519	188	8	chibabhai	chibabhai	PROPN
ajlm-2519	188	9	v	v	PROPN
ajlm-2519	188	10	,	,	PUNCT
ajlm-2519	188	11	et	et	PROPN
ajlm-2519	188	12	al	al	PROPN
ajlm-2519	188	13	.	.	PROPN
ajlm-2519	189	1	acinetobacter	acinetobacter	PROPN
ajlm-2519	189	2	baumannii	baumannii	PROPN
ajlm-2519	189	3	complex	complex	ADJ
ajlm-2519	189	4	,	,	PUNCT
ajlm-2519	189	5	national	national	ADJ
ajlm-2519	189	6	laboratory	laboratory	NOUN
ajlm-2519	189	7	-	-	PUNCT
ajlm-2519	189	8	based	base	VERB
ajlm-2519	189	9	surveillance	surveillance	NOUN
ajlm-2519	189	10	in	in	ADP
ajlm-2519	189	11	south	south	PROPN
ajlm-2519	189	12	africa	africa	PROPN
ajlm-2519	189	13	,	,	PUNCT
ajlm-2519	189	14	2017	2017	NUM
ajlm-2519	189	15	to	to	ADP
ajlm-2519	189	16	2019	2019	NUM
ajlm-2519	189	17	.	.	PUNCT
ajlm-2519	190	1	plos	plos	PROPN
ajlm-2519	190	2	one	one	NUM
ajlm-2519	190	3	.	.	PUNCT
ajlm-2519	191	1	2024;17(8):e0271355	2024;17(8):e0271355	NUM
ajlm-2519	191	2	.	.	PUNCT
ajlm-2519	191	3	https://doi.org/10.1371/journal.pone.0271355	https://doi.org/10.1371/journal.pone.0271355	VERB
ajlm-2519	191	4	singh	singh	ADJ
ajlm-2519	191	5	-	-	PUNCT
ajlm-2519	191	6	moodley	moodley	NOUN
ajlm-2519	191	7	a	a	NOUN
ajlm-2519	191	8	,	,	PUNCT
ajlm-2519	191	9	duse	duse	PROPN
ajlm-2519	191	10	a	a	PRON
ajlm-2519	191	11	,	,	PUNCT
ajlm-2519	191	12	naicker	naicker	NOUN
ajlm-2519	191	13	p	p	NOUN
ajlm-2519	191	14	,	,	PUNCT
ajlm-2519	191	15	et	et	PROPN
ajlm-2519	191	16	al	al	PROPN
ajlm-2519	191	17	.	.	PROPN
ajlm-2519	191	18	laboratory	laboratory	PROPN
ajlm-2519	191	19	based	base	VERB
ajlm-2519	191	20	antimicrobial	antimicrobial	ADJ
ajlm-2519	191	21	resistance	resistance	NOUN
ajlm-2519	191	22	surveillance	surveillance	NOUN
ajlm-2519	191	23	for	for	ADP
ajlm-2519	191	24	pseudomonas	pseudomona	NOUN
ajlm-2519	191	25	aeruginosa	aeruginosa	NOUN
ajlm-2519	191	26	blood	blood	NOUN
ajlm-2519	191	27	isolates	isolate	NOUN
ajlm-2519	191	28	from	from	ADP
ajlm-2519	191	29	south	south	PROPN
ajlm-2519	191	30	africa	africa	PROPN
ajlm-2519	191	31	.	.	PUNCT
ajlm-2519	192	1	j	j	PROPN
ajlm-2519	192	2	infect	infect	PROPN
ajlm-2519	192	3	dev	dev	PROPN
ajlm-2519	192	4	ctries	ctrie	NOUN
ajlm-2519	192	5	.	.	PUNCT
ajlm-2519	193	1	2018;12(8):616–624	2018;12(8):616–624	X
ajlm-2519	193	2	.	.	PUNCT
ajlm-2519	193	3	https://doi.org/10.3855/jidc.9539	https://doi.org/10.3855/jidc.9539	NOUN
ajlm-2519	193	4	lebea	lebea	PROPN
ajlm-2519	193	5	m	m	PROPN
ajlm-2519	193	6	,	,	PUNCT
ajlm-2519	193	7	davies	davy	NOUN
ajlm-2519	193	8	v.	v.	ADP
ajlm-2519	193	9	evaluation	evaluation	NOUN
ajlm-2519	193	10	of	of	ADP
ajlm-2519	193	11	culture	culture	NOUN
ajlm-2519	193	12	-	-	PUNCT
ajlm-2519	193	13	proven	prove	VERB
ajlm-2519	193	14	neonatal	neonatal	ADJ
ajlm-2519	193	15	sepsis	sepsis	NOUN
ajlm-2519	193	16	at	at	ADP
ajlm-2519	193	17	a	a	DET
ajlm-2519	193	18	tertiary	tertiary	ADJ
ajlm-2519	193	19	care	care	NOUN
ajlm-2519	193	20	hospital	hospital	NOUN
ajlm-2519	193	21	in	in	ADP
ajlm-2519	193	22	south	south	PROPN
ajlm-2519	193	23	africa	africa	PROPN
ajlm-2519	193	24	.	.	PUNCT
ajlm-2519	194	1	s	s	PROPN
ajlm-2519	194	2	afr	afr	PROPN
ajlm-2519	194	3	j	j	PROPN
ajlm-2519	194	4	child	child	PROPN
ajlm-2519	194	5	health	health	PROPN
ajlm-2519	195	1	[	[	X
ajlm-2519	195	2	serial	serial	ADJ
ajlm-2519	195	3	online	online	NOUN
ajlm-2519	195	4	]	]	PUNCT
ajlm-2519	195	5	.	.	PUNCT
ajlm-2519	196	1	2017;11(4):170–173	2017;11(4):170–173	NUM
ajlm-2519	197	1	[	[	X
ajlm-2519	197	2	cited	cite	VERB
ajlm-2519	197	3	2023	2023	NUM
ajlm-2519	197	4	may	may	PROPN
ajlm-2519	197	5	23	23	NUM
ajlm-2519	197	6	]	]	PUNCT
ajlm-2519	197	7	.	.	PUNCT
ajlm-2519	198	1	available	available	ADJ
ajlm-2519	198	2	from	from	ADP
ajlm-2519	198	3	:	:	PUNCT
ajlm-2519	198	4	http://www.sajch.org.za/index.php/sajch/article/view/1395	http://www.sajch.org.za/index.php/sajch/article/view/1395	NOUN
ajlm-2519	198	5	lochan	lochan	PROPN
ajlm-2519	198	6	h	h	PROPN
ajlm-2519	198	7	,	,	PUNCT
ajlm-2519	198	8	pillay	pillay	PROPN
ajlm-2519	198	9	v.	v.	ADP
ajlm-2519	198	10	bloodstream	bloodstream	NOUN
ajlm-2519	198	11	infections	infection	NOUN
ajlm-2519	198	12	at	at	ADP
ajlm-2519	198	13	a	a	DET
ajlm-2519	198	14	tertiary	tertiary	ADJ
ajlm-2519	198	15	level	level	NOUN
ajlm-2519	198	16	paediatric	paediatric	ADJ
ajlm-2519	198	17	hospital	hospital	NOUN
ajlm-2519	198	18	in	in	ADP
ajlm-2519	198	19	south	south	PROPN
ajlm-2519	198	20	africa	africa	PROPN
ajlm-2519	198	21	.	.	PUNCT
ajlm-2519	199	1	bmc	bmc	PROPN
ajlm-2519	199	2	infect	infect	PROPN
ajlm-2519	199	3	dis	dis	PROPN
ajlm-2519	199	4	.	.	PUNCT
ajlm-2519	200	1	2017;17(1):750	2017;17(1):750	NUM
ajlm-2519	200	2	.	.	PUNCT
ajlm-2519	201	1	https://doi.org/10.1186/s12879-017-2862-2	https://doi.org/10.1186/s12879-017-2862-2	PROPN
ajlm-2519	201	2	pillay	pillay	PROPN
ajlm-2519	201	3	d	d	PROPN
ajlm-2519	201	4	,	,	PUNCT
ajlm-2519	201	5	naidoo	naidoo	PROPN
ajlm-2519	201	6	l	l	PROPN
ajlm-2519	201	7	,	,	PUNCT
ajlm-2519	201	8	swe	swe	PROPN
ajlm-2519	201	9	swe	swe	PROPN
ajlm-2519	201	10	-	-	PUNCT
ajlm-2519	201	11	han	han	PROPN
ajlm-2519	201	12	k	k	PROPN
ajlm-2519	201	13	,	,	PUNCT
ajlm-2519	201	14	mahabeer	mahabeer	NOUN
ajlm-2519	201	15	y.	y.	NOUN
ajlm-2519	201	16	neonatal	neonatal	ADJ
ajlm-2519	201	17	sepsis	sepsis	NOUN
ajlm-2519	201	18	in	in	ADP
ajlm-2519	201	19	a	a	DET
ajlm-2519	201	20	tertiary	tertiary	ADJ
ajlm-2519	201	21	unit	unit	NOUN
ajlm-2519	201	22	in	in	ADP
ajlm-2519	201	23	south	south	PROPN
ajlm-2519	201	24	africa	africa	PROPN
ajlm-2519	201	25	.	.	PUNCT
ajlm-2519	202	1	bmc	bmc	PROPN
ajlm-2519	202	2	infect	infect	PROPN
ajlm-2519	202	3	dis	dis	PROPN
ajlm-2519	202	4	.	.	PUNCT
ajlm-2519	203	1	2021;21(1):225	2021;21(1):225	NUM
ajlm-2519	203	2	.	.	PUNCT
ajlm-2519	204	1	https://doi.org/10.1186/s12879-021-05869-3	https://doi.org/10.1186/s12879-021-05869-3	PROPN
ajlm-2519	205	1	reddy	reddy	PROPN
ajlm-2519	205	2	k	k	PROPN
ajlm-2519	205	3	,	,	PUNCT
ajlm-2519	205	4	bekker	bekker	PROPN
ajlm-2519	205	5	a	a	PROPN
ajlm-2519	205	6	,	,	PUNCT
ajlm-2519	205	7	whitelaw	whitelaw	PROPN
ajlm-2519	205	8	ac	ac	PROPN
ajlm-2519	205	9	,	,	PUNCT
ajlm-2519	205	10	esterhuizen	esterhuizen	PROPN
ajlm-2519	205	11	tm	tm	NOUN
ajlm-2519	205	12	,	,	PUNCT
ajlm-2519	205	13	dramowski	dramowski	NOUN
ajlm-2519	205	14	a.	a.	NOUN
ajlm-2519	205	15	a	a	DET
ajlm-2519	205	16	retrospective	retrospective	ADJ
ajlm-2519	205	17	analysis	analysis	NOUN
ajlm-2519	205	18	of	of	ADP
ajlm-2519	205	19	pathogen	pathogen	NOUN
ajlm-2519	205	20	profile	profile	NOUN
ajlm-2519	205	21	,	,	PUNCT
ajlm-2519	205	22	antimicrobial	antimicrobial	ADJ
ajlm-2519	205	23	resistance	resistance	NOUN
ajlm-2519	205	24	and	and	CCONJ
ajlm-2519	205	25	mortality	mortality	NOUN
ajlm-2519	205	26	in	in	ADP
ajlm-2519	205	27	neonatal	neonatal	ADJ
ajlm-2519	205	28	hospital	hospital	NOUN
ajlm-2519	205	29	-	-	PUNCT
ajlm-2519	205	30	acquired	acquire	VERB
ajlm-2519	205	31	bloodstream	bloodstream	NOUN
ajlm-2519	205	32	infections	infection	NOUN
ajlm-2519	205	33	from	from	ADP
ajlm-2519	205	34	2009–2018	2009–2018	NUM
ajlm-2519	205	35	at	at	ADP
ajlm-2519	205	36	tygerberg	tygerberg	PROPN
ajlm-2519	205	37	hospital	hospital	PROPN
ajlm-2519	205	38	,	,	PUNCT
ajlm-2519	205	39	south	south	PROPN
ajlm-2519	205	40	africa	africa	PROPN
ajlm-2519	205	41	.	.	PUNCT
ajlm-2519	206	1	plos	plos	PROPN
ajlm-2519	206	2	one	one	NUM
ajlm-2519	206	3	.	.	PUNCT
ajlm-2519	207	1	2021;16(1):e0245089	2021;16(1):e0245089	NUM
ajlm-2519	207	2	.	.	PUNCT
ajlm-2519	208	1	https://doi.org/10.1371/journal.pone.0245089	https://doi.org/10.1371/journal.pone.0245089	PROPN
ajlm-2519	208	2	national	national	PROPN
ajlm-2519	208	3	health	health	PROPN
ajlm-2519	208	4	laboratory	laboratory	PROPN
ajlm-2519	208	5	services	service	NOUN
ajlm-2519	208	6	.	.	PUNCT
ajlm-2519	209	1	academic	academic	ADJ
ajlm-2519	209	2	affairs	affair	NOUN
ajlm-2519	209	3	and	and	CCONJ
ajlm-2519	209	4	research	research	NOUN
ajlm-2519	209	5	:	:	PUNCT
ajlm-2519	209	6	scope	scope	NOUN
ajlm-2519	209	7	of	of	ADP
ajlm-2519	209	8	research	research	NOUN
ajlm-2519	210	1	[	[	X
ajlm-2519	210	2	homepage	homepage	NOUN
ajlm-2519	210	3	on	on	ADP
ajlm-2519	210	4	the	the	DET
ajlm-2519	210	5	internet	internet	NOUN
ajlm-2519	210	6	]	]	PUNCT
ajlm-2519	210	7	.	.	PUNCT
ajlm-2519	211	1	2019	2019	NUM
ajlm-2519	212	1	[	[	X
ajlm-2519	212	2	cited	cite	VERB
ajlm-2519	212	3	2023	2023	NUM
ajlm-2519	212	4	may	may	PROPN
ajlm-2519	212	5	23	23	NUM
ajlm-2519	212	6	]	]	PUNCT
ajlm-2519	212	7	available	available	ADJ
ajlm-2519	212	8	from	from	ADP
ajlm-2519	212	9	:	:	PUNCT
ajlm-2519	212	10	https://www.nhls.ac.za/services/research/scope-of-research/	https://www.nhls.ac.za/services/research/scope-of-research/	PROPN
ajlm-2519	212	11	national	national	PROPN
ajlm-2519	212	12	department	department	PROPN
ajlm-2519	212	13	of	of	ADP
ajlm-2519	212	14	health	health	PROPN
ajlm-2519	212	15	(	(	PUNCT
ajlm-2519	212	16	south	south	PROPN
ajlm-2519	212	17	africa	africa	PROPN
ajlm-2519	212	18	)	)	PUNCT
ajlm-2519	212	19	.	.	PUNCT
ajlm-2519	213	1	limpopo	limpopo	PROPN
ajlm-2519	213	2	central	central	ADJ
ajlm-2519	213	3	hospital	hospital	PROPN
ajlm-2519	213	4	feasibility	feasibility	NOUN
ajlm-2519	213	5	report	report	NOUN
ajlm-2519	213	6	2018	2018	NUM
ajlm-2519	214	1	[	[	X
ajlm-2519	214	2	homepage	homepage	NOUN
ajlm-2519	214	3	on	on	ADP
ajlm-2519	214	4	the	the	DET
ajlm-2519	214	5	internet	internet	NOUN
ajlm-2519	214	6	]	]	PUNCT
ajlm-2519	214	7	.	.	PUNCT
ajlm-2519	214	8	2018	2018	NUM
ajlm-2519	215	1	[	[	X
ajlm-2519	215	2	cited	cite	VERB
ajlm-2519	215	3	2023	2023	NUM
ajlm-2519	215	4	dec	dec	PROPN
ajlm-2519	215	5	27	27	NUM
ajlm-2519	215	6	]	]	PUNCT
ajlm-2519	215	7	.	.	PUNCT
ajlm-2519	216	1	available	available	ADJ
ajlm-2519	216	2	from	from	ADP
ajlm-2519	216	3	:	:	PUNCT
ajlm-2519	216	4	https://sahris.sahra.org.za/sites/default/files/additionaldocs/appendix%20i%20complete.pdf	https://sahris.sahra.org.za/sites/default/files/additionaldocs/appendix%20i%20complete.pdf	PROPN
ajlm-2519	216	5	national	national	PROPN
ajlm-2519	216	6	health	health	PROPN
ajlm-2519	216	7	laboratory	laboratory	PROPN
ajlm-2519	216	8	services	services	PROPN
ajlm-2519	216	9	.	.	PUNCT
ajlm-2519	217	1	nhls	nhls	PROPN
ajlm-2519	217	2	handbook	handbook	PROPN
ajlm-2519	218	1	[	[	X
ajlm-2519	218	2	homepage	homepage	NOUN
ajlm-2519	218	3	on	on	ADP
ajlm-2519	218	4	the	the	DET
ajlm-2519	218	5	internet	internet	NOUN
ajlm-2519	218	6	]	]	PUNCT
ajlm-2519	218	7	.	.	PUNCT
ajlm-2519	218	8	2018	2018	NUM
ajlm-2519	219	1	[	[	X
ajlm-2519	219	2	cited	cite	VERB
ajlm-2519	219	3	2024	2024	NUM
ajlm-2519	219	4	may	may	AUX
ajlm-2519	219	5	15	15	NUM
ajlm-2519	219	6	]	]	PUNCT
ajlm-2519	219	7	.	.	PUNCT
ajlm-2519	220	1	available	available	ADJ
ajlm-2519	220	2	from	from	ADP
ajlm-2519	220	3	:	:	PUNCT
ajlm-2519	220	4	https://health.uct.ac.za/sites/default/files/media/documents/health_uct_ac_za/358/nhls_handbook_2015.pdf	https://health.uct.ac.za/sites/default/files/media/documents/health_uct_ac_za/358/nhls_handbook_2015.pdf	PROPN
ajlm-2519	220	5	centers	center	NOUN
ajlm-2519	220	6	for	for	ADP
ajlm-2519	220	7	disease	disease	NOUN
ajlm-2519	220	8	prevention	prevention	NOUN
ajlm-2519	220	9	and	and	CCONJ
ajlm-2519	220	10	control	control	NOUN
ajlm-2519	220	11	.	.	PUNCT
ajlm-2519	221	1	antimicrobial	antimicrobial	ADJ
ajlm-2519	221	2	-	-	PUNCT
ajlm-2519	221	3	resistant	resistant	ADJ
ajlm-2519	221	4	phenotype	phenotype	NOUN
ajlm-2519	221	5	definitions	definition	NOUN
ajlm-2519	222	1	[	[	X
ajlm-2519	222	2	homepage	homepage	NOUN
ajlm-2519	222	3	on	on	ADP
ajlm-2519	222	4	the	the	DET
ajlm-2519	222	5	internet	internet	NOUN
ajlm-2519	222	6	]	]	PUNCT
ajlm-2519	222	7	.	.	PUNCT
ajlm-2519	223	1	2022	2022	NUM
ajlm-2519	224	1	[	[	X
ajlm-2519	224	2	cited	cite	VERB
ajlm-2519	224	3	2023	2023	NUM
ajlm-2519	224	4	jun	jun	PROPN
ajlm-2519	224	5	17	17	NUM
ajlm-2519	224	6	]	]	PUNCT
ajlm-2519	224	7	.	.	PUNCT
ajlm-2519	225	1	available	available	ADJ
ajlm-2519	225	2	from	from	ADP
ajlm-2519	225	3	:	:	PUNCT
ajlm-2519	225	4	https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/phenotype_definitions.pdf	https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/phenotype_definitions.pdf	PROPN
ajlm-2519	225	5	clinical	clinical	ADJ
ajlm-2519	225	6	&	&	CCONJ
ajlm-2519	225	7	laboratory	laboratory	PROPN
ajlm-2519	225	8	standards	standards	PROPN
ajlm-2519	225	9	institute	institute	PROPN
ajlm-2519	225	10	.	.	PUNCT
ajlm-2519	226	1	performance	performance	NOUN
ajlm-2519	226	2	standards	standard	NOUN
ajlm-2519	226	3	for	for	ADP
ajlm-2519	226	4	antimicrobial	antimicrobial	ADJ
ajlm-2519	226	5	susceptibility	susceptibility	NOUN
ajlm-2519	226	6	testing	testing	NOUN
ajlm-2519	226	7	.	.	PUNCT
ajlm-2519	227	1	29th	29th	ADJ
ajlm-2519	227	2	ed	ed	NOUN
ajlm-2519	227	3	.	.	PUNCT
ajlm-2519	228	1	wayne	wayne	PROPN
ajlm-2519	228	2	,	,	PUNCT
ajlm-2519	228	3	pa	pa	PROPN
ajlm-2519	228	4	:	:	PUNCT
ajlm-2519	228	5	m100	m100	PROPN
ajlm-2519	228	6	;	;	PUNCT
ajlm-2519	228	7	2019	2019	NUM
ajlm-2519	228	8	.	.	PUNCT
ajlm-2519	229	1	clinical	clinical	PROPN
ajlm-2519	229	2	&	&	CCONJ
ajlm-2519	229	3	laboratory	laboratory	PROPN
ajlm-2519	229	4	standards	standards	PROPN
ajlm-2519	229	5	institute	institute	PROPN
ajlm-2519	229	6	.	.	PUNCT
ajlm-2519	230	1	analysis	analysis	NOUN
ajlm-2519	230	2	and	and	CCONJ
ajlm-2519	230	3	presentation	presentation	NOUN
ajlm-2519	230	4	of	of	ADP
ajlm-2519	230	5	cumulative	cumulative	ADJ
ajlm-2519	230	6	antimicrobial	antimicrobial	ADJ
ajlm-2519	230	7	susceptibility	susceptibility	NOUN
ajlm-2519	230	8	test	test	NOUN
ajlm-2519	230	9	data	datum	NOUN
ajlm-2519	230	10	.	.	PUNCT
ajlm-2519	231	1	5th	5th	ADJ
ajlm-2519	231	2	ed	ed	NOUN
ajlm-2519	231	3	.	.	PUNCT
ajlm-2519	232	1	malvern	malvern	PROPN
ajlm-2519	232	2	,	,	PUNCT
ajlm-2519	232	3	pa	pa	PROPN
ajlm-2519	232	4	:	:	PUNCT
ajlm-2519	232	5	m39	m39	PROPN
ajlm-2519	232	6	;	;	PUNCT
ajlm-2519	232	7	2022	2022	NUM
ajlm-2519	232	8	.	.	PUNCT
ajlm-2519	233	1	pohlert	pohlert	NOUN
ajlm-2519	233	2	t.	t.	NOUN
ajlm-2519	233	3	trend	trend	NOUN
ajlm-2519	233	4	:	:	PUNCT
ajlm-2519	233	5	non	non	ADJ
ajlm-2519	233	6	-	-	ADJ
ajlm-2519	233	7	parametric	parametric	ADJ
ajlm-2519	233	8	trend	trend	NOUN
ajlm-2519	233	9	tests	test	NOUN
ajlm-2519	233	10	and	and	CCONJ
ajlm-2519	233	11	change	change	NOUN
ajlm-2519	233	12	-	-	PUNCT
ajlm-2519	233	13	point	point	NOUN
ajlm-2519	233	14	detection	detection	NOUN
ajlm-2519	234	1	[	[	X
ajlm-2519	234	2	homepage	homepage	NOUN
ajlm-2519	234	3	on	on	ADP
ajlm-2519	234	4	the	the	DET
ajlm-2519	234	5	internet	internet	NOUN
ajlm-2519	234	6	]	]	PUNCT
ajlm-2519	234	7	.	.	PUNCT
ajlm-2519	235	1	2023	2023	NUM
ajlm-2519	236	1	[	[	X
ajlm-2519	236	2	cited	cite	VERB
ajlm-2519	236	3	2024	2024	NUM
ajlm-2519	236	4	may	may	AUX
ajlm-2519	236	5	28	28	NUM
ajlm-2519	236	6	]	]	PUNCT
ajlm-2519	236	7	.	.	PUNCT
ajlm-2519	237	1	available	available	ADJ
ajlm-2519	237	2	from	from	ADP
ajlm-2519	237	3	:	:	PUNCT
ajlm-2519	237	4	https://cran.r-project.org/web/packages/trend/index.html	https://cran.r-project.org/web/packages/trend/index.html	PROPN
ajlm-2519	237	5	maweya	maweya	NOUN
ajlm-2519	237	6	s.	s.	PROPN
ajlm-2519	237	7	microbiological	microbiological	ADJ
ajlm-2519	237	8	profile	profile	NOUN
ajlm-2519	237	9	of	of	ADP
ajlm-2519	237	10	organisms	organism	NOUN
ajlm-2519	237	11	causing	cause	VERB
ajlm-2519	237	12	bloodstream	bloodstream	NOUN
ajlm-2519	237	13	infections	infection	NOUN
ajlm-2519	237	14	between	between	ADP
ajlm-2519	237	15	2004	2004	NUM
ajlm-2519	237	16	and	and	CCONJ
ajlm-2519	237	17	2016	2016	NUM
ajlm-2519	237	18	in	in	ADP
ajlm-2519	237	19	a	a	DET
ajlm-2519	237	20	tertiary	tertiary	ADJ
ajlm-2519	237	21	hospital	hospital	NOUN
ajlm-2519	237	22	limpopo	limpopo	PROPN
ajlm-2519	237	23	province	province	PROPN
ajlm-2519	237	24	south	south	PROPN
ajlm-2519	237	25	africa	africa	PROPN
ajlm-2519	238	1	[	[	X
ajlm-2519	238	2	homepage	homepage	NOUN
ajlm-2519	238	3	on	on	ADP
ajlm-2519	238	4	the	the	DET
ajlm-2519	238	5	internte	internte	NOUN
ajlm-2519	238	6	]	]	PUNCT
ajlm-2519	238	7	.	.	PUNCT
ajlm-2519	239	1	doctoral	doctoral	ADJ
ajlm-2519	239	2	dissertation	dissertation	NOUN
ajlm-2519	239	3	,	,	PUNCT
ajlm-2519	239	4	university	university	NOUN
ajlm-2519	239	5	of	of	ADP
ajlm-2519	239	6	pretoria	pretoria	PROPN
ajlm-2519	239	7	.	.	PROPN
ajlm-2519	239	8	2017	2017	NUM
ajlm-2519	239	9	.	.	PUNCT
ajlm-2519	240	1	[	[	X
ajlm-2519	240	2	cited	cite	VERB
ajlm-2519	240	3	2023	2023	NUM
ajlm-2519	240	4	nov	nov	NOUN
ajlm-2519	240	5	20	20	NUM
ajlm-2519	240	6	]	]	PUNCT
ajlm-2519	240	7	.	.	PUNCT
ajlm-2519	241	1	available	available	ADJ
ajlm-2519	241	2	from	from	ADP
ajlm-2519	241	3	:	:	PUNCT
ajlm-2519	241	4	https://repository.up.ac.za/bitstream/handle/2263/65837/maweya_microbiology_2017.pdf?sequence=1&isallowed=y	https://repository.up.ac.za/bitstream/handle/2263/65837/maweya_microbiology_2017.pdf?sequence=1&isallowed=y	PROPN
ajlm-2519	241	5	ramsamy	ramsamy	PROPN
ajlm-2519	241	6	y	y	PROPN
ajlm-2519	241	7	,	,	PUNCT
ajlm-2519	241	8	essack	essack	VERB
ajlm-2519	241	9	sy	sy	PROPN
ajlm-2519	241	10	,	,	PUNCT
ajlm-2519	241	11	sartorius	sartorius	NOUN
ajlm-2519	241	12	b	b	PROPN
ajlm-2519	241	13	,	,	PUNCT
ajlm-2519	241	14	patel	patel	PROPN
ajlm-2519	241	15	m	m	PROPN
ajlm-2519	241	16	,	,	PUNCT
ajlm-2519	241	17	mlisana	mlisana	PROPN
ajlm-2519	242	1	kp	kp	PROPN
ajlm-2519	242	2	.	.	PUNCT
ajlm-2519	243	1	antibiotic	antibiotic	ADJ
ajlm-2519	243	2	resistance	resistance	NOUN
ajlm-2519	243	3	trends	trend	NOUN
ajlm-2519	243	4	of	of	ADP
ajlm-2519	243	5	eskape	eskape	NOUN
ajlm-2519	243	6	pathogens	pathogen	NOUN
ajlm-2519	243	7	in	in	ADP
ajlm-2519	243	8	kwazulu	kwazulu	NOUN
ajlm-2519	243	9	-	-	PUNCT
ajlm-2519	243	10	natal	natal	ADJ
ajlm-2519	243	11	,	,	PUNCT
ajlm-2519	243	12	south	south	PROPN
ajlm-2519	243	13	africa	africa	PROPN
ajlm-2519	243	14	:	:	PUNCT
ajlm-2519	243	15	a	a	DET
ajlm-2519	243	16	five	five	NUM
ajlm-2519	243	17	-	-	PUNCT
ajlm-2519	243	18	year	year	NOUN
ajlm-2519	243	19	retrospective	retrospective	ADJ
ajlm-2519	243	20	analysis	analysis	NOUN
ajlm-2519	243	21	.	.	PUNCT
ajlm-2519	244	1	afr	afr	PROPN
ajlm-2519	244	2	j	j	PROPN
ajlm-2519	244	3	lab	lab	PROPN
ajlm-2519	244	4	med	me	VERB
ajlm-2519	244	5	.	.	PUNCT
ajlm-2519	245	1	2018;7(2):887	2018;7(2):887	X
ajlm-2519	245	2	.	.	PUNCT
ajlm-2519	245	3	https://doi.org/10.4102/ajlm.v7i2.887	https://doi.org/10.4102/ajlm.v7i2.887	PROPN
ajlm-2519	245	4	toh	toh	PROPN
ajlm-2519	245	5	hj	hj	PROPN
ajlm-2519	245	6	,	,	PUNCT
ajlm-2519	245	7	lim	lim	PROPN
ajlm-2519	245	8	zy	zy	PROPN
ajlm-2519	245	9	,	,	PUNCT
ajlm-2519	245	10	yap	yap	PROPN
ajlm-2519	245	11	p	p	X
ajlm-2519	245	12	,	,	PUNCT
ajlm-2519	245	13	tang	tang	ADJ
ajlm-2519	245	14	t.	t.	NOUN
ajlm-2519	245	15	factors	factor	NOUN
ajlm-2519	245	16	associated	associate	VERB
ajlm-2519	245	17	with	with	ADP
ajlm-2519	245	18	prolonged	prolonged	ADJ
ajlm-2519	245	19	length	length	NOUN
ajlm-2519	245	20	of	of	ADP
ajlm-2519	245	21	stay	stay	NOUN
ajlm-2519	245	22	in	in	ADP
ajlm-2519	245	23	older	old	ADJ
ajlm-2519	245	24	patients	patient	NOUN
ajlm-2519	245	25	.	.	PUNCT
ajlm-2519	246	1	singapore	singapore	PROPN
ajlm-2519	246	2	med	med	PROPN
ajlm-2519	246	3	j.	j.	PROPN
ajlm-2519	246	4	2017;58(3):134–138	2017;58(3):134–138	PROPN
ajlm-2519	246	5	.	.	PUNCT
ajlm-2519	247	1	https://doi.org/10.11622/smedj.2016158	https://doi.org/10.11622/smedj.2016158	PROPN
ajlm-2519	247	2	russell	russell	PROPN
ajlm-2519	247	3	nj	nj	PROPN
ajlm-2519	247	4	,	,	PUNCT
ajlm-2519	247	5	stöhr	stöhr	PROPN
ajlm-2519	247	6	w	w	PROPN
ajlm-2519	247	7	,	,	PUNCT
ajlm-2519	247	8	plakkal	plakkal	NOUN
ajlm-2519	247	9	n	n	CCONJ
ajlm-2519	247	10	,	,	PUNCT
ajlm-2519	247	11	et	et	PROPN
ajlm-2519	247	12	al	al	PROPN
ajlm-2519	247	13	.	.	PUNCT
ajlm-2519	247	14	patterns	pattern	NOUN
ajlm-2519	247	15	of	of	ADP
ajlm-2519	247	16	antibiotic	antibiotic	ADJ
ajlm-2519	247	17	use	use	NOUN
ajlm-2519	247	18	,	,	PUNCT
ajlm-2519	247	19	pathogens	pathogen	NOUN
ajlm-2519	247	20	,	,	PUNCT
ajlm-2519	247	21	and	and	CCONJ
ajlm-2519	247	22	prediction	prediction	NOUN
ajlm-2519	247	23	of	of	ADP
ajlm-2519	247	24	mortality	mortality	NOUN
ajlm-2519	247	25	in	in	ADP
ajlm-2519	247	26	hospitalized	hospitalize	VERB
ajlm-2519	247	27	neonates	neonate	NOUN
ajlm-2519	247	28	and	and	CCONJ
ajlm-2519	247	29	young	young	ADJ
ajlm-2519	247	30	infants	infant	NOUN
ajlm-2519	247	31	with	with	ADP
ajlm-2519	247	32	sepsis	sepsis	NOUN
ajlm-2519	247	33	:	:	PUNCT
ajlm-2519	247	34	a	a	DET
ajlm-2519	247	35	global	global	ADJ
ajlm-2519	247	36	neonatal	neonatal	ADJ
ajlm-2519	247	37	sepsis	sepsis	NOUN
ajlm-2519	247	38	observational	observational	ADJ
ajlm-2519	247	39	cohort	cohort	NOUN
ajlm-2519	247	40	study	study	NOUN
ajlm-2519	247	41	(	(	PUNCT
ajlm-2519	247	42	neoobs	neoobs	PROPN
ajlm-2519	247	43	)	)	PUNCT
ajlm-2519	247	44	.	.	PUNCT
ajlm-2519	248	1	plos	plos	PROPN
ajlm-2519	248	2	med	med	PROPN
ajlm-2519	248	3	.	.	PUNCT
ajlm-2519	249	1	2023;20(6):e1004179	2023;20(6):e1004179	X
ajlm-2519	249	2	.	.	PUNCT
ajlm-2519	250	1	https://doi.org/10.1371/journal.pmed.1004179	https://doi.org/10.1371/journal.pmed.1004179	PROPN
ajlm-2519	250	2	moema	moema	PROPN
ajlm-2519	251	1	i	i	PRON
ajlm-2519	251	2	,	,	PUNCT
ajlm-2519	251	3	shuping	shupe	VERB
ajlm-2519	251	4	l	l	NOUN
ajlm-2519	251	5	,	,	PUNCT
ajlm-2519	251	6	kuonza	kuonza	ADP
ajlm-2519	251	7	l	l	PROPN
ajlm-2519	251	8	,	,	PUNCT
ajlm-2519	251	9	perovic	perovic	ADJ
ajlm-2519	251	10	o.	o.	NOUN
ajlm-2519	251	11	blood	blood	NOUN
ajlm-2519	251	12	culture	culture	NOUN
ajlm-2519	251	13	specimen	speciman	NOUN
ajlm-2519	251	14	collection	collection	NOUN
ajlm-2519	251	15	practices	practice	NOUN
ajlm-2519	251	16	among	among	ADP
ajlm-2519	251	17	patients	patient	NOUN
ajlm-2519	251	18	with	with	ADP
ajlm-2519	251	19	suspected	suspect	VERB
ajlm-2519	251	20	bloodstream	bloodstream	NOUN
ajlm-2519	251	21	infections	infection	NOUN
ajlm-2519	251	22	at	at	ADP
ajlm-2519	251	23	an	an	DET
ajlm-2519	251	24	emergency	emergency	NOUN
ajlm-2519	251	25	department	department	NOUN
ajlm-2519	251	26	of	of	ADP
ajlm-2519	251	27	a	a	DET
ajlm-2519	251	28	tertiary	tertiary	ADJ
ajlm-2519	251	29	hospital	hospital	NOUN
ajlm-2519	251	30	in	in	ADP
ajlm-2519	251	31	johannesburg	johannesburg	PROPN
ajlm-2519	251	32	,	,	PUNCT
ajlm-2519	251	33	14–20	14–20	PROPN
ajlm-2519	251	34	june	june	PROPN
ajlm-2519	251	35	2018	2018	NUM
ajlm-2519	251	36	.	.	PUNCT
ajlm-2519	252	1	nicd	nicd	PROPN
ajlm-2519	252	2	bull	bull	PROPN
ajlm-2519	253	1	[	[	X
ajlm-2519	253	2	serial	serial	ADJ
ajlm-2519	253	3	online	online	NOUN
ajlm-2519	253	4	]	]	X
ajlm-2519	253	5	.	.	PUNCT
ajlm-2519	253	6	2018;18:14–20	2018;18:14–20	NUM
ajlm-2519	254	1	[	[	X
ajlm-2519	254	2	cited	cite	VERB
ajlm-2519	254	3	2023	2023	NUM
ajlm-2519	254	4	dec	dec	PROPN
ajlm-2519	254	5	27	27	NUM
ajlm-2519	254	6	]	]	PUNCT
ajlm-2519	254	7	.	.	PUNCT
ajlm-2519	255	1	available	available	ADJ
ajlm-2519	255	2	from	from	ADP
ajlm-2519	255	3	:	:	PUNCT
ajlm-2519	255	4	https://www.nicd.ac.za/wp-content/uploads/2020/06/blood-culture-specimen-collection-practices-among-patients-with-suspected-bloodstream-infections.pdf	https://www.nicd.ac.za/wp-content/uploads/2020/06/blood-culture-specimen-collection-practices-among-patients-with-suspected-bloodstream-infections.pdf	PROPN
ajlm-2519	255	5	majavie	majavie	PROPN
ajlm-2519	255	6	l	l	PROPN
ajlm-2519	255	7	,	,	PUNCT
ajlm-2519	255	8	johnston	johnston	PROPN
ajlm-2519	255	9	d	d	PROPN
ajlm-2519	255	10	,	,	PUNCT
ajlm-2519	255	11	messina	messina	PROPN
ajlm-2519	255	12	a.	a.	PROPN
ajlm-2519	255	13	a	a	DET
ajlm-2519	255	14	retrospective	retrospective	ADJ
ajlm-2519	255	15	review	review	NOUN
ajlm-2519	255	16	of	of	ADP
ajlm-2519	255	17	colistin	colistin	NOUN
ajlm-2519	255	18	utilisation	utilisation	NOUN
ajlm-2519	255	19	at	at	ADP
ajlm-2519	255	20	a	a	DET
ajlm-2519	255	21	tertiary	tertiary	ADJ
ajlm-2519	255	22	care	care	NOUN
ajlm-2519	255	23	academic	academic	ADJ
ajlm-2519	255	24	hospital	hospital	NOUN
ajlm-2519	255	25	in	in	ADP
ajlm-2519	255	26	south	south	PROPN
ajlm-2519	255	27	africa	africa	PROPN
ajlm-2519	255	28	.	.	PUNCT
ajlm-2519	256	1	s	s	AUX
ajlm-2519	256	2	afr	afr	PROPN
ajlm-2519	256	3	j	j	PROPN
ajlm-2519	256	4	infect	infect	PROPN
ajlm-2519	256	5	dis	dis	PROPN
ajlm-2519	256	6	.	.	PUNCT
ajlm-2519	256	7	2021;36(1):205	2021;36(1):205	PROPN
ajlm-2519	256	8	.	.	PUNCT
ajlm-2519	256	9	https://doi.org/10.4102/sajid.v36i1.205	https://doi.org/10.4102/sajid.v36i1.205	PROPN
ajlm-2519	256	10	mendelson	mendelson	PROPN
ajlm-2519	256	11	m	m	PROPN
ajlm-2519	256	12	,	,	PUNCT
ajlm-2519	256	13	brink	brink	VERB
ajlm-2519	256	14	a	a	PRON
ajlm-2519	256	15	,	,	PUNCT
ajlm-2519	256	16	gouws	gouw	VERB
ajlm-2519	256	17	j	j	PROPN
ajlm-2519	256	18	,	,	PUNCT
ajlm-2519	256	19	et	et	PROPN
ajlm-2519	256	20	al	al	PROPN
ajlm-2519	256	21	.	.	PUNCT
ajlm-2519	257	1	the	the	DET
ajlm-2519	257	2	one	one	NUM
ajlm-2519	257	3	health	health	NOUN
ajlm-2519	257	4	stewardship	stewardship	NOUN
ajlm-2519	257	5	of	of	ADP
ajlm-2519	257	6	colistin	colistin	PROPN
ajlm-2519	257	7	as	as	ADP
ajlm-2519	257	8	an	an	DET
ajlm-2519	257	9	antibiotic	antibiotic	NOUN
ajlm-2519	257	10	of	of	ADP
ajlm-2519	257	11	last	last	ADJ
ajlm-2519	257	12	resort	resort	NOUN
ajlm-2519	257	13	for	for	ADP
ajlm-2519	257	14	human	human	ADJ
ajlm-2519	257	15	health	health	NOUN
ajlm-2519	257	16	in	in	ADP
ajlm-2519	257	17	south	south	PROPN
ajlm-2519	257	18	africa	africa	PROPN
ajlm-2519	257	19	.	.	PUNCT
ajlm-2519	258	1	lancet	lancet	PROPN
ajlm-2519	258	2	infect	infect	PROPN
ajlm-2519	258	3	dis	dis	PROPN
ajlm-2519	258	4	.	.	PUNCT
ajlm-2519	259	1	2018;18(9):e288	2018;18(9):e288	NOUN
ajlm-2519	259	2	–	–	PUNCT
ajlm-2519	259	3	e294	e294	NUM
ajlm-2519	259	4	.	.	PUNCT
ajlm-2519	260	1	https://doi.org/10.1016/s1473-3099(18)30119-1	https://doi.org/10.1016/s1473-3099(18)30119-1	PROPN
ajlm-2519	260	2	brink	brink	PROPN
ajlm-2519	260	3	aj	aj	PROPN
ajlm-2519	260	4	,	,	PUNCT
ajlm-2519	260	5	bizos	bizos	PROPN
ajlm-2519	260	6	d	d	NOUN
ajlm-2519	260	7	,	,	PUNCT
ajlm-2519	260	8	boffard	boffard	VERB
ajlm-2519	260	9	kd	kd	PROPN
ajlm-2519	260	10	,	,	PUNCT
ajlm-2519	260	11	et	et	PROPN
ajlm-2519	260	12	al	al	PROPN
ajlm-2519	260	13	.	.	PROPN
ajlm-2519	260	14	guideline	guideline	PROPN
ajlm-2519	260	15	:	:	PUNCT
ajlm-2519	260	16	appropriate	appropriate	ADJ
ajlm-2519	260	17	use	use	NOUN
ajlm-2519	260	18	of	of	ADP
ajlm-2519	260	19	tigecycline	tigecycline	NOUN
ajlm-2519	260	20	.	.	PUNCT
ajlm-2519	261	1	s	s	AUX
ajlm-2519	261	2	afr	afr	PROPN
ajlm-2519	261	3	med	med	PROPN
ajlm-2519	261	4	j.	j.	PROPN
ajlm-2519	261	5	2010;100(6	2010;100(6	PROPN
ajlm-2519	261	6	pt	pt	PROPN
ajlm-2519	261	7	2):388–394	2):388–394	PROPN
ajlm-2519	261	8	.	.	PROPN
ajlm-2519	261	9	https://doi.org/10.7196/samj.4109	https://doi.org/10.7196/samj.4109	VERB
ajlm-2519	261	10	zha	zha	PROPN
ajlm-2519	261	11	l	l	PROPN
ajlm-2519	261	12	,	,	PUNCT
ajlm-2519	261	13	pan	pan	PROPN
ajlm-2519	261	14	l	l	PROPN
ajlm-2519	261	15	,	,	PUNCT
ajlm-2519	261	16	guo	guo	PROPN
ajlm-2519	261	17	j	j	PROPN
ajlm-2519	261	18	,	,	PUNCT
ajlm-2519	261	19	french	french	ADJ
ajlm-2519	261	20	n	n	CCONJ
ajlm-2519	261	21	,	,	PUNCT
ajlm-2519	261	22	villanueva	villanueva	PROPN
ajlm-2519	261	23	ev	ev	PROPN
ajlm-2519	261	24	,	,	PUNCT
ajlm-2519	261	25	tefsen	tefsen	PROPN
ajlm-2519	261	26	b.	b.	PROPN
ajlm-2519	261	27	effectiveness	effectiveness	PROPN
ajlm-2519	261	28	and	and	CCONJ
ajlm-2519	261	29	safety	safety	NOUN
ajlm-2519	261	30	of	of	ADP
ajlm-2519	261	31	high	high	ADJ
ajlm-2519	261	32	dose	dose	NOUN
ajlm-2519	261	33	tigecycline	tigecycline	NOUN
ajlm-2519	261	34	for	for	ADP
ajlm-2519	261	35	the	the	DET
ajlm-2519	261	36	treatment	treatment	NOUN
ajlm-2519	261	37	of	of	ADP
ajlm-2519	261	38	severe	severe	ADJ
ajlm-2519	261	39	infections	infection	NOUN
ajlm-2519	261	40	:	:	PUNCT
ajlm-2519	261	41	a	a	DET
ajlm-2519	261	42	systematic	systematic	ADJ
ajlm-2519	261	43	review	review	NOUN
ajlm-2519	261	44	and	and	CCONJ
ajlm-2519	261	45	meta	meta	ADJ
ajlm-2519	261	46	-	-	PUNCT
ajlm-2519	261	47	analysis	analysis	NOUN
ajlm-2519	261	48	.	.	PUNCT
ajlm-2519	262	1	adv	adv	INTJ
ajlm-2519	262	2	ther	ther	ADV
ajlm-2519	262	3	.	.	PUNCT
ajlm-2519	263	1	2020;37(3):1049–1064	2020;37(3):1049–1064	NUM
ajlm-2519	263	2	.	.	PUNCT
ajlm-2519	264	1	https://doi.org/10.1007/s12325-020-01235-y	https://doi.org/10.1007/s12325-020-01235-y	PROPN
ajlm-2519	264	2	cain	cain	PROPN
ajlm-2519	264	3	ak	ak	PROPN
ajlm-2519	264	4	,	,	PUNCT
ajlm-2519	264	5	hamidian	hamidian	ADJ
ajlm-2519	264	6	m.	m.	NOUN
ajlm-2519	264	7	portrait	portrait	NOUN
ajlm-2519	264	8	of	of	ADP
ajlm-2519	264	9	a	a	DET
ajlm-2519	264	10	killer	killer	NOUN
ajlm-2519	264	11	:	:	PUNCT
ajlm-2519	264	12	uncovering	uncover	VERB
ajlm-2519	264	13	resistance	resistance	NOUN
ajlm-2519	264	14	mechanisms	mechanism	NOUN
ajlm-2519	264	15	and	and	CCONJ
ajlm-2519	264	16	global	global	ADJ
ajlm-2519	264	17	spread	spread	NOUN
ajlm-2519	264	18	of	of	ADP
ajlm-2519	264	19	acinetobacter	acinetobacter	ADJ
ajlm-2519	264	20	baumannii	baumannii	PROPN
ajlm-2519	264	21	.	.	PUNCT
ajlm-2519	265	1	plos	plos	PROPN
ajlm-2519	265	2	pathog	pathog	PROPN
ajlm-2519	265	3	.	.	PUNCT
ajlm-2519	266	1	2023;19(8):e1011520	2023;19(8):e1011520	NUM
ajlm-2519	266	2	.	.	PUNCT
ajlm-2519	267	1	https://doi.org/10.1371/journal.ppat.1011520	https://doi.org/10.1371/journal.ppat.1011520	PROPN
ajlm-2519	267	2	world	world	PROPN
ajlm-2519	267	3	health	health	PROPN
ajlm-2519	267	4	organization	organization	PROPN
ajlm-2519	267	5	.	.	PUNCT
ajlm-2519	268	1	world	world	PROPN
ajlm-2519	268	2	health	health	PROPN
ajlm-2519	268	3	statistics	statistic	NOUN
ajlm-2519	268	4	2023	2023	NUM
ajlm-2519	269	1	[	[	X
ajlm-2519	269	2	homepage	homepage	NOUN
ajlm-2519	269	3	on	on	ADP
ajlm-2519	269	4	the	the	DET
ajlm-2519	269	5	internet	internet	NOUN
ajlm-2519	269	6	]	]	PUNCT
ajlm-2519	269	7	.	.	PUNCT
ajlm-2519	270	1	2023	2023	NUM
ajlm-2519	271	1	[	[	X
ajlm-2519	271	2	cited	cite	VERB
ajlm-2519	271	3	2023	2023	NUM
ajlm-2519	271	4	nov	nov	NOUN
ajlm-2519	271	5	27	27	NUM
ajlm-2519	271	6	]	]	PUNCT
ajlm-2519	271	7	.	.	PUNCT
ajlm-2519	272	1	available	available	ADJ
ajlm-2519	272	2	from	from	ADP
ajlm-2519	272	3	:	:	PUNCT
ajlm-2519	272	4	https://www.who.int/publications/i/item/9789240074323	https://www.who.int/publications/i/item/9789240074323	PROPN
ajlm-2519	272	5	segal	segal	PROPN
ajlm-2519	272	6	b	b	PROPN
ajlm-2519	272	7	,	,	PUNCT
ajlm-2519	272	8	langham	langham	PROPN
ajlm-2519	272	9	a	a	PRON
ajlm-2519	272	10	,	,	PUNCT
ajlm-2519	272	11	klevansky	klevansky	ADJ
ajlm-2519	272	12	r	r	NOUN
ajlm-2519	272	13	,	,	PUNCT
ajlm-2519	272	14	et	et	PROPN
ajlm-2519	272	15	al	al	PROPN
ajlm-2519	272	16	.	.	PUNCT
ajlm-2519	273	1	analysis	analysis	NOUN
ajlm-2519	273	2	of	of	ADP
ajlm-2519	273	3	the	the	DET
ajlm-2519	273	4	trends	trend	NOUN
ajlm-2519	273	5	of	of	ADP
ajlm-2519	273	6	methicillin	methicillin	NOUN
ajlm-2519	273	7	-	-	PUNCT
ajlm-2519	273	8	resistant	resistant	ADJ
ajlm-2519	273	9	staphylococcus	staphylococcus	NOUN
ajlm-2519	273	10	aureus	aureus	NOUN
ajlm-2519	273	11	in	in	ADP
ajlm-2519	273	12	gauteng	gauteng	PROPN
ajlm-2519	273	13	public	public	ADJ
ajlm-2519	273	14	hospitals	hospital	NOUN
ajlm-2519	273	15	from	from	ADP
ajlm-2519	273	16	2009	2009	NUM
ajlm-2519	273	17	to	to	ADP
ajlm-2519	273	18	2018	2018	NUM
ajlm-2519	273	19	.	.	PUNCT
ajlm-2519	274	1	microbiol	microbiol	PROPN
ajlm-2519	274	2	spectr	spectr	PROPN
ajlm-2519	274	3	.	.	PUNCT
ajlm-2519	275	1	2023;11(4):e0362322	2023;11(4):e0362322	X
ajlm-2519	275	2	.	.	PUNCT
ajlm-2519	276	1	https://doi.org/10.1128/spectrum.03623-22	https://doi.org/10.1128/spectrum.03623-22	PROPN
ajlm-2519	276	2	world	world	PROPN
ajlm-2519	276	3	health	health	PROPN
ajlm-2519	276	4	organization	organization	PROPN
ajlm-2519	276	5	.	.	PUNCT
ajlm-2519	277	1	indicator	indicator	PROPN
ajlm-2519	277	2	3.d.2	3.d.2	NOUN
ajlm-2519	277	3	:	:	PUNCT
ajlm-2519	277	4	proportion	proportion	NOUN
ajlm-2519	277	5	of	of	ADP
ajlm-2519	277	6	bloodstream	bloodstream	NOUN
ajlm-2519	277	7	infections	infection	NOUN
ajlm-2519	277	8	due	due	ADJ
ajlm-2519	277	9	to	to	ADP
ajlm-2519	277	10	selected	select	VERB
ajlm-2519	277	11	antimicrobial	antimicrobial	ADJ
ajlm-2519	277	12	-	-	PUNCT
ajlm-2519	277	13	resistant	resistant	ADJ
ajlm-2519	277	14	organisms	organism	NOUN
ajlm-2519	277	15	(	(	PUNCT
ajlm-2519	277	16	%	%	INTJ
ajlm-2519	277	17	)	)	PUNCT
ajlm-2519	278	1	[	[	X
ajlm-2519	278	2	homepage	homepage	NOUN
ajlm-2519	278	3	on	on	ADP
ajlm-2519	278	4	the	the	DET
ajlm-2519	278	5	internet	internet	NOUN
ajlm-2519	278	6	]	]	PUNCT
ajlm-2519	278	7	.	.	PUNCT
ajlm-2519	278	8	2023	2023	NUM
ajlm-2519	279	1	[	[	X
ajlm-2519	279	2	cited	cite	VERB
ajlm-2519	279	3	2023	2023	NUM
ajlm-2519	279	4	jun	jun	PROPN
ajlm-2519	279	5	18	18	NUM
ajlm-2519	279	6	]	]	PUNCT
ajlm-2519	279	7	.	.	PUNCT
ajlm-2519	280	1	available	available	ADJ
ajlm-2519	280	2	from	from	ADP
ajlm-2519	280	3	:	:	PUNCT
ajlm-2519	280	4	https://www.who.int/data/gho/indicator-metadata-registry/imr-details/5751	https://www.who.int/data/gho/indicator-metadata-registry/imr-details/5751	NOUN
ajlm-2519	280	5	simner	simner	PROPN
ajlm-2519	280	6	pj	pj	PROPN
ajlm-2519	280	7	,	,	PUNCT
ajlm-2519	280	8	hindler	hindler	PROPN
ajlm-2519	280	9	ja	ja	PROPN
ajlm-2519	280	10	,	,	PUNCT
ajlm-2519	280	11	bhowmick	bhowmick	PROPN
ajlm-2519	280	12	t	t	PROPN
ajlm-2519	280	13	,	,	PUNCT
ajlm-2519	280	14	et	et	PROPN
ajlm-2519	280	15	al	al	PROPN
ajlm-2519	280	16	.	.	PUNCT
ajlm-2519	281	1	what	what	PRON
ajlm-2519	281	2	’s	’	VERB
ajlm-2519	281	3	new	new	ADJ
ajlm-2519	281	4	in	in	ADP
ajlm-2519	281	5	antibiograms	antibiogram	NOUN
ajlm-2519	281	6	?	?	PUNCT
ajlm-2519	282	1	updating	update	VERB
ajlm-2519	282	2	clsi	clsi	NOUN
ajlm-2519	282	3	m39	m39	NOUN
ajlm-2519	282	4	guidance	guidance	NOUN
ajlm-2519	282	5	with	with	ADP
ajlm-2519	282	6	current	current	ADJ
ajlm-2519	282	7	trends	trend	NOUN
ajlm-2519	282	8	.	.	PUNCT
ajlm-2519	283	1	j	j	PROPN
ajlm-2519	283	2	clin	clin	PROPN
ajlm-2519	283	3	microbiol	microbiol	PROPN
ajlm-2519	283	4	.	.	PUNCT
ajlm-2519	284	1	2022;60(10):e0221021	2022;60(10):e0221021	NUM
ajlm-2519	284	2	.	.	PUNCT
ajlm-2519	285	1	https://doi.org/10.1128/jcm.02210-21	https://doi.org/10.1128/jcm.02210-21	NOUN
ajlm-2519	285	2	dramowski	dramowski	VERB
ajlm-2519	285	3	a	a	X
ajlm-2519	285	4	,	,	PUNCT
ajlm-2519	285	5	cotton	cotton	NOUN
ajlm-2519	285	6	mf	mf	NOUN
ajlm-2519	285	7	,	,	PUNCT
ajlm-2519	285	8	rabie	rabie	PROPN
ajlm-2519	285	9	h	h	PROPN
ajlm-2519	285	10	,	,	PUNCT
ajlm-2519	285	11	whitelaw	whitelaw	PROPN
ajlm-2519	285	12	a.	a.	NOUN
ajlm-2519	285	13	trends	trend	NOUN
ajlm-2519	285	14	in	in	ADP
ajlm-2519	285	15	paediatric	paediatric	ADJ
ajlm-2519	285	16	bloodstream	bloodstream	NOUN
ajlm-2519	285	17	infections	infection	NOUN
ajlm-2519	285	18	at	at	ADP
ajlm-2519	285	19	a	a	DET
ajlm-2519	285	20	south	south	ADJ
ajlm-2519	285	21	african	african	ADJ
ajlm-2519	285	22	referral	referral	ADJ
ajlm-2519	285	23	hospital	hospital	NOUN
ajlm-2519	285	24	.	.	PUNCT
ajlm-2519	286	1	bmc	bmc	ADJ
ajlm-2519	286	2	pediatr	pediatr	NOUN
ajlm-2519	286	3	.	.	PUNCT
ajlm-2519	287	1	2015;15:33	2015;15:33	NUM
ajlm-2519	287	2	.	.	PUNCT
ajlm-2519	288	1	https://doi.org/10.1186/s12887-015-0354-3	https://doi.org/10.1186/s12887-015-0354-3	PROPN
ajlm-2519	288	2	thomas	thomas	PROPN
ajlm-2519	288	3	r	r	PROPN
ajlm-2519	288	4	,	,	PUNCT
ajlm-2519	288	5	ondongo	ondongo	PROPN
ajlm-2519	288	6	-	-	PUNCT
ajlm-2519	288	7	ezhet	ezhet	NOUN
ajlm-2519	288	8	c	c	PROPN
ajlm-2519	288	9	,	,	PUNCT
ajlm-2519	288	10	motsoaledi	motsoaledi	PROPN
ajlm-2519	288	11	n	n	CCONJ
ajlm-2519	288	12	,	,	PUNCT
ajlm-2519	288	13	et	et	PROPN
ajlm-2519	288	14	al	al	PROPN
ajlm-2519	288	15	.	.	PROPN
ajlm-2519	288	16	incidence	incidence	NOUN
ajlm-2519	288	17	,	,	PUNCT
ajlm-2519	288	18	pathogens	pathogen	NOUN
ajlm-2519	288	19	and	and	CCONJ
ajlm-2519	288	20	antimicrobial	antimicrobial	ADJ
ajlm-2519	288	21	resistance	resistance	NOUN
ajlm-2519	288	22	of	of	ADP
ajlm-2519	288	23	blood	blood	NOUN
ajlm-2519	288	24	and	and	CCONJ
ajlm-2519	288	25	cerebrospinal	cerebrospinal	ADJ
ajlm-2519	288	26	fluid	fluid	NOUN
ajlm-2519	288	27	isolates	isolate	NOUN
ajlm-2519	288	28	from	from	ADP
ajlm-2519	288	29	a	a	DET
ajlm-2519	288	30	tertiary	tertiary	ADJ
ajlm-2519	288	31	neonatal	neonatal	ADJ
ajlm-2519	288	32	unit	unit	NOUN
ajlm-2519	288	33	in	in	ADP
ajlm-2519	288	34	south	south	PROPN
ajlm-2519	288	35	africa	africa	PROPN
ajlm-2519	288	36	:	:	PUNCT
ajlm-2519	288	37	a	a	DET
ajlm-2519	288	38	10	10	NUM
ajlm-2519	288	39	year	year	NOUN
ajlm-2519	288	40	retrospective	retrospective	ADJ
ajlm-2519	288	41	review	review	NOUN
ajlm-2519	288	42	.	.	PUNCT
ajlm-2519	289	1	plos	plos	PROPN
ajlm-2519	289	2	one	one	NUM
ajlm-2519	289	3	.	.	PUNCT
ajlm-2519	290	1	2024;19(1):e0297371	2024;19(1):e0297371	NUM
ajlm-2519	290	2	.	.	PUNCT
ajlm-2519	291	1	https://doi.org/10.1371/journal.pone.0297371	https://doi.org/10.1371/journal.pone.0297371	PROPN